cell_line_id,drug_id,response
OAW28,24964624,1.7856613849766505
NCI-H209,31703,-2.6785826900423206
SNU-423,selumetinib-vorinostat (8-1 mol-mol),2.465169855614971
SNU-119,9549297,4.628289370369748
SK-UT-1,10427712,4.800550596191128
KYSE-450,246676,4.496442396396831
SF539,10113978,1.3805891441937308
PF-382,12003241,-3.7051147214471114
ESS-1,11719255,3.627821400565806
Kasumi-2,9911830,1.88551459110434
KMS-12-BM,67291369,0.9867493208502254
LXF 289,56946209,-4.292268406284497
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076
HSC-3,159324,3.228445723809223
KMRC-20,selumetinib-piperlongumine (8-1 mol-mol),4.530795169334645
Ri-1,23635314,-2.3371584217228705
CML-T1,54618164,3.634689828068523
SK-UT-1,alisertib-navitoclax (2-1 mol-mol),3.539585462588412
KMS-12-BM,1242560,1.8091985739591805
ChaGo-K-1,navitoclax-pluripotin (1-1 mol-mol),0.8945727615491715
Mono-Mac-1,3025986,-1.3623567960722094
KYSE-180,selumetinib-vorinostat (8-1 mol-mol),4.1823671735531835
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
ESS-1,72734382,4.922090373409711
Kasumi-2,156414,1.0465549823430256
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
MIA PaCa-2,3136844,3.9100198187620223
RERF-LC-MS,375860,-0.2896823379882159
RKN,71304818,2.008207131108322
RERF-LC-MS,16736978,2.30801467798398
PE/CA-PJ41 (clone D2),4788,5.9726689722253
H-STS,carboplatin-etoposide (40-17 mol-mol),0.1150499890044187
Namalwa,42642645,0.3352240740036911
LXF 289,10231331,2.4249622135671824
KYSE-180,6610216,4.857625528938267
Mono-Mac-1,44137675,2.169476353998281
PE/CA-PJ41 (clone D2),5470400,1.7243098995077355
ChaGo-K-1,702558,5.016721785533269
AsPC-1,72734382,6.119259394736332
NCI-H1339,12003241,0.6707609457385758
Namalwa,12003241,-3.0032452893334596
BT 320,71729975,3.655690084257896
SNU-119,135440466,2.0351079961049905
RKN,31703,-0.7196573309741882
Becker,3384730,3.8286453062751233
AU565,1242560,3.5510894145829286
ACC-MESO-1,10385095,1.944189744357827
IST-Mes1,123631,3.330483874726673
SNU-119,984333,1.4760065970514793
RKN,9840324,5.059199694090175
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
AsPC-1,4705,5.582464580618905
H-STS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.187355615985605
HuT 78,445091,4.391722157853981
SK-MEL-5,3634881,3.4834319791934973
RT-4,SNX-2112-bortezomib (250-1 mol-mol),-1.6895298123650488
BT 248,135999136,1.3787773380664552
KMS-12-BM,selumetinib-tretinoin (2-1 mol-mol),1.12843511460163
BFTC-909,9826308,0.9467806471528852
HEC-108,5311,1.8736355088080991
Namalwa,doxorubicin-navitoclax (2-1 mol-mol),-3.10943912888444
KMS-12-BM,16720766,-1.5729698680950066
SNU-423,135421197,3.0122188559971725
BT 328,5287969,-1.46849607666092
MIA PaCa-2,24889392,4.053420963482879
Kasumi-2,400769,-1.337956311995758
HEC-108,24978538,-0.9824677506425258
LXF 289,2729026,2.289348740995074
KYSE-450,JQ-1-vorinostat (2-1 mol-mol),2.5632737661829488
Kasumi-2,9826308,-0.3836015857314186
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
BT 248,445643,3.6752138638176057
SNU-423,11640390,3.650531771581836
Ri-1,JQ-1-carboplatin (1-1 mol-mol),-0.4957222903174305
HuT 78,9933475,1.6695706910823258
OAW28,9825149,1.8591620922463772
ChaGo-K-1,53495165,-1.145661881311857
RT-4,11178236,-1.895969264263487
SNU-423,54143018,1.1903406522322812
RKO,1750826,1.760307875609834
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
RT-4,9915743,2.2914033994891847
Lu-65,54613361,0.2288955023122638
MIA PaCa-2,56946209,-5.316828012783855
HuT 78,1750826,-2.627767008630374
OAW28,11455910,2.4986666790908583
AU565,44489675,4.101715930322606
OAW28,73707398,1.2451215877479735
HuT 78,68056272,3.666874851860886
BT 286,SNX-2112-bortezomib (250-1 mol-mol),-2.9534628064080732
Namalwa,2871966,-1.9170848167407744
Becker,262093,3.305929946624271
Ri-1,208908,2.1688582057505275
Mono-Mac-1,71466380,3.259446139455592
ChaGo-K-1,4521392,4.240215977362856
RT-4,65628,4.4679434201664945
HuT 78,54618795,2.390754899552402
ACC-MESO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7593645992319382
RERF-LC-MS,49793307,-1.4864117200972382
SNU-119,6610216,4.326307589827554
SK-UT-1,1716436,3.7795606206738337
HEC-108,5738263,3.298542747172543
SNU-119,11234052,4.141539950400205
SNU-213,16720766,5.717733687016699
SNU-119,638278,4.6940839403885555
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
RKO,5978,-3.7617282032773582
OAW28,68056272,3.642995313586114
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
SW1783,2742550,4.177993888768022
Becker,44241473,5.200691051735636
SNU-423,11175137,2.118483191381137
Becker,23582824,0.522211888016452
KYSE-180,25126798,3.589811911556444
SK-MEL-5,16065773,1.1273169391673337
SNU-423,1716436,3.438303267646366
KYSE-180,44259,1.7448132984126952
AsPC-1,11234052,4.540853045838434
LXF 289,46174525,4.3838011857350585
ESS-1,36314,-8.425270671395753
Namalwa,3136844,3.7255251235468143
AsPC-1,16038120,0.5677006157285766
Namalwa,25227462,-4.7752798616367
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
ChaGo-K-1,11152667,-0.0716632534971208
IST-Mes1,carboplatin-etoposide (40-17 mol-mol),4.371414865626411
SNU-119,3825829,3.624299392396196
BT 328,11455910,1.1431162062454217
NCI-H2030,16722836,2.241413928549511
OAW28,5282054,3.6220988157242946
SK-MEL-5,selumetinib-UNC0638 (4-1 mol-mol),3.1483964049439614
WM793,24785538,4.089053013969586
ESS-1,702558,5.643160750991067
Lu-65,11494412,0.9324583231494612
KYSE-180,445455,4.928349979351992
PF-382,19582717,3.4720772442845296
AsPC-1,46191454,4.573546152494067
KYSE-180,6917907,-5.842795191649857
RERF-LC-MS,60700,0.497286081450591
HuT 78,16720766,0.837560054131659
KMRC-20,9444,4.017663478109875
NCI-H929,25126798,3.7313671343137673
ESS-1,25262965,-1.850856990715792
PE/CA-PJ41 (clone D2),25227462,1.527949554972427
PF-382,44202524,1.2151421852046318
LMSU,969516,2.7485422702500215
KMS-12-BM,selumetinib-PLX-4032 (8-1 mol-mol),4.308028949995008
Lu-65,11234052,4.358706299792741
NOMO-1,52947716,-3.339302012338735
AU565,16725315,3.19394291041594
OAW28,24978538,-0.39276463694641
Karpas-422,6918878,0.8908244199335652
NCI-H929,5743,-1.0610868770493211
OAW28,11485656,3.2643123414600645
KYSE-180,16725315,4.4704171730121685
KMS-12-BM,445091,3.61459918682191
BT 320,11485656,3.3413754154715796
AsPC-1,66577038,3.0978373542257973
RKO,11175137,2.9264569639519906
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
BT 328,156414,4.0443464949872645
SK-MEL-5,17755052,3.4815883106305137
AU565,3634881,4.304518749556461
HOP-62,11364421,0.1939440207571194
SNU-119,5284616,1.0337608354309102
ChaGo-K-1,2742550,3.263905661793297
AU565,613753,3.214352381260741
NOMO-1,60750,-2.6028640292275567
H-STS,4259181,0.3091139042767585
HCC2108,123631,2.550362488689637
PF-382,1641662,3.045007940950309
SK-MEL-5,9915743,2.239295477459583
Becker,2729026,3.1227212581970676
IST-Mes1,2746,3.2096433183027604
NOMO-1,9903786,1.612481289648159
LXF 289,46191454,2.351463869671111
Kasumi-2,135421197,0.8154486687594628
OAW28,25126798,4.214847534438453
SF539,2842253,5.830632520958069
ACC-MESO-1,66577038,3.862944855540308
RKO,9935249,5.020114551473781
BT 248,421610,3.3246840566564484
SF539,2949965,2.7185790269908003
Karpas-422,246676,4.416007405024325
ACC-MESO-1,vorinostat-carboplatin (1-1 mol-mol),4.134498627348827
RKN,1566236,1.687441004968786
Kasumi-2,10127622,5.115736544584973
SF539,4259181,0.2869057369152892
SNU-423,46926350,-3.9937351080347314
ACC-MESO-1,60700,4.823672327859709
SW1783,24821094,3.387006787045153
Kasumi-2,969516,1.973265868556714
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
SNU-423,10296883,4.1095294295281795
Karpas-422,25126798,3.878954460710037
LXF 289,9929138,7.38651684018349
Mono-Mac-1,9866186,0.1265272205341433
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
NOMO-1,2858523,2.9127751570608136
HuT 78,selumetinib-tretinoin (2-1 mol-mol),-3.3029302026602125
SNU-423,72193861,1.5776760665191312
LXF 289,446155,3.7142968943868073
ESS-1,25102847,3.139039712214138
Panc 02.03,54618164,4.482290203520866
Lu-65,10184653,1.797968418926877
ChaGo-K-1,navitoclax-MST-312 (1-1 mol-mol),0.8501822165973897
MIA PaCa-2,71680916,4.379626223011951
PE/CA-PJ41 (clone D2),7251185,3.1222161198320104
SK-UT-1,10184653,1.553177213936907
ESS-1,119607,5.640066336706725
HSC-3,26596,-1.4868403003967878
PF-382,JQ-1-navitoclax (2-1 mol-mol),-1.4600589253273593
NCI-H1339,2858523,3.31126282085598
SK-MEL-5,135440466,3.311967478820367
CML-T1,119607,4.0157878157192375
Becker,9933475,2.3299360060402297
BT 248,53481919,4.127258509947241
KLE,9967941,2.835048263891985
AsPC-1,5479543,3.7451312348556582
IST-Mes1,65064,5.185430309398801
AsPC-1,11656518,2.0782041289904845
AsPC-1,4259181,1.083384461798112
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
SNU-423,44632017,1.3194020598896097
KYSE-180,9868037,4.629723429656334
RT-4,444795,5.14749831666829
KMRC-20,159324,3.723725061334236
SNU-119,JQ-1-vorinostat (2-1 mol-mol),3.606308027934859
MIA PaCa-2,25227462,-3.7811371844480512
SNU-886,1750826,-2.8015436455469493
OAW28,42642645,0.9360886571737812
NOMO-1,10296883,3.647443685498321
NCI-H929,6917907,-6.25281779572784
SW1783,8515,3.491142478274941
RERF-LC-MS,241158,4.36087401910034
NCI-H2030,16725315,4.8179667053556345
NCI-H2030,446155,1.479611866961904
BT 328,24771867,5.867133384354764
SF539,42642645,-0.0077042862761951
SNU-423,613753,3.147569499194737
ChaGo-K-1,5291,4.023558989002335
BT 498,2828334,6.550760053460591
Mono-Mac-1,57519531,1.6991291407588482
ACC-MESO-1,9936388,3.1205070846652374
H-STS,24821094,1.6491011840853225
Karpas-422,3025944,3.9022555318755305
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
BT 286,53481919,3.917510700943226
Mono-Mac-1,9915743,-1.5760754079944657
SNU-119,23635314,-0.7073360701887041
MJ,119182,-0.7805536216457877
PE/CA-PJ41 (clone D2),9887053,5.327755452479389
PF-382,26596,-2.06856872789975
RKO,72376,-2.4980018930037673
RT-4,4096211,1.036713829931397
AsPC-1,9911830,2.936776162598985
BT 498,3854666,4.451868649055675
Ri-1,375860,-0.316355066244252
WM793,9915743,2.18814480431127
KMS-12-BM,44493528,3.477782404349953
HOP-62,969516,4.328157237863545
Ri-1,9866186,1.7713313048291
IST-Mes1,49867926,4.44564652397053
Kasumi-2,erlotinib-PLX-4032 (2-1 mol-mol),2.6918027963335827
BT 498,6610355,5.488343588917727
Panc 02.03,9866186,1.4364847380387245
BT 286,71680916,4.257745459661519
LMSU,46398810,2.8230145741890977
OAW28,23582824,0.6142488529896691
SF539,11455910,0.0331728686867912
SF539,BRD-K55473186,4.334676081622515
WM793,16038120,2.08609917753077
ChaGo-K-1,5460769,6.469611673758945
KLE,15983966,-4.1530046682155435
Karpas-422,5351362,1.828306864536144
SNU-886,124202324,2.9202052759291024
HSC-3,44589607,2.589263575512526
NCI-H1339,11625818,4.666003310760862
MJ,24771867,-4.046707231281286
HuT 78,24978538,1.2584289097403791
SNU-213,ISOX-bortezomib (250-1 mol-mol),1.194953783499087
HuT 78,44566777,1.359437800629114
RT-4,navitoclax-pluripotin (1-1 mol-mol),-1.5234215141375285
Karpas-422,44507138,3.472250272722531
SK-UT-1,9826308,0.8326524601340544
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114
ESS-1,11213558,1.497271752916858
MIA PaCa-2,16013152,4.154236855192705
H-STS,selumetinib-navitoclax (8-1 mol-mol),5.1723559591536015
SF539,25102847,1.4843193904497096
KLE,10427712,3.718999940973947
AU565,3552672,1.7684242008913282
NOMO-1,119182,-3.695250738066314
EHEB,3025986,-0.9608953944291202
PE/CA-PJ41 (clone D2),selumetinib-JQ-1 (4-1 mol-mol),1.3944144559858256
NCI-H2030,168312962,-2.4787410042856544
KMRC-20,2874250,5.815904450932631
SK-UT-1,54678924,1.6137433728432382
Kasumi-2,54596558,4.023508952920703
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715
OAW28,11222830,1.7030270245193828
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415
NOMO-1,10184653,1.080224838410231
ChaGo-K-1,49793307,-4.975701491282376
WM793,11964036,2.6064351819040885
KLE,navitoclax-gemcitabine (1-1 mol-mol),-1.442818690707718
ChaGo-K-1,BRD-K55473186,4.776921073930659
CML-T1,73707440,4.384977554594534
NCI-H929,10113978,2.6674788600772597
NOMO-1,46398810,2.1682472320454504
SNU-119,136227924,3.0573258202750253
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
KYSE-180,44507138,3.1582868511502524
SF539,5281321,-2.202189901262438
Namalwa,12001922,1.9514258181134656
Mono-Mac-1,67156097,-3.048740001729215
Lu-65,637858,2.878442664173332
AsPC-1,10184653,1.884059851333118
SW1783,44137675,4.848183688866269
WM793,tanespimycin-gemcitabine (1-1 mol-mol),-0.8794425804429231
LXF 289,60750,-4.482846219959503
LMSU,54596490,4.907866417372536
NCI-H929,135421197,1.062377968485951
NCI-H1339,36314,-6.499724688901822
OAW28,12003241,-0.542287488877267
ChaGo-K-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.484510987120187
SK-MEL-5,1750826,1.6566055402218314
Ri-1,25154868,3.4929550535226124
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
KMS-12-BM,1750826,-5.31704186496798
KYSE-450,11609586,3.5646213291444324
PE/CA-PJ41 (clone D2),17755052,2.460417072837074
SF539,969516,2.5473257168551666
IST-Mes1,3025944,4.475795844293571
EHEB,56946209,-4.4781864641183065
Kasumi-2,25154868,4.0151171723744765
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
MIA PaCa-2,5284616,3.409206974987919
OAW28,16725315,3.4000122970226196
MJ,navitoclax-MST-312 (1-1 mol-mol),0.5350142291634327
AU565,24856436,-0.2368560911374172
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
LMSU,5978,-1.3012469579809125
PE/CA-PJ41 (clone D2),6184667,3.24058579753897
Mono-Mac-1,5278396,3.5372373573667373
SF539,54613361,-1.5545710356973723
SF539,2858523,3.000626783089259
H-STS,JQ-1-navitoclax (2-1 mol-mol),0.1797969837721217
RERF-LC-MS,54613361,-1.445874788963763
KMS-12-BM,9915743,-0.3780298011492129
Lu-65,24771867,3.5458119260189194
KMS-12-BM,135928012,2.4606603364640995
CML-T1,10322450,3.1347292789416934
SNU-886,72376,-2.8445678356407043
RERF-LC-MS,5566,3.05978093065268
Ri-1,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3048620858233484
CML-T1,piperlongumine-MST-312 (1-1 mol-mol),1.169857653831876
OAW28,11626560,1.7877294085158288
HEC-108,44241473,4.4856951268247585
KMS-12-BM,568763,0.1321382887617515
Lu-65,doxorubicin-navitoclax (2-1 mol-mol),-1.4221733970931094
RKN,3552672,1.948192158503618
NCI-H196,vorinostat-navitoclax (4-1 mol-mol),2.1821758339508386
AsPC-1,6610216,4.465191830296224
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
HSC-3,17755052,1.3936775853499024
PE/CA-PJ41 (clone D2),219104,4.25374512452242
Becker,216239,2.021023688826764
RT-4,148198,-0.8360848986797086
Lu-65,11626560,1.1319488815614032
Kasumi-2,54678924,1.0609274738962189
KLE,46174525,3.970027845055867
CML-T1,9911463,2.5893115421622737
PF-382,44491742,5.368678247108403
H-STS,3634881,3.254926671083326
H-STS,JQ-1-vorinostat (2-1 mol-mol),0.6269555463342106
BT 248,1750826,0.7778964775949998
BT 286,selumetinib-tretinoin (2-1 mol-mol),-0.3313816649086816
OAW28,3025986,-0.5681838773369163
AsPC-1,10385095,2.76496705920137
ACC-MESO-1,5329102,2.602640313364048
AU565,2945648,3.081352201841014
HuT 78,9952709,1.8932187114351076
ChaGo-K-1,44489675,3.622154814470552
Namalwa,serdemetan-SCH-529074 (1-1 mol-mol),0.9967824467026186
BT 286,5113032,4.411456497828677
Ri-1,piperlongumine-MST-312 (1-1 mol-mol),0.5424428494600624
Karpas-422,24785538,1.2576413722636424
Ri-1,selumetinib-decitabine (4-1 mol-mol),1.4786911056222252
SNU-213,3384730,5.276674415765901
BT 248,409805,5.374494739188799
SNU-119,6184667,2.2923669732173093
HOP-62,5311,1.2768541791254775
MIA PaCa-2,4521392,4.256949723260046
OAW28,24785538,1.1869022382798196
SW1783,selumetinib-BRD-A02303741 (4-1 mol-mol),5.401452883960348
ChaGo-K-1,10127622,5.691652618871857
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828
WM793,25195348,2.400822719494433
CML-T1,selumetinib-MK-2206 (8-1 mol-mol),2.7460107356112644
LMSU,46215462,1.6132445260269193
SNU-886,10322450,3.968731934637612
NOMO-1,409805,3.6617718212828874
HSC-3,5329102,2.5585253388451807
HOP-62,285033,-1.086459700106236
SNU-423,3062316,-0.4734418758890504
BT 248,24964624,0.9785580517881716
IST-Mes1,6505803,0.837907313306775
CML-T1,46224516,0.9570028124056976
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
Mono-Mac-1,10026128,4.356045161202684
Karpas-422,969516,2.27875212195007
PF-382,11175137,1.0890287092924258
RERF-LC-MS,49766530,0.7744144603938863
NCI-H929,568763,0.1324523108623163
Kasumi-2,carboplatin-UNC0638 (2-1 mol-mol),1.808252059410855
HuT 78,72199292,0.6737146382384092
SK-UT-1,16013152,4.42318413525966
BT 498,4917,3.1875438777941167
Namalwa,122327,4.141900721710582
Karpas-422,tanespimycin-gemcitabine (1-1 mol-mol),-2.8780840785015944
SNU-213,selumetinib-PLX-4032 (8-1 mol-mol),-0.364480846216524
ACC-MESO-1,675434,4.208302365354324
NOMO-1,71466445,1.8310961714544176
RT-4,71466380,4.899760942476526
SNU-423,15983966,-4.104535660378808
HuT 78,11427553,0.3947942526358813
PE/CA-PJ41 (clone D2),vorinostat-navitoclax (4-1 mol-mol),2.2069497935289992
SNU-886,25262965,-1.963536165555311
Lu-65,10385095,0.4710137676717799
SK-UT-1,16741245,3.1689132411737244
Becker,3503,1.2240350209605926
SF539,10172275,5.0855442389334105
PF-382,JQ-1-vorinostat (2-1 mol-mol),-1.4348852294654668
NCI-H929,15547703,-0.209100400299692
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073
AU565,72193861,-0.1764123403705666
ESS-1,12003241,-1.211695248693708
EHEB,44507138,1.7056650657187078
KMS-12-BM,10077130,2.5047652451380857
PE/CA-PJ41 (clone D2),135659046,4.325865774807889
BT 248,5978,2.367827241369892
SNU-119,46907787,2.5271615138386054
Mono-Mac-1,9868037,1.9108517803242744
SNU-423,446155,0.4016067899943888
BFTC-909,148198,-2.03933057080943
WM793,42642645,1.6343237729440876
Becker,9444,4.396045476360631
H-STS,5287969,-2.1266541754976513
Lu-65,25262965,-1.8559569622213667
NCI-H196,10074640,3.6788769373365016
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
CML-T1,4261,-0.2906672064872484
NCI-H1339,JQ-1-vorinostat (2-1 mol-mol),2.0008841316187125
NOMO-1,2729026,1.9247353379999697
MIA PaCa-2,11404337,-1.8965485173920145
HOP-62,71729975,2.57008704117282
KMRC-20,JQ-1-MK-0752 (1-1 mol-mol),6.181134550910211
CML-T1,2841722,3.5416474270082796
Lu-65,9933475,2.209817994970435
Namalwa,11152667,-1.2838817681822148
BFTC-909,11175137,1.859642091823866
PE/CA-PJ41 (clone D2),11175137,3.6725738856580663
HOP-62,46843906,3.1260529463455726
RKN,107985,-3.0900461086436404
Mono-Mac-1,252682,8.469235580129757
BT 286,421610,2.9885412691069195
HEC-108,126941,-2.7817702272816267
ACC-MESO-1,25126798,4.023971823370827
EHEB,60750,-4.448701675460919
HEC-108,selumetinib-PLX-4032 (8-1 mol-mol),6.183444970425624
Lu-65,selumetinib-vorinostat (8-1 mol-mol),0.948619360922771
KYSE-180,24951314,1.8172088790949268
HuT 78,60700,-3.11385512766576
EHEB,9935249,3.177814055372344
KLE,448949,0.9264382828941904
IST-Mes1,241158,4.374014389295604
ChaGo-K-1,44493528,4.285653924871417
CML-T1,3689413,-2.671933251411637
CML-T1,6450551,-1.1017942434712815
ChaGo-K-1,5746,1.5665459857254316
Mono-Mac-1,25105715,3.239622858410376
ChaGo-K-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8935336207243505
NOMO-1,11178236,-2.492998231075174
KLE,421610,3.1712689131891074
RKN,65064,4.855719732775604
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
MIA PaCa-2,54596558,4.174983268743628
KYSE-180,10427712,3.555551591768758
NOMO-1,12003241,-0.5951695723430065
SF539,1641662,3.001281709092091
Mono-Mac-1,135440466,1.0237642683593615
OAW28,44607530,1.1070032957823266
Karpas-422,12001922,1.302445651758517
RKN,241158,3.8611150596916577
BFTC-909,51039095,2.7594177275421403
ChaGo-K-1,selumetinib-MK-2206 (8-1 mol-mol),4.060516227486996
BFTC-909,135398516,3.047749913114312
Mono-Mac-1,9840324,5.352033005026378
ACC-MESO-1,selumetinib-PLX-4032 (8-1 mol-mol),4.943500149137048
RT-4,11626560,2.0350958135834656
KMS-12-BM,2130404,3.4441142127860696
HOP-62,JQ-1-vorinostat (2-1 mol-mol),0.5006545993602405
Becker,6852167,2.488549626227047
Kasumi-2,2733526,2.6717950038671003
ACC-MESO-1,9967941,3.035265547475742
BFTC-909,9868037,3.24226767674478
ACC-MESO-1,52912189,5.0178402045782535
BT 498,15547703,5.01668051089873
AsPC-1,46199207,3.695579616421397
KYSE-450,46199207,3.793080332052943
ACC-MESO-1,12001922,2.4993315613358926
RT-4,56946209,-3.9033190222100824
Becker,65064,5.59556726027644
RKN,3062316,2.6330403907451863
Lu-65,selumetinib-piperlongumine (8-1 mol-mol),2.3460237733143106
MIA PaCa-2,3854666,0.8531836291018433
NCI-H196,navitoclax-piperlongumine (1-1 mol-mol),2.767680054960315
BT 286,24964624,0.7571254121052671
Ri-1,9911463,2.719411575193649
H-STS,216468,0.2818757493359613
MIA PaCa-2,5329102,1.5000029259047023
KYSE-180,135398516,2.6781533642805933
Panc 02.03,3503,2.8594786206641514
NCI-H929,5351362,0.2210032032775228
HOP-62,71466445,1.9622269092656943
AU565,104842,-3.8153307910583014
Mono-Mac-1,53301938,4.309444242776755
SF539,5284616,2.797909464914647
H-STS,100016,5.985929376611731
Becker,5113032,4.8230203093991815
KYSE-450,16722836,3.1649590100923732
HuT 78,6450551,0.5524678941583652
LMSU,24964624,3.0894427581884334
LXF 289,24821094,2.4128137194258215
BT 248,2749,1.3146464590197295
KLE,15953870,2.3268887568767767
SF539,5978,-5.613486711901469
RT-4,JQ-1-vorinostat (2-1 mol-mol),2.118819013371158
KMS-12-BM,52947716,-7.113059308361459
HEC-108,9911463,4.37199271437254
ACC-MESO-1,decitabine-navitoclax (2-1 mol-mol),0.8720161508690694
Kasumi-2,5278396,3.160923329427041
SK-MEL-5,24821094,3.388741132646637
AU565,44185566,1.721131526136141
KMRC-20,16722836,1.4149264521986569
ESS-1,24779724,4.457445117995274
HEC-108,216345,4.4823048447920755
WM793,1716436,1.7539283172933289
HEC-108,selumetinib-UNC0638 (4-1 mol-mol),4.806918156541826
Panc 02.03,31703,0.91391851070637
RKN,9935249,4.428036529076262
BFTC-909,3854666,1.1654585644167257
Becker,16736978,1.6726604349760967
Panc 02.03,25227462,-1.0518848939229315
KYSE-450,57519531,6.208309628107499
LXF 289,5311,1.216776445363927
RT-4,46398810,2.84559074478432
BT 328,11152667,1.7027658226426858
Mono-Mac-1,445643,2.6169348294716164
Panc 02.03,322968,4.613737356937267
Kasumi-2,10427712,4.152130511624211
EHEB,71466380,4.118712365127363
BT 320,6184667,3.5325258636094934
HOP-62,702558,5.5009425061549315
SK-MEL-5,107970,3.0501102581579977
KLE,navitoclax-sorafenib (1-1 mol-mol),-1.1377907715980664
BFTC-909,9915743,2.0959000942543025
SF539,11977753,-1.5349757438855824
EHEB,57519531,1.438200929613056
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
HSC-3,3815108,3.409091117249246
LMSU,4788,5.893858428733075
CML-T1,16720766,-1.7114419714530344
KMRC-20,409805,5.905260063235434
SK-UT-1,285033,-2.26051652032599
NCI-H1339,26596,-1.3893901381267089
PE/CA-PJ41 (clone D2),25105715,3.71980975243517
SF539,89928392,1.1675794201375844
NCI-H1339,tretinoin-carboplatin (2-1 mol-mol),5.766498387623692
SF539,135984461,4.130188481564332
EHEB,2828334,6.1224071915617735
RERF-LC-MS,46174525,5.020740506928848
HuT 78,tretinoin-carboplatin (2-1 mol-mol),-1.6984319930029828
Namalwa,44491742,4.1395858329172235
Lu-65,25183872,0.3383859794560597
SF539,24856436,-1.421470853407074
OAW28,71466380,4.3449274646859495
BT 248,9967941,3.931710866923424
Karpas-422,72193861,1.151901981366233
SK-MEL-5,51037431,2.2293778167880864
MIA PaCa-2,10410894,2.918838225153396
LMSU,65064,5.4965008599922145
HEC-108,11178236,-4.583978166396032
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919
NOMO-1,4259181,0.2459758371125145
KLE,9911830,2.855789588066899
MIA PaCa-2,9823820,4.179730833084768
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
RT-4,10184653,0.8000143447696744
Karpas-422,11612883,2.1985682639193023
NOMO-1,56946209,-4.862706213909506
RERF-LC-MS,11238147,2.4729298726299147
EHEB,4788,5.846509507330705
NCI-H929,16736978,-1.8944362557879229
HuT 78,1641662,3.992228724834443
NCI-H1339,46907787,4.303951587914797
SNU-423,9911463,4.2882741176819446
RKN,11485656,2.343665915939472
BT 286,374536,3.426675663898697
LMSU,5281321,-2.8892706249231512
KMS-12-BM,JQ-1-navitoclax (2-1 mol-mol),-3.0294043604496363
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
MIA PaCa-2,262093,3.1147038686055812
AU565,44620216,3.755834453350393
H-STS,6505803,0.5486553702983976
Karpas-422,135984461,4.3057747311374746
OAW28,11222830,1.7030270245193828
SF539,135875424,2.4028504168317473
BT 286,24753719,5.642521821790082
HuT 78,1242560,3.6169776257670345
KMS-12-BM,49836020,4.363885927749537
Namalwa,5329102,1.349042289795257
HOP-62,445091,4.12247730605986
LMSU,24180719,3.8300426500348177
SF539,9952709,2.216028342098009
BT 286,285033,-1.921415895264567
CML-T1,25062766,1.440222571379222
SNU-119,9927531,4.042335314323924
CML-T1,6184667,4.239961832830672
NCI-H2030,3689413,1.2400324738328432
AU565,6436223,-4.706952881213825
HCC2108,11427553,2.403363421771595
HCC2108,638278,3.3485085363474285
HSC-3,60750,-2.881991949302989
OAW28,3825829,4.635564939734502
SNU-423,10231331,4.762188035854746
NOMO-1,46843906,1.7610241193794407
LXF 289,24785538,0.6202102990423739
BT 248,5738263,3.817096252163507
OAW28,10427712,4.195688642509306
Becker,24901704,5.073780247486695
Kasumi-2,3634881,1.9476495169521624
EHEB,15953870,4.2659113550785595
CML-T1,selumetinib-piperlongumine (8-1 mol-mol),3.07705446138146
BT 328,17755052,2.7457916392526247
AsPC-1,10302451,4.160835682979353
AsPC-1,16720766,4.029008761480653
PF-382,451668,-1.5679120589003597
Karpas-422,9926054,1.7787061620357676
ACC-MESO-1,124202324,3.762951160491622
BT 286,54619267,4.206221744763978
SF539,44185566,2.0579628999661117
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
SW1783,89928392,2.216727995281777
BT 286,16659841,3.8289465528596542
KMS-12-BM,5280436,2.8744585986860236
SK-MEL-5,11485656,3.020253832456298
KYSE-180,11178236,-2.9076352351606394
KMS-12-BM,2708,2.6805418133728747
Ri-1,6918328,-4.123040432896102
HCC2108,11640390,5.072951155223495
Becker,1641662,3.409993688003908
HOP-62,44607531,1.5421969187921007
ChaGo-K-1,3676137,3.7968759357432464
MIA PaCa-2,11955716,-2.798852632916128
HuT 78,3136844,3.938412897897032
KMRC-20,72193861,2.2130895784665148
Panc 02.03,36462,3.4500230117265933
Karpas-422,5281321,-2.196822682341022
SK-UT-1,16038120,1.834689793828048
WM793,16741245,6.304850832164104
MIA PaCa-2,docetaxel-tanespimycin (2-1 mol-mol),-0.3990888618952469
HEC-108,4477,-0.1758732099665472
EHEB,3854666,0.7564347377790305
SK-MEL-5,5470400,0.7518880653915619
RKN,54649381,4.194319964969153
Ri-1,52912189,-0.453209199025633
LXF 289,16038120,0.5250135720403194
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772
SK-MEL-5,serdemetan-SCH-529074 (1-1 mol-mol),2.407919605173646
SF539,56973724,2.7207033026610974
BFTC-909,119607,6.015893315993201
NCI-H929,crizotinib-PLX-4032 (2-1 mol-mol),1.1143694059459794
Kasumi-2,11507802,0.0513516992758086
RKO,400769,-0.364727826621167
BT 248,46398810,1.9244684206215508
PF-382,135875424,3.2130182861195076
CML-T1,16736978,1.2014198902848654
WM793,navitoclax-MST-312 (1-1 mol-mol),0.5700872528599389
BT 328,613753,3.4687194971891184
SF539,2126,3.755804454049341
AsPC-1,53325874,4.506725704395743
MIA PaCa-2,3543504,3.4240638805726493
RKN,2729026,3.0549768432694377
H-STS,11494412,-0.8730313423515421
AsPC-1,24797083,1.5655308519339004
BT 498,11404337,1.4735257645837956
PF-382,9935249,1.8009635209130423
Mono-Mac-1,10077130,2.3094568580600296
BT 320,135999136,1.9088296274535188
ACC-MESO-1,5738263,3.969640298508432
SNU-119,16725315,4.275634814543551
NCI-H196,71304818,3.304710493941327
H-STS,9927531,5.457961831541725
AsPC-1,107970,2.236934549480267
SNU-423,44498493,4.431214994890045
IST-Mes1,16720766,0.7299606902549882
KLE,42642645,1.516537245777594
RT-4,5566,2.9903378984967546
IST-Mes1,73707398,1.324483483158502
ESS-1,42642645,1.3351553509560612
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
NCI-H1339,9907093,4.242858415135094
BT 328,53495165,1.3387140928137258
Karpas-422,selumetinib-MK-2206 (8-1 mol-mol),0.7605062920110189
EHEB,159324,2.208250970812642
ESS-1,navitoclax-pluripotin (1-1 mol-mol),-0.2560996080158209
HOP-62,25227462,0.8519692318516471
KYSE-450,4477,0.7200921978595938
Karpas-422,9908783,4.557264022303007
Ri-1,selumetinib-PLX-4032 (8-1 mol-mol),3.967143255386252
HSC-3,6852167,3.108712764007485
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401
OAW28,6917907,-5.603755883192341
SK-MEL-5,6918837,-2.5775816022488103
NCI-H1339,25062766,2.7213199166868836
OAW28,11977753,-1.87780111267196
BT 328,31703,-0.2898094024615853
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
SW1783,168313200,3.606419156743755
KYSE-180,2742550,4.361413861886047
EHEB,5335621,4.71040970914542
AU565,374536,-0.7311314672583101
SNU-886,6450551,0.4843129346186465
KYSE-450,9926054,1.8553044985655331
HuT 78,71751553,4.273670469751914
RERF-LC-MS,24785538,0.8057743011820994
NCI-H196,107985,-2.614031076452801
HuT 78,BRD-A02303741-carboplatin (1-1 mol-mol),3.8369942625366
KMS-12-BM,4788,4.217370600333275
BT 286,54618771,0.8427122634128117
Mono-Mac-1,3385,1.9570122377763095
Namalwa,24785538,0.8043164607604679
Namalwa,49793307,-4.82638673619915
HCC2108,24785538,0.6113377434133814
IST-Mes1,46224516,1.3511239581863117
HEC-108,3384730,3.335460233588695
ACC-MESO-1,11175137,3.3506590774184635
SNU-886,BRD-A02303741-navitoclax (2-1 mol-mol),-5.741782833272406
MIA PaCa-2,ISOX-bortezomib (250-1 mol-mol),0.1760619682505216
Namalwa,navitoclax-piperlongumine (1-1 mol-mol),1.1479801451227785
KMS-12-BM,9823820,3.407131386822144
RT-4,24785538,1.6038296110526935
BT 286,9868037,4.125737289056318
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
H-STS,5311,0.9489728897085792
AsPC-1,45279963,4.120012544363151
NOMO-1,3689413,-2.5325178418163174
Kasumi-2,11960529,3.120745126362072
KLE,navitoclax-PLX-4032 (1-1 mol-mol),-1.3670051186656096
RKO,54618771,2.3159310195777985
RERF-LC-MS,42642645,-0.4358765804877467
BT 286,6450551,1.4228047573938862
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
BT 248,46199207,1.879415157386071
AsPC-1,9911830,2.936776162598985
LXF 289,9915743,1.5678711489122208
NCI-H2030,73707371,5.115486799100736
AU565,11234052,4.466615830851295
SNU-119,9956119,2.9397923190583866
PE/CA-PJ41 (clone D2),24951314,2.460576025484623
SNU-213,11609586,2.9747545588590776
Lu-65,24785538,0.987209197048792
RT-4,3025944,4.0203592479598225
Namalwa,4261,-0.1998131485517298
SK-MEL-5,156422,4.118853121070512
SW1783,11175137,2.286839278211157
ACC-MESO-1,4788,5.4001840643992605
Namalwa,5738263,2.2051594160726067
PF-382,crizotinib-PLX-4032 (2-1 mol-mol),1.1615999412597993
RKO,11404337,-0.3534280477619294
MIA PaCa-2,104842,-2.85264341377728
H-STS,71304818,2.454900724059108
NCI-H929,16038120,-2.3089398873167872
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
SNU-213,crizotinib-PLX-4032 (2-1 mol-mol),1.6829565666585489
Ri-1,docetaxel-tanespimycin (2-1 mol-mol),-8.150549947962872
SNU-213,11626560,1.2138536733413132
KMS-12-BM,tanespimycin-gemcitabine (1-1 mol-mol),-2.331991876675554
NOMO-1,46215462,1.6253213091786816
RKN,54613361,0.2026815444056028
LMSU,24785538,3.035127880697954
Mono-Mac-1,53481919,3.5538110484829835
KYSE-180,5566,3.0696761250239204
Mono-Mac-1,168313047,1.7048785524305352
EHEB,23635314,-1.6580881181075813
HCC2108,11625818,5.912984069907385
SNU-886,15547703,2.7270775608273174
OAW28,11178236,-3.057015425639644
LXF 289,168312962,1.364587801939814
Mono-Mac-1,107970,1.267448776766495
LXF 289,285033,-1.4335563326434544
MIA PaCa-2,100016,4.223400842588871
SNU-423,5113032,5.670902663678431
MIA PaCa-2,5978,-4.253866013054402
SF539,selumetinib-MK-2206 (8-1 mol-mol),2.7695496094715875
BT 320,24821094,3.905918214519909
SF539,24821094,1.7680388640350837
RERF-LC-MS,16741245,3.282184197465347
ESS-1,66577038,3.102682313302671
Namalwa,11364421,-5.95321406074749
ACC-MESO-1,123631,3.3434313523705144
LXF 289,4259181,0.8555931132792622
MIA PaCa-2,285033,-4.694923786796806
AsPC-1,24821094,4.10595231639086
OAW28,3062316,-0.5042902382709098
NCI-H196,54454,2.43861256379555
SF539,4917,2.886212068318384
Kasumi-2,57519531,1.2182883326717542
Becker,25154868,5.49474478911542
NCI-H196,19582717,3.121711938945128
BFTC-909,3676137,5.055523871435828
SNU-119,9926054,2.3608984923700036
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
CML-T1,ISOX-bortezomib (250-1 mol-mol),-0.7676441178316211
Becker,16725315,4.176702684464043
CML-T1,11507802,-0.1369004319183971
NCI-H196,11640390,5.704404098029019
IST-Mes1,4917,3.386112443694605
EHEB,tanespimycin-gemcitabine (1-1 mol-mol),-4.432752806947547
Becker,56649450,3.4802228057114073
HSC-3,25150857,2.2248636704221476
HuT 78,navitoclax-sorafenib (1-1 mol-mol),1.735834872159947
RKO,17755052,3.988455753476612
NCI-H1339,49793307,-2.796356491844092
SNU-119,17759555,3.1197691897400435
SK-UT-1,23725625,5.077881708764169
RKO,3062316,2.656751778030552
SW1783,31703,0.5342280043570855
BT 328,11612883,4.649689158242477
AsPC-1,45279963,4.120012544363151
MJ,89928392,1.2062541110163645
AU565,9911830,3.457946854316075
BT 498,44607531,1.7990314038019075
LXF 289,107985,-2.691798131563437
KYSE-450,25183872,-0.8618407646936664
NCI-H2030,3385,5.339957284168376
NCI-H196,5291,4.116968852005061
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
Mono-Mac-1,navitoclax-birinapant (1-1 mol-mol),-0.6305584759579668
OAW28,doxorubicin-navitoclax (2-1 mol-mol),-0.325587572552389
H-STS,17755052,1.4518907441282063
Ri-1,44607531,-2.466333838341234
Becker,5566,3.1215882284049097
Mono-Mac-1,5738263,3.5727157948594757
BT 286,5351362,2.1492192428575203
Karpas-422,3038522,3.6277226222899697
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
RT-4,11404337,1.401838262846579
HuT 78,387447,-5.436092440743046
RT-4,vorinostat-carboplatin (1-1 mol-mol),3.924557304364806
Becker,448949,1.5877010563376748
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
Ri-1,6852167,-0.591407289651703
RT-4,23725625,5.6003160205481874
MIA PaCa-2,6438330,2.864716697344165
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
NCI-H1339,11175137,2.789615167236726
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
AU565,6918638,0.3564513775218086
WM793,568763,-0.2625590328104358
HOP-62,9444,4.365244468454382
ESS-1,2871966,0.4858563694283366
HSC-3,1242560,3.3956324395360427
AsPC-1,11485656,3.206693439346989
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
HuT 78,2828334,5.4247855811567645
PF-382,9926054,1.6899693166343082
ACC-MESO-1,25150857,2.6233395806994104
AU565,12001922,1.255153902569356
H-STS,46199207,2.757122877037558
EHEB,60700,-2.619794830780626
KMRC-20,56946209,-1.705053096437228
MIA PaCa-2,54678924,3.5009557896469876
EHEB,navitoclax-gemcitabine (1-1 mol-mol),-3.439930210813986
IST-Mes1,5278396,4.120493778859633
CML-T1,644241,-4.543158274485358
OAW28,67291369,5.503883029091299
SNU-213,44486219,4.443724602041866
PF-382,969516,2.499968363258948
HOP-62,3038522,2.3481472611270884
Karpas-422,6505803,-0.6034425689167541
EHEB,637858,1.5977612521222773
Becker,11609586,3.8238987470849897
RKO,25154868,3.654559992823761
CML-T1,23725625,2.2812581172519124
HSC-3,10074640,2.7864686905688676
Namalwa,25195348,1.420945820920828
Lu-65,6450551,2.7504557030292536
HOP-62,107970,2.340316246371355
SW1783,46907787,3.9046818317286944
MJ,5978,-4.258969391666035
SNU-119,10026128,4.4148318530797885
Becker,4261,2.108826753895035
BT 286,4477,0.4436486581336739
SNU-423,2746,3.5801912517104695
PF-382,6917907,-6.431709944016271
SK-MEL-5,25195348,3.2915110992128658
SNU-423,navitoclax-piperlongumine (1-1 mol-mol),0.9297060154176142
SNU-213,60750,2.5027121259815557
MJ,11364421,-5.505393606714309
KYSE-180,docetaxel-tanespimycin (2-1 mol-mol),-5.030018128034541
BT 320,5281672,4.443718212515123
HEC-108,984333,1.245430533507037
EHEB,11238147,2.9573925088138537
RERF-LC-MS,439501,-1.3704502050640626
KLE,doxorubicin-navitoclax (2-1 mol-mol),-2.507709419306591
Becker,3062316,1.5685235643097857
OAW28,5335621,5.136061685098042
NCI-H929,126941,-0.648952926168031
Karpas-422,5328940,1.907258053285574
SNU-423,4917,3.783227754006492
RKO,10385095,1.2981289243482117
Kasumi-2,selumetinib-decitabine (4-1 mol-mol),-0.5593050771503721
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
H-STS,5978,-3.0576178887146592
NCI-H2030,322968,4.6726346667135035
Kasumi-2,44607530,0.8991199704837235
LXF 289,9956119,3.057634534881657
NOMO-1,1750826,-5.797741098147838
SF539,JQ-1-vorinostat (2-1 mol-mol),0.5454424746711817
BFTC-909,44137675,3.23817368119839
Becker,44202524,1.1247864080321957
CML-T1,216345,1.8584843601432488
BT 286,57519531,1.337766734279075
Ri-1,17755052,-4.720683576415072
KMS-12-BM,216239,1.5581321141848137
SF539,148198,-6.422680321892083
NCI-H1339,selumetinib-piperlongumine (8-1 mol-mol),4.670247782356622
MIA PaCa-2,2871966,1.166927532814639
Lu-65,676352,1.7416294973197106
BT 248,156422,4.367304785746438
SW1783,441298,4.0307638761656435
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
Ri-1,426756,4.640789349676716
AU565,5329102,2.0441914674842008
Panc 02.03,44819697,-0.6097657869730747
MIA PaCa-2,73707371,5.326975910300329
PE/CA-PJ41 (clone D2),JQ-1-navitoclax (2-1 mol-mol),2.6711993613472194
NCI-H1339,135398516,2.559194515275264
SNU-119,54618771,1.6343524810724477
H-STS,11234052,1.696059842903999
EHEB,6505803,-0.4928001321157277
Namalwa,24978538,3.895308829975735
Kasumi-2,16659841,3.619219766502468
Mono-Mac-1,16720766,-1.4946997026536737
H-STS,44819697,-0.0809498053641322
Becker,24856436,1.009680150246275
LXF 289,44185566,2.4809324153017265
AsPC-1,16725315,5.210607806565737
IST-Mes1,docetaxel-tanespimycin (2-1 mol-mol),2.3952937403433685
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
NCI-H929,11609586,2.312289051564489
PE/CA-PJ41 (clone D2),374536,4.452656033627249
Panc 02.03,2828334,6.385741192046609
NCI-H196,25126798,4.528385606804446
NCI-H929,6623618,2.0780887581605714
KYSE-450,3854666,3.622949827534998
ChaGo-K-1,25195348,3.4341296169097464
LMSU,5746,2.5570316142886136
SK-MEL-5,31703,-0.2732129481584813
RT-4,73707398,0.8448009736616658
ACC-MESO-1,6918837,-1.6227702434824125
HEC-108,24964624,3.1655733599312126
AU565,11647372,-0.7623159020318493
ESS-1,16722836,2.4138886266191086
Panc 02.03,46174525,6.272327915554807
KMRC-20,1716436,3.2166067738770603
Panc 02.03,4259181,2.0313571914007604
LXF 289,6918328,-0.239589445073231
RT-4,selumetinib-navitoclax (8-1 mol-mol),2.485762476290879
SF539,9444,4.192195040935243
Kasumi-2,24785538,0.7031648291020229
PE/CA-PJ41 (clone D2),24748573,2.6616390878971297
EHEB,54454,1.897710954280459
KMS-12-BM,262093,1.1865999929989532
KYSE-180,400769,-0.4834890789520504
HCC2108,24772860,-2.301082023311665
AU565,439501,-2.8703859168743384
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128
SNU-886,docetaxel-tanespimycin (2-1 mol-mol),-1.966397975894796
Ri-1,53495165,-1.735989283439336
SNU-213,73707398,1.7452345044805029
LMSU,19582717,5.5691455475886595
Lu-65,71751553,4.665406208764287
CML-T1,24772860,-2.9357343941167713
BFTC-909,6438330,3.0201113942824436
MIA PaCa-2,44819697,-0.0792657567654076
BT 320,73707438,3.918904444875683
Mono-Mac-1,445455,4.450423753030739
PE/CA-PJ41 (clone D2),3854666,3.9258785658494166
Ri-1,104842,-11.03841530798714
SW1783,25262965,3.8156807624637734
OAW28,2729026,2.5871569751548047
RERF-LC-MS,9936388,-8.273067767637817
WM793,3543504,4.269438666760458
NCI-H2030,17759555,3.677599129227919
NOMO-1,6918736,-3.755126975181922
Karpas-422,24753719,4.137089222307065
OAW28,71304818,3.062868675930112
NCI-H2030,navitoclax-piperlongumine (1-1 mol-mol),3.2614918076249357
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885
SNU-119,erlotinib-PLX-4032 (2-1 mol-mol),0.7167448472722272
CML-T1,15953870,2.3626237456804025
AU565,10385095,1.377392665812461
HOP-62,selumetinib-MK-2206 (8-1 mol-mol),1.4114337530028662
SNU-886,107970,2.7037771874608034
RERF-LC-MS,3062316,3.070306969339253
HEC-108,441298,2.5312141311049214
BT 248,2729026,1.163283415080523
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
AU565,71729975,2.800801196457704
HuT 78,322968,0.3476030188480727
LMSU,285033,0.1916696238645653
SF539,2733526,2.647768601693724
SK-UT-1,navitoclax-pluripotin (1-1 mol-mol),0.5029199208338406
SNU-886,5738263,4.1230602968372585
SF539,9866186,-1.1784053961495549
SK-UT-1,11494412,1.7393092296584682
Karpas-422,9903786,1.5566107707645094
LXF 289,3025944,3.4981276099044134
Namalwa,72734382,3.923598258147051
KLE,126941,-0.581421523160804
HOP-62,11707110,0.0407603914396423
KYSE-180,3025986,-1.575125214964891
SNU-213,52912189,1.8515796327492853
CML-T1,20959075,-3.2800173274392983
SK-MEL-5,24901704,3.633567608703879
SNU-886,675434,3.265808885335484
RKN,11625818,5.974552631000589
KMRC-20,5113032,5.593210295000311
ACC-MESO-1,crizotinib-PLX-4032 (2-1 mol-mol),2.746301693286097
BT 328,3543504,5.231432946006072
LMSU,168313016,4.430377140485892
KYSE-180,44589607,3.5167084117795513
BFTC-909,2749,2.0212973698927184
ESS-1,44819697,-1.0610912171108204
Lu-65,135398516,2.8001749856176734
Ri-1,tretinoin-carboplatin (2-1 mol-mol),2.829663815817562
PE/CA-PJ41 (clone D2),2113511,6.396262945032129
BT 248,5351362,1.0725587198101878
SNU-119,5311,3.0436313599319673
CML-T1,67156097,-2.1928175380469477
SNU-423,piperlongumine-MST-312 (1-1 mol-mol),1.4300428603015891
HSC-3,31703,-0.4062327367714799
BFTC-909,4788,5.986704833543041
KMRC-20,107970,2.3183049291357953
CML-T1,8515,3.304453494146528
Kasumi-2,17755052,-2.6649013271346744
SW1783,54626689,3.693361817042254
AsPC-1,24964624,2.5492070232527424
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
SNU-886,168312962,-3.108064596774625
LMSU,25262965,-0.9564445185198788
OAW28,2871966,-1.501513911524366
BT 320,JQ-1-vorinostat (2-1 mol-mol),2.723123137570139
MIA PaCa-2,46843906,1.917381207952335
PE/CA-PJ41 (clone D2),753704,5.093510117133769
AU565,11497983,3.5183187315924185
BT 328,44607530,2.310615312338521
HuT 78,24856436,-0.4041118949053068
KMS-12-BM,5287620,-2.183306507553873
WM793,vorinostat-navitoclax (4-1 mol-mol),2.767153736935034
BFTC-909,3025986,-2.0399601309440336
ACC-MESO-1,24964624,3.857946270972098
NCI-H2030,216468,4.3643018896295365
EHEB,26596,-2.0876334457911727
NOMO-1,11497983,-3.443590431300748
HOP-62,135875424,2.89405317867683
LXF 289,135398516,1.6034740470130215
NCI-H929,72734382,3.667669568515042
Mono-Mac-1,6918878,0.1376589659678193
Mono-Mac-1,54613361,-0.8229864401453336
HuT 78,3081361,3.7119512098568945
NCI-H2030,25126798,3.671839570354219
Becker,9926054,2.0290907819284283
BT 498,52947716,1.0091545143518104
PE/CA-PJ41 (clone D2),23582824,0.3090990193641486
Karpas-422,2729026,2.7362492758301187
BT 248,11612883,3.485439835170839
KMRC-20,11964036,1.4818667570891622
KYSE-450,5311,3.212765544074189
PE/CA-PJ41 (clone D2),637858,2.8065176462831034
KYSE-450,9444,4.430571093374375
RKO,54613361,0.2998145946125954
KMS-12-BM,107970,1.2280769647153718
NCI-H929,4477,0.4411881433632111
RERF-LC-MS,9907093,3.840365222907794
BT 286,24951314,1.7166749305741291
NOMO-1,3384730,0.781590014898287
IST-Mes1,10113978,3.525341044523829
NCI-H1339,10184653,2.376921574496489
KLE,5287620,0.9182057456501032
SF539,49867930,4.3730716554773235
LXF 289,613753,3.241655631161551
NCI-H1339,16065773,3.0125822193221525
PF-382,44507138,1.103120922160699
SF539,5494449,1.5774689724302169
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
ACC-MESO-1,656346,3.4615508285005956
SNU-213,11152667,-0.7142929754084242
SNU-119,374536,-1.8347712072853533
SNU-119,2841722,2.795149248179567
ESS-1,135875424,3.182582939188363
SF539,49766530,-1.8483208282069583
KMS-12-BM,644241,2.605305599492216
BT 248,25105715,2.686391114115495
AU565,5311,0.7700744364318666
NCI-H1339,navitoclax-piperlongumine (1-1 mol-mol),3.121869388124161
HOP-62,104842,-5.353293882155422
PF-382,613753,3.2428568441024535
IST-Mes1,11152667,-0.1137559634255308
NCI-H1339,53392493,3.5051602427052635
EHEB,5311,0.7316765744080972
RERF-LC-MS,3384730,3.247206310046507
KYSE-450,11494412,3.783526385415406
BT 498,16722836,3.164527752748671
SNU-213,89928392,4.8113412324352
LXF 289,9911830,2.045852319971143
KLE,44137675,4.105797549386638
SK-MEL-5,44607531,2.2436404414566424
HSC-3,439501,-2.291291548686292
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
CML-T1,56973724,1.0958106846759064
EHEB,25150857,2.0197951403724224
SK-MEL-5,crizotinib-PLX-4032 (2-1 mol-mol),2.2894089732020886
WM793,71304818,2.8457825987612293
SNU-886,54143018,-0.1190337834405888
H-STS,49766530,-3.13255748664254
OAW28,49793307,-1.8076729764727852
SNU-423,2113511,5.831364294214667
MJ,SNX-2112-bortezomib (250-1 mol-mol),-3.5361660121199545
H-STS,5328940,1.248159196656948
ACC-MESO-1,4261,3.2786620703894584
SW1783,2746,4.238030101530504
KYSE-180,44137675,3.5547718056396
AsPC-1,16219061,4.6595447221902955
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
Lu-65,24797083,-0.526956987968481
AU565,44566777,1.2994228207825576
IST-Mes1,439501,-2.4971864822052767
BT 320,3025944,4.750339696858045
NCI-H1339,11364421,-4.045000202269178
BT 498,67156097,5.308227092292175
H-STS,3543504,2.597342605893142
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203
BT 248,9956119,4.3886748820117925
OAW28,44566777,2.367961844085161
KMRC-20,carboplatin-UNC0638 (2-1 mol-mol),3.446275029594072
HCC2108,16725315,3.712302127233507
NCI-H929,11152667,-0.508669926836867
AsPC-1,11640390,5.159931420709134
SF539,5328940,1.185373887783132
WM793,262093,3.640026682877067
BFTC-909,56973724,3.22598802973391
KMS-12-BM,2828334,4.379653513423718
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
KLE,selumetinib-MK-2206 (8-1 mol-mol),2.611642542572268
Ri-1,24180125,1.2545611778962542
ChaGo-K-1,4477,0.5485405501498112
ACC-MESO-1,24771867,3.511510808680287
LXF 289,6918878,2.1668969721619833
CML-T1,24964624,2.008023563128915
Ri-1,676352,1.7475794658703674
BT 286,9926054,2.06315076189255
SNU-886,6184667,1.0916410821784486
RERF-LC-MS,6852167,1.8897499878184068
HOP-62,400769,-0.804531166567042
HuT 78,carboplatin-etoposide (40-17 mol-mol),1.9720174218366708
Mono-Mac-1,49766530,-2.16205133655403
SK-UT-1,24821094,3.742351584541763
CML-T1,44491742,2.876043803936746
HOP-62,53232,0.9294550567608532
HuT 78,9903786,-0.2471360619469426
Karpas-422,54613361,0.0102420299691995
KYSE-450,216239,1.9385995729786167
ChaGo-K-1,9915743,2.151950733066917
SK-UT-1,15983966,-3.143048923201685
BT 248,5566,1.2795658146577915
PE/CA-PJ41 (clone D2),selumetinib-UNC0638 (4-1 mol-mol),2.6809565117678984
SF539,navitoclax-PLX-4032 (1-1 mol-mol),2.1497325977392636
RKO,5328940,1.7974237645790871
ESS-1,11404337,-0.7954778123034105
ACC-MESO-1,65064,3.065425412429416
SNU-119,BRD-A02303741-navitoclax (2-1 mol-mol),3.084106743145068
Kasumi-2,10385095,0.5473944457717855
WM793,17759555,4.44870242372694
Becker,11234052,5.6053513923812925
NOMO-1,9915743,0.4758643096003905
Lu-65,3543504,4.861867816458105
Lu-65,JQ-1-vorinostat (2-1 mol-mol),1.3673322876667977
H-STS,168312962,2.3265280063565177
SK-UT-1,462382,0.5572290876246132
NCI-H1339,3689413,0.3064961832206241
RKO,11485656,2.16906736756012
MJ,36462,-0.8152461099885887
LXF 289,123631,1.612545473594554
AsPC-1,16736978,1.4850226649426823
ACC-MESO-1,15983966,1.990338557522609
Ri-1,9908783,0.8388131027576593
ChaGo-K-1,navitoclax-gemcitabine (1-1 mol-mol),3.7271167983392433
NCI-H2030,2749,4.339658606449754
ESS-1,9903786,1.7886366060040666
EHEB,72734382,4.1680701190018965
AsPC-1,136227924,3.2025742465891938
KMS-12-BM,12003241,-2.27657533610394
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
PE/CA-PJ41 (clone D2),12001922,2.6504343623639732
AsPC-1,16736978,1.4850226649426823
HuT 78,151289,1.040242806613575
WM793,49766530,-0.085641441031448
IST-Mes1,11214940,2.2228722379077857
SNU-423,89928392,1.4625426886142474
SK-MEL-5,12001922,2.0688607607777856
BFTC-909,650361,3.8112149600795706
WM793,6914657,-2.064615991168629
NOMO-1,36314,1.6795260413615891
KYSE-180,72193861,-0.0777927374537977
HuT 78,54618305,4.369358935790669
Kasumi-2,71466380,3.646549475683979
AsPC-1,25154868,4.981069474579037
NCI-H1339,6917907,-5.63495602514643
SK-MEL-5,5566,3.097089595159475
Ri-1,11647372,-5.7202974695301805
HSC-3,selumetinib-vorinostat (8-1 mol-mol),1.9164073521640128
ChaGo-K-1,5311,1.8438071976377644
AU565,11178236,-4.26632575473861
BT 498,JQ-1-carboplatin (1-1 mol-mol),6.0311872836348535
H-STS,135999136,1.636218584553822
BT 320,6918837,0.518825985636162
MIA PaCa-2,11396600,3.289038329533777
RKN,119607,5.106543735080002
Becker,15547703,3.827394424157001
SK-UT-1,24180125,3.450035886510637
LMSU,6438330,2.2496708259228364
OAW28,9911463,4.007690751229585
BT 286,25105715,3.509672270573532
NCI-H196,1242560,5.26706022636309
KLE,6918289,2.4096746231988995
BFTC-909,3385,6.578023483143935
HCC2108,42611257,3.7693662038027
KYSE-180,9887053,4.517108897198139
SW1783,11719255,3.4036440848936063
NOMO-1,168312962,2.6221164331885003
NCI-H1339,navitoclax-pluripotin (1-1 mol-mol),0.5930684699171267
BT 286,17755052,1.4603603440503543
EHEB,9866186,-0.355142067370403
HEC-108,54143018,-0.2958313294856644
Lu-65,5281321,-0.5328695352213001
BT 320,10410894,4.180150860885228
RKO,9866186,0.3829002704071885
MIA PaCa-2,52912189,0.9006637264845482
Namalwa,JQ-1-UNC0638 (2-1 mol-mol),-1.843208201635932
Mono-Mac-1,46191454,0.1350664799202493
NCI-H1339,24951314,1.5659987762809044
AsPC-1,216239,1.707935704723652
NOMO-1,9935249,2.770043096032674
SF539,navitoclax-birinapant (1-1 mol-mol),2.277929243582673
MJ,6505803,-0.8623373124046138
HOP-62,carboplatin-UNC0638 (2-1 mol-mol),4.291543478845534
NCI-H929,46943432,-0.7846111801119194
Kasumi-2,216468,0.9994844042695143
OAW28,15983966,1.5707780698474574
RKN,168313047,2.366456695786382
BT 248,54454,4.901618168416747
HEC-108,selumetinib-navitoclax (8-1 mol-mol),1.4557838229690625
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
MJ,374536,1.9717818313070976
BFTC-909,71304818,3.116417285157316
RERF-LC-MS,11152667,0.0782441689403026
NOMO-1,168313200,3.152434526133537
SK-MEL-5,SNX-2112-bortezomib (250-1 mol-mol),0.961953465517882
BT 328,navitoclax-MST-312 (1-1 mol-mol),1.0481188204981575
LXF 289,241158,4.717778097263283
KMS-12-BM,3689413,-2.359728446736426
BT 498,12001922,1.1592789388500984
BFTC-909,55508,3.078625314561866
PF-382,11964036,0.0769506444989081
Kasumi-2,56649450,1.224051068091054
Karpas-422,11609586,2.991831439823751
BT 498,4705,4.208148450276773
Kasumi-2,docetaxel-tanespimycin (2-1 mol-mol),-5.507046356769771
BT 328,4705,3.594890989297502
EHEB,11178236,-3.253133430351509
Karpas-422,24951314,0.6964643593384264
CML-T1,9915743,1.9836361869709076
NCI-H1339,9549297,3.877142055462748
OAW28,54618771,1.1011370240470315
NCI-H196,135411,1.5759989708641096
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
NOMO-1,71466380,3.4384411266907295
NCI-H1339,73707398,1.5517116600994163
ChaGo-K-1,5702613,1.0084739984497502
Karpas-422,25227462,-5.497189538867502
Ri-1,54649381,2.8324832014718155
LMSU,9911830,1.6369573582733428
KYSE-180,65064,4.87684368224317
NCI-H1339,11234052,4.400085931998601
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
RT-4,3062316,1.5013745922534365
Lu-65,JQ-1-carboplatin (1-1 mol-mol),1.9478415319376168
HEC-108,11238147,3.83834503247448
CML-T1,42642645,-1.8637300463446456
Ri-1,969516,1.821646541672716
Kasumi-2,42611257,3.9292605095902857
BT 286,448949,2.088592715997419
HSC-3,5291,3.263159547564743
RERF-LC-MS,46199207,3.61094494328213
SK-UT-1,54619267,4.514007614998197
SK-UT-1,3825829,4.314395004241866
HOP-62,10385095,0.93787190415745
HuT 78,25105715,3.229078580605203
AU565,5566,3.0303294385930584
HuT 78,44486219,3.8943973878115985
ESS-1,6184667,3.505716491924749
IST-Mes1,25262965,-0.2533063216587133
Lu-65,11717001,3.784678462419639
OAW28,2746,2.637952220594215
RERF-LC-MS,3025986,-0.71270364092759
ChaGo-K-1,JQ-1-UNC0638 (2-1 mol-mol),1.6534960397455791
NCI-H1339,navitoclax-gemcitabine (1-1 mol-mol),-4.509040126661822
Becker,5328940,2.4021986396944133
KMS-12-BM,66577038,2.5748125108917312
KYSE-180,4477,0.5315017524747986
SK-UT-1,409805,5.339094874610304
SK-UT-1,4521392,4.374260531561281
NCI-H196,71466380,3.764128537230398
AsPC-1,119607,5.550900919397946
BFTC-909,5311281,3.2468587214362175
HEC-108,5329102,3.413313733369096
NCI-H1339,5282054,4.651074990998048
KLE,3689413,-1.503166424361693
RT-4,6918837,-1.3567481481628696
NCI-H929,44507138,1.4351733932332458
PF-382,selumetinib-UNC0638 (4-1 mol-mol),3.164054400704207
Karpas-422,46199207,3.4102201085473007
AsPC-1,1566236,2.844580785967763
HSC-3,selumetinib-JQ-1 (4-1 mol-mol),1.0715718666689311
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
Namalwa,156422,4.036118027723875
PE/CA-PJ41 (clone D2),66577038,3.48656665486357
LXF 289,10184653,0.2846387514020494
KMRC-20,selumetinib-JQ-1 (4-1 mol-mol),2.987450194991694
Kasumi-2,44486219,4.4104720165674145
BT 248,6852167,2.795606288509473
KMS-12-BM,375860,-0.7808796284755947
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
SNU-423,vorinostat-navitoclax (4-1 mol-mol),0.9372094532636858
PE/CA-PJ41 (clone D2),984333,1.6296190436427669
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053
BT 286,decitabine-navitoclax (2-1 mol-mol),-0.0152132620036723
SNU-213,67156097,6.483469517568511
Namalwa,9907093,3.9799374533472744
KMS-12-BM,6252,-2.6216972044804723
Becker,25183872,-0.6086335185182962
SF539,1750826,-3.058718862660788
KYSE-450,119607,5.938330428290203
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
AsPC-1,10302451,4.160835682979353
AsPC-1,11707110,-3.3734075653106506
Kasumi-2,44607531,1.0542160339181526
NCI-H2030,119607,5.632028507909797
NCI-H2030,6918837,-1.7786733607203498
Namalwa,6252,-4.382124329646984
AsPC-1,46398810,3.192713565122567
KMS-12-BM,176870,2.4229038104943457
SK-UT-1,6252,5.554705519214965
HSC-3,11485656,2.2428743548360863
KMS-12-BM,9929138,5.078790269314151
HEC-108,168313016,6.1351198054698575
KMS-12-BM,selumetinib-decitabine (4-1 mol-mol),-1.3154987364301634
BT 328,4788,5.982911703327575
LMSU,53325874,5.502506435516271
Becker,65628,4.34244809682726
RERF-LC-MS,44543605,4.169252612552019
SK-MEL-5,5329102,1.6824496733918386
NCI-H196,400769,-0.3348431458221283
BT 286,409805,3.8987037297039056
MIA PaCa-2,11178236,-3.5313754625987843
LXF 289,676352,2.537691956872654
NCI-H929,73707398,-1.1294071073635834
HSC-3,135398516,2.17751858320145
HCC2108,387447,-3.2029305155754657
BT 286,135875424,2.624951262486574
KYSE-450,6918328,1.5468903828461986
SNU-213,25183872,-0.4867996852076448
Mono-Mac-1,72376,-4.015210702515702
Namalwa,9549297,1.4031808932781888
CML-T1,11222830,0.9922056813064216
BT 286,68056272,3.758013058674078
SNU-423,44486219,4.5785480934535725
KMS-12-BM,3552672,5.9542999196624775
BT 248,135659046,3.5168747963796636
KLE,11964036,2.71484537703424
SK-UT-1,4259181,0.5247904304596981
AsPC-1,11612883,5.278069767960674
EHEB,docetaxel-tanespimycin (2-1 mol-mol),-5.11927619590754
BT 498,66577038,3.2580433340261226
KMRC-20,656346,3.07452123258755
Kasumi-2,44202524,1.2131871054756846
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
SW1783,17755052,3.585209697722452
Kasumi-2,16219061,1.087081093705916
LMSU,46191454,1.9443488630816397
KYSE-180,9967941,4.960769213293647
Panc 02.03,16725315,5.289216895099664
WM793,5566,3.1211189784720923
HSC-3,638278,3.3252951717806014
Lu-65,6918328,0.9220320643754802
Lu-65,docetaxel-tanespimycin (2-1 mol-mol),-4.94417117541267
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
Namalwa,445455,4.434639779414414
NCI-H1339,15983966,-4.134600252769006
HCC2108,ISOX-bortezomib (250-1 mol-mol),1.2590401469034869
MJ,56946209,-4.259299613292059
OAW28,5351362,2.5555782345102407
KMS-12-BM,24180719,3.687281269749717
RERF-LC-MS,5291,3.9873816513243785
OAW28,135411,2.218427323792269
SK-MEL-5,6918878,1.446817120772073
OAW28,5287969,-1.4958665626980858
Mono-Mac-1,3384730,0.9129507679094716
KMS-12-BM,53481919,3.061997154400898
NOMO-1,67156097,-2.629595584457773
Namalwa,44185566,2.0464342011420085
Kasumi-2,11455910,-0.3707966959989963
AsPC-1,168312962,4.080126214508297
AU565,9956119,3.3766215860348368
AsPC-1,6438330,3.2823568933486196
SK-MEL-5,3081361,2.7977779800137443
KYSE-180,2828334,7.128860440334806
SK-MEL-5,53392493,3.062967220476644
Panc 02.03,44566777,1.8066319547984584
NCI-H929,56946209,-4.927465594530247
HuT 78,5335621,4.006139745042012
BT 320,selumetinib-UNC0638 (4-1 mol-mol),5.097773746306877
HEC-108,6852167,3.774395558261256
Ri-1,5329102,1.1587105315253556
KMS-12-BM,3815108,1.5057478423514148
H-STS,3062316,1.2556156573704025
RKN,375860,0.0559819210079563
HSC-3,16741245,1.8902841178977503
AsPC-1,6450551,4.162604073037061
Namalwa,9887053,0.2875319408170879
ESS-1,16065773,2.1890853873316596
MIA PaCa-2,5278396,3.2881813032043303
RKO,57330099,4.8516025997257275
IST-Mes1,46907787,2.643041583848796
EHEB,168312962,3.113364364376791
NCI-H196,24785538,2.9685310971552945
HEC-108,9911830,3.642303707567872
Panc 02.03,11404337,1.528571500956484
KMRC-20,135411,1.924751982395428
RKN,246676,4.414592383854902
HuT 78,11152667,-1.8885306635916228
HuT 78,navitoclax-birinapant (1-1 mol-mol),-0.5043518643676743
BFTC-909,216239,2.6603594422751136
KMS-12-BM,4915,4.427523198943996
PF-382,208908,1.8787534323757689
ESS-1,doxorubicin-navitoclax (2-1 mol-mol),-3.174683950808786
Mono-Mac-1,carboplatin-UNC0638 (2-1 mol-mol),2.892149328251194
HuT 78,984333,1.4807762289322746
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
Karpas-422,44566777,-0.8369167569085558
IST-Mes1,262093,3.164571948045499
HuT 78,9803433,5.134294603794936
BT 320,46398810,3.263265417740268
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
NCI-H929,12001922,1.6200785055416655
NOMO-1,72376,-3.881755374018637
ESS-1,4096211,2.024431300625148
RKO,24951314,1.467797052763695
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522
SNU-423,JQ-1-vorinostat (2-1 mol-mol),1.4797620883628588
LXF 289,119607,4.549732560104057
HEC-108,72193861,0.4949264975227585
KLE,89928392,0.0725246038766898
ChaGo-K-1,44819697,-1.7321119268385738
BT 286,tanespimycin-gemcitabine (1-1 mol-mol),-2.647439718160363
BT 286,676352,1.7872148842320963
OAW28,637858,2.2776250733597085
BT 248,6914657,-2.576788872604972
SNU-213,doxorubicin-navitoclax (2-1 mol-mol),0.7570343879914795
NCI-H1339,11719255,5.227414732740707
KMRC-20,25062766,3.4155735971940704
IST-Mes1,54454,3.4404607016766264
NOMO-1,6505803,0.1224616163714439
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514
Mono-Mac-1,23725625,5.447781404402003
RKN,25154868,3.091821445991922
PF-382,24771867,-1.6533655868224757
Ri-1,3815108,1.201236864182909
Karpas-422,10074640,3.4361637685293944
RKO,4477,1.7070595719756474
AU565,568763,-0.2996152351915113
HSC-3,49836020,-1.9036219787804456
OAW28,24951314,0.5571772807313425
KMRC-20,613753,3.2568220179713614
Karpas-422,10427712,3.1818475677437252
OAW28,24821094,3.6183900250040497
SW1783,9933475,2.066701345248221
MJ,26596,-3.924273415415616
HSC-3,navitoclax-MST-312 (1-1 mol-mol),1.2665262183799604
BFTC-909,44491742,4.0640318167931255
Namalwa,72193861,0.4860643993613396
MJ,9935249,-0.0346265394865933
SF539,10427712,3.91731820186957
HuT 78,6852167,0.2624976594092375
H-STS,11404337,-0.7903033287308603
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
PF-382,176870,2.767344828111714
BT 248,637858,2.256250159493538
HCC2108,49850262,3.743305220709595
MJ,piperlongumine-MST-312 (1-1 mol-mol),1.1519621120420176
RT-4,23635314,-1.9773718066539765
Mono-Mac-1,176870,1.794271492997917
BT 320,53301938,4.424260786877386
BFTC-909,46907787,2.3649992203474515
BT 248,11222830,0.9088188698521174
Namalwa,selumetinib-MK-2206 (8-1 mol-mol),2.37951803478302
ESS-1,675434,5.557520418917079
WM793,53392493,3.001064949916278
SNU-119,107970,2.4008728686512617
Ri-1,11625818,-4.483334986870143
SNU-119,5738263,3.822274048298037
SF539,5278396,3.068667570965669
HOP-62,9911463,3.8769302944036266
NOMO-1,54619267,3.207870909981956
H-STS,6918878,0.8588702567283845
KLE,89183176,-2.483352111006337
Karpas-422,4578,4.102594872772706
SNU-423,2945648,3.085895507775502
AsPC-1,445091,6.474898015897582
ACC-MESO-1,15547703,5.527714198479006
SK-UT-1,11955716,-2.40204232410625
CML-T1,71680916,4.411758468982172
IST-Mes1,10296883,4.238957650390159
AsPC-1,44202524,5.110549363526631
Kasumi-2,navitoclax-MST-312 (1-1 mol-mol),-2.959240355083437
Lu-65,67156097,-0.9623130440812842
HEC-108,57519531,4.18371886542851
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
Mono-Mac-1,selumetinib-piperlongumine (8-1 mol-mol),2.29885991355253
ESS-1,89928392,1.2376133771759263
AU565,1750826,-0.6805778178680736
H-STS,426756,4.2891566150656875
AsPC-1,135398516,2.7517064972229415
ACC-MESO-1,3689413,0.4162012666414902
RERF-LC-MS,11364421,-3.8493036468537265
SK-UT-1,11719255,5.479588049288889
RKO,56963564,0.5825206420774123
SNU-213,9936388,2.0534039631402994
ChaGo-K-1,445643,4.017836416998069
WM793,119607,5.577999044145194
HOP-62,3503,1.774181520682938
AsPC-1,568763,2.040921390287386
NCI-H1339,3503,2.6374444046453034
SNU-213,5280436,4.039307371149868
ChaGo-K-1,107985,-4.444294596677252
OAW28,25150857,2.5691026408672957
ChaGo-K-1,1239801,5.4340716776967
BT 328,salermide-PLX-4032 (12-1 mol-mol),4.7270242729207625
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
ESS-1,49793307,-2.776813429548929
KLE,71466578,4.494231116067741
Mono-Mac-1,6450551,2.178466389519658
SK-UT-1,46199207,3.7020798689093466
SF539,decitabine-carboplatin (1-1 mol-mol),4.471103195582989
SK-MEL-5,60750,-4.3522881886018885
RERF-LC-MS,72193861,1.0218744083195843
LMSU,54626689,4.479048602124445
HEC-108,119607,5.2604571432303
EHEB,9907093,3.575019057407179
AsPC-1,25126798,4.196072723195887
AsPC-1,119607,5.550900919397946
MJ,31703,-4.653725426044044
HEC-108,SNX-2112-bortezomib (250-1 mol-mol),-0.4374113289550588
WM793,9935249,4.106686148008307
WM793,9926054,1.9861694749243135
CML-T1,11396600,3.3654395371867425
RKN,5329102,3.127163305072316
BFTC-909,11167602,2.8757137848929006
KMS-12-BM,17759555,4.020532745562922
RKO,36314,-4.63858923378885
Lu-65,148198,-3.5921377356072397
OAW28,11964036,1.3272537866850969
SW1783,serdemetan-SCH-529074 (1-1 mol-mol),2.8062060654486953
RKO,24771867,6.323343540042099
CML-T1,JQ-1-vorinostat (2-1 mol-mol),-0.0778878507242399
BFTC-909,10127622,5.216996592058982
KMS-12-BM,327653,2.270237785805321
BT 328,52947716,2.920977634750811
NOMO-1,3025986,-1.4139862297409005
NCI-H196,5329102,2.9936778783637674
SF539,12001922,1.3704910391128322
Lu-65,7326481,2.282359860124297
Namalwa,25161177,4.36797235746559
SNU-213,JQ-1-MK-0752 (1-1 mol-mol),2.5673364417924853
MIA PaCa-2,2113511,5.475319803599009
RT-4,1716436,2.9161940059185985
LMSU,24771867,2.7605292141618945
H-STS,119182,0.2834032478354432
NCI-H929,6918736,-2.069198249683734
BT 328,5328940,3.187680057709996
BFTC-909,24771867,4.730369684143592
AsPC-1,6918638,0.7071735542476161
AU565,53495165,0.1395352595616783
LMSU,11625818,5.059170877046766
WM793,5328940,2.305774199257107
SNU-423,44137675,3.771329187315914
Kasumi-2,4259181,-0.4186991216348978
BT 498,24180125,4.887627247892678
SNU-423,selumetinib-MK-2206 (8-1 mol-mol),2.6852698386469136
LMSU,2945648,2.8278602599693805
SNU-119,11964036,1.0686978114131611
EHEB,24964624,0.9586889430420278
Kasumi-2,60700,-3.733340750045026
RT-4,6252,2.4296681174551664
SNU-886,3101542,4.147310950875089
RERF-LC-MS,2708,5.106155932743474
SK-UT-1,44462760,4.294065343841732
H-STS,36314,2.0613869853420685
Becker,151289,0.655779143245145
IST-Mes1,9866186,0.9671533169607398
SNU-423,15547703,3.1301132391172146
NOMO-1,2733487,3.664178503465112
OAW28,24856436,0.1607500363529794
HEC-108,11152667,0.9436637108805932
AsPC-1,4261,2.35820288641389
KYSE-450,53232,2.6046887103681993
SNU-423,400769,-0.3777485753223125
HOP-62,1242560,3.5362921857618717
NCI-H1339,44202524,1.827057501254713
RKN,46224516,3.695788234754723
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635
KYSE-180,441298,2.642638918815539
KMS-12-BM,54619267,2.4046016005161315
Ri-1,400769,-2.1174667362307087
Kasumi-2,54649381,3.5158481033233593
HCC2108,126941,-1.9407933202051555
SNU-213,5287620,-2.815537066378191
HOP-62,135928012,5.236707943844288
MIA PaCa-2,252682,6.325670827636382
SNU-423,375860,-0.141425947999252
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
CML-T1,219104,2.3392357294314055
WM793,44607530,2.440109588672552
OAW28,2708,5.3328257603707545
IST-Mes1,44202524,3.78616908386864
RKN,439501,-1.5558449248177562
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
KMS-12-BM,71466578,1.9338301399273083
Karpas-422,46191454,-0.7986292729302961
Becker,375860,-0.5928207112259023
IST-Mes1,16725315,5.212250641781058
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
BT 286,4788,5.375781609747508
WM793,24901704,3.981835922445403
KYSE-450,42642645,1.660330797131617
BT 328,3689413,2.3836323832860673
MIA PaCa-2,26596,-1.1158295610303952
KLE,31703,-0.6562509778186947
NCI-H929,168312962,-0.2256493233866316
IST-Mes1,151289,3.762568892374828
Lu-65,10231331,-0.1827270457349836
SK-MEL-5,119607,4.558840645647786
LMSU,selumetinib-vorinostat (8-1 mol-mol),4.672884739471154
BFTC-909,26596,-1.7437210940555867
KYSE-180,24753719,4.5603328664886815
SK-UT-1,135875424,3.143376991018657
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
MIA PaCa-2,148124,-8.04655725116999
HSC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.8583190838455068
IST-Mes1,72193861,3.6955595837075137
NOMO-1,702558,2.777027807122979
NCI-H196,216239,3.63042521476176
MIA PaCa-2,navitoclax-sorafenib (1-1 mol-mol),2.5811605514663447
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
KLE,selumetinib-PLX-4032 (8-1 mol-mol),4.210157254606348
SK-MEL-5,71304818,2.344029822810695
HSC-3,25183872,-0.7081908982509552
NCI-H2030,54618305,5.554359715807879
HCC2108,409805,5.256429084033282
AsPC-1,5291,4.446798964395248
Kasumi-2,3062316,1.0772152233383698
BT 320,doxorubicin-navitoclax (2-1 mol-mol),-0.1344051428167206
NCI-H929,241158,1.4883272197282302
SK-MEL-5,54613361,0.715893590160925
SF539,44632017,1.0950732195529729
OAW28,5280436,5.165372214799318
BT 286,11222830,1.070248725926738
SNU-423,navitoclax-MST-312 (1-1 mol-mol),0.8206276110191193
ChaGo-K-1,11485656,1.7653957410813437
PE/CA-PJ41 (clone D2),285033,-2.223317280953266
HOP-62,644241,3.1135369440994767
SW1783,11238147,3.3496391304042747
SNU-213,66577038,2.1743073235901065
CML-T1,44202524,1.467740802576286
HOP-62,44185566,3.047597660054579
SNU-119,26596,2.579410873890194
ChaGo-K-1,25262965,-2.1300903092101384
HEC-108,selumetinib-JQ-1 (4-1 mol-mol),4.622936143310662
Karpas-422,3825829,3.984444104401659
BFTC-909,24964624,2.4776408698208003
KYSE-180,4521392,4.793023543550177
KYSE-180,3385,2.5391949123618036
HOP-62,11175137,2.747771523845805
SNU-119,11427553,3.011079133606584
Namalwa,9884685,-0.9006349124358586
H-STS,12003241,-1.720451684377523
SK-MEL-5,54678924,1.4850480657343377
EHEB,49850262,3.0589099968114986
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
Becker,702558,5.747196665834739
PF-382,56946209,-4.827856930300663
Panc 02.03,44607531,1.9299895981807216
KMS-12-BM,72734382,2.6336747797962445
HSC-3,navitoclax-piperlongumine (1-1 mol-mol),2.297950806600239
HEC-108,375860,-0.0015834583996186
SNU-119,322968,3.936087902128088
SF539,53232,2.519991468251329
BFTC-909,135411,0.8518885281649031
PE/CA-PJ41 (clone D2),5329102,2.79941940372049
SK-UT-1,23635314,-1.1981704896676824
SNU-119,54626689,4.267759657725626
IST-Mes1,44607531,1.530053859314775
KMS-12-BM,49850262,1.3155226448331834
Kasumi-2,5287969,-1.8638241340536708
LXF 289,25183872,-1.882522005728347
NCI-H1339,151289,1.086653425019276
Panc 02.03,57519531,5.330694472788803
HEC-108,3062316,2.505322411201139
SF539,6610216,3.974614801985701
RKN,46843906,3.906010302389018
Kasumi-2,6505803,-2.445084849944434
Mono-Mac-1,11317348,1.4875586729173769
AsPC-1,16725315,5.210607806565737
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
Namalwa,11656518,1.1355675996213976
SNU-423,23582824,0.3032934737671689
AsPC-1,54613361,2.957295670472447
Kasumi-2,11626560,0.3916500490858549
PE/CA-PJ41 (clone D2),49867926,4.481140924469175
BT 286,66577038,1.2367598503014738
BFTC-909,9911463,4.114346930944119
BT 498,selumetinib-navitoclax (8-1 mol-mol),3.9903083753932767
RERF-LC-MS,1566236,3.687566928717542
PF-382,serdemetan-SCH-529074 (1-1 mol-mol),1.5995010454222542
AsPC-1,7251185,2.99432826291256
KYSE-450,126941,-4.1478729331459006
IST-Mes1,3689413,0.9013533734229402
Lu-65,969516,2.532419728264248
KMS-12-BM,51037431,3.9425054893267326
ESS-1,6852167,2.0941643944902055
Mono-Mac-1,25150857,1.766777170038874
NCI-H929,5746,0.47536469132715
EHEB,9911463,3.619047359567488
LXF 289,3503,2.5386473527097837
Namalwa,439501,-2.8468436546580524
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
KLE,49766530,-2.017018761794788
Mono-Mac-1,2858523,2.440143154781653
Mono-Mac-1,54618164,2.5791045372216703
NCI-H1339,11152667,-1.000017899668529
Kasumi-2,4788,5.288898541322949
Ri-1,JQ-1-MK-0752 (1-1 mol-mol),-0.6260374122813487
SF539,selumetinib-decitabine (4-1 mol-mol),4.614699351264478
LMSU,56649450,5.764663213375745
ESS-1,52912189,1.4491066421108545
WM793,11497983,4.66927640579722
RERF-LC-MS,5113032,4.48589538963195
ACC-MESO-1,24951314,2.4018862580106344
Karpas-422,2858523,3.079059560811171
EHEB,71466445,3.460498363916868
Kasumi-2,67291369,1.3044869974839717
RT-4,9956119,3.103226813532622
HuT 78,56649450,2.503642191453737
HCC2108,24180125,3.362517679132719
NCI-H929,5311281,3.339013406601059
NOMO-1,23582824,0.0799476906959343
Karpas-422,9444,3.821620615279606
CML-T1,452548,-3.528686830959828
AsPC-1,53392493,3.5744228182767164
OAW28,16725315,3.4000122970226196
ChaGo-K-1,71751553,4.486695284730435
KYSE-450,51039095,3.763234499146495
RERF-LC-MS,25161177,4.303824118845859
PE/CA-PJ41 (clone D2),9884685,0.9202237029017308
BFTC-909,262093,3.5924629632259792
LXF 289,6918736,-2.4177135652368476
HEC-108,10127622,5.316186973162969
Mono-Mac-1,44185566,1.2179415517046666
HSC-3,selumetinib-piperlongumine (8-1 mol-mol),4.55078157659231
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
CML-T1,SNX-2112-bortezomib (250-1 mol-mol),-2.787489120690278
LXF 289,24901704,2.332916050939017
Kasumi-2,23725625,0.6917734152233637
NCI-H929,135398738,4.7642664235998815
Panc 02.03,1641662,3.717230762709902
Lu-65,148124,-0.361922200988903
EHEB,409805,3.764078268707581
MIA PaCa-2,53481919,3.693165756222
SK-MEL-5,25126798,4.177648861488895
KYSE-180,208908,4.633003996676137
AU565,135421197,1.4743648854968991
RKO,11507802,1.7455765117352984
SNU-213,123631,2.3363847745895683
AsPC-1,676352,1.9564823338284063
KMS-12-BM,3081361,2.7736505977581056
BT 286,15547703,2.95083845262102
Becker,51039095,3.232874650132705
SNU-119,11396600,3.5657342992920547
HOP-62,navitoclax-MST-312 (1-1 mol-mol),1.076073120479153
AU565,54678924,2.5293429329053763
RKO,136227924,3.256787131627037
PE/CA-PJ41 (clone D2),5978,4.677104950562766
WM793,31703,-1.1808506154596277
RERF-LC-MS,10184653,1.661334722418144
NOMO-1,2828334,5.727397129817869
BT 286,10184653,1.951842124920023
SNU-213,docetaxel-tanespimycin (2-1 mol-mol),-0.3946224211038461
KMS-12-BM,selumetinib-vorinostat (8-1 mol-mol),2.1031452809096827
KYSE-180,219104,4.692697004252791
SNU-213,vorinostat-carboplatin (1-1 mol-mol),3.930687467685816
LXF 289,31703,0.1888440469000175
Karpas-422,10385095,1.106745644266175
NOMO-1,135411,-0.3073928829727976
ChaGo-K-1,6610216,4.215426179079186
RT-4,11640390,3.689473360751719
Becker,54626689,5.068066609576423
SNU-423,36314,-6.274263194422466
HSC-3,24964624,2.6735244242436864
KYSE-450,11427553,3.7801306516191384
BT 498,selumetinib-MK-2206 (8-1 mol-mol),4.151434834860726
BT 328,25105715,3.784465780287459
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505
Ri-1,9840324,5.4110799890547545
H-STS,46215462,1.7095245533302474
H-STS,11719255,3.4202837995113025
Lu-65,11222830,1.16139858795039
BT 328,1714884,3.4592731205549225
NCI-H2030,4477,-1.1805863916245418
LXF 289,53392493,2.5437082258312804
Lu-65,3384730,2.7772804583801105
RKO,4096211,2.0568907070726397
SNU-119,11497983,3.6896133673877207
EHEB,151289,0.953950234753323
MIA PaCa-2,676352,1.5948637153539005
SF539,9911463,3.3415175792660854
AsPC-1,9907093,4.363482739155403
BT 328,SNX-2112-bortezomib (250-1 mol-mol),-2.692646777339037
SK-MEL-5,44486219,4.423845629482486
Becker,7251185,3.049813442259434
SNU-886,5287620,-2.170628852003526
HuT 78,126941,-2.6954395482949844
SNU-119,44137675,3.0443625578269096
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
EHEB,400769,-1.1131056733057492
Lu-65,3025944,4.489379745189235
H-STS,5113032,5.339439762793735
Karpas-422,navitoclax-birinapant (1-1 mol-mol),1.786219624038126
MIA PaCa-2,439501,-4.331404793236993
HuT 78,25227462,-5.166030621754822
CML-T1,selumetinib-UNC0638 (4-1 mol-mol),2.45517668205048
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
KLE,17759555,3.4987624371380095
Becker,2858523,3.0599242132907154
PF-382,9444,3.9294096917802106
HOP-62,4705,3.552280933872326
BT 320,6918638,3.210777195522013
AU565,2858523,2.8415967437488443
Lu-65,3689413,-0.1410308041132627
BFTC-909,644241,3.062866082016443
SF539,45100481,5.034110607379183
Namalwa,613000,2.319534394708418
KYSE-180,11964036,1.5417763505782551
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
NCI-H2030,11175137,3.165352687365522
WM793,12001922,1.7029195893812905
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
Ri-1,25195348,1.73301830515513
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083
Lu-65,17755052,2.1688330235092197
OAW28,262093,2.853078829548121
SK-UT-1,selumetinib-PLX-4032 (8-1 mol-mol),4.7803100019835005
RT-4,49793307,-1.8490869702405208
Panc 02.03,71680916,5.6819891784443595
Mono-Mac-1,44632017,0.6207752840578831
Becker,148198,-3.822753548425191
H-STS,53232,2.3734460475104275
RKO,9915743,2.8851858618766957
KMRC-20,100016,7.210629640241846
BT 498,6852167,6.0420041098120985
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
KYSE-450,6918638,1.5500469019976144
LXF 289,23582824,0.8647594683412683
SK-MEL-5,11455910,0.3432757840716531
KMRC-20,15953870,3.781161229519325
BT 328,46199207,1.7290666248648392
Kasumi-2,25262965,-2.503194884241619
AsPC-1,71466380,6.178949844697013
KMRC-20,44197249,3.899612901236983
H-STS,5291,3.872294840120784
NCI-H1339,426756,4.378478200663483
Kasumi-2,46191454,0.4638336944386738
RKN,452548,0.7515073582009456
Lu-65,16722836,3.079487594255957
Ri-1,3385,2.794410660318534
SF539,54678924,1.2476819079209422
NCI-H196,60700,2.6116008481858275
NCI-H1339,46199207,3.766066508345173
SNU-119,216468,1.5589878703095297
BT 328,262093,2.379096363022233
Lu-65,5282054,4.5299048818747325
KMS-12-BM,24797083,1.2365117165456094
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
SF539,11175137,2.017622399930718
BT 328,crizotinib-PLX-4032 (2-1 mol-mol),2.7816896231682886
KYSE-450,10074640,3.7244937676634735
BT 328,9933475,2.2718026120514216
HCC2108,72193861,0.1943107246781484
SW1783,6252,4.426958357245536
BT 286,56946209,-3.3525827059100983
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
SW1783,2945648,3.5321993021385367
Mono-Mac-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.310124768965731
KMS-12-BM,selumetinib-UNC0638 (4-1 mol-mol),2.7847421040854603
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
Mono-Mac-1,24772860,-4.461344884032207
SNU-119,JQ-1-navitoclax (2-1 mol-mol),0.5509382626965866
Panc 02.03,6438330,3.381062774421129
AU565,9868037,3.1053436778875843
HSC-3,637858,2.0652307033731097
SK-UT-1,151289,2.928498055248494
AU565,23635314,-4.115690790244737
RT-4,285033,-2.016111545796812
RERF-LC-MS,135398516,2.452363199699896
KMS-12-BM,322968,1.914773928139573
Mono-Mac-1,52912189,-0.3351512701335604
ACC-MESO-1,51037431,1.6325795920503512
SW1783,16038120,2.009287788618318
H-STS,11612883,2.0759775526312096
Becker,navitoclax-birinapant (1-1 mol-mol),5.226638008391343
SNU-119,selumetinib-tretinoin (2-1 mol-mol),0.2138866552869755
Kasumi-2,73707398,-0.974822208153436
MIA PaCa-2,10322450,3.5979699373077585
SW1783,2749,2.9108764618452456
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
SNU-886,3854666,1.448080837770843
EHEB,10090485,5.892161708902715
HuT 78,9967941,3.6248756588046382
CML-T1,54454,4.932328921432074
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
SF539,9549297,3.209839506985017
MJ,6252,-0.2110286359243735
Mono-Mac-1,selumetinib-navitoclax (8-1 mol-mol),1.236534180983602
CML-T1,969516,2.44416602520126
PF-382,15953870,2.669476849035499
BT 320,ISOX-bortezomib (250-1 mol-mol),1.4901983753773511
BT 328,44607531,1.5766345227803793
RKO,1641662,3.3091455873155367
Namalwa,tretinoin-navitoclax (4-1 mol-mol),3.8973285666851543
OAW28,49766530,-0.5315014966120291
ACC-MESO-1,44589607,4.343564105396685
HEC-108,alisertib-navitoclax (2-1 mol-mol),-0.2691749995476873
KYSE-450,3025986,1.0073883663070609
AsPC-1,5280436,2.0433035906644696
Kasumi-2,decitabine-navitoclax (2-1 mol-mol),-3.2819175731867927
AsPC-1,5287620,-2.2438477065180233
MIA PaCa-2,11485656,1.8953661577719088
H-STS,7251185,1.0219328536539296
SF539,54649381,3.7800507892247337
BT 286,9911830,2.3367947096317927
AsPC-1,12003241,0.1897400127907629
ACC-MESO-1,6914657,-4.821892559924658
WM793,54618164,4.258619603305177
Namalwa,135398738,2.090145253399199
PF-382,3543504,2.094275160861191
RERF-LC-MS,23582824,0.1470987082457378
BFTC-909,11178236,-2.4757289909406683
Mono-Mac-1,67291369,0.1054152136065154
HOP-62,46224516,2.895420651410814
Ri-1,9927531,3.385054072969868
Panc 02.03,168313200,4.226618217059218
ChaGo-K-1,25154868,5.309533626163277
ChaGo-K-1,53481919,3.8711533004139977
BT 286,54618795,3.5839759074897937
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096
LMSU,9823820,5.175471992537328
SNU-213,5311281,1.2937037798945257
KLE,54143018,-0.8237191874413499
SNU-119,49793307,-3.2764253324389268
AU565,3136844,3.8072298284959385
IST-Mes1,9884685,0.6527999920478087
AsPC-1,11485656,3.206693439346989
HuT 78,49793307,-3.123496799876953
Ri-1,44489675,3.6880997948063743
HOP-62,serdemetan-SCH-529074 (1-1 mol-mol),2.377021307588857
KMS-12-BM,1566236,0.5726482736694104
OAW28,135999136,1.5944266420299655
BT 328,123631,3.6473377820687847
BT 286,227681,3.851915377022569
ChaGo-K-1,421610,2.67400864037601
BT 248,44566777,-0.50911829246694
BFTC-909,56963564,-0.1720168824982637
KMRC-20,navitoclax-piperlongumine (1-1 mol-mol),2.618402251211732
Karpas-422,25262965,-5.549042575691541
RKO,16725315,5.119694523443236
BT 320,6438330,2.745053768259143
BT 248,4788,5.6007343352714605
HSC-3,3825829,3.2177804213288757
SK-MEL-5,2828334,5.833391997776046
KMRC-20,49766530,-1.4976923868030616
BT 286,10385095,0.5786279467469033
RT-4,10427712,4.289155491450476
HOP-62,6918878,4.215530396127894
SNU-423,25062766,1.7832585279986426
PE/CA-PJ41 (clone D2),11222830,1.6922518785490088
RKO,89928392,1.6264666324972337
RKO,3385,4.410917651107157
SNU-119,44607531,1.0035867478806315
MIA PaCa-2,1239801,4.687665562632846
SNU-119,carboplatin-etoposide (40-17 mol-mol),4.59312893478617
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
RERF-LC-MS,168313016,4.277512101574917
HSC-3,11364421,1.6206871903423576
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
BT 248,11364421,0.4256883677591794
OAW28,2828334,6.258958244852924
Becker,SNX-2112-bortezomib (250-1 mol-mol),-1.918322757641904
SK-UT-1,11717001,5.457019686559972
Mono-Mac-1,9927531,4.461355065468675
PF-382,5284616,-4.488730736751072
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
KMS-12-BM,156422,3.026990510346846
MIA PaCa-2,44566777,0.7650908790499256
KYSE-180,11427553,3.160880704621236
ESS-1,46843906,3.355969876815747
AsPC-1,25126798,4.196072723195887
KMS-12-BM,9903786,0.6537757100604409
SK-UT-1,5470400,0.3907308309201836
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
HCC2108,44507138,1.6442706606036075
LMSU,17755052,3.9730762231411703
SNU-423,2742550,3.778188563180187
HSC-3,9866186,-0.1394143358773219
ESS-1,6918878,4.817127721204009
SNU-423,676352,1.6973821345572693
SW1783,7251185,1.718988263559794
H-STS,25262965,-3.423231216338223
HSC-3,5978,-1.2997783390438526
Mono-Mac-1,44493952,3.7343174451902144
KMS-12-BM,carboplatin-etoposide (40-17 mol-mol),0.8739137522045413
BT 328,135398744,6.520469371663204
SNU-423,448949,2.1424419878841756
OAW28,15953870,5.078636607909671
ACC-MESO-1,136227924,3.807440016829928
BT 286,24785538,-1.6779940438439616
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
WM793,24748573,4.504607526938656
PE/CA-PJ41 (clone D2),72376,-0.3106711811041045
Kasumi-2,9967941,2.996370075692804
Namalwa,56963564,-0.1426634179014898
Ri-1,11238147,1.7540053934106563
ACC-MESO-1,16038120,1.156287682803386
OAW28,2729026,2.5871569751548047
Ri-1,73707398,0.2154037021026328
Namalwa,3385,2.140825833931489
KYSE-450,9907093,5.309173304412392
HEC-108,262093,2.510970460452122
BT 248,7251185,2.921625124470224
Karpas-422,446155,2.8317664081108687
HuT 78,107985,-4.626222476681204
BT 286,119607,5.752743449749315
SF539,4261,3.034812096929495
OAW28,44491742,4.754653012158477
ESS-1,3503,2.154082374677134
RKN,11427553,3.6372919842764424
NOMO-1,11626560,1.0628914473501356
HEC-108,107970,2.8725679938480817
SNU-886,71304818,2.0640703956829003
ChaGo-K-1,409805,3.8445782197925022
SF539,vorinostat-navitoclax (4-1 mol-mol),1.4705483951350276
HEC-108,vorinostat-navitoclax (4-1 mol-mol),0.2481940777627734
RKO,24856436,0.2423564692967549
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
WM793,3634881,3.628870809117573
RT-4,24180719,5.152911409441223
Karpas-422,doxorubicin-navitoclax (2-1 mol-mol),-1.5981473164277809
SNU-423,637858,2.0123731637810875
NCI-H2030,11238147,3.895551084717726
PE/CA-PJ41 (clone D2),45279963,3.8380832697665217
HSC-3,57519531,1.7430503426578488
Ri-1,54639665,5.943871116773062
ESS-1,969516,2.694807880886465
MJ,135875424,3.3337154689139914
Kasumi-2,426756,1.7072417198911318
Namalwa,11396600,2.5581294543218616
CML-T1,568763,0.104759642693247
SW1783,11404337,0.7381457579106708
RKO,11222830,1.6656419736189183
Becker,2828334,6.24127035036214
SNU-886,3038522,3.968715088935437
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993
HSC-3,6917907,-5.720511046177551
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
ESS-1,5282054,2.6666271713695906
ACC-MESO-1,4378219,4.550142070750771
AU565,6610216,3.647426232490327
SNU-119,4259181,-0.8929687482279648
Ri-1,12001922,2.5045482624061552
RT-4,6505803,-1.736360108528808
SNU-886,46907787,3.408086497020091
HuT 78,11238147,3.7315717543629057
KYSE-450,49793307,-1.8889821153375816
BT 498,613753,4.782193759336145
ESS-1,SNX-2112-bortezomib (250-1 mol-mol),-1.8592325691556872
ChaGo-K-1,11507802,1.056587148436248
Mono-Mac-1,448949,1.4047243456978296
LMSU,16659841,3.696369337873645
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
Kasumi-2,72199292,0.0568572050486096
NCI-H1339,17755052,2.4500760972098785
EHEB,6918736,-2.350232551992923
SK-UT-1,676352,1.600998738511555
HSC-3,selumetinib-UNC0638 (4-1 mol-mol),4.596860577258544
EHEB,176870,3.9888726880158054
Kasumi-2,216239,2.0875832120118605
Lu-65,25062766,2.685201295328945
EHEB,5113032,4.507896458249702
HOP-62,BRD9876-MK-1775 (4-1 mol-mol),4.491099162688316
HuT 78,selumetinib-decitabine (4-1 mol-mol),-2.9552795966960823
NCI-H2030,vorinostat-navitoclax (4-1 mol-mol),2.0180777261594463
CML-T1,49793307,-4.188413118061572
HOP-62,2729026,3.06200446811759
RT-4,49850262,5.649428604777749
Ri-1,451668,0.865663462706742
EHEB,656346,0.7724879117712764
KMS-12-BM,3136844,3.1587649853094795
Kasumi-2,5328940,0.1344355450802072
MIA PaCa-2,53495165,-1.0987819755309485
SNU-886,2858523,3.0096792141672837
LMSU,salermide-PLX-4032 (12-1 mol-mol),5.363735492393686
EHEB,54649381,3.7669466213883425
RT-4,54613361,0.2615829847949534
CML-T1,10302451,-1.0288409878116755
IST-Mes1,136227924,2.313131576565863
MJ,5460769,-0.0196671860810318
SW1783,9911830,2.094357885918856
SNU-886,72193861,1.870912317242216
IST-Mes1,2871966,0.3614602719279896
SNU-213,168312962,4.562373659336835
SNU-119,36314,-3.9355379366515586
CML-T1,2858523,2.0919777443937715
BT 328,12003241,0.43959296828198
Karpas-422,11167602,5.140993072754682
NCI-H1339,6505803,-2.1203038529931857
Kasumi-2,5287620,-1.535744105024607
NCI-H929,navitoclax-gemcitabine (1-1 mol-mol),-2.8250972812481714
HOP-62,71304818,2.773626162825868
AU565,9866186,0.5690553044247834
AU565,11222830,1.6780695218323665
RKO,54626689,4.750442055573677
NCI-H209,9915743,-2.0620663235985797
HEC-108,168313047,3.5343278963000033
ESS-1,262093,3.0427773228942057
KYSE-450,11167602,4.298081277499996
LXF 289,6610216,3.700752852024682
NCI-H1339,46215462,3.074364246378648
Mono-Mac-1,24785538,0.7882917783042087
SNU-423,4521392,4.30152676997697
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
IST-Mes1,9933475,1.3564169932051346
KMS-12-BM,UNC0638-navitoclax (1-1 mol-mol),-0.7236362684252565
ChaGo-K-1,11427553,2.807543556240953
LMSU,2858523,3.056643520102809
AsPC-1,9926054,1.8957621767397328
NCI-H196,3062316,3.4269696902087965
HEC-108,piperlongumine-MST-312 (1-1 mol-mol),1.556813220853092
KLE,6918837,-3.4864458388429416
PF-382,49766530,-3.617209334662046
Ri-1,6918837,-5.1970473220815965
LXF 289,675434,4.434927450149955
IST-Mes1,16065773,3.0641757349077925
HOP-62,11152667,-0.1983015993822777
HuT 78,11964036,-0.1137295311814781
KMS-12-BM,439501,-2.5993845366115016
BT 286,6438330,1.1975316745843965
OAW28,654092,-1.8070222863139416
BT 320,3634881,4.591305105456608
Kasumi-2,135398738,1.5778578151552838
SNU-213,6610216,4.06770286109328
EHEB,9967941,3.291160377443194
SK-UT-1,5738263,2.328132593934741
IST-Mes1,4578,4.452023444310014
KYSE-450,6610216,4.803414401111398
H-STS,327653,2.5353230161110014
WM793,4261,1.9169510803510963
KMS-12-BM,54143018,-1.751115897433141
NCI-H929,6252,0.9780799453656184
Kasumi-2,675434,3.537694279705698
Ri-1,135398516,-0.9997229127952316
BT 286,11178236,-5.080102511527813
BT 286,46224516,1.3699390915436929
H-STS,10410894,3.204211008569323
MIA PaCa-2,54618305,4.257702417709433
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533
SNU-886,123631,3.0273089025763817
AU565,23582824,-0.1593812680979049
RT-4,16722836,1.304866960728928
AU565,11152667,-0.8659767610796402
MJ,5281321,1.2441841726389662
LMSU,445643,3.9937426860066982
Ri-1,168313200,2.421861912259082
RERF-LC-MS,52947716,-5.597592816818683
Becker,16065773,3.089193480337579
ChaGo-K-1,23582824,0.7783531266666978
RERF-LC-MS,54618164,3.9158352593779377
RERF-LC-MS,54143018,1.1379926617289184
OAW28,208908,1.9779710002494069
NCI-H2030,10302451,2.0984974298740484
HuT 78,11717001,2.148899417206966
SNU-119,doxorubicin-navitoclax (2-1 mol-mol),-1.1544106992080023
SK-MEL-5,1242560,4.359269086710968
Ri-1,16065773,0.7521068096426003
SNU-886,2708,4.666368688758876
HuT 78,9866186,-0.7405908316391746
AsPC-1,409805,5.083096669481897
SK-MEL-5,4917,3.0625088748071656
KMS-12-BM,11213558,1.176856532865763
RERF-LC-MS,285033,-2.0574538896256587
PE/CA-PJ41 (clone D2),3081361,1.7117945154872471
MIA PaCa-2,9956119,3.801226375239901
IST-Mes1,4096211,2.0722665154973052
RT-4,44607530,3.804226542421099
PF-382,alisertib-navitoclax (2-1 mol-mol),-3.018293825143377
RERF-LC-MS,216468,3.2358353560937267
Mono-Mac-1,387447,-4.177588984938143
HCC2108,16722836,1.4931143772418354
HEC-108,26596,-0.981636576627464
BFTC-909,16038120,1.74161234898449
RKO,6918328,0.803085247134139
RT-4,9929138,7.578104590024713
PE/CA-PJ41 (clone D2),tretinoin-navitoclax (4-1 mol-mol),4.488669009711073
SNU-213,24951314,1.6516092011379235
PE/CA-PJ41 (clone D2),10385095,0.9808392410745812
IST-Mes1,135398738,4.689828903809361
Ri-1,9911830,1.4351255803096743
HOP-62,753704,5.052379590990168
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
Karpas-422,24964624,-1.061360838070699
HOP-62,11178236,-4.948356936614416
MIA PaCa-2,5281321,-2.236046377402632
ESS-1,11626560,2.39928314153679
ESS-1,10385095,0.0154495368261296
CML-T1,3385,2.6066574492649184
SNU-119,5566,3.0036278847764923
SW1783,219104,3.206819219402643
KMRC-20,9903786,3.936421872110463
AsPC-1,135421197,1.8824248695595285
Becker,5281321,-1.5139545464417634
KLE,serdemetan-SCH-529074 (1-1 mol-mol),1.7024898854961308
Kasumi-2,2828334,5.794074438385768
NCI-H1339,4788,5.9220808605874256
RERF-LC-MS,148198,-3.5927713028936834
SK-UT-1,7326481,2.0066663774179108
SF539,2828334,6.046575048370249
LMSU,erlotinib-PLX-4032 (2-1 mol-mol),3.803932013345548
SK-MEL-5,4477,1.0694476690172137
BT 498,25161177,3.959327779504269
HEC-108,3503,1.40407452628706
MIA PaCa-2,11625818,4.432768975944194
KLE,46907787,0.6768942529427939
KYSE-450,10184653,1.1641913359919105
RKO,2841722,4.522769482159767
MIA PaCa-2,135659046,3.7193443303471727
H-STS,135875424,3.212810522479317
KLE,252682,6.230481421217852
SNU-886,5702613,4.595415249382652
AsPC-1,5460769,5.795061807453513
HuT 78,675434,4.061234501182394
HSC-3,11964036,1.6239434474378724
BT 498,5281321,2.76295217428265
SNU-119,2858523,2.542556177546106
AU565,60750,-2.174078373186638
KMS-12-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),5.565016030045443
LXF 289,54143018,0.7636513295056184
SNU-423,11626560,1.6493886052642734
PF-382,4788,5.110775522740739
Becker,36314,4.027610361260836
Karpas-422,285033,-4.28202596716821
SW1783,11427553,2.7214554119768253
Namalwa,227681,2.1728209408907295
AsPC-1,5738263,4.8764899816054905
RKN,216345,4.602972623005823
SF539,9926054,1.722417855539817
Mono-Mac-1,5280436,2.9762388958592707
SNU-886,49793307,-1.2846012118525447
BT 328,4259181,1.754792833603723
HCC2108,vorinostat-carboplatin (1-1 mol-mol),3.476281574567543
NCI-H196,6917907,-4.1817502536593
HOP-62,54618771,0.1660184306238314
SNU-119,135421197,4.049091304293704
AsPC-1,11707110,-3.3734075653106506
Karpas-422,54618771,1.0964695949683176
NCI-H196,9927531,5.55374615852481
SK-UT-1,1750826,-1.6569845659636762
Namalwa,11238147,1.4159052686917426
SK-UT-1,26596,0.4182972999713699
ACC-MESO-1,4477,0.0409070539342514
NCI-H929,119607,5.121308216855954
RKO,219104,3.7756995047121658
NCI-H196,448949,2.6638024526067
CML-T1,11214940,-0.4703282723698588
OAW28,322968,3.926433659329745
HSC-3,vorinostat-navitoclax (4-1 mol-mol),2.1572530061323523
CML-T1,3081361,0.8904525598046117
HCC2108,119607,5.317172466903883
SK-UT-1,11214940,1.922253876673372
Mono-Mac-1,54143018,-1.0580597648683372
SF539,135421197,1.037431947377599
KMS-12-BM,15983966,-6.367162129369465
KMRC-20,selumetinib-navitoclax (8-1 mol-mol),4.19466226338092
SNU-423,11494412,1.245479972676825
BT 248,56649450,1.4607260014057133
RKO,262093,2.7220373961576834
Panc 02.03,702558,5.477624163348055
SF539,44566777,1.5412322768682447
ChaGo-K-1,11640390,2.9098538749736833
ChaGo-K-1,5329102,2.841007298547535
PF-382,4915,5.4300848417035725
LMSU,vorinostat-navitoclax (4-1 mol-mol),3.537964387470637
ESS-1,5738263,3.9330786709823986
Lu-65,7251185,3.101114407523891
SNU-886,selumetinib-decitabine (4-1 mol-mol),0.1903285486813963
BFTC-909,12003241,-0.8371396827795129
CML-T1,6918837,-4.73728443815153
SNU-886,71680916,4.355410406943834
Panc 02.03,56649450,3.905458120664549
KYSE-180,selumetinib-BRD-A02303741 (4-1 mol-mol),6.582201455750035
RERF-LC-MS,24856436,0.2419222597799965
Lu-65,44566777,0.2365389638707438
ACC-MESO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.857628487891416
PE/CA-PJ41 (clone D2),selumetinib-BRD-A02303741 (4-1 mol-mol),2.2896148913317087
WM793,3854666,3.254480086465336
HEC-108,107985,-3.7063937347849696
Becker,3136844,4.385531960303477
ESS-1,104842,-6.678898835642602
RT-4,123631,3.0084600892391875
Becker,9911463,4.366530732677302
Namalwa,119607,5.137391391620056
BT 286,60750,-3.8919827883839937
KYSE-180,10113978,4.975324753626726
BT 248,9911830,3.0671224453630326
BT 286,24821094,3.0634317138315756
SNU-423,10302451,3.566969310878258
HEC-108,5566,3.7962472662927143
AsPC-1,23582824,1.2589428940506815
NOMO-1,3854666,1.0231806307237967
OAW28,3854666,2.969576020962734
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
LMSU,11640390,3.606539387611797
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
ChaGo-K-1,11228183,3.5565369410830887
PE/CA-PJ41 (clone D2),selumetinib-piperlongumine (8-1 mol-mol),3.1639027929740977
H-STS,10385095,1.1550393753572457
SF539,10127622,4.044481500829827
ESS-1,44202524,1.7594814112354966
SK-UT-1,15547703,4.119517534228275
LXF 289,52912189,-0.1394416798850269
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
KYSE-180,135411,0.6343145122787996
KMS-12-BM,44185566,1.0129713840485208
SF539,439501,-3.28606941940852
Mono-Mac-1,25062766,0.4601096632803972
Mono-Mac-1,10074640,3.3063713625163857
Kasumi-2,3038522,2.07744827479205
ESS-1,49766530,-0.3205579652733103
ESS-1,9825149,3.69415886776762
RERF-LC-MS,24753719,5.208830602571573
RKO,2858523,3.1569923390566332
LXF 289,24180125,2.8590757937383517
BT 498,53232,4.313794339780105
SF539,navitoclax-pluripotin (1-1 mol-mol),-1.4182272937250473
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
BT 286,54678924,1.5355225095604494
WM793,136227924,4.7819042035619255
MJ,11955716,-2.5618962222638575
KMS-12-BM,44507138,1.2526701604401855
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
ESS-1,11234052,5.5778807496063765
LMSU,9803433,4.684361429379855
ChaGo-K-1,36462,1.940737547002896
KMRC-20,5738263,3.585563727578386
SNU-213,16038120,0.5394155086125938
Lu-65,6918878,4.903767394022953
Karpas-422,6918328,-1.5024187814152252
BT 328,6505803,-1.1568571975604598
Mono-Mac-1,65628,3.8711624211456215
HuT 78,11404337,-1.1966282759274738
SNU-213,44185566,2.160657644781875
SW1783,5329102,3.5851018985132663
HuT 78,UNC0638-navitoclax (1-1 mol-mol),0.0082226538693411
BT 320,3503,3.052625173384868
NCI-H1339,tanespimycin-gemcitabine (1-1 mol-mol),-1.510356876239625
SNU-886,selumetinib-vorinostat (8-1 mol-mol),0.3326918028445991
ESS-1,126941,-4.948247383785425
KMS-12-BM,9866186,1.4538422549800163
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143
HuT 78,46224516,1.0193234135657596
KMS-12-BM,serdemetan-SCH-529074 (1-1 mol-mol),1.618935341635423
Karpas-422,44462760,1.042048322720737
HSC-3,6918837,-2.212600896181265
KMS-12-BM,135440466,0.2668313754655885
HCC2108,12003241,-1.7779849182593923
HOP-62,11317348,4.640311098885742
NCI-H1339,42642645,1.6149753620501943
HEC-108,navitoclax-sorafenib (1-1 mol-mol),2.4263859453349914
PF-382,36462,-0.7112012842580974
PF-382,4521392,4.102056118448562
IST-Mes1,9903786,2.7623614356082458
AU565,42642645,1.544546710659079
HEC-108,3815108,3.3299414273071273
AU565,135659046,3.967998335471068
HOP-62,25154868,4.686337763872305
BFTC-909,11485656,2.882750602975944
LMSU,11609586,4.078801405634202
KYSE-180,56963564,-0.5572024388331268
PE/CA-PJ41 (clone D2),11404337,1.298340763398175
AU565,148198,-3.941648532890003
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
PF-382,1242560,1.4811412739619612
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
NCI-H1339,387447,-3.859692304272627
ACC-MESO-1,46398810,3.3906393593614745
Kasumi-2,65628,2.2018759133614987
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788
KMRC-20,135440466,2.836143933224848
Mono-Mac-1,374536,0.5970051529194348
Lu-65,15953870,3.741719586955095
RERF-LC-MS,11719255,3.775646564562419
AsPC-1,637858,2.8111542457272605
Becker,53392493,3.211103768073299
NCI-H2030,navitoclax-birinapant (1-1 mol-mol),0.6953114998601013
AsPC-1,52947716,3.328482082087177
RKO,3503,2.683687073265507
Mono-Mac-1,9911463,2.4863663707883723
OAW28,16065773,3.4526029247448973
RT-4,9840324,5.695184545393867
WM793,3062316,1.9641420987669005
SK-UT-1,6184667,3.933294050011487
CML-T1,JQ-1-navitoclax (2-1 mol-mol),-0.3838204075177596
KLE,10231331,5.289162464767698
SW1783,148124,3.5822290901632545
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
OAW28,9884685,1.3567472374362477
NCI-H196,56946209,-3.322371827574061
HuT 78,3062316,2.376024867755132
RERF-LC-MS,135984461,4.284403636339015
RERF-LC-MS,5328940,2.240356815676024
MIA PaCa-2,16065773,1.640511461382333
NCI-H196,66577038,4.220953948603063
KLE,176870,4.949336345274128
ESS-1,2749,1.483117566277163
SNU-119,10302451,1.573205462567535
Kasumi-2,11494412,-0.1140662522158316
RKO,65064,4.5178366082525
SK-UT-1,5746,2.0150479755751425
HOP-62,9840324,5.857824813653661
CML-T1,11427553,0.3447104584156399
KYSE-180,25183872,-0.5863433825832977
AU565,4477,0.8975719043136093
SNU-423,53232,1.233628163391212
HuT 78,10385095,0.3743213193570641
PE/CA-PJ41 (clone D2),675434,4.34619521110513
LXF 289,4096211,2.4023988219433337
Mono-Mac-1,navitoclax-PLX-4032 (1-1 mol-mol),0.2984522529277024
NCI-H2030,5280436,3.82299409241294
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
H-STS,9908783,4.356832739470904
RERF-LC-MS,107985,-3.0933260647006215
BT 498,JQ-1-navitoclax (2-1 mol-mol),1.0517743513764657
AU565,24748573,1.9131971710517224
HuT 78,568763,0.026722170308136
NOMO-1,135398744,6.340708200805823
Ri-1,66577038,2.5588645698684807
KMRC-20,2708,5.098804144930118
HOP-62,3062316,-0.1499106985099995
SK-UT-1,carboplatin-etoposide (40-17 mol-mol),2.668759687344188
NCI-H929,135875424,3.2591057623275006
KMS-12-BM,421610,2.052297409032463
LMSU,6450551,2.7750286997333515
Kasumi-2,54619267,3.817493003311882
Karpas-422,71466380,4.4193301914367185
PE/CA-PJ41 (clone D2),135999136,4.2765037519460565
Karpas-422,11507802,1.0681748147748091
NCI-H196,11485656,3.8330163114503337
NCI-H2030,452548,0.7027193175453731
CML-T1,56946209,-4.816302217893272
MIA PaCa-2,135999136,4.438724153803844
NCI-H1339,57519531,2.1207390625581968
ChaGo-K-1,25102847,2.843403225598923
Karpas-422,12003241,0.4573968210074843
MIA PaCa-2,3689413,-2.455927464924985
OAW28,252682,6.460081465786461
EHEB,3815108,2.965320927013124
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
ESS-1,11507802,2.580294278940104
SNU-423,241158,3.874082799654454
HEC-108,navitoclax-pluripotin (1-1 mol-mol),-0.960955516945734
RKO,11640390,5.295981617059328
HCC2108,44589607,3.0217801905225365
RKO,5287620,-1.9975210326345276
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
NOMO-1,9927531,5.049638663441057
NCI-H2030,3384730,4.123453898598414
KMS-12-BM,10231331,5.965261420703939
BT 286,42611257,5.657257060628102
SF539,73707398,1.0308821565374424
BT 498,135999136,3.3192669973744273
KMS-12-BM,navitoclax-pluripotin (1-1 mol-mol),-1.9896147371140072
KMS-12-BM,2841722,2.937327067206498
SK-UT-1,65064,5.311545954072784
Ri-1,10113978,1.818759778383803
PF-382,9825149,1.7969028915446674
CML-T1,6610355,4.414519429527798
BT 286,BRD9876-MK-1775 (4-1 mol-mol),1.848774169614639
SW1783,9956119,4.824776064092986
NCI-H2030,5281321,-1.9340682809287928
IST-Mes1,serdemetan-SCH-529074 (1-1 mol-mol),2.635765253356215
HSC-3,44259,0.63507415156471
Kasumi-2,168313016,3.99242446715415
BT 320,24797083,3.954904976663047
RERF-LC-MS,4578,4.625372786711685
ESS-1,16725315,4.522564141114606
NCI-H2030,11222830,2.304040670550321
OAW28,148124,5.441417229348929
SNU-423,54454,0.6144277931079349
BFTC-909,9927531,5.31835549136936
HOP-62,11455910,0.5971366632673413
AU565,3025944,3.700689922668097
EHEB,73707438,3.85222556690395
NCI-H196,24964624,2.7632019893764124
RT-4,676352,2.39607769576444
MJ,5470400,1.1074139352068628
BT 328,5311,4.9120281347164525
HEC-108,66577038,3.3902057561836436
BT 328,11364421,2.7356800342957777
Karpas-422,23635314,-3.907281565392564
LXF 289,24797083,1.462636821965973
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
KYSE-180,11507802,1.642318486353166
SF539,56946209,-5.157192597253952
KLE,53232,1.234342412255229
HEC-108,24951314,2.044375448042514
KYSE-450,219104,4.59986524517568
Ri-1,1641662,2.4942223839776463
SK-MEL-5,16736978,1.3366068727007083
HuT 78,16722836,0.3632946203875747
ACC-MESO-1,11404337,0.4174226395883805
NCI-H929,452548,-1.297254287564457
Panc 02.03,4578,4.394890119629889
Mono-Mac-1,11238147,2.129695973361118
OAW28,9907093,4.094861416701174
KMS-12-BM,637858,0.99115660334439
NCI-H196,44589607,3.0896712074396895
WM793,15547703,2.941015852165493
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
Mono-Mac-1,3062316,0.1210141261163289
SK-UT-1,2746,4.836098417840603
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557
Ri-1,445643,0.8767098375675455
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
Namalwa,71466445,4.063090897069234
BT 286,9549297,1.6241378099255253
LXF 289,2708,6.094251503540483
SK-MEL-5,6610355,5.037380249558903
NCI-H929,5978,-3.149795005815329
HuT 78,6914657,-4.847386491977826
NCI-H2030,11612883,2.4957659850651774
HEC-108,navitoclax-MST-312 (1-1 mol-mol),0.398713254172199
HOP-62,salermide-PLX-4032 (12-1 mol-mol),4.05448827815528
SNU-886,2126,2.9580246654622275
EHEB,1641662,3.4928026962929075
SF539,107970,2.309030481029931
KMS-12-BM,3503,1.8657686630799155
Karpas-422,54619267,4.140871616777423
SK-MEL-5,6918328,-0.2289900507197424
SNU-119,409805,3.7561778624984585
RERF-LC-MS,44486219,4.018485879154908
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
Lu-65,8515,3.512181420890395
SF539,246676,6.084250396214504
AU565,24951314,-0.2220635763258615
Lu-65,navitoclax-sorafenib (1-1 mol-mol),1.3439919091242982
CML-T1,46191454,-1.3100798451488396
BT 498,16219061,3.633329359759088
AsPC-1,16720766,4.029008761480653
Lu-65,16065773,3.747390125773909
NCI-H1339,2733487,7.603904657833405
HOP-62,73707371,2.551931688807385
LMSU,3634881,3.35269539341832
Ri-1,navitoclax-sorafenib (1-1 mol-mol),-2.8508296212987223
BFTC-909,568763,0.745825262149274
BT 328,71729975,3.0990455270892365
HSC-3,decitabine-navitoclax (2-1 mol-mol),2.62326284379121
H-STS,57519531,1.7536520840543603
CML-T1,11228183,0.9343365693589996
ACC-MESO-1,6918328,1.0135488660695875
SK-UT-1,36462,1.790037225485122
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
SW1783,JQ-1-MK-0752 (1-1 mol-mol),2.969975074260421
NCI-H929,613753,3.174052302519367
SNU-119,2945648,1.887531870064612
EHEB,24856436,0.0947774634089656
NCI-H196,24180125,2.7124009343781665
Karpas-422,11626560,1.2123192441609394
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
BT 498,5329102,2.4000610555700885
NCI-H929,1750826,-3.89812639428639
HuT 78,1566236,0.8672075486868017
Lu-65,6505803,-2.14133792645673
Mono-Mac-1,9952709,2.6915799998926966
LMSU,6852167,2.6209493875982277
BT 286,23582824,0.769238844518323
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
Kasumi-2,100016,5.973936097539331
EHEB,24753719,3.508920403296929
Kasumi-2,135423438,1.5853456579896534
ChaGo-K-1,15953870,3.0294240657930955
SK-UT-1,16725315,3.0339469216482127
HOP-62,24772860,-2.449488462755842
MIA PaCa-2,24753719,4.169307227992716
IST-Mes1,135440466,1.140650487435685
BT 286,11625818,4.774350290702803
ESS-1,10231331,5.566440371270769
HOP-62,10172275,5.618844279452778
MIA PaCa-2,54619267,3.838868317387971
Namalwa,451668,-2.1603727921767666
BT 286,11364421,-4.053062558323996
PE/CA-PJ41 (clone D2),216468,4.149233535755013
HOP-62,11167602,2.5582425778829356
BT 286,4917,2.072486515780226
AU565,23725625,4.73732544358888
KYSE-180,selumetinib-JQ-1 (4-1 mol-mol),4.706272098527088
ESS-1,24753719,4.181647881164435
NOMO-1,5280436,3.413613220161409
CML-T1,selumetinib-tretinoin (2-1 mol-mol),2.254120654073675
SNU-423,11955716,-1.3120452604292694
NCI-H2030,navitoclax-sorafenib (1-1 mol-mol),1.3272751544111323
Panc 02.03,53392493,3.617637281515077
SNU-423,24951314,1.7762274267173075
PF-382,9549297,1.2295304859743053
SF539,3081361,1.6013360559039176
Becker,322968,4.664074347969188
ChaGo-K-1,9840324,5.755771001589306
BT 328,25183872,0.4527606216465452
SK-MEL-5,637858,2.5788242810991537
Mono-Mac-1,439501,-2.692243954974466
ESS-1,445455,4.4559986013916815
WM793,54619267,5.3024181995472635
SNU-119,15983966,2.01130055779656
Kasumi-2,375860,-0.7090394918812726
H-STS,11214940,-0.2831016216432358
NCI-H1339,44491742,4.759108525431012
ESS-1,984333,0.2604103930211148
WM793,9956119,2.719502921417229
EHEB,12001922,1.634649199110844
SF539,227681,3.913765849966807
ESS-1,54626689,4.894766460355583
SW1783,selumetinib-JQ-1 (4-1 mol-mol),4.8105600035571126
NCI-H929,5287620,-2.9527713293437734
BT 498,11719255,3.558741439213583
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445
KYSE-180,3825829,3.0319007091325267
ACC-MESO-1,16722836,1.9772459884622784
ESS-1,11656518,2.306800559161758
HEC-108,11485656,3.338600175698492
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
Mono-Mac-1,168313016,3.482496352370787
RERF-LC-MS,12003241,-0.3897829713203344
CML-T1,25154868,3.739287072403725
BFTC-909,5311,1.6846521587280363
BT 248,613753,3.1927723368663976
Karpas-422,54618164,3.784290437567208
Lu-65,4096211,2.271037978717641
BT 320,25150857,3.33324545252111
LMSU,44487872,4.479427716264116
ESS-1,426756,3.7262870837192503
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
Karpas-422,216239,3.091609126676661
ESS-1,11238147,2.0354593401256382
SF539,vorinostat-carboplatin (1-1 mol-mol),2.36336585394669
KYSE-450,374536,3.719128608597957
EHEB,53232,2.0797733628932
SF539,6918837,-1.7926544447707695
Becker,45279963,3.89874578276641
Becker,10074640,3.78121889041583
MIA PaCa-2,57519531,3.173906038307624
Lu-65,322968,4.84113499629306
MJ,42642645,-0.910764146609361
HOP-62,9887053,4.379241554178957
OAW28,5281321,-1.4060991234994806
OAW28,2858523,3.071437644261336
ACC-MESO-1,42642645,1.530706527419768
HuT 78,3025986,-0.0982635511462348
OAW28,24964624,1.7856613849766505
BT 248,5479543,3.7849708026150406
BT 328,2126,6.023692748820712
KMS-12-BM,decitabine-carboplatin (1-1 mol-mol),-3.2192264428924755
RERF-LC-MS,4259181,-1.273108977623296
KLE,2708,3.7521843050752457
IST-Mes1,16736978,2.528104664048346
KLE,11364421,-3.6177571319013455
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
OAW28,6852167,2.294169410796982
BT 498,216345,4.450396918440382
KMS-12-BM,6610355,3.820739817382138
SW1783,24771867,4.842203084909567
ESS-1,9823820,4.0277339286187
KYSE-180,6918878,4.793960218409927
BFTC-909,10302451,3.622269240471498
Ri-1,navitoclax-piperlongumine (1-1 mol-mol),-3.5258320570039285
SK-MEL-5,23582824,0.6417142351505073
AsPC-1,1641662,3.9838157290035
NCI-H929,159324,1.2295170877350825
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
SNU-423,123631,3.30108094965045
SNU-119,44589607,2.031679026028789
KMS-12-BM,selumetinib-navitoclax (8-1 mol-mol),1.0992303518305886
BT 286,10074640,2.3159474451917452
RKO,10231331,2.816804700080647
PE/CA-PJ41 (clone D2),400769,-0.2880595320475859
SW1783,selumetinib-PLX-4032 (8-1 mol-mol),4.758526701715075
BT 248,11497983,5.371692371312494
Karpas-422,11485656,3.579952167071255
SNU-423,644241,4.521136945345214
NCI-H1339,46843906,4.205971108333302
NCI-H196,71466445,5.320372938858583
KMS-12-BM,4477,0.337852436385288
HOP-62,6918837,-2.6537320914215705
SF539,1239801,4.247259889123834
EHEB,BRD-K03911514,2.273371159476054
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
RERF-LC-MS,57519531,1.5399611647939
EHEB,4378219,1.3108988632273402
KYSE-450,1242560,3.7226437458360895
NCI-H1339,6610216,4.6247766816350495
PF-382,24772860,-3.0726224407745435
HEC-108,9903786,3.9980769668892706
RKO,11497983,5.954072388877685
RKO,9911830,2.9376280530386123
SF539,selumetinib-tretinoin (2-1 mol-mol),2.8969216636074635
BT 286,selumetinib-decitabine (4-1 mol-mol),-0.5242434333966475
PE/CA-PJ41 (clone D2),navitoclax-gemcitabine (1-1 mol-mol),-1.557578844999666
MJ,421610,3.5833092727741427
Mono-Mac-1,73707398,0.6980623217810987
Ri-1,56963564,-0.683540701908738
BFTC-909,4261,3.835594401773327
Kasumi-2,2945648,2.1908336830751436
KMS-12-BM,16038120,-1.4386618861105946
H-STS,11609586,0.7770634294621763
ACC-MESO-1,49793307,0.3404426654654701
NCI-H2030,2729026,3.166677954271788
SF539,16065773,1.5731134772148812
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
BT 498,54618771,3.343910197755889
NCI-H196,11427553,3.4194506465962977
SF539,11955716,-1.5322335585538187
AsPC-1,56973724,5.500241353025212
H-STS,637858,1.1585331861261023
PE/CA-PJ41 (clone D2),54454,3.556753106123293
KMS-12-BM,erlotinib-PLX-4032 (2-1 mol-mol),2.242242916875039
OAW28,11175137,3.6697867992343607
ChaGo-K-1,1242560,3.30727018349844
KLE,10074640,3.248880197029389
Namalwa,216239,1.624905694563111
SNU-886,11213558,0.3239659195711419
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914
RKO,675434,4.252493680505022
SNU-119,49850262,4.203409740866064
Ri-1,36462,-0.3836251292851517
KMS-12-BM,24753719,3.8340594609092
Lu-65,44543605,5.217530079977961
ChaGo-K-1,5287969,-1.0782192014553775
SNU-423,5287620,-0.5057300619999656
SNU-119,selumetinib-JQ-1 (4-1 mol-mol),2.003564395289463
HuT 78,5743,-2.915718812288148
BT 286,11167602,0.1521684661712007
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
Namalwa,9915743,0.490557645352366
NCI-H1339,5351362,1.1725984936880274
OAW28,89928392,1.6809049325642302
HSC-3,4788,5.36548063999016
BT 286,25183872,-1.583688881910038
RKO,5291,3.391339544898264
HOP-62,selumetinib-navitoclax (8-1 mol-mol),2.307851384246924
SNU-423,46191454,1.8759847872608528
RKO,46398810,2.934390735401444
LMSU,4917,3.70267650395279
NCI-H1339,568763,0.4787351372359879
RERF-LC-MS,119607,4.38818595494476
AsPC-1,104842,0.0602967281328717
HuT 78,5282054,1.191616800468705
HuT 78,44819697,-0.2139990316964177
SF539,9907093,3.8198522822567655
Kasumi-2,3854666,0.5999676074569762
RKN,53392493,3.005817826052642
NOMO-1,11152667,-1.8753376491976492
SK-UT-1,selumetinib-piperlongumine (8-1 mol-mol),4.6362910530737595
Kasumi-2,6852167,0.8229890671000598
Kasumi-2,135999136,3.771420948620172
SW1783,46199207,2.830132612084652
AU565,444795,4.595530435398324
NCI-H929,444795,0.5078215400494521
Lu-65,135411,0.4933451720371167
MJ,219104,2.3503160587955647
Panc 02.03,45279963,4.323488067826322
HCC2108,23725625,5.803627153290559
KMS-12-BM,2949965,2.1073962260494348
IST-Mes1,doxorubicin-navitoclax (2-1 mol-mol),-0.5203692654605504
Karpas-422,JQ-1-vorinostat (2-1 mol-mol),-1.372676579050444
MIA PaCa-2,613000,2.1639468020666826
WM793,11404337,-0.7690985454206903
Becker,navitoclax-piperlongumine (1-1 mol-mol),2.5229326011074567
Becker,navitoclax-gemcitabine (1-1 mol-mol),-0.9834702537896932
Ri-1,carboplatin-etoposide (40-17 mol-mol),0.6778426114886354
CML-T1,65628,2.7154825762494057
HSC-3,44819697,-1.2152124180192134
Kasumi-2,135875424,2.5938758238859494
NCI-H196,6918328,0.149769113265571
LXF 289,9926054,2.043368643335034
EHEB,66577038,2.720898706959581
Ri-1,119607,3.524560001231187
RKO,16722836,2.0172870973895085
NCI-H1339,11222830,1.781857962831655
AsPC-1,25227462,2.9060868065293195
SNU-213,tanespimycin-gemcitabine (1-1 mol-mol),0.7260002272239208
KMS-12-BM,11640390,-0.5684033392466148
PF-382,10427712,3.727131590251748
RKO,4705,3.750134101835121
OAW28,327653,3.155680016062074
HCC2108,SNX-2112-bortezomib (250-1 mol-mol),-2.1987674626028504
LXF 289,4705,5.10311909598278
EHEB,49793307,-3.85106101427491
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
SNU-423,24821094,2.9581810311098176
NCI-H196,5281321,2.863278470278903
BT 320,25227462,3.0496366497602025
Namalwa,5291,3.7006229898027128
NCI-H2030,10074640,4.267882831955008
AU565,119182,0.402305157716339
Ri-1,BRD-K03911514,4.2263735934291775
SNU-423,135875424,3.328445896940313
CML-T1,5282054,3.0197566265123754
OAW28,219104,3.640461878438656
BT 320,54678924,3.6890866492224106
NCI-H1339,5746,0.6163516648320136
ChaGo-K-1,5738263,3.7956881789600168
ChaGo-K-1,1750826,-1.5272683487068526
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
RT-4,159324,1.8094112077356237
SK-MEL-5,10074640,3.1391211801993806
KMRC-20,439501,-2.469138258710991
Kasumi-2,67156097,-2.3799018148926363
LXF 289,9911463,2.935801973679381
Kasumi-2,374536,-0.2175337956908027
Mono-Mac-1,9935249,2.3948099372524965
ESS-1,19582717,4.154053780498712
HOP-62,11234052,3.9644322290477305
AsPC-1,123631,3.3144447888973048
KYSE-450,2871966,1.4934903304989255
Namalwa,9935249,0.8927496794896076
ACC-MESO-1,1750826,-0.1495576178007003
SF539,11625818,4.190042053470209
RKN,11497983,4.544575984994342
RKN,10127622,5.371150210721622
EHEB,11427553,3.092795318424686
KLE,10184653,1.244487800757798
ChaGo-K-1,24748573,2.5402055759228364
KLE,6917907,-6.139157013602895
PE/CA-PJ41 (clone D2),9911463,4.289796480511007
HOP-62,9935249,3.1113084784743
AsPC-1,1566236,2.844580785967763
LMSU,25102847,2.404236783403615
NCI-H1339,46224516,4.957875644044714
PE/CA-PJ41 (clone D2),3543504,4.90695304156819
Ri-1,25102847,1.6589673431928054
BT 248,17755052,0.6696435234843453
SK-MEL-5,25154868,3.9897594746456098
ACC-MESO-1,5351362,2.4055173887272496
Ri-1,5281672,2.461757068656666
BT 498,400769,-0.381234378827963
HEC-108,5278396,3.63044129466019
MIA PaCa-2,4378219,1.989659969490472
RKO,89183176,-5.254565057669901
AsPC-1,8515,4.986545700595871
SF539,25105715,3.397362341594616
SNU-423,2828334,6.005008017468347
KMRC-20,16725315,4.64742637635284
Panc 02.03,11626560,2.1710424521283427
ACC-MESO-1,selumetinib-MK-2206 (8-1 mol-mol),3.944415523130493
IST-Mes1,tanespimycin-gemcitabine (1-1 mol-mol),1.7121373731851923
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581
AU565,71466445,4.046585104708946
RKN,11640390,3.613472996393559
SF539,3384730,1.03759179550133
BT 328,71304818,3.21596633578744
SNU-423,65628,4.328235834084208
AsPC-1,11626560,2.2683411612930637
HSC-3,53232,1.9828236974708795
LXF 289,71680916,5.339150924844951
NCI-H929,11507802,0.9864152558176
SK-UT-1,11427553,3.3051570066468248
Kasumi-2,52947716,-3.704060756771708
LXF 289,53232,1.5859701947912777
Panc 02.03,71304818,4.256945507775637
Mono-Mac-1,6852167,1.1013775883292647
BT 286,400769,-0.6076188000996261
SW1783,66577038,3.5105114202230396
HuT 78,5470400,1.1962895680163173
SK-UT-1,5282054,3.4735400684673077
IST-Mes1,4259181,1.4706848514509867
LXF 289,6438330,5.338014468481796
SNU-423,3025986,0.0846204421525102
SK-UT-1,6914657,-5.220536780204265
BT 248,448949,1.935087924253196
HSC-3,5460769,0.5796773846600773
Kasumi-2,24180125,1.6711646659047346
Lu-65,25195348,2.2063642677239
Kasumi-2,119607,5.143919911790516
Kasumi-2,9915743,-0.5759730647314978
LXF 289,9907093,2.975231625485398
SNU-423,5311281,1.00024651229924
MIA PaCa-2,44185566,2.358125757500078
LMSU,375860,0.9440264058556476
PF-382,selumetinib-PLX-4032 (8-1 mol-mol),4.556490015738598
SF539,1285940,2.084694719582332
OAW28,23725625,6.509051762822527
SNU-119,23725625,6.436017901271369
IST-Mes1,alisertib-navitoclax (2-1 mol-mol),2.2852376454563896
EHEB,navitoclax-pluripotin (1-1 mol-mol),-1.9165707205627271
RKN,44137675,5.459450119186335
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
Kasumi-2,42642645,-0.9002721123779656
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306
LMSU,54596558,4.409593333652482
MJ,25183872,-3.3306106480928683
SK-UT-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4516773204775215
AU565,25154868,3.4836730381065424
BT 498,216239,4.010979166713856
PE/CA-PJ41 (clone D2),3038522,3.4117410479416432
NCI-H209,1750826,-3.5869009293489507
SNU-423,44607531,1.5801842386267164
ChaGo-K-1,3503,2.0887417789054847
OAW28,71466380,4.3449274646859495
NCI-H1339,44486219,3.922591489913905
ESS-1,25183872,-2.0695789812237058
BT 320,135875424,3.1120862947515255
MIA PaCa-2,107970,1.625165459581556
LMSU,462382,0.7289653516874284
NCI-H2030,5287620,-1.3151289536016495
ChaGo-K-1,151289,0.8276592767141736
HOP-62,5494449,2.5914632586944757
BT 320,439501,-1.927418392306892
EHEB,3689413,-1.930959129148268
SNU-886,navitoclax-gemcitabine (1-1 mol-mol),-7.729946623130621
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
HCC2108,10427712,4.666619490685044
Becker,25150857,3.3425977387372385
BT 320,2729026,2.399631543883215
Kasumi-2,5351362,0.8391907710572402
OAW28,252682,6.460081465786461
KMS-12-BM,42642645,-0.399689528391991
RERF-LC-MS,25102847,0.6953191965745218
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
Namalwa,65064,5.205979247876378
NOMO-1,44819697,-3.3724853213010895
ChaGo-K-1,2733526,4.06837326515645
BFTC-909,124202324,2.9321657702899295
Lu-65,3385,6.707810534579362
MIA PaCa-2,5287620,-1.6803051400762947
NCI-H1339,11964036,1.884295102990518
Lu-65,44607531,1.435733537882106
HuT 78,5284373,3.1403236788776314
KMS-12-BM,crizotinib-PLX-4032 (2-1 mol-mol),1.6093595565016696
RERF-LC-MS,322968,4.758979615786181
SNU-119,11175137,3.479199701022153
SF539,11657048,3.82012123465622
OAW28,44607531,1.5392912313773788
Kasumi-2,3011155,3.05813684599445
MIA PaCa-2,11234052,4.196582036386762
Mono-Mac-1,9825149,1.1152139328912305
ChaGo-K-1,9952709,3.267431153016336
BFTC-909,6184667,3.207156937684644
SK-MEL-5,ISOX-bortezomib (250-1 mol-mol),1.3006689889653265
SF539,9903786,2.8297220739955993
PF-382,984333,-1.854257938200321
PE/CA-PJ41 (clone D2),10427712,5.991443692046267
NOMO-1,10113978,3.435868796737405
WM793,navitoclax-piperlongumine (1-1 mol-mol),2.3781458373034976
NCI-H2030,72193861,2.967483909024043
H-STS,1716436,2.174736460628774
SK-UT-1,54618164,4.334674071191232
SNU-886,9915743,1.7822621128192635
Namalwa,52947716,2.8584194612059206
RKN,24771867,0.8860225124393014
KYSE-450,11626560,3.018886838641868
LXF 289,44632017,2.313535350982782
AsPC-1,11228183,2.8237254667802474
Karpas-422,216345,4.476804412824838
SK-MEL-5,16722836,2.463448660750138
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
Kasumi-2,54618305,4.391643278203803
HOP-62,16013152,3.830141163681858
KYSE-450,89928392,1.680457877716282
HuT 78,6918638,-1.8650927856269544
NCI-H929,49793307,-4.29401842302784
BT 498,17755052,4.125935712570811
KYSE-180,6623618,2.424847215991005
Panc 02.03,3062316,2.5231792980774
CML-T1,66577038,2.0285847507138017
Lu-65,9926054,1.7186862089776234
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
SNU-886,452548,-1.461802443454938
NOMO-1,168313047,1.7455342513633885
HCC2108,135440466,2.000453402842669
HOP-62,676352,2.0582091635847704
SNU-423,11222830,1.7618743718370904
BT 328,11167602,4.034112762840579
SF539,104842,-5.162287402795691
HSC-3,6252,1.360193253312079
Becker,11214940,5.239157871042591
CML-T1,25262965,-1.9815055926190612
ChaGo-K-1,1641662,2.43249974698459
KYSE-180,9903786,3.667884143051944
NCI-H2030,241158,3.7184725002314183
Mono-Mac-1,135928012,3.3963935861333816
MIA PaCa-2,46943432,1.539225582233631
RT-4,10385095,2.2650869360881742
H-STS,11964036,1.8558762688812251
Panc 02.03,11175137,3.7353172411310696
KYSE-180,12001922,1.7478221517465942
LXF 289,3634881,3.11935208210029
RKO,5113032,5.90165838842917
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
RKN,11626560,2.593417875894138
IST-Mes1,25183872,0.0748637978909832
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
NCI-H929,9444,4.093260386369905
KMRC-20,11175137,3.0694696383235645
WM793,107985,-3.039809125194022
CML-T1,11455910,-0.3388293365451558
BT 498,568763,1.2156282548875836
LXF 289,24964624,1.3940062455599875
MIA PaCa-2,16219061,3.125044749529742
AU565,31703,-1.2264921928318224
KYSE-450,448949,2.8281207411790374
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153
SNU-886,navitoclax-birinapant (1-1 mol-mol),-7.871373993775583
BFTC-909,16720766,-0.0189955240044846
ESS-1,6918638,0.5362706870956574
IST-Mes1,52912189,1.1075207421426316
OAW28,216239,4.152270593115834
RERF-LC-MS,11657048,4.330866638894723
BT 286,11656518,0.2537918660411107
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
KYSE-450,216345,4.4435224891329
Ri-1,2749,0.5134622353101342
SK-UT-1,3136844,6.414538606040479
HSC-3,2729026,3.0997094123177527
BT 248,57330099,3.914766288587865
AU565,387447,-4.131425766006191
NCI-H1339,3634881,3.887494899039192
KYSE-450,9903786,5.350068255808832
SNU-886,25126798,4.09091896335188
HEC-108,JQ-1-navitoclax (2-1 mol-mol),1.4144543388665205
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
IST-Mes1,54596558,4.6034089904468125
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
AU565,5282054,3.2331302005717153
KLE,carboplatin-UNC0638 (2-1 mol-mol),5.218929523126634
HCC2108,52947716,-4.821545884859311
RKO,26596,-1.341584325458414
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
NCI-H1339,11609586,3.50234715510395
WM793,6918328,0.9320540007065896
Kasumi-2,carboplatin-etoposide (40-17 mol-mol),0.2542153417603036
EHEB,2945648,4.948774095176571
ACC-MESO-1,6918289,4.071566792460107
SNU-423,46199207,3.733643800535606
SNU-423,3038522,1.9901012300049743
BT 286,49836020,4.709879888093613
Ri-1,54686904,2.7416946204865997
AU565,11175137,1.8234152921093247
KMRC-20,400769,-0.3273926657641918
PE/CA-PJ41 (clone D2),6505803,-0.4507500369158054
KYSE-180,1641662,2.753321741973846
KYSE-450,23582824,2.052408979108203
CML-T1,71466578,2.784294880886227
KYSE-450,107985,-2.5991622295290413
OAW28,44185566,1.918306011480311
NCI-H209,navitoclax-gemcitabine (1-1 mol-mol),-1.5210743778486835
HCC2108,selumetinib-navitoclax (8-1 mol-mol),2.406642843246067
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559
BT 320,9935249,2.6939509810826294
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
Lu-65,4259181,-0.4284059095013066
LXF 289,11175137,1.607203821415342
Ri-1,9907093,0.4090438219291824
HuT 78,selumetinib-PLX-4032 (8-1 mol-mol),-3.310365038603551
Panc 02.03,148198,-4.053337817942692
SNU-119,15547703,3.1947959639355834
BT 248,15983966,1.8194061419836256
NCI-H2030,11404337,0.8105383061900018
Kasumi-2,11647372,-1.94314797775666
OAW28,24797083,1.7501511491860735
KYSE-450,56649450,5.522708558477712
Mono-Mac-1,4788,4.990760691798778
RKN,36462,2.460575122343829
PE/CA-PJ41 (clone D2),107970,2.3655447470564774
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645
SNU-119,ISOX-bortezomib (250-1 mol-mol),0.3565845670857949
BT 248,6438330,0.9229397913759128
CML-T1,17759555,3.491613035913433
MIA PaCa-2,72376,-2.0402961051166164
HOP-62,5284616,2.917606348987241
HuT 78,135423438,1.6811720044411254
KMS-12-BM,25126798,2.689658126945382
Panc 02.03,5281672,4.500820026656837
WM793,104842,-1.8319129864722523
CML-T1,25150857,1.621602747179882
HEC-108,9926054,2.177226179063823
HuT 78,9936388,-7.168553730777331
AsPC-1,42642645,1.2436203489585118
BT 248,2871966,0.7814721484275546
PF-382,3062316,-2.906652546684618
NCI-H929,5284616,-3.61642631777644
NCI-H196,11175137,3.231563975100378
BT 286,navitoclax-birinapant (1-1 mol-mol),1.0621958537472391
BT 248,45279963,3.7107289938294135
HuT 78,15953870,2.5576152772998832
SK-MEL-5,66577038,3.092435629541179
H-STS,1242560,3.458516939321499
BT 498,676352,2.3132532098483685
SK-MEL-5,24753719,4.331970921396319
RT-4,60750,-4.938890545189148
NCI-H1339,24856436,0.5202265970203059
SNU-119,3136844,3.853712010646443
KMS-12-BM,5282054,2.7090393270562796
NCI-H2030,6852167,3.664120569274895
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116
SK-UT-1,135398516,5.33568205462979
OAW28,1716436,3.318226269910468
Karpas-422,56963564,0.5479930709748855
Mono-Mac-1,tretinoin-carboplatin (2-1 mol-mol),3.5434770977176107
SK-UT-1,11626560,3.0514544041221043
Lu-65,56649450,2.0971819083510512
Ri-1,SNX-2112-bortezomib (250-1 mol-mol),-3.4846614338424153
RERF-LC-MS,10410894,3.034247655874134
ACC-MESO-1,4917,3.2089053418545985
LMSU,25183872,-1.684481128175181
NCI-H2030,36462,2.530734561122129
BT 328,15953870,4.378443753461669
IST-Mes1,4477,0.8135431021107292
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
NCI-H209,4261,0.8103975012989882
MIA PaCa-2,2828334,6.048303989502281
HOP-62,60750,-0.8412438712824618
KYSE-180,3854666,2.7659153089015898
BT 286,136227924,1.3356746395497436
HEC-108,322968,3.0271522101080532
BT 328,119607,6.140002337362805
SNU-886,53232,-1.4461211490785335
CML-T1,46174525,3.020182372643586
LMSU,54454,1.1076118788914329
MIA PaCa-2,1323703,5.702291663028901
Karpas-422,168312962,2.0358328340743976
PE/CA-PJ41 (clone D2),119182,0.5370908024623297
MIA PaCa-2,5746,1.2927758062815462
KLE,444795,4.58251515525995
HCC2108,10074640,3.185327985640923
RKO,119182,-2.4803685643523
SNU-886,60700,0.021220261997993
NCI-H196,4521392,4.497970742345613
HOP-62,984333,0.4675048788051116
NCI-H929,1242560,2.1865471387936513
BT 248,25227462,1.1845227545958306
AsPC-1,31703,0.7807561035178269
Becker,409805,5.716119591245028
Karpas-422,71751553,4.158262906049952
Mono-Mac-1,10385095,1.4007420160965849
EHEB,46224516,2.156286002861633
EHEB,selumetinib-UNC0638 (4-1 mol-mol),3.5739302718016597
LMSU,2828334,6.025176975178222
ChaGo-K-1,10410894,3.5392929764573844
ESS-1,11427553,2.850757771456098
KMRC-20,54619267,4.002299235726132
IST-Mes1,JQ-1-MK-0752 (1-1 mol-mol),2.655505520266403
MIA PaCa-2,2746,3.119583352790748
LMSU,5284616,3.630952322980812
RERF-LC-MS,72734382,4.885789692793362
KMS-12-BM,2746,1.2802142564618226
ESS-1,446155,0.8462553588843746
BT 320,4917,2.82304614910839
AsPC-1,65064,5.237570806440869
RKO,676352,2.3070338313311547
NCI-H929,9903786,1.9183912305018265
RKN,54618771,1.93479648501244
ESS-1,5470400,4.483121200297247
RT-4,46191454,2.354061820255486
HOP-62,15953870,3.4456314683727154
HEC-108,135875424,4.07561778301408
NCI-H1339,44185566,3.1608972179921504
LXF 289,5328940,2.0490491787199687
Mono-Mac-1,selumetinib-UNC0638 (4-1 mol-mol),3.227378592409404
SK-UT-1,119607,5.172021096327679
BT 286,9952709,2.5643743915301145
Becker,4477,0.418729890718949
BT 498,208908,2.540282915890303
BT 328,44185566,3.0844866112877916
RERF-LC-MS,53392493,1.949934555719578
KMS-12-BM,5351362,1.0681546231333583
HEC-108,navitoclax-gemcitabine (1-1 mol-mol),-1.2713189320537277
BT 320,400769,-0.2737977451215982
HEC-108,9868037,3.1019775097215554
ESS-1,1750826,-1.919918883471636
Mono-Mac-1,5746,-1.53803336813333
NCI-H2030,54454,1.7234672206469932
BT 248,3825829,4.117903271720201
H-STS,2113511,5.446449899751943
H-STS,5335621,4.075403306660697
HOP-62,12003241,-2.147728480634193
BT 248,984333,1.3539050434846691
ESS-1,24889392,3.924374920251665
AsPC-1,16722836,2.2980478994816425
OAW28,24180719,4.377592888188756
LXF 289,51039095,1.6878089310027404
Mono-Mac-1,3136844,3.2810332522096575
SW1783,6610216,4.1970131352388265
KMRC-20,6918837,-1.6564527147795
Becker,53232,4.57215785181602
MIA PaCa-2,2949965,2.338534195568356
MIA PaCa-2,3825829,4.074033438975014
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383
RERF-LC-MS,31703,0.0184985959907658
MIA PaCa-2,11167602,2.3171919978995636
Mono-Mac-1,vorinostat-carboplatin (1-1 mol-mol),1.5624224218664264
Ri-1,3025986,-1.4888288278969202
KLE,25126798,3.674885583881781
SNU-213,4788,5.9691408326864295
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
BT 286,selumetinib-piperlongumine (8-1 mol-mol),-0.2965188310208848
SK-MEL-5,46843906,3.395392152130591
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636
Mono-Mac-1,42611257,2.522098896743852
HEC-108,676352,2.944885570053704
AU565,54618164,4.092787142183454
AsPC-1,9825149,2.485133390345911
Karpas-422,67291369,2.023218261714344
NCI-H1339,6918837,-3.0709410358717713
HSC-3,89928392,1.3069545260692466
Karpas-422,44819697,-0.4261845245346083
KMRC-20,44507138,4.202309918297686
ChaGo-K-1,11214940,4.722023398176141
RERF-LC-MS,2749,2.1448012118135176
SK-UT-1,11640390,4.3621330098002815
HSC-3,24785538,1.6945658877136145
KMS-12-BM,387447,-5.588552036556516
MIA PaCa-2,2945648,3.161205294183321
NOMO-1,71304818,2.372593058500035
BT 286,6852167,3.4826351863854295
IST-Mes1,10127622,4.960728342788448
SNU-119,11214940,-0.1259721095383459
Kasumi-2,16720766,-0.2515973340383426
BT 498,2858523,3.124320310328437
SF539,11612883,2.0930175228596037
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874
RT-4,448949,1.759750827005002
SNU-119,4096211,1.6502614157208848
Namalwa,16722836,1.2777099451107474
SNU-886,439501,-0.6078207224909147
BT 328,42642645,1.526904383487112
ESS-1,4705,3.449305158476875
PF-382,5284373,-1.433673800360202
RKN,56946209,-4.407104587623599
Mono-Mac-1,10302451,2.661721795389531
H-STS,navitoclax-pluripotin (1-1 mol-mol),-0.8846642449593193
IST-Mes1,10385095,2.3784865098232255
Kasumi-2,decitabine-carboplatin (1-1 mol-mol),-0.2922568730993647
SNU-886,135440466,1.015207658153798
SK-MEL-5,322968,4.821456208157591
SK-UT-1,44491742,5.121507877742128
NCI-H2030,135984461,5.0269440888877135
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
H-STS,613753,2.542792713259053
Lu-65,73707398,1.7319675343544505
BT 328,16065773,3.5166527038097906
HSC-3,9935249,4.975494741872852
AU565,54649381,3.996593912741648
HuT 78,BRD-A02303741-navitoclax (2-1 mol-mol),0.2900830981041313
LXF 289,25062766,1.8533275351899623
SNU-886,135398744,6.3424886084429435
SNU-423,26596,-1.230407332735001
BFTC-909,54454,2.6967031082973527
LXF 289,44607531,1.6515112206427849
KYSE-180,439501,-1.6605779697575254
OAW28,5311,0.8600755425080211
RT-4,crizotinib-PLX-4032 (2-1 mol-mol),2.875224727461572
RT-4,24856436,1.1504694171178176
SK-MEL-5,5328940,2.4152084388950863
ChaGo-K-1,10184653,2.772883802390891
RKO,67156097,-1.3338800856316015
Becker,15983966,-4.434782339210091
NCI-H1339,25126798,3.699685698057144
PE/CA-PJ41 (clone D2),44493528,4.345645378925518
NCI-H929,56963564,-0.3004346894334608
Ri-1,54454,5.695791954111341
SNU-213,selumetinib-decitabine (4-1 mol-mol),0.9662990781402068
KYSE-450,navitoclax-PLX-4032 (1-1 mol-mol),4.746447722583796
PE/CA-PJ41 (clone D2),24753719,4.254731595705647
HuT 78,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.768713578692631
Ri-1,25150857,1.9754346751489589
MJ,49793307,-2.108453133471835
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
Ri-1,159324,0.7122942359336857
ESS-1,54619267,4.300915522093122
Mono-Mac-1,25102847,1.794362073331052
Namalwa,56946209,-6.682218305307108
ESS-1,selumetinib-piperlongumine (8-1 mol-mol),3.862491311780521
Panc 02.03,676352,3.0262590525496895
HEC-108,44484440,3.2684255567443
Kasumi-2,3384730,0.4985599128931971
ChaGo-K-1,44137675,3.810994198806368
RT-4,65064,5.007603522761181
BT 248,9825149,2.247604687491298
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
EHEB,11683005,4.401325437142657
MIA PaCa-2,navitoclax-gemcitabine (1-1 mol-mol),-2.3995955359028107
SNU-886,23635314,-2.1595159166484685
KMS-12-BM,9935249,1.0143045497874623
WM793,24951314,1.9814754728046269
HSC-3,11178236,-3.0740013881602426
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
SK-UT-1,72376,-0.4045590861192394
BT 286,219104,3.403941737257678
KMS-12-BM,44241473,4.1211159216828035
CML-T1,6918736,-1.6116924986143133
AU565,4259181,-0.781957409712965
MIA PaCa-2,54143018,0.7884510241483783
RKO,2828334,5.934464187728916
HOP-62,44819697,-1.199398229691176
SNU-886,6918837,-1.8312241518150647
SK-MEL-5,16038120,2.3323122199408215
MIA PaCa-2,2729026,2.202536609030734
KLE,12003241,-1.9975693903430911
BT 286,54143018,-0.4077318593794814
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
ACC-MESO-1,216468,4.389986400214309
Lu-65,49766530,1.0861089243329392
KMS-12-BM,46215462,1.145613842689034
NCI-H929,71466445,3.0733288534415233
BT 328,322968,2.861041928630023
ACC-MESO-1,439501,-2.1177142805540163
NCI-H209,5746,-1.6890980018136772
MJ,54619267,3.7819804924234703
ACC-MESO-1,107970,3.0129300087399744
KYSE-180,24772860,-1.944704874720706
RKO,10074640,2.8357111382750646
SK-MEL-5,676352,2.4631090651558476
RKN,54143018,1.3184566027416504
BT 328,12001922,1.7973322325176817
CML-T1,676352,1.5222388602604249
PF-382,6610355,4.684201543631857
NCI-H1339,ISOX-bortezomib (250-1 mol-mol),0.3050611513978097
MIA PaCa-2,selumetinib-JQ-1 (4-1 mol-mol),-0.019734255481758
SK-UT-1,46215462,2.208029425657124
SW1783,135440466,3.5592190192568114
HSC-3,65064,5.231951688651485
SNU-119,54619267,3.4840179257423447
HSC-3,24753719,4.387222706020441
KYSE-180,44185566,2.1212784922440258
BT 248,107970,1.564508535325896
KMRC-20,73707398,1.7254732299327342
HEC-108,navitoclax-piperlongumine (1-1 mol-mol),-0.8310694921552283
KYSE-180,4259181,-2.278337111185809
CML-T1,124202324,0.7419542279604492
H-STS,72193861,0.730927574550533
WM793,49793307,-1.6505636238066363
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474
Namalwa,53232,2.2331592104894917
Kasumi-2,salermide-PLX-4032 (12-1 mol-mol),2.944713771170232
NOMO-1,24856436,-0.4465471145990737
PF-382,24753719,2.156979591404902
ESS-1,9927531,5.52249907084491
CML-T1,5284616,-2.6047133462283276
SW1783,24901704,2.457662340178976
PE/CA-PJ41 (clone D2),vorinostat-carboplatin (1-1 mol-mol),4.068145028137521
ChaGo-K-1,15547703,3.6843699542516273
IST-Mes1,7251185,3.206804970970884
BT 328,navitoclax-gemcitabine (1-1 mol-mol),1.6667788304977649
ChaGo-K-1,11707110,3.866052585258933
Namalwa,crizotinib-PLX-4032 (2-1 mol-mol),1.0699462995067208
HuT 78,135875424,3.0458075465752694
Mono-Mac-1,16065773,1.4173575235689688
Namalwa,2828334,5.967356000456756
Becker,67156097,-1.305519261143652
NCI-H929,104842,-3.822816655471148
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673
HuT 78,123631,3.101357526527429
AsPC-1,3854666,3.565227366628202
Namalwa,5284616,2.9338527651265824
BT 286,24772860,-2.7013383956612684
SNU-423,53392493,1.705779071563144
LMSU,9927531,5.404187778104352
NCI-H1339,613000,2.637869291837759
KMRC-20,6623618,2.3324454815197546
SK-UT-1,11625818,5.186074210783149
BT 248,11955716,-0.8129800870812356
Becker,72193861,0.1888089388769935
KMS-12-BM,216345,3.047571531104052
Karpas-422,11494412,1.1821757343676855
KLE,10113978,4.613150784757447
BT 248,285033,1.6288115150650024
ESS-1,3038522,2.815775388267638
NCI-H196,57519531,4.101700077109555
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
Karpas-422,selumetinib-vorinostat (8-1 mol-mol),1.6918556367520698
SK-MEL-5,2742550,3.3094903780657368
HuT 78,5351362,0.379509393598873
LXF 289,89928392,2.4967474535679623
SW1783,selumetinib-navitoclax (8-1 mol-mol),1.5346000994793692
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644
AsPC-1,11955716,-2.13511164723979
Becker,3038522,5.367160453178797
Kasumi-2,11977753,-3.013388327331023
MJ,11234052,3.3276359247001124
HSC-3,216468,3.7445952975115735
KYSE-450,11625818,5.066786117132594
BT 498,4261,5.558947340213016
BT 320,5738263,4.511639431207419
RKN,25183872,-1.1518449365963386
AsPC-1,5278396,3.912005463923024
HOP-62,6438330,2.309996098194817
SNU-119,24772860,-1.5346173858714742
ACC-MESO-1,448949,2.651018278601144
RKO,16038120,2.1201165412688385
NCI-H209,9936388,1.6716697805480627
Lu-65,252682,6.482866894813884
SK-UT-1,60700,0.6162687225827331
KMS-12-BM,2113511,4.224689679804032
RERF-LC-MS,5280436,-0.2566098032119844
NCI-H196,11717001,4.441114574365772
SK-UT-1,46174525,5.191035054740717
RT-4,54618771,0.6660630053371256
HSC-3,44507138,1.907572830390568
SNU-886,3062316,2.775013755019221
HOP-62,10427712,5.542499439845473
NCI-H209,54143018,0.8491553630521773
EHEB,52912189,0.500352140326513
CML-T1,241158,2.0968023336421227
Mono-Mac-1,4705,2.1526940159262593
SNU-423,11625818,4.3756500171926875
OAW28,4259181,0.9119817479539226
AsPC-1,3854666,3.565227366628202
Mono-Mac-1,6610355,3.782829055188725
HuT 78,46943432,0.3707901357093127
Lu-65,66577038,2.7956766049340147
KYSE-180,17755052,1.875580831960164
Kasumi-2,5281672,3.402650415017694
ACC-MESO-1,2874250,4.963672999573585
Namalwa,3825829,3.564454365962588
ACC-MESO-1,2749,1.8588259991256275
RKN,23939,4.640348748177221
BT 286,135411,0.4622735027269605
KMS-12-BM,doxorubicin-navitoclax (2-1 mol-mol),-2.1380196151601845
NCI-H1339,9915743,3.628924415446368
BFTC-909,3081361,3.110656330811392
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
NCI-H2030,docetaxel-tanespimycin (2-1 mol-mol),-0.4991862010243447
KMS-12-BM,11609586,2.2614384485200625
SK-MEL-5,285033,-1.4568960685730863
KMRC-20,5287620,-2.9460819990219687
HuT 78,374536,0.782001012085031
NOMO-1,135398738,0.7085728369009435
CML-T1,72376,-3.431780344099396
HEC-108,100016,6.393272881400893
BT 328,5351362,3.058518390164376
BT 286,2733526,2.614715736192337
RKO,5738263,3.4166283525852523
ChaGo-K-1,44589607,1.9883997231834751
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
SF539,4378219,1.830086902499326
BT 248,46224516,2.5816980785990875
SNU-886,11152667,-0.5084903707284607
ESS-1,11178236,-5.021714388014341
RERF-LC-MS,1242560,3.610791422912421
ChaGo-K-1,7251185,2.5727888380300588
BT 328,25227462,1.995910036473872
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
NCI-H1339,123631,3.731065146489379
Lu-65,3062316,2.546228679669324
BFTC-909,3503,3.411270469206907
Namalwa,56649450,1.7446151160804089
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
NCI-H2030,11427553,3.3992931563100615
Mono-Mac-1,navitoclax-pluripotin (1-1 mol-mol),-3.51267924056218
BT 498,2130404,2.5951087655925043
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
HuT 78,11497983,0.3896895605416182
OAW28,10296883,4.314409366833216
BT 328,216239,3.5186612290950148
NCI-H196,5566,3.8820743046521127
Mono-Mac-1,650361,3.717997934004441
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
RT-4,23582824,2.530849045703681
OAW28,66577038,2.5027239379183666
CML-T1,2749,0.3257235213594381
OAW28,4096211,1.5501495805084426
SNU-423,11609586,3.037399927166333
BT 248,23582824,0.3842375588836932
HCC2108,445091,6.46099491199368
HCC2108,135999136,4.648622110630223
KYSE-180,23725625,5.7318866037383165
SF539,16736978,2.0915382548726353
PE/CA-PJ41 (clone D2),11455910,-0.0174306689930347
CML-T1,374536,2.401691970017444
BT 286,241158,3.931607244311501
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
Ri-1,24978538,-4.011089430683387
SNU-119,54618305,4.480526935824261
Panc 02.03,262093,3.467425891303458
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
LMSU,3136844,4.51908400506557
SNU-886,49867926,2.0094382345952377
H-STS,44493528,4.270078015163244
Lu-65,208908,2.2463872486590235
ChaGo-K-1,55283,3.5819941327008507
LMSU,4261,2.446120037363317
RERF-LC-MS,24821094,3.899392046553833
AsPC-1,2746,3.619198032462304
HEC-108,73707398,1.5484357778063762
RERF-LC-MS,44566777,0.4059341966526995
NCI-H1339,16722836,2.785965080041655
MIA PaCa-2,72734382,4.846117233609802
NCI-H929,44259,-0.1109306277503226
NCI-H1339,168312962,1.6385487975879267
HEC-108,68056272,3.6278104442075736
BT 328,136227331,5.061934875267611
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
SNU-213,11427553,3.13292622218242
SNU-119,15953870,2.479349019849552
Lu-65,11167602,5.906692389190635
SNU-213,6610355,4.708262799420277
KMS-12-BM,44137675,1.9058431411693373
WM793,53495165,1.4251272821754086
LMSU,11455910,2.490355648913592
Namalwa,44607531,1.0104056237764891
MJ,2708,2.9106731157178194
OAW28,49850262,3.3861243312442264
SF539,9956119,2.7951996654139664
SF539,9911830,1.1022803108352155
AsPC-1,2858523,3.256128469853813
HuT 78,54765302,4.2796964156487665
HuT 78,2874250,-2.74453547874646
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
LMSU,637858,2.7447242272748924
ChaGo-K-1,46907787,2.3551908782612068
Ri-1,5311281,0.8433532864146127
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179
Panc 02.03,46843906,3.852893526574364
ESS-1,5311281,1.2479290608780562
KMRC-20,carboplatin-etoposide (40-17 mol-mol),4.439397714943588
HOP-62,2130404,3.6362735335083016
SW1783,119607,5.1966620860731965
SK-UT-1,753704,5.7414548623534305
BT 328,6917907,3.783088770502935
Becker,135411,0.5687348881548171
NCI-H929,54639024,4.491044339124744
BFTC-909,5335621,5.263558209813896
Namalwa,6610216,4.155862937962793
H-STS,9887053,3.8773696813734246
Ri-1,46191454,-0.1787336144336715
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005
KMS-12-BM,46907787,-3.5146066785265746
SNU-423,44202524,2.0073707598305717
BT 328,5282054,4.480246853772489
Mono-Mac-1,445091,4.03507762760952
HuT 78,44607530,0.9490207020575367
MIA PaCa-2,24772860,-2.8067404690630435
ChaGo-K-1,5282054,2.4734190149171815
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
ChaGo-K-1,5287620,0.378035829194828
SF539,11647372,0.1364544950678034
EHEB,9915743,0.5785876427148751
ChaGo-K-1,navitoclax-sorafenib (1-1 mol-mol),1.7217103067030983
ESS-1,71466578,4.727259089012869
BT 498,24775005,3.556771957231718
BT 248,3081361,2.663958705985954
SW1783,676352,2.0801298645045274
RERF-LC-MS,753704,5.128075002459309
SW1783,44241473,6.157052132127655
ESS-1,docetaxel-tanespimycin (2-1 mol-mol),-6.30643911780066
Kasumi-2,2871966,-1.247169917955711
SW1783,53495165,2.348659450699313
AsPC-1,10074640,3.638861482782184
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
RERF-LC-MS,5329102,2.8374518121885637
SW1783,5566,2.9899549454947305
OAW28,387447,-4.631995500074297
NCI-H1339,25154868,5.0319171953179085
KYSE-450,71466380,4.437575150411749
SNU-886,10231331,-0.2281959370366189
HCC2108,54618164,5.127082823492277
BT 286,2749,-0.1297410045217301
WM793,46398810,3.0163067396292944
Karpas-422,409805,3.3322180704918876
PF-382,44241473,4.707549872781651
MIA PaCa-2,8515,4.279549136929449
ESS-1,salermide-PLX-4032 (12-1 mol-mol),5.510207558856386
EHEB,selumetinib-JQ-1 (4-1 mol-mol),-0.0163446257701156
PE/CA-PJ41 (clone D2),11214940,4.762762375853721
SW1783,11222830,3.574830884827046
ESS-1,23635314,-3.6853445659402704
SF539,24901704,2.077858553177028
Karpas-422,9911463,4.381699719624804
WM793,selumetinib-MK-2206 (8-1 mol-mol),3.306491798199423
NCI-H1339,54596490,5.682943703162134
SNU-886,11222830,1.0742925940982535
SF539,5282054,3.5125630378284667
NCI-H2030,441298,0.3914913419109978
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
Kasumi-2,135398516,1.3882982648798712
HOP-62,11656518,1.540061386933048
BT 320,11214940,4.494237160276683
PF-382,72193861,0.0573496234018987
PF-382,decitabine-carboplatin (1-1 mol-mol),-0.7722926629328009
Becker,11485656,3.616159279519061
MIA PaCa-2,136227331,4.243512473772355
LMSU,57330099,5.920156910327882
HOP-62,45100481,5.138647464622458
HOP-62,selumetinib-JQ-1 (4-1 mol-mol),-0.1175997595945407
LMSU,9911463,4.298553287365515
Namalwa,702558,3.15631292690116
HuT 78,285033,-3.0605390542745092
HuT 78,219104,1.1531069030640524
NCI-H1339,JQ-1-carboplatin (1-1 mol-mol),3.0025540987138326
RKN,9936388,2.306220468641662
KYSE-450,400769,-0.8881298454848809
NCI-H1339,44819697,0.5202266859972607
Karpas-422,16725315,3.0879220385886774
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
SK-MEL-5,119182,-0.6540271157928708
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
RERF-LC-MS,54596558,4.400747096440468
MIA PaCa-2,3025944,4.191414132665553
AsPC-1,3062316,2.757974416117501
Karpas-422,11364421,-4.613053554314196
Mono-Mac-1,5311,0.3309390956392478
HCC2108,6610216,4.333266627123119
ACC-MESO-1,409805,5.492965963250371
KMS-12-BM,1317464,5.551631719777859
OAW28,168312962,3.352489814007426
Karpas-422,387447,-5.164381252871863
Mono-Mac-1,119182,-8.162617097236367
Mono-Mac-1,decitabine-navitoclax (2-1 mol-mol),0.9115309079674628
ESS-1,285033,-3.536353243580582
BT 248,44607531,1.181861447118321
RT-4,17755052,3.016553259782671
IST-Mes1,216345,3.619183672475448
PF-382,16720766,-1.1055655551486072
KMS-12-BM,piperlongumine-MST-312 (1-1 mol-mol),1.2051347484874666
WM793,73707438,4.408840784597168
NCI-H1339,6914657,-1.8219556979894729
RKO,6918736,-1.762610939534952
LMSU,navitoclax-piperlongumine (1-1 mol-mol),2.8977701094185586
RT-4,656346,1.221442346270773
MIA PaCa-2,6918638,-0.2858557386208528
AsPC-1,9956119,2.16125044927063
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
SK-UT-1,vorinostat-carboplatin (1-1 mol-mol),4.302325577715062
ChaGo-K-1,navitoclax-piperlongumine (1-1 mol-mol),2.187526491756389
ESS-1,5278396,4.110324353246352
KLE,9936388,-3.639802417260702
KMRC-20,11152667,-0.0779110822248748
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
KMS-12-BM,24964624,-0.7604581964304247
RKO,51037431,1.443783779144223
SNU-886,piperlongumine-MST-312 (1-1 mol-mol),1.4218788713745412
CML-T1,123631,1.8980514916470088
ACC-MESO-1,5566,4.169029471712344
RKN,227681,3.7901732699912585
BFTC-909,10184653,1.6906150005550105
Namalwa,9866186,-0.5798489087704481
HOP-62,navitoclax-pluripotin (1-1 mol-mol),-1.411092695129254
RERF-LC-MS,65628,5.693639897620667
Lu-65,6610216,3.857091251569688
LMSU,11494412,2.9419044574604554
SF539,426756,4.818547451090759
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
CML-T1,navitoclax-birinapant (1-1 mol-mol),0.167080687914587
HOP-62,2749,1.4001550595714545
AU565,107970,1.9067452119355752
RT-4,5329102,2.779535568248952
BT 498,9933475,1.803791311469253
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008
SNU-423,vorinostat-carboplatin (1-1 mol-mol),3.904430843633692
Lu-65,11507802,1.055248828588956
AU565,5278396,3.257778157431963
SW1783,135411,2.3314592986122453
ChaGo-K-1,439501,-4.217436880778372
CML-T1,11175137,2.223157836501134
SNU-119,19582717,4.915003831541955
PE/CA-PJ41 (clone D2),676352,1.7961404336249642
AsPC-1,44185566,2.682305355629655
Namalwa,3384730,2.2152164600769946
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992
PF-382,selumetinib-vorinostat (8-1 mol-mol),2.136528432975779
OAW28,71466445,4.188405368682896
Lu-65,11977753,-0.7315410872896725
SNU-213,159324,3.5982392765945344
Kasumi-2,51039095,2.172369026283552
SNU-423,SNX-2112-bortezomib (250-1 mol-mol),-1.6386202904690086
AsPC-1,1750826,-1.5700020776253725
RT-4,24951314,2.159360193185554
Panc 02.03,219104,4.2068478561753375
NCI-H929,doxorubicin-navitoclax (2-1 mol-mol),-2.4469674599934574
NCI-H929,17755052,-1.864844387301065
H-STS,5280436,0.3080604203440315
Lu-65,9903786,2.0553359532496875
Namalwa,123631,2.7984892241691735
Ri-1,vorinostat-navitoclax (4-1 mol-mol),-3.0348365764984946
WM793,219104,4.075990982755825
NCI-H929,9967941,4.011440111055957
HCC2108,2729026,3.184070590056279
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
CML-T1,24856436,-1.6072060020086385
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
KMS-12-BM,11364421,-6.458256547246502
Karpas-422,71466578,2.1474385211920297
HOP-62,9823820,6.013100500768476
H-STS,44566777,0.8546674055066537
SNU-119,serdemetan-SCH-529074 (1-1 mol-mol),2.302427714477216
EHEB,148198,-2.104475544842142
NCI-H929,984333,-0.3425783149230363
IST-Mes1,navitoclax-MST-312 (1-1 mol-mol),2.625426297409908
Panc 02.03,5311,2.7910052639268415
PF-382,24856436,-1.472575782331219
EHEB,11175137,2.3201035229404186
SNU-213,42642645,1.3935899873683228
H-STS,4096211,0.7701877892455814
Ri-1,5746,0.0852982082944755
HEC-108,9967941,3.882245660335456
NCI-H929,6852167,0.2588908385559714
SNU-213,5282054,4.422121273871097
HOP-62,5278396,3.1649905019319107
MIA PaCa-2,2742550,3.852651019611259
HuT 78,9444,3.580412600741262
RKN,44197249,3.9607888926275217
NOMO-1,16725315,4.952538276899841
H-STS,2729026,3.2634172065243656
SF539,24753719,4.7612365798691405
Karpas-422,6914657,-5.262185677430442
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
KYSE-450,crizotinib-PLX-4032 (2-1 mol-mol),2.9466068447817126
Panc 02.03,11955716,-1.8470517927785437
MIA PaCa-2,5282054,3.8521450366894903
SK-MEL-5,9911463,3.724914838124911
RERF-LC-MS,8515,3.770178660744851
LMSU,46199207,3.57619912371696
NCI-H929,439501,-2.3111413664478513
NCI-H209,89928392,0.5845708332842495
NCI-H929,51037431,3.389715853394355
ACC-MESO-1,9926054,4.037988480167424
PF-382,104842,-5.768830303921508
AU565,7326481,2.6950900258123256
PF-382,6450551,1.027271835386555
PE/CA-PJ41 (clone D2),navitoclax-MST-312 (1-1 mol-mol),0.9803419699577952
Kasumi-2,selumetinib-tretinoin (2-1 mol-mol),7.516580529144076
MIA PaCa-2,9866186,0.7636785286436597
KLE,9840324,5.142146685631956
AsPC-1,53232,3.925663364010775
HuT 78,73707398,-1.0733102034167783
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
HOP-62,5470400,1.633979056860879
ChaGo-K-1,24180719,4.090680478392621
WM793,675434,6.301966569766523
NCI-H196,54618771,3.538687286650074
KYSE-180,375860,-0.0718407094344544
PF-382,11214940,-0.2172300020723663
HOP-62,vorinostat-carboplatin (1-1 mol-mol),1.8572569013705305
ChaGo-K-1,10296883,3.916138257208464
AsPC-1,19582717,4.191920632274723
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
SNU-119,6918328,1.4012338898143128
HEC-108,3025986,-0.5174612953614975
Namalwa,9911463,2.7572577056870022
MIA PaCa-2,71466578,4.8412338676147275
Mono-Mac-1,BRD-K27188169-navitoclax (2-1 mol-mol),0.3663100658261126
BT 286,44607531,1.3385588713906706
Panc 02.03,4261,3.516583077320981
KMRC-20,navitoclax-gemcitabine (1-1 mol-mol),-1.4557054407433547
SK-UT-1,24951314,2.3185939064766954
KYSE-180,25150857,2.8174172252005127
RKO,2749,1.3580925102381314
ChaGo-K-1,262093,3.038007559777189
BT 286,11257553,3.066784891840144
Lu-65,ISOX-bortezomib (250-1 mol-mol),0.2931749043366788
MIA PaCa-2,9887053,3.4042551427681103
SF539,53495165,-1.7347604840136983
SF539,216239,1.8940195388550165
NCI-H1339,JQ-1-navitoclax (2-1 mol-mol),1.6105623837388292
PE/CA-PJ41 (clone D2),2742550,5.692172963582456
EHEB,selumetinib-vorinostat (8-1 mol-mol),1.837404923820544
AsPC-1,4578,5.074011683523406
HuT 78,10127622,5.47630186372846
Karpas-422,7251185,1.4754335931389329
PF-382,carboplatin-UNC0638 (2-1 mol-mol),1.6704329476660973
NOMO-1,16065773,2.6012917178973405
BT 286,25195348,4.118327733963511
HEC-108,44486219,4.957991177382761
Namalwa,426756,1.9219137313726855
BT 248,11404337,-1.3909400551472375
SNU-423,969516,2.699391176615435
KYSE-180,44632017,0.527293974927918
AU565,10184653,-2.737102807310711
MIA PaCa-2,462382,0.4936091832075975
KMRC-20,24753719,4.050847735561683
BT 286,9884685,0.8858351843955082
KMS-12-BM,10322450,2.7501974340219575
NCI-H209,60700,-5.0994667891224505
NCI-H209,5281321,-2.3877363696817944
KMS-12-BM,654092,-2.2721779873504224
SK-UT-1,5311281,3.3992849767981297
SK-UT-1,123631,3.6786616828036
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
Mono-Mac-1,erlotinib-PLX-4032 (2-1 mol-mol),1.6620082119632882
Mono-Mac-1,6918837,-5.093539844656542
HuT 78,55508,4.04712313060397
SK-UT-1,71680916,6.2215373772831875
CML-T1,11656518,-0.3565307280161567
Kasumi-2,613000,1.0071641049539857
SK-UT-1,49867930,6.152644057002921
ESS-1,45279963,4.196559746594957
WM793,17755052,2.1349114715081345
NCI-H1339,16659841,4.177024509515593
NCI-H2030,ISOX-bortezomib (250-1 mol-mol),1.4675443519714482
ACC-MESO-1,72193861,3.3380031142897684
SNU-213,656346,4.349548786088633
SNU-119,6852167,1.9740525769719148
RKN,4259181,0.9508926940780028
BT 320,5311,2.686412240878293
Namalwa,1641662,2.840791178800267
BT 248,54618164,4.1848059637542585
HuT 78,16065773,1.7912473078063993
AU565,1716436,0.9342430141979629
KMS-12-BM,19582717,2.19026036658904
BT 498,10410894,3.105544275008135
KYSE-450,65064,5.6341173249680345
BT 328,44566777,0.5494237323450607
Karpas-422,4521392,4.321390005947519
Namalwa,44137675,1.71079520317736
BT 498,3025986,0.5586221106551145
SNU-119,navitoclax-MST-312 (1-1 mol-mol),1.0798653444132074
RKN,969516,2.6409066030454804
LMSU,10322450,5.4992145641719095
PE/CA-PJ41 (clone D2),decitabine-navitoclax (2-1 mol-mol),4.0972631886919135
KMS-12-BM,selumetinib-piperlongumine (8-1 mol-mol),2.5465910856240512
Ri-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.598711788254512
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
RERF-LC-MS,10385095,0.7812016081678173
Becker,11507802,0.7319410814237062
KYSE-180,984333,0.4630057299456917
BFTC-909,656346,-0.1018552101429806
MIA PaCa-2,10074640,2.6457096957685495
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
BT 286,3025944,4.579041975607849
NCI-H209,6918837,-5.3764922976435265
AsPC-1,57519531,4.317220146110072
HEC-108,445455,5.031008976461082
SNU-213,135421197,2.2792835673188687
NCI-H2030,10184653,1.4604745429556456
Namalwa,11404337,-2.5348333703062575
NCI-H929,54618305,4.349731057515986
NCI-H1339,23582824,1.3537108550784316
KLE,9825149,2.9770455391230506
ACC-MESO-1,2729026,3.1292375102639194
PE/CA-PJ41 (clone D2),60700,-0.746077064191772
SK-UT-1,73707398,0.9883439046575164
NCI-H929,100016,3.8135603062591
ESS-1,53392493,1.9514593982408732
HSC-3,3543504,4.437917604645005
WM793,JQ-1-vorinostat (2-1 mol-mol),2.1043160686090174
Lu-65,3854666,0.9157071351936018
RT-4,452548,0.6609517448162834
HuT 78,5566,2.7990159644878
BT 286,9933475,1.51807034446665
KLE,3384730,5.5798007151101325
Lu-65,2858523,3.053901623946623
KMRC-20,tanespimycin-gemcitabine (1-1 mol-mol),3.002722893797395
MJ,9915743,1.766638415426978
ACC-MESO-1,2858523,4.1548273733947605
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
Mono-Mac-1,selumetinib-tretinoin (2-1 mol-mol),2.434810789058858
EHEB,9825149,2.329615332433461
SNU-119,53481919,4.072571105351551
BT 328,11626560,2.3893583978213617
PF-382,387447,-5.996282081470132
BT 320,44241473,4.3699389688619945
Karpas-422,135398738,1.4669923353082115
AU565,45279963,3.869118795762884
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
CML-T1,9907093,3.685523679081733
HCC2108,carboplatin-etoposide (40-17 mol-mol),4.105964444699461
Lu-65,219104,4.835008857489988
SNU-886,2746,2.8162256970394295
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
Becker,selumetinib-navitoclax (8-1 mol-mol),4.743429307691993
Ri-1,262093,1.5615741003890895
NCI-H209,5284616,-2.6002796256202254
OAW28,3634881,3.2370607224140473
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
IST-Mes1,24180719,3.838804357743771
BT 286,11238147,1.609564465759162
NCI-H929,25183872,-2.352025063826196
SNU-119,2708,4.611503362669174
AU565,3465537,1.0667310492419344
OAW28,11612883,3.952715585132085
SK-UT-1,5280436,0.2448868472823603
ChaGo-K-1,68056272,4.112191288499106
NCI-H196,53232,3.10060239776482
BT 248,3503,0.874016545693445
RKO,31703,-1.8438289452025527
SNU-119,216239,2.5472186615534893
EHEB,2858523,2.936982583884496
NCI-H2030,73707398,1.6875070689591785
LMSU,10113978,1.557712519717613
Mono-Mac-1,tretinoin-navitoclax (4-1 mol-mol),0.4415195445851007
HCC2108,6852167,3.7271551469098583
BT 328,5566,3.1707222601804803
KLE,11222830,1.1739941214880287
ChaGo-K-1,44632017,1.7469122629446598
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808
SNU-886,16722836,1.47024614694785
KMS-12-BM,11625818,2.552202137572075
SNU-213,piperlongumine-MST-312 (1-1 mol-mol),3.0367843929765206
KMS-12-BM,54618164,3.5838118675433783
SNU-423,135411,0.8949713421437451
HuT 78,11317348,2.425204796310932
IST-Mes1,168312962,2.5289389848934647
OAW28,10385095,1.310156197215646
KYSE-180,4261,3.0762998469253366
LMSU,selumetinib-PLX-4032 (8-1 mol-mol),4.555801564467133
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
SNU-119,16722836,1.1666058390455762
H-STS,262093,1.3358664140686949
LMSU,327653,3.6010830884894824
PF-382,60700,-3.3166709344214342
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
NCI-H1339,54618164,4.412872879489402
MIA PaCa-2,445643,4.056602044586297
Kasumi-2,5494449,-3.67008601278043
Karpas-422,SNX-2112-bortezomib (250-1 mol-mol),-2.980575279346319
MIA PaCa-2,11626560,1.2394941984724543
SK-MEL-5,9907093,6.380326986267721
Karpas-422,serdemetan-SCH-529074 (1-1 mol-mol),0.955947916041782
EHEB,2708,3.688555693681277
Karpas-422,54596558,3.601826483825698
OAW28,46224516,2.3854099680927523
Panc 02.03,5281321,1.7682996743542674
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
SK-UT-1,148198,-4.4190978779578565
BFTC-909,49867926,6.076136735210805
SNU-886,156414,1.8221946579264756
SNU-423,6918328,0.4022127106807914
AU565,46926350,-5.126810871510528
Namalwa,10113978,2.497019663606501
HOP-62,119182,-0.9189096668150032
NCI-H1339,5311,1.9237434970940073
AU565,6852167,0.824199435407992
KMS-12-BM,11485656,1.287590694324435
Panc 02.03,136227924,3.0839082623333387
PF-382,135984461,1.6582229573318208
SK-UT-1,168313200,3.914325756565286
Namalwa,969516,2.093862466919586
HCC2108,navitoclax-gemcitabine (1-1 mol-mol),1.646339925390015
RT-4,16741245,3.9190611982266503
ChaGo-K-1,11647372,2.7758694049748813
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
H-STS,15547703,3.2281511582174875
Ri-1,doxorubicin-navitoclax (2-1 mol-mol),-3.5903984468333996
Ri-1,10296883,1.1182456491009578
Lu-65,5287620,-2.128449758644444
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
SF539,carboplatin-UNC0638 (2-1 mol-mol),3.439871222147057
SNU-423,11427553,2.9805935522696685
BT 286,57330099,3.888056128977329
Mono-Mac-1,5281321,-2.6672170422542507
KYSE-180,135440466,2.158709883591087
HEC-108,675434,4.085694536082024
HuT 78,46174525,1.5214422285401947
BFTC-909,2945648,3.347829093032643
BT 320,7251185,3.9998923472411008
RKN,6505803,1.4092626649390017
SK-UT-1,9911830,2.8726761747893756
AsPC-1,9926054,1.8957621767397328
KLE,25154868,4.76220314265069
PE/CA-PJ41 (clone D2),4261,2.790759894736724
SK-UT-1,11178236,-3.1476087704036453
SNU-423,16736978,1.660698360063597
PF-382,73707398,0.3361294473850881
SF539,16013152,3.768432455806556
Panc 02.03,44462760,5.147948611944762
NCI-H1339,5566,3.600004227180683
HEC-108,serdemetan-SCH-529074 (1-1 mol-mol),2.423945319779485
Kasumi-2,9887053,0.7760357688642865
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
Becker,148124,-6.351335533141373
ChaGo-K-1,11494412,-1.211362160076409
HEC-108,15547703,3.396555621710324
LMSU,2708,4.741018084625804
NCI-H2030,176870,5.856063157434044
Kasumi-2,216345,1.8251746878221435
NCI-H1339,1750826,-0.6854486173534331
SF539,82146,2.9766155224529576
Becker,5329102,2.932365308374823
RKN,11222830,1.5707482267531538
CML-T1,67291369,-1.213032955096986
HOP-62,60700,-1.6777236199232357
NCI-H2030,439501,-1.2331748188079374
LXF 289,11609586,2.9430338892136354
PE/CA-PJ41 (clone D2),56946209,-4.305283227067405
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857
PE/CA-PJ41 (clone D2),6917907,-5.703070030958968
CML-T1,2113511,4.359369559056824
SK-MEL-5,44589607,3.099496776426073
LMSU,ISOX-bortezomib (250-1 mol-mol),0.2979423367293473
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
NOMO-1,24753719,4.496099764979975
BFTC-909,52947716,3.1995758728854224
SNU-119,3384730,4.617278289213739
SNU-213,24964624,2.577057311876958
RT-4,serdemetan-SCH-529074 (1-1 mol-mol),2.3514467892397852
ESS-1,5328940,1.6515492105558514
HEC-108,135421197,3.884784600125324
ESS-1,24772860,-2.7433674764679097
Mono-Mac-1,44202524,1.1420883070842414
ChaGo-K-1,9956119,3.903719385984719
Kasumi-2,44589607,0.7324041454669186
RERF-LC-MS,5287969,-2.0564845219287555
BFTC-909,17755052,1.7621152527207813
KMRC-20,44493528,4.509843443263092
KLE,4261,0.7692438055073919
NCI-H929,67156097,-1.392693443988792
RKO,446155,4.170579555483674
MJ,49766530,1.2980181747447994
LMSU,448949,2.5624283498682594
CML-T1,3038522,2.3382153755761372
EHEB,439501,-2.4217048608799097
HEC-108,2945648,2.8918279332914074
AU565,53232,3.892352285865555
Lu-65,9866186,0.7836388553492847
AsPC-1,24821094,4.10595231639086
Ri-1,54143018,-1.264443943913558
SNU-423,2749,2.17630076176396
BT 286,2949965,2.469719512433079
KMRC-20,12003241,-0.2043728031762648
Lu-65,9444,4.326130099496892
Kasumi-2,navitoclax-pluripotin (1-1 mol-mol),-2.9755028456871866
WM793,135999136,5.309745002054086
PF-382,11152667,-1.8592814828562831
SF539,56646779,2.3266434385228667
IST-Mes1,6610216,4.781215155625892
BFTC-909,6450551,3.0302116860685886
Mono-Mac-1,9926054,3.1061890381784187
HEC-108,374536,1.892261126227868
KMRC-20,2828334,6.318285048549249
NCI-H1339,25183872,-0.470185695101433
RERF-LC-MS,2874250,4.628157945253743
KYSE-450,serdemetan-SCH-529074 (1-1 mol-mol),2.594112814660752
Namalwa,11977753,-2.7430299621207563
HSC-3,24856436,3.0509145508427675
OAW28,124202324,1.9264961190623875
LMSU,4705,3.840410851100799
CML-T1,60700,-4.046906202956944
AU565,1239801,6.39587237663574
ESS-1,JQ-1-UNC0638 (2-1 mol-mol),1.0012685328426527
SNU-886,JQ-1-navitoclax (2-1 mol-mol),-7.589926641213618
NCI-H209,9887053,0.254400305901777
RT-4,400769,-0.8649429705916083
RERF-LC-MS,2729026,3.1361811776879644
Panc 02.03,100016,6.582809568040202
Lu-65,46907787,3.3131734896161444
AsPC-1,126941,-0.909933311518488
ACC-MESO-1,navitoclax-piperlongumine (1-1 mol-mol),2.173592219651161
Kasumi-2,25105715,3.2709711323954536
BT 248,327653,3.4402013175237394
OAW28,119607,5.347849335106357
BT 320,17755052,3.980908422662348
EHEB,322968,2.810351153697849
HCC2108,46224516,5.492132817641468
PE/CA-PJ41 (clone D2),3062316,-1.418857079831338
LMSU,2746,4.6094970791668315
PF-382,46191454,0.6842895726793522
IST-Mes1,969516,2.6899901133592103
Becker,107970,3.0116017692585406
AU565,6918837,-4.408945103298963
SK-UT-1,72193861,1.4667643802381731
PF-382,44489367,4.604182803409816
AsPC-1,selumetinib-MK-2206 (8-1 mol-mol),1.6860334273273738
SF539,9935249,2.423475425325452
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885
EHEB,5328940,1.102391401728389
Lu-65,135659046,2.9879940161565206
IST-Mes1,6918837,-3.247555275823077
SF539,5951923,5.228397463824485
AsPC-1,3634881,3.56845743908184
Kasumi-2,23582824,0.0696466908969853
WM793,44632017,4.453745957700664
RKO,11364421,1.233720517884939
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
ChaGo-K-1,216468,4.582013123120093
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
MIA PaCa-2,crizotinib-PLX-4032 (2-1 mol-mol),1.2391956697808102
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
CML-T1,navitoclax-pluripotin (1-1 mol-mol),-4.409543307902375
OAW28,6610216,3.9661844518771185
Karpas-422,11175137,1.2910199720693991
Kasumi-2,49846579,-4.472892287565064
HEC-108,10184653,1.654851711294291
RT-4,17759555,2.661650836721078
Karpas-422,24821094,0.1426723029223498
IST-Mes1,51039095,1.641675506171098
EHEB,3384730,2.786060611815292
PE/CA-PJ41 (clone D2),1242560,3.4666813536449284
RT-4,53392493,2.7443643173433454
Namalwa,148124,-8.376959890675789
MJ,67156097,-2.074825443329949
PE/CA-PJ41 (clone D2),6450551,5.006652312044534
NCI-H1339,24180125,3.3577258152264635
BT 286,135999136,1.5966853845263294
Karpas-422,11152667,-1.1823612296931902
RKO,5566,3.2270609816668308
BT 248,9933475,1.8575466823142976
Lu-65,400769,0.4689570429959745
Becker,285033,-0.6028258460336342
ACC-MESO-1,54618771,0.8381740730227087
KMS-12-BM,9907093,3.643463351047445
NCI-H929,3025944,3.918293488310436
HOP-62,168313200,1.5949515806080656
RT-4,9926054,1.7601963161522494
KYSE-450,100016,6.589468110151047
Namalwa,409805,3.552483226107591
CML-T1,216239,1.5759445467703133
Kasumi-2,11178236,-5.568204380320254
NCI-H929,89183176,-3.1165008066026085
SK-MEL-5,53495165,1.2994435982035408
BT 286,45279963,4.069315818685172
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
HOP-62,1714884,3.484379130958529
CML-T1,9868037,1.2045012402986977
KMS-12-BM,44607530,1.8742389530579
Mono-Mac-1,654092,-1.4403827648525325
Mono-Mac-1,31703,-4.137829291800657
BT 320,44607531,2.095455849416377
NCI-H929,6438330,0.6628289141006722
KMS-12-BM,7251185,3.495873339291499
Karpas-422,5280436,-0.2684967291987384
LXF 289,24180719,2.719444673565486
SNU-119,3552672,2.2512141905066203
CML-T1,5738263,2.8352523784169525
NCI-H1339,613753,3.230985138130339
KLE,12001922,1.8770805284945848
RKO,3689413,3.093382349703003
HCC2108,36462,2.7422106684318077
NCI-H929,6918878,1.2577940998028925
KYSE-180,5282054,4.445709887408605
HOP-62,53393127,5.1983956780419165
SNU-119,119607,5.736335030874665
HEC-108,2113511,5.8682734581201705
Kasumi-2,navitoclax-birinapant (1-1 mol-mol),-3.1912080416511355
Namalwa,10296883,3.754455655563699
Ri-1,selumetinib-MK-2206 (8-1 mol-mol),0.0435914915818819
Ri-1,44507138,0.6592887443998028
KYSE-180,2945648,3.004828096065946
Kasumi-2,54454,5.727506476700654
HOP-62,31703,-0.8503417724593266
H-STS,16720766,0.6181925299457043
AsPC-1,11497983,4.51017072011312
BFTC-909,439501,-2.4866456286351095
SK-UT-1,25150857,3.291116369436408
H-STS,44607531,1.532888966032803
SNU-886,9907093,3.676979603066549
Ri-1,44202524,1.1523860177568743
PF-382,17759555,3.607895848401572
KYSE-450,4261,3.512938253123631
Lu-65,24180719,4.093355084092675
LMSU,89928392,1.5528019914558755
AsPC-1,71304818,2.27524368423619
BT 286,3634881,2.47192305940937
HCC2108,168312962,1.890328048752136
KMRC-20,72376,-0.7899915244048435
Namalwa,24772860,-2.8459289590629937
ACC-MESO-1,54618305,4.946353791859653
KMRC-20,navitoclax-MST-312 (1-1 mol-mol),3.022643345531742
CML-T1,675434,3.803383794807122
HuT 78,selumetinib-navitoclax (8-1 mol-mol),-3.3209959202803323
KYSE-450,984333,1.1711925405074113
KYSE-180,serdemetan-SCH-529074 (1-1 mol-mol),2.3762708337041993
ACC-MESO-1,44259,2.1931156888577807
RT-4,55283,3.030224345806742
BT 248,73707398,1.2475621750333084
NCI-H929,5566,2.7784584402230266
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026
Ri-1,selumetinib-UNC0638 (4-1 mol-mol),2.6892324005846873
KYSE-450,969516,2.907932259173941
OAW28,753704,4.708152366597851
Lu-65,24748573,1.9267593359475736
KYSE-180,613753,3.360667218558787
RERF-LC-MS,4096211,1.8582313750529689
SF539,9868037,3.16067122997076
Becker,46926350,-4.071547217187583
SF539,135411,-0.8521595547181242
Namalwa,46215462,1.3795153892876229
KMS-12-BM,5566,2.9351867752080887
RERF-LC-MS,9967941,1.5454786965180345
OAW28,5281672,6.00346703144391
SF539,24951314,1.5641800235140235
Lu-65,24901704,4.087024583205145
Panc 02.03,107985,-4.238430695688479
KMRC-20,119607,3.891658736403049
SNU-119,11609586,3.0973958164397013
Mono-Mac-1,16725315,4.63798082197868
Mono-Mac-1,44241473,4.325172344907564
Ri-1,24951314,-1.7836482207225228
PE/CA-PJ41 (clone D2),piperlongumine-MST-312 (1-1 mol-mol),1.385125005299621
PE/CA-PJ41 (clone D2),24964624,3.1911374387835596
Namalwa,11955716,-2.6032735104865643
BT 498,72376,-0.0404401265218914
AsPC-1,12003241,0.1897400127907629
HCC2108,5351362,2.023612240814503
Karpas-422,19582717,2.669831317762961
Lu-65,409805,4.990129571781812
WM793,54454,5.104198308699605
NCI-H2030,selumetinib-JQ-1 (4-1 mol-mol),3.0704561739948737
EHEB,selumetinib-MK-2206 (8-1 mol-mol),0.5537503173054988
NCI-H196,219104,4.963735754845671
ChaGo-K-1,6184667,1.7457874071867656
Lu-65,6914657,-3.6612157004781705
Mono-Mac-1,24753719,5.146647018593083
ACC-MESO-1,3062316,2.585794570393164
NCI-H929,8515,3.198792100225454
NCI-H209,285033,-0.5036060100929018
AU565,2746,2.9112036552039737
KMS-12-BM,5702613,3.076262318494198
Kasumi-2,89183176,5.250973362639219
WM793,10302451,3.996584762768067
Mono-Mac-1,11427553,-0.2417321050983487
HOP-62,40482356,5.176244995623167
Lu-65,44819697,-1.4367548400629455
BT 498,5566,3.4106844889366523
ACC-MESO-1,2828334,6.678342989737849
RT-4,4788,5.796241294754794
RERF-LC-MS,46843906,4.323049782377064
KYSE-450,5566,4.0898855069679785
BT 286,135398516,3.3849722776709923
ChaGo-K-1,72376,-1.2287910784221336
RERF-LC-MS,73707371,5.9060077591992375
Lu-65,24753719,4.200901719906933
LMSU,12003241,-1.0531077396215482
MJ,navitoclax-sorafenib (1-1 mol-mol),1.3487900981296097
KLE,439501,-2.1797784747958477
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
ACC-MESO-1,3384730,1.608685383996302
Karpas-422,462382,1.2043639070752885
MIA PaCa-2,71751553,4.303479284138883
KMS-12-BM,2749,1.1667301765067617
IST-Mes1,SNX-2112-bortezomib (250-1 mol-mol),1.249422428379272
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
BT 286,123631,2.3130563445679733
SNU-213,selumetinib-UNC0638 (4-1 mol-mol),1.1702895891126708
LXF 289,54618305,4.64176895308047
KMS-12-BM,168313047,1.7734190846374434
CML-T1,16722836,0.8135653137043857
NCI-H2030,selumetinib-vorinostat (8-1 mol-mol),2.944898179545911
ACC-MESO-1,637858,3.0332515622117016
NCI-H1339,2113511,5.7247036401777445
Panc 02.03,9911463,4.953148943637795
Namalwa,3854666,0.1539435938538964
HuT 78,11955716,-3.02864832586091
Panc 02.03,10074640,3.562403354758929
KMRC-20,selumetinib-PLX-4032 (8-1 mol-mol),4.800972275106229
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
WM793,10296883,3.657255931485473
AsPC-1,9911463,3.4970941612274693
SNU-423,10427712,5.313919411961389
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558
LXF 289,5566,2.9960878643930218
HEC-108,crizotinib-PLX-4032 (2-1 mol-mol),2.8622947616000984
Ri-1,3081361,2.3220085024904185
Mono-Mac-1,135875424,3.0350686584049473
HuT 78,135411,-0.1860381511558323
HuT 78,9927531,5.1568522769540674
AsPC-1,9936388,-0.8199656713038528
IST-Mes1,89928392,1.562289834411229
RERF-LC-MS,5287620,-3.2415128958876123
SF539,4096211,1.1700950606218037
KYSE-180,16038120,1.625383238797563
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
ChaGo-K-1,16065773,1.9755218058173556
SK-UT-1,4917,3.615993600878312
KMRC-20,168312962,-1.9289630106650897
ESS-1,119182,0.4984219071249969
HEC-108,6438330,3.5129329347136027
Ri-1,4096211,0.8804339359424012
SNU-213,136227924,3.1812992174761696
NCI-H2030,107970,3.119598892281485
HSC-3,6914657,-4.096069958773948
NCI-H929,24856436,1.1628618903895551
AsPC-1,11214940,2.3233429785878443
HEC-108,136227924,3.134071919213167
Mono-Mac-1,19582717,2.6339018489596957
Lu-65,54618164,4.000249960497271
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084
AsPC-1,984333,1.2969820633088274
SNU-886,135999136,4.094662341834861
BT 248,2742550,4.585670765822412
Becker,5311281,1.1907774458631617
NCI-H929,3634881,1.384558879628874
KMRC-20,71466380,5.209336168619487
CML-T1,9866186,-1.0355523545849354
BT 286,4096211,1.723481586132858
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
IST-Mes1,135875424,5.039969018342982
SK-MEL-5,6852167,3.3711794080976594
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
Kasumi-2,11964036,-0.3814812468505845
HuT 78,3676137,4.565046002929079
RKN,104842,-2.3241286690000265
NOMO-1,24951314,-0.0494287054100275
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
BT 328,11222830,1.4031048122319796
NCI-H2030,navitoclax-gemcitabine (1-1 mol-mol),1.4501970702857692
CML-T1,5311,-0.0657355385312412
OAW28,10184653,1.1706980363621209
MJ,docetaxel-tanespimycin (2-1 mol-mol),-7.655243886133082
IST-Mes1,10184653,1.5276072056435492
KYSE-180,6914657,-3.948494720102188
ChaGo-K-1,56973724,4.0885467210720075
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643
Ri-1,5291,3.0570905184934896
ChaGo-K-1,3854666,1.588542463335614
SK-MEL-5,73707398,1.781035477419176
LMSU,4096211,2.6268822987004947
SNU-423,148198,-4.2261536044419765
EHEB,446155,2.5622028140590083
WM793,11175137,2.573938317060376
KLE,52912189,2.543092460133613
ChaGo-K-1,carboplatin-UNC0638 (2-1 mol-mol),3.84747498040297
HSC-3,9915743,0.268265478867946
HCC2108,9903786,2.237017286795856
BT 320,44819697,2.9489346663339187
H-STS,148124,4.085792664518574
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
KYSE-450,44462760,5.018979644026392
SNU-886,44819697,2.856258446406514
SF539,26596,-2.288089999638428
SF539,5702613,3.2712252993550384
Kasumi-2,71304818,2.3604520648914136
HOP-62,24753719,5.014649450364504
SK-MEL-5,JQ-1-carboplatin (1-1 mol-mol),5.709362170357264
HCC2108,54649381,3.8131747738004567
SNU-119,5291,3.2986963310167714
ACC-MESO-1,5281321,1.7806950931960217
AU565,11455910,2.266336610800082
CML-T1,71466380,3.6658800118854673
KMS-12-BM,10427712,2.780946081565878
BT 248,5328940,2.875094995002875
H-STS,219104,3.0414715393637937
RKN,23582824,1.7370647325872666
IST-Mes1,9926054,1.778703370274458
KYSE-450,4788,5.909868922921636
HOP-62,71466380,3.3648670809010603
KMS-12-BM,selumetinib-JQ-1 (4-1 mol-mol),-0.820838989236415
AsPC-1,51039095,3.058915175873227
HEC-108,44620216,4.0504389741939635
ChaGo-K-1,2949965,2.4204656541606533
AsPC-1,36462,3.6552458214160506
Lu-65,285033,-2.1331342476122925
NCI-H196,613753,2.6616424659877005
RKN,6918837,-0.6134153399361431
SNU-213,25126798,3.874546717760269
ESS-1,54765302,4.90712121180697
Panc 02.03,54678924,2.4878586568917536
Ri-1,53245473,3.751494812612455
ChaGo-K-1,675434,4.913986112322382
SK-MEL-5,3038522,3.2178299780365847
Lu-65,52947716,-5.122167932786324
PE/CA-PJ41 (clone D2),16722836,2.611972062158048
NCI-H1339,176870,5.0790709272100285
Karpas-422,5284616,-7.1986779453146825
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
Kasumi-2,11404337,-1.9658161518336
NCI-H2030,11485656,2.3036086259885526
OAW28,44491742,4.754653012158477
OAW28,5278396,3.588828047742794
Namalwa,11178236,-7.034373828105963
RERF-LC-MS,72376,-2.3536044208150644
IST-Mes1,16038120,1.0913997834143612
SF539,4705,3.4621418210440296
Karpas-422,46926350,-4.5458503553552365
RT-4,1242560,3.444710229960461
KYSE-180,carboplatin-UNC0638 (2-1 mol-mol),4.06711505487647
HCC2108,65064,5.202771624484401
KMS-12-BM,9911830,2.539717819095299
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
KYSE-450,9840324,5.8174625933687265
SK-MEL-5,10127622,3.8805251608719935
NCI-H2030,123631,3.869005003693507
SK-MEL-5,11228183,3.692037298067025
PF-382,10302451,0.8944755236764494
BT 286,44137675,3.839918217335364
NCI-H2030,66577038,4.032519015541418
KMS-12-BM,46943432,-0.1840385129667849
PF-382,219104,1.153997513178665
Namalwa,46907787,-1.1716727326146228
BT 320,51039095,3.427316698358292
Karpas-422,11396600,4.033756538148708
NOMO-1,44493528,4.211717002525977
BT 498,107970,2.860609306082874
KMRC-20,5311281,2.943166998255785
SF539,56649450,3.257832178779862
Kasumi-2,71466445,1.815897736576068
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
SW1783,15547703,5.783856550562672
SK-MEL-5,5311,1.005186361519784
MJ,54143018,1.2156401491436408
NCI-H196,5278396,5.36521769307123
AsPC-1,25105715,4.199758530142014
AsPC-1,56946209,-4.100794030874608
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009
RKO,25183872,-1.1635703485572924
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509
BFTC-909,46901937,4.445112058189045
H-STS,11178236,-6.19923215257486
BT 286,navitoclax-piperlongumine (1-1 mol-mol),1.4762165911418568
BFTC-909,16115403,-3.993091010962378
Becker,6450551,3.994700694716569
OAW28,17759555,2.4276686354020223
NCI-H2030,24856436,2.270745300131024
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
BT 498,navitoclax-gemcitabine (1-1 mol-mol),3.75277818219556
SNU-423,3825829,4.083312388937309
EHEB,72193861,-0.1168553281087315
BT 498,136227924,4.389685115045935
Mono-Mac-1,8515,3.2918667240053643
LMSU,60700,0.2696486188737008
Karpas-422,15953870,3.6595418641007895
BT 320,11494412,4.421767883618589
KMS-12-BM,5394,3.997526892316944
AsPC-1,5479543,3.7451312348556582
PE/CA-PJ41 (clone D2),docetaxel-tanespimycin (2-1 mol-mol),-0.3463731783951276
BT 320,11427553,4.124967356317301
SNU-423,11977753,-2.3250413939058663
CML-T1,57519531,1.0516100309241616
RKO,44491742,4.905526099010324
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
NCI-H1339,navitoclax-PLX-4032 (1-1 mol-mol),5.73538695596653
BT 498,6610216,4.077552585304459
BT 498,82146,4.101761137978197
HCC2108,15547703,2.896833120042048
CML-T1,3634881,2.472630922180769
AU565,445643,3.872431437053606
EHEB,11960529,4.94849976240243
Mono-Mac-1,15983966,-5.789773098471852
Panc 02.03,637858,2.766769284687194
SK-MEL-5,doxorubicin-navitoclax (2-1 mol-mol),-0.1967922597194684
AsPC-1,73707398,2.3690176063372888
SW1783,BRD-A02303741-carboplatin (1-1 mol-mol),4.341275119932719
SW1783,10385095,3.137926014779676
AsPC-1,135999136,4.3448843965381965
WM793,5281321,-1.0068304363485172
PF-382,1750826,-5.215741275914632
NCI-H1339,135875424,4.767141568633495
KLE,46199207,2.9361016730339697
HOP-62,54619267,4.367790390641184
HCC2108,44137675,4.225822582282624
Karpas-422,2749,1.5953519603424242
RKN,20959075,-2.033811748726601
HOP-62,136227331,3.5608481617611165
NCI-H196,262093,3.244471483790871
RKO,3025944,4.391654014934833
ChaGo-K-1,2113511,5.882662121576482
Panc 02.03,1566236,1.9322803720882225
Kasumi-2,46174525,2.7896977924424218
BT 328,carboplatin-etoposide (40-17 mol-mol),5.134403751038302
BT 248,51039095,3.103752706938284
NCI-H929,25262965,-4.479075794204223
Karpas-422,25161177,5.207009803272956
BT 248,11228183,2.0159399448324065
RERF-LC-MS,9933475,2.253072026550434
NCI-H929,ISOX-bortezomib (250-1 mol-mol),-0.7959511173514853
NCI-H196,JQ-1-navitoclax (2-1 mol-mol),1.860973028750606
HOP-62,5280436,3.564174206782728
LXF 289,9903786,1.8485652979864533
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
RERF-LC-MS,168312962,0.3496483928324376
KMS-12-BM,3543504,3.65561309678176
Kasumi-2,4378219,6.192429128955844
WM793,60700,0.4501720050415228
H-STS,53392493,1.7634078986228434
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296
ESS-1,25154868,5.124827046157549
RERF-LC-MS,54626689,4.221264321270605
BFTC-909,24978538,2.589526114093726
KMRC-20,638278,3.6532270710098818
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
KLE,9868037,3.52213609317776
BT 286,24180125,3.4057895340262445
KYSE-180,11640390,4.050800421029737
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
BT 320,11257553,3.955696091315844
H-STS,71466578,4.205777917887045
RERF-LC-MS,17755052,1.8057357372617977
Kasumi-2,11612883,1.7782552978814286
SF539,5566,3.0115367431942865
ESS-1,44462760,5.293674505936234
Becker,16013152,6.289892146912785
BFTC-909,49850262,4.237463012213885
RERF-LC-MS,4705,3.292681011259135
Karpas-422,16722836,0.9584493031420234
NOMO-1,11396600,3.3888037624860674
MIA PaCa-2,11497983,3.759815603301495
AsPC-1,1242560,3.922175022537436
OAW28,44137675,4.561686598527574
BT 248,148198,-3.920391313180545
Lu-65,12003241,0.1595843887204832
BT 498,5738263,3.648812853075705
KMS-12-BM,decitabine-navitoclax (2-1 mol-mol),-4.759135600180924
SK-MEL-5,675434,4.343298887458213
SF539,46224516,1.728004349053643
PE/CA-PJ41 (clone D2),10074640,3.7957214869884424
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
LXF 289,67156097,-1.7104573080698593
NCI-H2030,2858523,2.977003820472243
IST-Mes1,6918328,0.8508470020259952
BT 286,53232,4.623732019696622
Lu-65,123631,1.6427461920564876
RERF-LC-MS,148124,-5.592640359076286
SK-UT-1,12001922,1.8761579048113184
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
ESS-1,216239,3.396393497889356
NCI-H929,25195348,3.383350427765997
PF-382,24951314,-0.325943641902455
AsPC-1,1750826,-1.5700020776253725
Panc 02.03,10127622,3.4148938287456776
LMSU,tretinoin-navitoclax (4-1 mol-mol),4.538664740757784
Mono-Mac-1,SNX-2112-bortezomib (250-1 mol-mol),-2.764721763135708
ACC-MESO-1,carboplatin-etoposide (40-17 mol-mol),3.981012697138959
BT 320,71751553,4.331550413851084
RKN,753704,4.966407297087677
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
ChaGo-K-1,445091,3.937856738391293
Kasumi-2,387447,-5.322857892005912
NCI-H929,49850262,3.128406990217982
AsPC-1,11175137,3.2351214827225956
PF-382,3011155,1.384120809938285
Mono-Mac-1,11640390,2.8193027776915605
SNU-213,serdemetan-SCH-529074 (1-1 mol-mol),2.3489182261592396
SNU-423,25150857,2.785663245467314
H-STS,60750,-4.358992814054535
HOP-62,9967941,3.751035139313707
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
PF-382,1716436,4.358638458244471
CML-T1,54618305,-5.881736901302383
HEC-108,135398516,2.4406871230924385
BT 328,5113032,4.3388133731022585
AsPC-1,54618771,1.0442216511349782
ACC-MESO-1,969516,3.1968217861477015
SK-UT-1,51039095,3.5731759350620345
LMSU,JQ-1-MK-0752 (1-1 mol-mol),4.2327882239703
Kasumi-2,135984461,1.6284116850001094
LXF 289,44493528,4.295099384269069
NOMO-1,11612883,1.4996443311921075
ESS-1,12001922,2.286773298620945
ACC-MESO-1,1716436,3.110385863355361
PF-382,168313016,4.6371186800984745
Lu-65,navitoclax-birinapant (1-1 mol-mol),3.958849647004374
PF-382,2708,3.3018060761805774
SNU-886,selumetinib-navitoclax (8-1 mol-mol),-7.607672884091839
HOP-62,doxorubicin-navitoclax (2-1 mol-mol),-0.946699681174633
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
ESS-1,49836020,-4.193111027878734
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
WM793,65628,5.352978394453619
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
IST-Mes1,44632017,4.619480314320218
ChaGo-K-1,navitoclax-PLX-4032 (1-1 mol-mol),3.5988961173594975
NCI-H209,ISOX-bortezomib (250-1 mol-mol),1.9023291222008245
SK-UT-1,5281321,0.6651666607918505
KLE,5282054,1.2490004235770853
NCI-H2030,100016,6.672614959068411
CML-T1,446155,3.2304119453056632
LMSU,1716436,3.7603795285051818
HSC-3,54143018,-0.1249296162497747
AsPC-1,selumetinib-UNC0638 (4-1 mol-mol),1.8710456800697877
Ri-1,10074640,2.328205384294345
HuT 78,tanespimycin-gemcitabine (1-1 mol-mol),-3.1990435340994043
BT 328,168313200,2.3539430397400523
WM793,44493528,4.356787444460569
SF539,11214940,4.4904347227847845
NCI-H196,3815108,3.850058544040323
KLE,vorinostat-navitoclax (4-1 mol-mol),-1.450020647356142
NCI-H1339,148124,-5.674249092402399
HSC-3,9911463,3.6821530137729983
EHEB,119607,5.753474154470325
SNU-119,445643,3.745068929793647
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
AsPC-1,7251185,2.99432826291256
AU565,11609586,0.8886557909894768
KYSE-450,2729026,3.1949435983644414
BT 248,4477,0.1181412005602309
Mono-Mac-1,24797083,1.4926989883124837
KYSE-450,16065773,3.8243324962121914
KMS-12-BM,151289,-0.2601572179099301
HSC-3,JQ-1-vorinostat (2-1 mol-mol),1.5521244042740985
ChaGo-K-1,44486219,4.293398866953343
HCC2108,4788,5.8441996671956105
NCI-H1339,675434,4.467732679344732
NCI-H2030,15983966,1.0787102395140626
BFTC-909,11507802,1.7199271215311116
HuT 78,5328940,1.35372142133129
MIA PaCa-2,23582824,0.8302475552181157
SNU-213,5566,2.8335437208552263
Becker,24785538,1.980714235788152
HuT 78,JQ-1-vorinostat (2-1 mol-mol),-2.017178846521955
Karpas-422,decitabine-carboplatin (1-1 mol-mol),1.1507447768473271
NCI-H929,9907093,2.342525327576932
SW1783,53232,4.066111432329494
Ri-1,135421197,1.0934360104975305
Karpas-422,6252,-0.618618589447053
HOP-62,2842253,6.129246689275758
PF-382,444795,3.785413836559396
PF-382,3503,1.22639137886012
Mono-Mac-1,568763,-0.04140676124599
PE/CA-PJ41 (clone D2),9936388,2.7789010886628422
HEC-108,9929138,6.458847770997077
KLE,3634881,3.3251841919327805
ChaGo-K-1,42611257,3.592729168280832
RKO,124202324,3.4391315101947386
KYSE-180,11222830,1.7439687500469427
Namalwa,24901704,3.273003218825604
SNU-423,216239,2.7358843595153477
Kasumi-2,selumetinib-PLX-4032 (8-1 mol-mol),4.8744745414665145
OAW28,31703,0.1585101679236112
Mono-Mac-1,46174525,3.0671616962684336
AU565,15547703,3.2970552657128325
KMRC-20,15547703,3.8030034015972807
RT-4,262093,3.3301279648450985
SNU-886,16736978,1.1893425576042655
SNU-213,6917907,-4.366757744444296
ACC-MESO-1,9803433,3.719754418164016
Panc 02.03,24797083,1.7288458125332262
KMRC-20,6852167,4.09361379982572
AsPC-1,docetaxel-tanespimycin (2-1 mol-mol),-2.3470176928652204
BT 286,10296883,4.151589590813863
HCC2108,9911830,2.581322243172156
HOP-62,1716436,2.852163068438644
AsPC-1,25062766,3.1635616497742283
CML-T1,60168763,3.1201048573104395
RKO,4917,3.097539294413192
NOMO-1,9825149,1.4944850939332062
NCI-H196,51039095,3.6341138272935622
RKO,9926054,1.883626680074333
Namalwa,60700,-2.9629923455274776
H-STS,462382,0.7084919916713189
Karpas-422,selumetinib-piperlongumine (8-1 mol-mol),2.6929607327143468
OAW28,5282054,3.6220988157242946
NCI-H929,16725315,0.430149891023638
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
SNU-423,151289,1.2049619409118173
RKO,52947716,-6.611161073849914
BT 248,24889392,1.8419989874192408
SK-UT-1,selumetinib-vorinostat (8-1 mol-mol),3.855507066103229
HSC-3,6438330,1.1603419304147438
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
RKN,11455910,3.815213247766997
HSC-3,10113978,3.768062627679758
BT 286,2842253,6.302891068687999
PF-382,5280436,3.3535132704910784
Mono-Mac-1,107985,-4.510683187416183
KYSE-180,2858523,2.9324338012206845
BT 320,navitoclax-piperlongumine (1-1 mol-mol),3.22781533773438
IST-Mes1,54613361,2.804102088673467
KLE,44589607,1.3436468299943964
HuT 78,2871966,-0.2683725528046166
MIA PaCa-2,carboplatin-UNC0638 (2-1 mol-mol),3.385632682123634
HCC2108,6623618,2.894339950820384
KLE,387447,-3.4483101569970804
RKO,44632017,0.9673312213076444
SW1783,46215462,1.5074771125721502
BT 248,3062316,2.7315660903773606
SNU-886,16720766,-3.5476315542779364
PF-382,16722836,0.500687178002076
PE/CA-PJ41 (clone D2),262093,3.3360750662244443
MIA PaCa-2,89928392,1.5224119152536262
KYSE-180,54618164,4.682866725736199
Karpas-422,46224516,1.1121151322289515
OAW28,5311281,1.8509970799423736
KMS-12-BM,46199207,2.5727127947453585
SNU-119,107985,-4.156641254925639
RERF-LC-MS,12001922,2.43602915295576
Mono-Mac-1,11485656,2.9972427080576836
IST-Mes1,11626560,1.5280230569409714
SNU-423,3136844,4.260601533804775
HuT 78,135928012,5.03508248735035
NCI-H1339,11485656,3.447182893453246
NCI-H196,9884685,-0.0340951711946578
HOP-62,135421197,0.8812919220198131
ACC-MESO-1,piperlongumine-MST-312 (1-1 mol-mol),2.5356121721724354
AU565,9549297,3.94244046983191
Namalwa,56949517,4.132859022124254
SF539,44491742,4.105649274647132
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
Namalwa,45279963,3.210185637005973
SNU-119,16741245,5.112197771644654
Lu-65,vorinostat-carboplatin (1-1 mol-mol),3.813757203413742
NCI-H1339,24180719,4.777839850801867
BT 286,11717001,2.163953812936934
BT 328,1566236,2.4214904059930156
WM793,11178236,-2.656687439817939
NCI-H1339,71751553,4.829519613793705
Becker,JQ-1-vorinostat (2-1 mol-mol),2.247746806810153
Mono-Mac-1,11719255,0.6442430615646344
SK-UT-1,135411,0.7872586171820456
BFTC-909,23635314,-1.3241610546701814
BT 286,BRD-A02303741-navitoclax (2-1 mol-mol),1.9078817739450291
Lu-65,piperlongumine-MST-312 (1-1 mol-mol),1.0978652677191336
RKN,24797083,0.944322820476056
NCI-H929,5329102,0.3399377983022085
KYSE-180,JQ-1-vorinostat (2-1 mol-mol),2.469302562652029
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
NOMO-1,6852167,1.234836949550939
HOP-62,2742550,5.0895590073246595
AU565,54618795,2.974070020268914
NOMO-1,9444,3.521396869825756
BT 320,11625818,5.9690326446968935
RKO,656346,1.2468664563159324
Namalwa,2733487,3.3542570551345356
MIA PaCa-2,16725315,4.586093250425383
LMSU,11152667,0.2226803323304874
BT 320,409805,6.1406982436622
KYSE-180,navitoclax-piperlongumine (1-1 mol-mol),3.2533869345330446
SNU-886,3081361,3.1313223505952132
Mono-Mac-1,26596,-2.0508737654950036
MIA PaCa-2,219104,3.665575033373056
ESS-1,11485656,1.966597488234831
HSC-3,44185566,1.8853350434555631
AsPC-1,81146,4.947223766743442
Mono-Mac-1,68056272,2.1960795131164357
HOP-62,100016,6.313498249886369
ESS-1,10410894,3.4736910874659648
WM793,10184653,0.3319580671106031
BT 320,5280436,4.79134990721052
SK-UT-1,16065773,2.499708535833016
NCI-H196,11152667,-0.3084820466732423
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
BT 328,24748573,3.666462316296569
Karpas-422,67156097,-1.5831947892164298
Panc 02.03,12001922,2.5444953584324193
PE/CA-PJ41 (clone D2),24821094,0.7752416250698981
HCC2108,262093,2.915848941362045
NCI-H196,676352,3.015082175831645
RT-4,1750826,-0.6566840301254596
SK-MEL-5,2749,2.076988980388519
Ri-1,73707386,2.473234427573793
Namalwa,25150857,1.9088019645088363
RT-4,4259181,0.4956946540898031
SK-MEL-5,1716436,0.9417842907205056
KMS-12-BM,1716436,2.2490231702489956
SNU-119,44489367,5.127022911687477
MJ,52947716,4.013188084373533
Ri-1,56949517,1.825800201043262
RT-4,3825829,3.4258833117884064
MIA PaCa-2,135423438,2.2894715060157553
NCI-H929,327653,2.3561667456594986
NCI-H196,ISOX-bortezomib (250-1 mol-mol),0.7504794663682204
PF-382,5328940,0.3302899082502404
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546
SNU-423,73707398,1.089223560310694
IST-Mes1,53232,2.11135293708232
PF-382,24978538,-1.2784497861997195
Ri-1,5335621,3.5849906536782252
Becker,327653,3.7069027046220024
OAW28,3825829,4.635564939734502
AsPC-1,11178236,-3.0731642515052098
OAW28,11609586,2.8574541529278883
KMRC-20,637858,2.2731698678706027
Becker,637858,2.787561829247156
PE/CA-PJ41 (clone D2),5351362,1.231122848271496
RERF-LC-MS,3025944,4.157794890121567
Ri-1,24785538,0.9665697902420332
Namalwa,2742550,3.645148069005769
ChaGo-K-1,19582717,4.576534267477968
Mono-Mac-1,42642645,-3.779947759429327
Mono-Mac-1,16038120,-0.6637799816204304
BT 286,selumetinib-MK-2206 (8-1 mol-mol),-0.8651778836923494
CML-T1,2126,4.385584292912835
HSC-3,400769,-1.1119474923220969
KLE,11626560,2.541931063465937
CML-T1,5329102,0.8946748960608596
Becker,135999136,4.331325475055123
SK-MEL-5,168312962,-1.254533954039552
BT 286,5280436,3.4211846964985937
Mono-Mac-1,11152667,-4.583124026355614
RERF-LC-MS,702558,6.005509402748126
RERF-LC-MS,9884685,0.4531053665233772
ESS-1,2708,3.2385388289614583
KYSE-180,656346,0.5035259214869502
AU565,60700,-0.684074891390158
OAW28,9935249,3.684332158484572
KYSE-180,6918837,-1.892651842131766
BT 320,45279963,4.337631582225757
LXF 289,439501,-1.653941874457911
SNU-423,135999136,4.547106106138672
NCI-H929,24951314,0.3525234026902946
HOP-62,568763,1.3742847398893925
SK-MEL-5,9911830,3.188235338246222
NCI-H196,445091,5.113159041837577
OAW28,31703,0.1585101679236112
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
OAW28,46224516,2.3854099680927523
PF-382,135421197,0.9667662585436329
HEC-108,2708,6.110657664739327
SNU-886,10113978,1.5939546192174308
AsPC-1,2708,5.587707055847425
Lu-65,46398810,3.002641296730853
SNU-886,BRD-K27188169-navitoclax (2-1 mol-mol),-4.5731831283745095
OAW28,25195348,5.036760517156048
MJ,11222830,1.6104329121472218
RKO,11626560,1.596896929931414
KMS-12-BM,54678924,0.980772180306658
HSC-3,241158,3.419773075540372
HuT 78,3025944,4.291408043863783
BT 498,2708,6.0510362109636455
RKN,637858,2.0099352926359533
Kasumi-2,24753719,3.2877720740856815
Panc 02.03,71466380,5.929652601038649
Mono-Mac-1,11977753,0.507212198852303
MIA PaCa-2,44607531,1.828336008484694
RERF-LC-MS,4261,2.068565192175152
SF539,4788,3.861213831162074
CML-T1,6438330,0.4811462042672619
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
SNU-423,selumetinib-piperlongumine (8-1 mol-mol),2.5953943474884382
RERF-LC-MS,2828334,5.9123201087220325
OAW28,11494412,4.413959214794941
EHEB,44589607,1.92892141933537
BFTC-909,3038522,3.685618431455981
NOMO-1,969516,2.327280884248625
Kasumi-2,53232,4.135119610512006
SF539,11222830,0.6495721704540977
SK-MEL-5,5284616,3.1246661587067446
KMRC-20,JQ-1-vorinostat (2-1 mol-mol),1.7391648557061274
NCI-H929,24180719,3.664799403319753
PE/CA-PJ41 (clone D2),11234052,5.082198224280487
ChaGo-K-1,24964624,3.0515539572091512
ChaGo-K-1,136227331,4.028131370047934
Mono-Mac-1,navitoclax-MST-312 (1-1 mol-mol),0.5984340536339148
SNU-423,5282054,4.220806432863004
SF539,11167602,1.5763974980915605
RKN,54454,2.1815674244706407
SNU-119,676352,1.897114472435228
SNU-213,262093,3.638008939275064
SNU-886,navitoclax-PLX-4032 (1-1 mol-mol),-7.656166203992468
Becker,123631,3.6541086582376914
MJ,60700,-0.4552708025681623
PE/CA-PJ41 (clone D2),4477,0.8581598158487629
HSC-3,5311,1.6159558865121677
SK-UT-1,9911463,4.1504947350424315
CML-T1,52947716,-5.195799479557534
HuT 78,vorinostat-navitoclax (4-1 mol-mol),0.0137878809652615
ESS-1,89183176,5.005336079724086
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
SW1783,4788,5.6219233668192174
HuT 78,selumetinib-JQ-1 (4-1 mol-mol),-4.078257117596482
SK-UT-1,3384730,2.824211371066942
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282
RT-4,36314,1.420570755930605
AU565,71466380,5.723316888337632
BT 286,49793307,-4.224113468350936
ACC-MESO-1,219104,4.703668674528299
ChaGo-K-1,25062766,2.5286145290937903
Lu-65,2871966,1.1705483639287513
KMS-12-BM,11507802,0.0118265671826585
BT 248,675434,4.340673839490162
HSC-3,11152667,0.7686574426782067
RKN,23725625,4.172652901782409
Lu-65,262093,3.3965218788249407
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
Ri-1,11213558,-0.1281148771629731
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
NOMO-1,5281672,5.39154363605107
SF539,44589607,2.1989651923928375
CML-T1,11238147,1.550777100551064
PE/CA-PJ41 (clone D2),168312962,3.915035257448421
Kasumi-2,25102847,1.9985292692576584
HEC-108,11427553,3.7826747165213086
RT-4,216345,2.153757010037062
WM793,5470400,2.631713444324304
Panc 02.03,44589607,4.606435993835204
RKN,613753,3.037549827357118
ACC-MESO-1,54649381,3.866115711509678
H-STS,5329102,1.888507265760659
AU565,4788,5.691461260554478
KYSE-450,SNX-2112-bortezomib (250-1 mol-mol),-1.628342695469425
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
IST-Mes1,selumetinib-piperlongumine (8-1 mol-mol),4.502033014563436
PF-382,9884685,-1.5269409733501682
WM793,446155,3.930863255707362
SNU-213,44493528,4.322072480687394
ACC-MESO-1,SNX-2112-bortezomib (250-1 mol-mol),0.0592821214299193
RKN,11364421,-3.590581417405073
ACC-MESO-1,11238147,4.907932653734244
MIA PaCa-2,46907787,-0.2565491752841508
BT 286,erlotinib-PLX-4032 (2-1 mol-mol),3.302249298038756
PF-382,54619267,3.0349882951687124
BT 286,9887053,1.2721711931799218
H-STS,448949,1.6135505463804922
MIA PaCa-2,vorinostat-carboplatin (1-1 mol-mol),2.756428927556822
SNU-119,400769,-0.9034553072694146
KYSE-450,135999136,4.777760732357945
KYSE-450,72193861,3.11569572197334
SNU-886,15983966,2.2650754807835622
Lu-65,5328940,1.4363623184528207
HOP-62,613753,4.0419201274044445
KYSE-180,10184653,1.7037524343136865
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
HOP-62,24785538,1.3439344503188932
Namalwa,9927531,3.1365070733929663
Karpas-422,26596,-1.4945297758647662
RERF-LC-MS,16720766,0.5604118097796991
KLE,6610216,4.690158924143472
SK-MEL-5,11612883,3.663296316497211
SK-MEL-5,49793307,-1.9293314616169488
RKO,445091,4.342692134156949
NCI-H1339,241158,4.172701274103716
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824
MIA PaCa-2,selumetinib-UNC0638 (4-1 mol-mol),1.630767658500955
HSC-3,5281321,-1.07888071456113
KMRC-20,3689413,-2.0293333018936877
HOP-62,46398810,2.3106949719473153
SK-MEL-5,123631,1.8735076791711176
SF539,11497983,4.935206812157441
NOMO-1,753704,4.4431191000277375
HCC2108,49766530,-2.150620999142696
PE/CA-PJ41 (clone D2),16725315,5.310170656438465
ESS-1,2113511,5.741051028329071
KYSE-180,5978,-1.6510640748820715
Ri-1,54626689,4.174115404148546
NCI-H2030,56946209,-3.809257166478618
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528
NCI-H929,2708,3.7525965920977007
BT 286,alisertib-navitoclax (2-1 mol-mol),-2.5565503486403576
CML-T1,11317348,-0.5508465073970409
SNU-213,10385095,2.7554812107877065
ChaGo-K-1,9803433,4.814410473469276
BT 498,2126,4.791438742350041
Becker,1242560,3.428661477159298
NCI-H2030,3025944,4.9407835702905
MIA PaCa-2,6852167,2.446025976555517
NCI-H929,72193861,0.6140343557798097
Ri-1,24901704,1.5524847191985809
MJ,11404337,2.657052353931515
Mono-Mac-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.6474160384820955
AsPC-1,25183872,-0.8583413037674358
IST-Mes1,216239,2.2087908746431517
SNU-423,10127622,4.761112660173214
BT 320,11455910,4.86644863423661
SF539,17755052,0.186903454349707
SNU-886,4917,3.2978202495952336
SF539,135928012,3.885367249068042
KLE,452548,0.408592435214394
SW1783,216345,3.5979971294588147
SNU-119,44486219,4.148857305108833
RERF-LC-MS,11485656,1.5190166417661397
AU565,44137675,3.533476650788096
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413
HCC2108,11214940,0.9644297504836672
SNU-213,4261,2.536630318307326
RT-4,11152667,0.7569607325973031
BT 286,54649381,3.967150181655946
EHEB,5978,-2.167378408908765
BT 248,71751553,4.279070264679743
BT 328,selumetinib-navitoclax (8-1 mol-mol),1.1111417470564258
SNU-423,24901704,3.5814452106629053
ChaGo-K-1,2945648,2.7056269027367468
KMRC-20,54649381,3.798675470632658
AsPC-1,5329102,1.9734309343360383
RERF-LC-MS,9866186,0.0636323256725951
Panc 02.03,969516,3.806573436208542
SK-UT-1,6918837,-1.386854700757193
ChaGo-K-1,104842,-0.5641432467884121
Lu-65,16659841,4.400532062307719
Mono-Mac-1,44507138,0.2590910226176092
RT-4,2708,5.689057420087821
HuT 78,carboplatin-UNC0638 (2-1 mol-mol),1.5408742669191249
SNU-213,9915743,1.2181447895342674
MIA PaCa-2,9952709,3.824307570177284
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314
RT-4,11485656,2.1371904728142
RERF-LC-MS,119182,-0.645974794966856
HuT 78,24785538,1.710563314926326
ChaGo-K-1,16219061,2.7846250315534036
SNU-119,navitoclax-gemcitabine (1-1 mol-mol),1.782334179456962
LXF 289,107970,2.2922723928752307
AU565,15953870,2.093538779145719
RT-4,44589607,2.871102674918077
BT 320,3552672,1.9342456765414169
Ri-1,JQ-1-UNC0638 (2-1 mol-mol),-0.2670899012636173
SNU-423,3503,1.990171514859812
AU565,753704,4.59624742359194
MIA PaCa-2,2749,1.5862657990210698
SF539,5351362,1.1304414550964104
Becker,4788,5.864425996120983
BT 320,54143018,4.726719249085395
Ri-1,53232,3.9417926556630154
MIA PaCa-2,54765302,3.634792833492495
RT-4,168312962,1.4764557241805851
HSC-3,4259181,0.6256880265153872
ChaGo-K-1,5284329,2.795250008792205
BT 286,135423438,1.7051552017965996
Ri-1,49766530,-2.264065529315868
LXF 289,5282054,3.512278681739004
BT 328,6438330,1.8463189750437397
SNU-213,135398516,0.0152388717051578
PF-382,44620216,3.605530573538089
Panc 02.03,6918638,1.5939476449475074
Kasumi-2,49766530,-3.7396811929647513
MIA PaCa-2,644241,2.2485281362376677
HuT 78,3385,4.463035201043826
WM793,216345,3.0524169144377615
AsPC-1,9936388,-0.8199656713038528
KMS-12-BM,2842253,3.641564107870781
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
Namalwa,156414,1.5666485323210588
HCC2108,71304818,2.5553265093356186
Kasumi-2,1242560,3.251932247793875
SK-UT-1,24964624,3.065767628621786
NCI-H929,11647372,-2.313105757149245
LXF 289,54454,1.7599180903835134
RT-4,5281321,-0.1129489879810674
SF539,675434,4.646875008530426
CML-T1,5113032,5.118103556540756
AU565,44632017,0.8977842888684593
PF-382,11640390,2.579258356674951
KLE,57519531,1.524352024978553
Lu-65,439501,-2.896459054469027
Karpas-422,16736978,0.4633777346739987
Karpas-422,5460769,4.127517160029383
WM793,25150857,2.2772862447818047
WM793,5278396,3.634614455861616
NCI-H929,10385095,0.7754305798230204
RKN,446155,3.7628691651204234
PF-382,107970,1.4805149558229411
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305
SK-MEL-5,3062316,3.0724762007977917
PE/CA-PJ41 (clone D2),selumetinib-MK-2206 (8-1 mol-mol),1.5178122707062027
SF539,123631,1.7030857136426885
KLE,44185566,2.7760403729820085
Lu-65,5311281,4.045906858909323
HSC-3,11214940,0.9661571472664509
Panc 02.03,135875424,4.996461687769912
Kasumi-2,4917,2.8909802401946565
KMRC-20,23725625,4.838709119621016
CML-T1,44493528,3.9716542826771297
Namalwa,SNX-2112-bortezomib (250-1 mol-mol),-3.7975545956256505
SW1783,448949,1.229106792188085
AsPC-1,24964624,2.5492070232527424
EHEB,24951314,0.722947577043057
BFTC-909,6918837,-1.9878509916437357
WM793,984333,0.8846427573574175
PF-382,123631,2.005412532111485
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
Ri-1,11427553,1.3261471799784323
NCI-H196,11178236,-1.2379232510907854
AsPC-1,168312962,4.080126214508297
MIA PaCa-2,3062316,2.7877907850834225
RKO,44137675,4.282234128328841
LXF 289,46199207,3.0446562724495676
HuT 78,11364421,-5.802708456365859
OAW28,71466578,4.4029072721322455
OAW28,6918328,-0.6493981710218658
BT 286,44589607,2.85251609454855
Panc 02.03,9933475,2.3025810529048205
SW1783,5328940,3.054752986364744
BT 286,selumetinib-UNC0638 (4-1 mol-mol),-0.4867103603027745
BT 498,25227462,1.3760459786660628
Mono-Mac-1,676352,2.251881742384123
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397
OAW28,11625818,4.459236282412159
BT 286,65064,5.257116101297063
AsPC-1,10127622,2.6030187662085384
ChaGo-K-1,9884685,1.4931363766033252
RT-4,24772860,-3.0358788359895543
H-STS,16065773,1.8153092417887848
ACC-MESO-1,148198,-2.036295291578454
HOP-62,56946209,-2.0884661212322317
HCC2108,vorinostat-navitoclax (4-1 mol-mol),1.8283883364659943
AsPC-1,6918328,0.3822733035015269
NCI-H196,crizotinib-PLX-4032 (2-1 mol-mol),2.9036893656102247
H-STS,24772860,-2.67708885899535
NCI-H929,9956119,1.818516846968062
NCI-H2030,crizotinib-PLX-4032 (2-1 mol-mol),2.9391292975387944
SNU-213,12001922,1.7290947375839942
Kasumi-2,11175137,1.5162390215690418
WM793,5281672,4.440104889072824
BFTC-909,3825829,4.25128930140834
SF539,10410894,2.254370966764811
PE/CA-PJ41 (clone D2),11152667,0.8748020996772465
LMSU,6610355,5.0974562936039645
NCI-H1339,16720766,0.3905164617769229
AU565,5978,-4.241011158819041
Panc 02.03,9935249,3.920507280118285
KYSE-180,navitoclax-birinapant (1-1 mol-mol),5.391613379714011
Karpas-422,327653,2.503082809882216
NCI-H929,10302451,2.7551907478934465
RKN,5978,-1.5379865785523688
Becker,2746,3.675450807498904
Mono-Mac-1,53392493,0.4855947054327226
KMS-12-BM,11238147,0.8062576818407409
OAW28,2749,3.2113189756487683
SK-MEL-5,9935249,4.115682360197781
LMSU,9866186,2.2286939019864813
BT 320,24771867,4.382883452747231
SNU-213,439501,-0.6838743591109449
RERF-LC-MS,5282054,4.065617468844444
SF539,984333,-1.8112760815883828
CML-T1,vorinostat-navitoclax (4-1 mol-mol),0.0862805898320609
ACC-MESO-1,159324,5.7222118158510344
CML-T1,3025986,-2.237853890359125
Lu-65,44241473,4.745952871370416
HuT 78,8515,3.8606402282287657
ChaGo-K-1,1716436,2.640307012974755
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797
KLE,alisertib-navitoclax (2-1 mol-mol),-2.1079832786046486
ESS-1,46926350,-4.410058245118817
HSC-3,44202524,1.6578409101204128
RT-4,doxorubicin-navitoclax (2-1 mol-mol),-0.4200341898170817
Becker,11175137,2.5882807141403363
BT 286,11175137,2.1679374278293246
SNU-423,6505803,0.7785757061169877
SK-UT-1,675434,4.504318177888332
Mono-Mac-1,285033,-3.4365762455863895
BFTC-909,5351362,0.3148685714677321
MIA PaCa-2,446155,1.1238502373282009
Kasumi-2,2749,0.3805959448623131
WM793,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9195666143098356
IST-Mes1,5328940,2.5729000547912397
SK-UT-1,6917907,-5.759127548873742
Lu-65,selumetinib-BRD-A02303741 (4-1 mol-mol),0.2536220160137153
Becker,selumetinib-JQ-1 (4-1 mol-mol),4.188822961792769
AU565,4521392,3.744925242939049
NCI-H929,6610216,4.64058383232424
SK-MEL-5,135875424,3.6602054011582137
ChaGo-K-1,285033,-2.8760812177959347
BT 286,11955716,-2.2212839478685393
SK-UT-1,56946209,-1.4025300669134206
SNU-119,9952709,2.3650460687962997
Kasumi-2,71466578,1.9217240593305729
WM793,3815108,3.0627718438622487
NCI-H929,selumetinib-UNC0638 (4-1 mol-mol),3.372508515122925
KYSE-450,6918837,-1.1193045710295215
HSC-3,1750826,-3.2516156524402415
HCC2108,452548,0.5467419816970324
EHEB,4261,0.2305529532215675
Becker,23725625,5.785203803556796
PE/CA-PJ41 (clone D2),54619267,4.212913000042618
LXF 289,4261,1.4002862892534345
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
NCI-H929,3815108,2.046773234087797
SNU-213,54618771,0.1807958320323681
OAW28,5328940,1.8035592963336344
KYSE-180,6918736,-2.1145791698894056
MIA PaCa-2,23725625,6.743361702812376
NCI-H1339,6918638,0.2750671891608724
SF539,5460769,-0.1125532875886319
Ri-1,24771867,-1.201447409529902
BT 248,5329102,2.143317374155595
SNU-886,11485656,2.594845566887895
AU565,10322450,3.206832643999438
KMS-12-BM,65064,2.717641893492065
Mono-Mac-1,3825829,3.369538014411621
MIA PaCa-2,7251185,2.099852340885803
KLE,4259181,-0.0203780302150134
AsPC-1,46174525,4.390753346499015
RKO,54454,4.6965621210229225
BT 328,100016,6.778172011931934
SNU-119,2828334,5.778213563087879
KLE,25150857,3.036039064371872
SNU-423,11228183,1.2661393913217065
RKN,25126798,3.956068538327861
Karpas-422,piperlongumine-MST-312 (1-1 mol-mol),1.2169544319971164
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934
ESS-1,24797083,1.4472359872095728
Ri-1,6450551,1.5942274465310526
NOMO-1,53392493,1.775943290565707
Becker,675434,4.855217201879122
Lu-65,23635314,-2.532055940883662
KMS-12-BM,452548,-2.9349157486062736
Ri-1,11507802,0.4513555699201265
CML-T1,10113978,1.6264516706818362
WM793,44137675,3.8583923269749465
Mono-Mac-1,65064,5.077395341935721
Namalwa,46926350,-5.521834277640312
NCI-H1339,44607531,1.9218786847890523
H-STS,6918638,-0.6396360846494638
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
Lu-65,26596,-0.6076566338784338
KYSE-450,44607531,1.4871997171976696
HCC2108,11404337,0.8287580393905775
OAW28,984333,0.3792215902143511
LMSU,73707398,1.6424339360302744
WM793,6610355,4.692334548375442
SK-UT-1,46907787,3.5849510733980265
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
SNU-886,2828334,8.007819818360458
RT-4,5287620,-2.3596459820452376
PE/CA-PJ41 (clone D2),11707110,-0.8098927019350898
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
SNU-119,11647372,1.96438955117864
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
Namalwa,71466578,1.7975023406641202
AsPC-1,5281321,-1.206156098851657
BT 328,11955716,-1.056274858719932
Kasumi-2,49867930,4.763867340262508
SNU-213,446155,3.297839333720223
KMS-12-BM,613000,1.9257169552973945
RKO,53495165,0.8925500623489324
SF539,49846579,1.5882622372705737
BT 248,53495165,3.0905684330313803
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518
KYSE-450,46843906,5.632374072388803
Lu-65,25102847,1.5685038357748828
KLE,400769,-0.1230661741359576
PF-382,6914657,-5.488618534431668
HEC-108,638278,3.526450795936247
WM793,6610216,4.179764818643997
BFTC-909,5281672,4.401358042981416
NCI-H929,11455910,1.7265755247991157
Namalwa,67156097,-2.959897720698589
PF-382,135999136,1.3874167482573283
H-STS,675434,4.034994029543359
OAW28,17755052,1.3145864766951243
NOMO-1,676352,2.3647709516043336
SK-MEL-5,erlotinib-PLX-4032 (2-1 mol-mol),2.9162129014385783
RERF-LC-MS,11640390,2.8932892314821927
RERF-LC-MS,374536,3.716253113618047
Ri-1,9936388,-7.695738985409057
NCI-H196,6184667,3.014456731561885
OAW28,439501,-0.9322268226633188
BT 498,44589607,2.960128909864039
SK-UT-1,24856436,-0.0772181005247894
OAW28,11626560,1.7877294085158288
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
Lu-65,448949,1.923751722037902
IST-Mes1,24797083,1.4429650511590184
AU565,9884685,0.3686008824574254
SK-UT-1,11238147,3.508126296570063
AsPC-1,46398810,3.192713565122567
PF-382,54619238,4.57773905156779
ChaGo-K-1,11167602,1.7675321969112785
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
BT 286,44566777,-1.350747922279793
LMSU,doxorubicin-navitoclax (2-1 mol-mol),0.2989425462047189
SNU-423,2858523,3.1102980621606213
KYSE-180,252682,7.9563998050087745
KMS-12-BM,57519531,1.217688684529343
HuT 78,426756,2.038203464685228
AsPC-1,10231331,1.7826677656602696
Namalwa,15547703,2.517060625499504
KMRC-20,5746,0.6434885523366748
PE/CA-PJ41 (clone D2),216239,3.289521243210842
H-STS,SNX-2112-bortezomib (250-1 mol-mol),-2.995018705819844
HuT 78,31703,-1.631625857843589
SNU-119,5746,1.4479530054186391
SNU-886,2742550,3.913973677845718
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
Namalwa,9840324,5.609444873218537
BT 248,969516,3.2750512548532136
RKO,6918837,-1.4612228483082623
SNU-886,54626689,3.741397063281634
AsPC-1,445643,4.30663769172778
HOP-62,135411,0.996647312538749
BT 328,5281321,2.1998966981580073
SF539,51039095,1.5941495610042506
RKN,46191454,2.1430961760764897
HuT 78,BRD9876-MK-1775 (4-1 mol-mol),0.7890849571488777
SNU-213,24180125,3.139959624084286
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
BT 320,216345,4.58398991647949
RERF-LC-MS,1750826,-0.5689233588179538
RKO,46215462,1.869666408515056
ESS-1,44632017,1.0852608734168645
NCI-H1339,4261,1.2872784807283144
LMSU,54619267,4.386146647321598
SK-MEL-5,navitoclax-pluripotin (1-1 mol-mol),-0.5112819426570592
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
SNU-119,9911830,2.5015276348474424
H-STS,alisertib-navitoclax (2-1 mol-mol),-1.762059403403842
NCI-H2030,JQ-1-navitoclax (2-1 mol-mol),-0.3679807108564211
SF539,445643,3.7676894820893896
Mono-Mac-1,navitoclax-gemcitabine (1-1 mol-mol),-0.471295143456593
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
HEC-108,613753,3.395991597715239
EHEB,9868037,2.9297052804513934
LXF 289,654092,-0.8888310934038361
BT 320,12001922,1.695610420399754
KMS-12-BM,31703,-3.250328951463323
Ri-1,16741245,2.5922161729617668
HuT 78,6252,0.7757631208196515
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
BFTC-909,11455910,1.958059547603208
RKN,53232,2.2291100881655037
HOP-62,11494412,2.9227878689679105
Mono-Mac-1,3503,2.12876225643187
OAW28,5113032,5.506773811436986
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
KYSE-180,11238147,3.6851797317879935
BT 498,doxorubicin-navitoclax (2-1 mol-mol),-0.3911006180562948
NCI-H929,44589607,1.024401977018112
SNU-423,54626689,4.589502893592808
AsPC-1,23725625,6.32859301599116
ESS-1,2828334,6.174159424614295
LMSU,3025944,4.305577187870561
MIA PaCa-2,136227924,2.1731844460154743
SK-UT-1,24753719,3.8954683516034194
KMRC-20,11178236,-3.1714013325057686
SNU-423,4259181,1.1208846332757925
RKO,4788,5.372325515812119
HOP-62,42611257,2.6813799404980765
BT 320,53393127,4.811652436573408
IST-Mes1,11234052,4.921331368768723
KYSE-180,25195348,3.031032559566134
HCC2108,5281321,-0.1705555691898866
NCI-H929,135398516,-0.7887215182835613
ChaGo-K-1,448949,1.8199000013041025
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
KLE,71466380,4.290621032590563
Becker,119607,5.773340917710597
HuT 78,10231331,-3.0866153075416376
MIA PaCa-2,2130404,3.0787780804735125
IST-Mes1,4261,1.7623274186426838
KMRC-20,selumetinib-BRD-A02303741 (4-1 mol-mol),6.461263224770076
Mono-Mac-1,3676137,3.340146241767567
SNU-423,11234052,4.663718212669009
AsPC-1,4521392,4.0696198883268275
ESS-1,JQ-1-MK-0752 (1-1 mol-mol),0.8350024005295179
Mono-Mac-1,5287620,-4.925359227811426
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
NCI-H1339,36462,1.5499539192290197
NCI-H196,15953870,6.198131940680453
KMS-12-BM,9936388,-7.442749057312851
SK-UT-1,selumetinib-JQ-1 (4-1 mol-mol),5.500503252581381
LMSU,53392493,3.125828973482696
KMS-12-BM,16065773,1.4565661119909743
RT-4,654092,0.6230468978254379
SNU-886,1285940,4.4592277116209775
BT 328,6610216,4.43822058219873
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062
LMSU,216345,4.559958439384078
WM793,285033,-1.0395353883933165
SK-UT-1,10296883,3.957718672541511
ESS-1,11175137,1.5326050179721749
RT-4,2858523,3.0846585781360782
Namalwa,2113511,4.478594560568948
OAW28,3689413,-1.4375749125930504
HuT 78,5978,-3.8963684246064014
Kasumi-2,16725315,3.214174294489856
Mono-Mac-1,11175137,2.381238246388858
ChaGo-K-1,122327,3.867171453362269
CML-T1,10231331,3.71504818577299
PF-382,piperlongumine-MST-312 (1-1 mol-mol),3.2738168360218727
RT-4,24901704,2.5115033957059776
RERF-LC-MS,11222830,1.7620759794741472
BT 286,25161177,0.4506413025185109
Mono-Mac-1,9908783,5.903020339725522
LMSU,31703,0.876277005526271
NOMO-1,5460769,4.769752092364765
RT-4,60700,0.1864967839530102
BT 498,navitoclax-piperlongumine (1-1 mol-mol),2.5013615718204742
H-STS,16038120,1.2852053797527971
SNU-423,16722836,2.1126180298649824
Kasumi-2,4477,0.978376283081578
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
BT 286,3465537,0.9211618438378432
RKN,9926054,2.8101544562472056
ChaGo-K-1,BRD-A02303741-navitoclax (2-1 mol-mol),3.5476583978507015
ACC-MESO-1,10113978,4.207808600250944
NCI-H2030,5282054,3.375861961069432
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
Mono-Mac-1,2733526,3.4115034722598683
SK-UT-1,322968,4.5187212828437815
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
PF-382,9887053,3.994345366087283
KMRC-20,46199207,3.496477573455405
RKO,71304818,0.9175289508752972
SNU-119,57330099,4.379346087111643
NCI-H2030,selumetinib-navitoclax (8-1 mol-mol),1.6765527243716944
BFTC-909,54143018,0.6300785047889099
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
NCI-H2030,54649500,6.42135485740904
SF539,54618164,4.674024000945265
Ri-1,4788,4.0169402339890805
HuT 78,56946209,-6.9577277527161625
Namalwa,327653,2.6135050132049167
KMRC-20,123631,2.7325982206325503
KYSE-450,navitoclax-piperlongumine (1-1 mol-mol),3.113777220831491
ChaGo-K-1,135423438,3.972168514727344
BT 328,9884685,2.9316032553217166
SNU-213,24785538,1.9191054152787268
KYSE-180,24856436,3.3632320307562185
SNU-423,9926054,1.7894708985292902
HOP-62,9915743,2.3333223593469947
EHEB,11364421,-3.039867247755455
Namalwa,5278396,1.1504569072002195
RERF-LC-MS,46398810,3.3112335021243977
PF-382,31703,-3.3313130558613864
SNU-213,11404337,0.895138111314107
AsPC-1,135875424,4.124114476494282
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
H-STS,5566,3.25870422892361
SNU-423,6918638,0.4106402962761268
KMRC-20,6610355,5.471217304519157
SNU-119,135875424,4.208481763945608
PF-382,11404337,-1.5613133934389778
MIA PaCa-2,navitoclax-PLX-4032 (1-1 mol-mol),3.5319614963047035
SF539,71304818,2.242612100692728
SNU-213,2729026,3.0209743245550587
Ri-1,5460769,1.1375471412538625
HOP-62,4578,4.644037168879469
Becker,15953870,5.473273860376091
MIA PaCa-2,vorinostat-navitoclax (4-1 mol-mol),1.0493649363864128
AsPC-1,71304818,2.27524368423619
NOMO-1,654092,-2.6158486127541343
Ri-1,3543504,2.7587120084990855
HuT 78,16736978,-0.4405557775162137
KMRC-20,6450551,3.0929190017182058
KMS-12-BM,49766530,-2.33896572420352
MJ,60750,-4.348443804943146
HSC-3,selumetinib-tretinoin (2-1 mol-mol),4.189404326176633
KYSE-180,44484440,3.483431565437074
ESS-1,3854666,1.0692309253016814
PF-382,8515,3.0389731440801224
LMSU,148198,-4.18626130759339
Namalwa,11507802,0.2634665018733878
Namalwa,462382,0.2685889730086447
NOMO-1,5311,-0.031303965270056
H-STS,446155,2.3675618978932924
Becker,11222830,2.6019107885979635
NCI-H1339,67156097,-1.183068157390194
NOMO-1,11455910,0.2303469505827257
IST-Mes1,1641662,3.7606227939030528
MJ,52912189,1.9135725109340456
SNU-213,54649381,3.760371456180229
Kasumi-2,9549297,1.4131024835139536
SK-MEL-5,24771867,4.627335356714736
RKN,25150857,2.829513348324473
Lu-65,6918638,0.8216407628444748
NCI-H929,654092,-1.4076135504033414
MJ,BRD-A02303741-navitoclax (2-1 mol-mol),1.2837915647364595
RERF-LC-MS,6917907,-5.461995819879327
BFTC-909,159324,4.114702101808939
KYSE-450,9936388,-0.9236320595886032
BFTC-909,46224516,1.8849058086882595
Lu-65,36314,-5.907229491355618
SNU-119,3038522,3.3866164987543654
SK-UT-1,568763,0.546342581161539
KMS-12-BM,9927531,3.2870919606414963
H-STS,52912189,1.096529678362862
Kasumi-2,10074640,2.978792769082284
SNU-119,11222830,0.2284603651401007
H-STS,23939,4.59491472423784
KLE,15547703,3.00093446443795
CML-T1,2874250,4.926765314452629
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
SNU-423,44491742,3.863177146863686
NCI-H1339,107970,3.0174891180051793
SNU-886,3825829,4.2404054797227735
HCC2108,selumetinib-MK-2206 (8-1 mol-mol),3.375677921262827
Lu-65,carboplatin-etoposide (40-17 mol-mol),3.473831368176095
RT-4,119607,4.891144020321078
SW1783,11396600,4.918648417758992
Lu-65,71466578,6.359394115515498
SNU-213,5328940,2.4318019623760816
SNU-119,selumetinib-piperlongumine (8-1 mol-mol),4.5887710430802215
HSC-3,52947716,-4.848984018159716
HSC-3,44543605,3.9014816323917816
SK-MEL-5,2945648,2.9185214709568172
Namalwa,26596,-3.71974803891978
NCI-H2030,89928392,1.93682484487372
Lu-65,46926350,-4.186313662197296
Namalwa,11612883,1.9664266013220393
Panc 02.03,6918328,1.3018368822202735
IST-Mes1,16722836,0.916062842065302
RKN,46398810,3.1612721401313792
SK-MEL-5,11497983,5.417293853746178
HOP-62,54618305,4.329207399796136
SNU-213,10231331,0.6074693800366775
BT 328,BRD-K55473186,3.4747994390176027
MJ,25126798,0.3363545399318757
HuT 78,tretinoin-navitoclax (4-1 mol-mol),-2.2971670367223243
Kasumi-2,5743,-2.32743694805066
HuT 78,42642645,0.2069800565131915
SK-UT-1,119182,-0.2389735645577043
WM793,ISOX-bortezomib (250-1 mol-mol),0.962793485948776
H-STS,10302451,3.908664464224374
Ri-1,6918289,3.0917931737632647
SNU-886,3025944,4.270077013000682
KMS-12-BM,135875424,3.5247186168283453
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
BT 286,6436223,-5.721526180117037
SK-UT-1,2828334,6.192773622415013
Namalwa,3634881,3.0415883550514806
RKO,46199207,3.448070090368443
RT-4,5282054,3.801249889065471
NCI-H209,carboplatin-etoposide (40-17 mol-mol),-0.98588134162935
Panc 02.03,51039095,3.661030142872421
AsPC-1,216239,1.707935704723652
KMRC-20,JQ-1-navitoclax (2-1 mol-mol),2.637620979600235
Becker,219104,4.4729058314747565
MIA PaCa-2,16720766,0.4830207288204527
H-STS,67156097,-2.7564383026884345
HuT 78,11647372,0.6475379223076121
KLE,46191454,0.8437389846099377
LMSU,374536,2.9263574161338046
SNU-119,156422,3.70265719969244
BT 498,16038120,2.0506806363109655
Kasumi-2,45279963,3.7710739544623233
HEC-108,2858523,3.032487777915684
SNU-119,17755052,2.19432063910622
PF-382,68056272,3.167967878005275
AsPC-1,42642645,1.2436203489585118
CML-T1,11152667,-2.6898641024331584
OAW28,16038120,1.1273660282184277
AU565,4261,1.5351844706992892
CML-T1,2729026,1.0181320426336582
ChaGo-K-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2895987004290532
AsPC-1,3689413,-2.062701377390924
ChaGo-K-1,241158,4.201927221282135
CML-T1,25105715,2.3891517916986684
ACC-MESO-1,6505803,0.753585399472996
Ri-1,60700,-4.577046497029594
RERF-LC-MS,44137675,3.373454428855253
Becker,6918638,0.8308628231051842
SNU-119,3543504,4.346237641095953
Kasumi-2,5311,-0.335738593661984
BT 286,11404337,-1.6660130116300145
OAW28,46907787,2.388022074777516
SNU-423,selumetinib-decitabine (4-1 mol-mol),4.775321711278399
RT-4,navitoclax-sorafenib (1-1 mol-mol),1.0712554861689316
KMRC-20,44607531,1.5618763783818437
NCI-H196,5328940,2.396861686321897
BT 248,156414,1.4948422332158926
NCI-H1339,46191454,1.8711538033054396
NCI-H209,124202324,0.7427053501525159
ChaGo-K-1,2130404,3.2691972531193394
H-STS,piperlongumine-MST-312 (1-1 mol-mol),1.017162018251856
NCI-H1339,54143018,0.7925743548274472
Ri-1,168313016,3.43203331304281
HOP-62,46907787,2.3496891847816905
ESS-1,4378219,1.976133617597145
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
NOMO-1,44632017,0.9405041708842384
KYSE-450,5278396,4.032614684188798
KMS-12-BM,168313016,3.5287146199889805
KLE,3503,3.2050182631848094
ChaGo-K-1,71680916,5.526927965273148
KYSE-180,piperlongumine-MST-312 (1-1 mol-mol),1.4705753188677493
KYSE-180,64971,4.515399284830646
ChaGo-K-1,135440466,3.4162124936554172
Mono-Mac-1,11213558,-3.0826510665478075
SF539,3676137,4.118081240228259
AsPC-1,67291369,5.582806392200744
HuT 78,navitoclax-pluripotin (1-1 mol-mol),-0.0445825989521908
HSC-3,71304818,2.245255922653997
SNU-119,219104,2.9063855496873416
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
Mono-Mac-1,decitabine-carboplatin (1-1 mol-mol),4.37925675376224
RKN,44819697,0.8547407464301948
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
Karpas-422,53392493,1.7677914883062382
SNU-119,6623618,1.934770207260526
BT 248,9868037,3.916296675967623
SNU-423,9927531,5.196680575825113
NCI-H1339,4521392,4.328766571208621
MJ,navitoclax-gemcitabine (1-1 mol-mol),-4.243920613796683
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337
Karpas-422,9915743,0.8862360651040179
PF-382,navitoclax-birinapant (1-1 mol-mol),-0.7298930011907772
NCI-H196,6438330,3.1538625241863296
PF-382,10113978,2.3756082009494066
RKN,73707398,1.136221501718042
PF-382,vorinostat-carboplatin (1-1 mol-mol),1.5687292736817784
AU565,44462760,4.31661778136252
RKO,10296883,4.075814636405189
HSC-3,656346,0.2990178564529029
SNU-213,54619267,4.402773025327593
KMS-12-BM,49793307,-4.548343844172568
SK-UT-1,67156097,0.3478511759074868
HuT 78,11228183,1.5356428914171083
NCI-H929,tretinoin-carboplatin (2-1 mol-mol),0.1432218131901559
BT 498,11152667,1.974918691110967
PF-382,3854666,0.8290647153929614
WM793,15953870,5.050143340220593
EHEB,6184667,4.2340057403581115
EHEB,selumetinib-navitoclax (8-1 mol-mol),1.9472378662197067
CML-T1,387447,-5.712019248069361
KMS-12-BM,132971,2.9129705347041495
SK-UT-1,11455910,0.1513173468225572
NCI-H1339,9926054,1.7994324687191725
Kasumi-2,676352,0.386616578071509
PF-382,25062766,1.5708468674433018
RERF-LC-MS,675434,4.646232548137413
WM793,241158,3.83369214528036
KMS-12-BM,4521392,3.943968483954013
RT-4,25062766,2.555082815499361
SK-MEL-5,42642645,1.5986422400461986
Karpas-422,5566,2.9701636740435684
KYSE-450,24856436,0.9513610633306496
HOP-62,24821094,3.2771504338924995
H-STS,3384730,2.3703448532527043
ESS-1,462382,0.8866034659436756
PF-382,676352,1.5594037701134436
EHEB,56963564,-0.4749386373308739
RERF-LC-MS,51039095,3.2453184174795324
PE/CA-PJ41 (clone D2),51037431,5.889878803115624
Kasumi-2,44632017,0.7335001301015701
LXF 289,2858523,3.038787864461457
NOMO-1,53232,3.2414615649348772
LMSU,10184653,1.8439035095967675
NCI-H209,11317348,1.789123984926599
KYSE-180,54618771,0.8276624799970426
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
KMS-12-BM,6450551,2.204544668217096
ChaGo-K-1,15983966,1.9276890630052224
SNU-213,15983966,1.7326463312194766
SNU-119,9877608,5.864690809801913
RERF-LC-MS,676352,1.6328584527608256
RT-4,5328940,2.539742147157725
KYSE-180,11612883,2.294010181376236
SNU-423,6610216,4.208625011644533
BT 248,676352,1.654368845250315
KMRC-20,9935249,4.274093683443108
SK-MEL-5,11507802,1.1311799974762815
BT 286,piperlongumine-MST-312 (1-1 mol-mol),0.9654454210734352
SK-MEL-5,selumetinib-vorinostat (8-1 mol-mol),1.478441576802813
IST-Mes1,9825149,1.824146809937508
HuT 78,46215462,0.912768914225953
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253
SK-UT-1,11609586,3.614390292326568
BT 320,2949965,3.703585539882772
LXF 289,46943432,1.4312531154305732
Lu-65,12001922,1.746900064695359
NOMO-1,53495165,-0.0338576092201104
HOP-62,46199207,3.239522230883076
NCI-H2030,9903786,2.824655549380346
KLE,219104,3.394006961912336
BFTC-909,4917,2.929839520827846
RERF-LC-MS,10074640,3.277461458690314
H-STS,5287620,-2.722598412844143
CML-T1,44259,0.1754844857900887
ESS-1,241158,3.69128431914065
OAW28,46191454,1.726492969979986
HOP-62,119607,5.216667488123864
PF-382,doxorubicin-navitoclax (2-1 mol-mol),-3.127730367250044
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
SNU-119,5281321,-2.123473343303991
AU565,26596,-1.0644098452654434
SNU-423,46215462,1.6217220916583457
Lu-65,89928392,1.711018630035882
RKN,135398516,1.9656218312143572
KYSE-450,25262965,0.1139193640059102
SK-MEL-5,carboplatin-UNC0638 (2-1 mol-mol),3.55936398047261
ACC-MESO-1,2742550,5.050370416732392
ChaGo-K-1,alisertib-navitoclax (2-1 mol-mol),2.403809638873206
SF539,135659046,3.181821233210504
MJ,navitoclax-pluripotin (1-1 mol-mol),-0.5584925920323
SK-MEL-5,60700,0.0306860885893293
PF-382,135398738,1.569926041171407
BT 248,11609586,2.7692010936053064
HuT 78,navitoclax-MST-312 (1-1 mol-mol),0.598412445003022
BT 286,serdemetan-SCH-529074 (1-1 mol-mol),1.5009672883066811
PE/CA-PJ41 (clone D2),44137675,3.861270231400088
BT 286,JQ-1-vorinostat (2-1 mol-mol),1.9328680890615244
AsPC-1,702558,5.7476960936684565
KMS-12-BM,2858523,2.6623892435665337
KMRC-20,2749,2.7463667580182816
BT 248,5287620,-3.0713737356172484
NCI-H196,4378219,2.689374955193756
ACC-MESO-1,151289,4.084741165182866
Becker,vorinostat-carboplatin (1-1 mol-mol),3.87916931787536
AU565,702558,5.325524002647016
Lu-65,5351362,2.5034830302649302
KMS-12-BM,tretinoin-navitoclax (4-1 mol-mol),-1.130622835397235
PF-382,56963564,-0.2593011060525333
NCI-H196,9826308,0.9763243446580108
HuT 78,5281321,-2.4358925400623797
HuT 78,15547703,4.385354526396273
HuT 78,11707110,-7.111344223172838
NOMO-1,17755052,-0.2814114025249274
ChaGo-K-1,36314,-6.24793194508115
SK-MEL-5,3543504,4.4234969279720895
AsPC-1,135440466,2.1679547773967314
Karpas-422,1641662,3.5098065736940476
HEC-108,decitabine-navitoclax (2-1 mol-mol),0.2916022830293501
KYSE-450,2858523,3.2293705558979813
EHEB,54618771,1.2042140049426533
PF-382,SNX-2112-bortezomib (250-1 mol-mol),-3.001055376524997
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
EHEB,11152667,-1.348021466254982
Lu-65,serdemetan-SCH-529074 (1-1 mol-mol),1.9278893488035571
Panc 02.03,11707110,-0.717341284128793
EHEB,17755052,0.9739934122056938
SNU-213,216345,4.485724357093233
KMRC-20,3854666,4.622266524166492
Ri-1,11222830,1.002314004002837
MIA PaCa-2,44607530,2.2158687440672686
RT-4,25154868,4.28218091835124
SF539,65064,4.983930962156341
BFTC-909,24748573,2.672786285704278
Karpas-422,navitoclax-gemcitabine (1-1 mol-mol),-3.5481331212227034
NCI-H929,serdemetan-SCH-529074 (1-1 mol-mol),2.524144751229143
SK-UT-1,44632017,3.336083034229006
SNU-119,2113511,5.762989771313452
OAW28,1750826,-3.338956149870334
IST-Mes1,19582717,4.57770755362997
SK-MEL-5,5351362,2.366559176054297
Becker,71466445,4.307879847711241
BT 328,400769,0.7243238216549931
BT 248,2828334,5.879853395133371
Panc 02.03,44493528,4.298055948100647
Kasumi-2,24901704,2.1856500624020994
AsPC-1,44491742,4.429887143828186
NCI-H929,23635314,-2.487103154782492
KYSE-450,12003241,-0.0119879221972118
H-STS,24785538,0.7812018408159317
OAW28,24856436,0.1607500363529794
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257
BT 320,16725315,5.30580008906936
SK-MEL-5,44185566,3.090372433987207
H-STS,decitabine-navitoclax (2-1 mol-mol),1.503430207514452
BT 498,vorinostat-navitoclax (4-1 mol-mol),2.200974334120634
BT 328,135440466,1.9729468656409803
WM793,168313016,5.214677912138177
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
AsPC-1,54618771,1.0442216511349782
Mono-Mac-1,9823820,2.873638007148911
Becker,135440466,2.4812333782474703
Ri-1,selumetinib-piperlongumine (8-1 mol-mol),2.320305378407513
SF539,2871966,0.3943318332274005
ESS-1,5287969,-2.291544510973284
SNU-886,656346,1.184079596970836
Kasumi-2,16722836,0.3444985018145829
OAW28,3081361,1.8855664708831448
BT 498,119182,1.205044713137845
Kasumi-2,tretinoin-carboplatin (2-1 mol-mol),2.8935059772434792
RERF-LC-MS,71751553,4.213964581210796
ACC-MESO-1,11612883,5.078595864486127
Mono-Mac-1,11612883,1.2269352855269329
LXF 289,17755052,1.3903450452706496
LXF 289,135984461,4.539632657840611
CML-T1,57330099,4.076691821950742
RT-4,15983966,1.8049995542525132
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
ChaGo-K-1,9936388,-4.876543253304364
NCI-H2030,11152667,0.1486125355085492
MJ,6450551,1.4297502177824069
NCI-H929,16720766,0.2039883469088212
KLE,ISOX-bortezomib (250-1 mol-mol),1.0539315287787143
SW1783,selumetinib-tretinoin (2-1 mol-mol),5.0766221097450845
BFTC-909,11238147,5.503103761619835
MIA PaCa-2,66577038,2.983091139827387
HOP-62,7251185,3.793199027205306
OAW28,3815108,1.950790900509605
CML-T1,10074640,0.1978471501959747
BFTC-909,44493528,4.370300807083883
HOP-62,5311281,2.99764161389912
BT 320,156414,4.178952757446285
NCI-H196,6852167,3.0057734574295765
SF539,6436223,-5.188827537901569
Namalwa,2733526,4.369977932427766
BT 320,9936388,1.7913306244505192
NCI-H196,49836020,1.0558785681395022
BT 248,135440466,3.298497559431859
LXF 289,10427712,4.0701965709145504
BFTC-909,BRD-K27188169,5.152610673434624
KMS-12-BM,168312962,0.4292683974856141
LMSU,104842,-1.1999760069124146
Becker,5291,4.297720804141337
SK-UT-1,10410894,3.1994132701076308
OAW28,168313016,5.164256635335989
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
ChaGo-K-1,5278396,3.4134345354269815
BT 248,89928392,0.7552276073317185
OAW28,5566,3.0868855994062137
HOP-62,25105715,3.068755512136371
AsPC-1,11719255,5.644609733763846
PE/CA-PJ41 (clone D2),44589607,2.944412828787781
KMS-12-BM,123631,1.8519032403273297
Karpas-422,ISOX-bortezomib (250-1 mol-mol),0.1595215058656458
Mono-Mac-1,159324,1.4923395471491
SK-MEL-5,241158,4.170979949638567
AsPC-1,44819697,-0.3025066533854976
SK-UT-1,104842,-1.774878693515325
NCI-H196,3025944,5.09320822042266
ChaGo-K-1,135421197,1.864105940411698
HuT 78,JQ-1-navitoclax (2-1 mol-mol),-0.7968607943270343
ESS-1,54596490,4.349195883265103
SK-UT-1,49766530,-1.8212556826920157
RKO,25102847,3.0524897378806033
LXF 289,6610355,4.558728947318035
SF539,285033,-3.6653668217695183
Lu-65,10427712,4.072538471037268
HCC2108,71466578,4.729290805364659
HuT 78,6918736,-0.9922912481789786
Namalwa,11222830,1.004223683138916
Mono-Mac-1,55508,1.7176981446448645
HSC-3,135398738,0.4499542950984881
BFTC-909,25062766,1.7422044094415416
CML-T1,2828334,5.888296080725352
Lu-65,156422,5.054623050878907
SNU-119,241158,3.4983662079339295
SK-UT-1,17755052,4.751735459117679
WM793,11960529,4.980101224880268
SF539,219104,3.671344894380296
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
OAW28,11977753,-1.87780111267196
HOP-62,1641662,3.962871086552293
ChaGo-K-1,selumetinib-PLX-4032 (8-1 mol-mol),4.737795315348964
AU565,4096211,1.4857810053347718
OAW28,53392493,2.314719178940984
Ri-1,327653,2.467525677033306
Mono-Mac-1,136227924,2.2269797620359864
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
AU565,54618771,1.1954147839624212
AsPC-1,5328940,1.7821313082315045
ESS-1,17755052,2.168026535406177
SNU-423,11364421,-5.437656498518107
NCI-H196,44259,1.5530683783507429
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
CML-T1,51039095,1.5406670560339248
NCI-H196,568763,0.2988260029434089
MIA PaCa-2,702558,5.663902265232039
BT 286,6918837,-0.1947148263566605
BFTC-909,24180125,2.699370118217823
Karpas-422,44185566,3.020953804682189
RKO,107970,2.3673735748138265
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
KMS-12-BM,15953870,2.0453814346354577
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
Mono-Mac-1,11609586,0.7295885847467773
SK-UT-1,54626689,4.825189757508342
IST-Mes1,107985,-3.865584471784785
AsPC-1,322968,4.827920048367381
RT-4,52947716,0.9303091042236448
LMSU,10127622,5.3178116835445195
Mono-Mac-1,9967941,4.049384928851452
SNU-119,11625818,3.656882116182555
H-STS,11175137,3.379012041415036
Kasumi-2,5329102,1.6326140590430216
HSC-3,46907787,0.9324024386936162
NCI-H2030,262093,3.6307250181599215
ChaGo-K-1,vorinostat-navitoclax (4-1 mol-mol),2.2170061777318693
HuT 78,104842,-4.970305265327912
NCI-H2030,6610355,3.582243758633091
Karpas-422,selumetinib-BRD-A02303741 (4-1 mol-mol),3.605523049740557
OAW28,3503,2.6573145013500743
HOP-62,11647372,1.1113076615645692
Namalwa,6505803,0.5277329545448584
Ri-1,11609586,1.210615825815208
Namalwa,3038522,1.3634755739913815
KYSE-450,6914657,-3.3347468513388994
PE/CA-PJ41 (clone D2),11977753,0.7680199278861632
SNU-119,9911463,2.8532899111041385
AsPC-1,25105715,4.199758530142014
Ri-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.968451246064357
ChaGo-K-1,49867926,3.853414720504991
RKO,16720766,-1.2722083569090707
HSC-3,56946209,-3.5059514829840603
BT 320,4261,3.457041279765096
KMS-12-BM,16219061,2.3730211419345477
Karpas-422,9866186,1.3861554791089596
MIA PaCa-2,5113032,4.609804183969185
SNU-423,387447,-5.098598596433983
Lu-65,168312962,-1.2301817974016382
MIA PaCa-2,11214940,1.115390680902948
KYSE-450,24797083,1.908715906165
MIA PaCa-2,11640390,2.9644725686892777
KYSE-450,5287969,-1.404660564702432
CML-T1,54649381,3.615747973120369
AU565,9840324,5.90463961449661
AU565,16722836,1.9939850778221897
BT 286,16725315,4.63641506470736
NCI-H196,322968,4.769593139388762
KMRC-20,3038522,3.6781934886194056
Lu-65,11455910,0.1308260352372195
OAW28,5311,0.8600755425080211
SNU-213,24753719,4.370347771119096
SNU-423,9915743,2.488155909988838
MJ,9933475,2.437576054324945
Becker,44632017,0.5330266067422236
SNU-119,56946209,-3.841507017590091
ACC-MESO-1,selumetinib-piperlongumine (8-1 mol-mol),5.193474652387318
PF-382,135398516,1.2279645894951243
ChaGo-K-1,11955716,-2.075681705170589
Namalwa,6438330,0.9334291886497746
LXF 289,11626560,1.452143156792952
MIA PaCa-2,11427553,1.2137196958123289
AsPC-1,12001922,2.2862775547931675
SK-UT-1,54454,4.804941672260084
Karpas-422,56973724,1.6302850453134334
BT 248,BRD-K55473186,1.6909762369263868
Lu-65,9915743,2.050551276197927
ChaGo-K-1,54618305,4.246058769958448
LXF 289,25195348,5.284501520866742
WM793,54618771,0.892561932009902
Lu-65,72193861,1.4354922532582175
HSC-3,carboplatin-etoposide (40-17 mol-mol),2.0650995733711777
Lu-65,54626689,4.680171395498018
LXF 289,55283,4.7983814176360715
Lu-65,46215462,1.222328166617798
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
EHEB,67291369,2.0490464679075813
PF-382,11455910,1.1839598995526908
BFTC-909,654092,0.6323398211983356
PF-382,16115403,-5.914744850998346
KMS-12-BM,23635314,-2.3782143441311954
HuT 78,5280436,3.170358590810086
KMS-12-BM,71466380,3.5437906276884696
OAW28,227681,3.168890693964491
EHEB,3825829,3.7186558518100705
HEC-108,56946209,-3.633344479104151
RERF-LC-MS,25195348,2.310586589861769
SK-MEL-5,54618164,3.941567949618183
MIA PaCa-2,45279963,3.811404358081299
Kasumi-2,16038120,1.393585308421038
SNU-119,24951314,2.332589086371041
Lu-65,11497983,4.173704063300202
NCI-H196,9868037,4.869553170308075
HuT 78,49766530,-1.6423396691241603
LXF 289,1716436,2.59582131383783
SNU-119,selumetinib-PLX-4032 (8-1 mol-mol),3.3924189372513123
KLE,73707386,3.2783445744557307
HEC-108,11364421,2.372411654135638
RKO,60700,-0.2024014556335324
HuT 78,67156097,-1.4779973758207117
Mono-Mac-1,54649381,3.5140339031114705
SF539,54626689,2.4541626708766855
HuT 78,445455,2.369844577955314
BT 286,36314,-4.002945974636151
RT-4,135984461,3.767018649492271
Karpas-422,11234052,4.0626170100794186
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
RT-4,54143018,0.4678710422160503
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
HuT 78,4477,0.82836425534414
Kasumi-2,262093,1.7604912977671856
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
PE/CA-PJ41 (clone D2),9933475,2.0891360136562644
SF539,6450551,0.8241072018867992
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
HuT 78,docetaxel-tanespimycin (2-1 mol-mol),-5.471210221464332
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
MIA PaCa-2,7326481,2.6127958061584984
KYSE-180,156422,3.987230408696769
LMSU,65628,4.981021352317802
BT 498,65064,5.2071108704456
HOP-62,16038120,1.067804066373853
ESS-1,135398516,2.488999023139088
SF539,3825829,3.026626259970261
RERF-LC-MS,135411,0.496828330774242
ACC-MESO-1,5311,2.6640640328267744
SF539,11178236,-5.337725586791056
KYSE-450,136227924,3.5350495950730645
ChaGo-K-1,44241473,4.641604791111675
SF539,11485656,1.8649737443723855
RKO,54649381,4.449908747747005
OAW28,2828334,6.258958244852924
MIA PaCa-2,53232,1.8749527399509325
BT 286,crizotinib-PLX-4032 (2-1 mol-mol),1.6245444859080926
SNU-886,73707398,1.147330182406101
IST-Mes1,5351362,3.046296530947078
SK-MEL-5,10296883,3.4956550108222775
Namalwa,151289,0.4825051830903394
KMRC-20,10385095,2.891783125869015
NCI-H2030,44491742,2.996823060755576
RERF-LC-MS,104842,-3.024577047260716
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
HCC2108,400769,-0.6211962512708786
ACC-MESO-1,selumetinib-navitoclax (8-1 mol-mol),2.377842633957304
H-STS,24771867,-2.0225510536358353
CML-T1,11404337,-1.4571467715346416
HuT 78,135421197,0.0616295171222303
MJ,44607531,1.34909742288371
BT 248,54649381,3.7327878949357394
Panc 02.03,2874250,4.438896474206821
KYSE-450,selumetinib-piperlongumine (8-1 mol-mol),5.043149849236574
BT 320,16722836,3.1587292617762435
PF-382,2949965,-4.532431292910685
Ri-1,selumetinib-vorinostat (8-1 mol-mol),1.7453072919465344
HOP-62,9936388,2.1829443174265997
KYSE-450,25102847,3.9805771767576057
SF539,3543504,3.049224466295834
BT 328,25150857,3.2556687678990612
BT 498,46224516,2.4804026956741736
NCI-H1339,docetaxel-tanespimycin (2-1 mol-mol),-6.507911757530347
Namalwa,2749,0.8772609351903448
Ri-1,67291369,-0.1856261156826838
SNU-886,vorinostat-navitoclax (4-1 mol-mol),-7.798745987828545
Ri-1,10427712,0.5895660730768243
ChaGo-K-1,31703,-1.2510653357476624
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983
KMRC-20,17755052,4.273856933322851
SNU-886,262093,3.428603865365944
NOMO-1,375860,-0.5184264862355304
AU565,9444,3.6632568473184888
LMSU,navitoclax-MST-312 (1-1 mol-mol),1.1685647983741614
OAW28,613753,3.2856198284724742
Namalwa,9903786,1.5886639412240358
BT 248,6450551,3.394353011187604
H-STS,25183872,-1.8884511256941123
ACC-MESO-1,tanespimycin-gemcitabine (1-1 mol-mol),1.2996427322835036
Becker,10427712,4.340316016638328
KMS-12-BM,6918289,1.1845429294568763
SNU-423,122327,5.666841554231471
LXF 289,656346,1.157307128170796
HEC-108,24753719,4.945792887212488
SNU-423,ISOX-bortezomib (250-1 mol-mol),0.2587809522365415
NCI-H2030,4259181,1.1105893163636829
Lu-65,54618771,-0.448084270947246
Ri-1,4259181,-1.255290292535843
HCC2108,10302451,4.138705922344902
OAW28,17755052,1.3145864766951243
AsPC-1,11964036,1.5618628535664978
EHEB,262093,2.39806678929768
Ri-1,227681,2.7126035937005923
H-STS,168313200,3.688822033835753
WM793,4259181,0.9321312927301734
Karpas-422,BRD-A02303741-navitoclax (2-1 mol-mol),2.7556561737270626
ChaGo-K-1,JQ-1-carboplatin (1-1 mol-mol),3.068818553236091
BT 248,25161177,3.821794472212993
IST-Mes1,11609586,2.670649923207088
SK-MEL-5,387447,-4.830533625987401
NCI-H196,selumetinib-MK-2206 (8-1 mol-mol),3.486277291066986
ACC-MESO-1,3825829,5.620049570908759
HuT 78,SNX-2112-bortezomib (250-1 mol-mol),-3.095377009148787
SF539,135398738,4.183953288764079
BT 248,11396600,1.9236183524788075
OAW28,24797083,1.7501511491860735
KMRC-20,24856436,1.166150223062635
SK-MEL-5,5460769,5.96903783579764
RERF-LC-MS,4788,5.0822281264538365
RKO,322968,3.8471310775605216
SNU-119,9840324,5.792176147063417
HSC-3,10385095,1.3564065222448
AsPC-1,5329102,1.9734309343360383
Ri-1,60750,-4.598583451004258
NCI-H1339,2729026,3.0533386554011295
HCC2108,2708,7.692601684388862
NCI-H1339,carboplatin-etoposide (40-17 mol-mol),2.749450753466417
BT 286,71304818,2.141622975364479
Becker,568763,1.2199844224955132
NCI-H1339,selumetinib-JQ-1 (4-1 mol-mol),2.2666299614605143
HOP-62,322968,4.873237616134347
BT 286,UNC0638-navitoclax (1-1 mol-mol),1.4427957482860168
NCI-H196,serdemetan-SCH-529074 (1-1 mol-mol),2.347593030611278
OAW28,24901704,3.441244042276163
Becker,5978,-2.9697287765936267
AsPC-1,9915743,1.396378280260739
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
SNU-886,54454,-1.127756504065537
BT 328,7251185,2.5751215328420676
KYSE-180,16722836,1.8171321654098664
KLE,60750,-0.0537222566520801
PE/CA-PJ41 (clone D2),4578,4.817726712421044
NCI-H929,67291369,2.695813932699893
SF539,1716436,2.913378639025297
Kasumi-2,6918878,1.1877992835952844
SF539,24964624,1.5849083379984652
CML-T1,9884685,1.1136090650670494
SNU-119,selumetinib-BRD-A02303741 (4-1 mol-mol),5.373099730339768
SNU-423,36462,3.755778828040023
AsPC-1,446155,5.1652347554602995
H-STS,45279963,3.2018194703407095
HuT 78,23582824,1.377489502141806
HuT 78,45279963,3.999861167525814
BT 498,969516,4.501631868808794
NCI-H196,168312962,5.424811162336187
SK-MEL-5,654092,0.5475945767149036
Lu-65,24821094,3.811678046554743
ESS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.558730455952703
KYSE-180,5470400,0.6957962839919276
CML-T1,1242560,3.0102013740079783
CML-T1,2733487,8.178067655910914
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177
RT-4,44486219,4.156179916043431
BT 248,3634881,2.1213928087500413
ChaGo-K-1,selumetinib-piperlongumine (8-1 mol-mol),4.196281185550965
RKN,11507802,1.1392194525963166
KMRC-20,46398810,2.3963620862507717
LXF 289,12003241,-2.348837864712453
KMRC-20,262093,3.714553986632731
BT 286,navitoclax-pluripotin (1-1 mol-mol),-1.088965440208862
WM793,11427553,3.4959048575417304
MIA PaCa-2,6184667,3.130245182492798
Kasumi-2,637858,0.3812755763700117
SNU-119,11612883,2.57942029058091
SNU-886,15953870,3.508651864027871
LXF 289,54619267,4.7435335143288935
NCI-H2030,46191454,1.6513830993355236
AU565,44486219,4.217962962304986
SF539,SNX-2112-bortezomib (250-1 mol-mol),-2.8372291884695326
PE/CA-PJ41 (clone D2),135440466,2.731145594233653
NCI-H209,25062766,1.4599836041351384
RERF-LC-MS,26596,-1.2372341703529914
MIA PaCa-2,53392493,1.9193988487134044
SNU-119,4917,2.930723431336195
BT 498,9803433,4.273025703586365
BT 320,216239,3.754471265318657
Karpas-422,71304818,1.7040784922976946
RKN,168312962,-2.199105388969794
CML-T1,5311281,3.0916675116608863
KMRC-20,11396600,4.3348303945761835
Panc 02.03,11364421,0.2085573081853932
SNU-423,doxorubicin-navitoclax (2-1 mol-mol),0.6046265004556602
AsPC-1,176870,5.289710540069244
SNU-886,400769,-1.7874528673919734
HuT 78,46926350,-4.333378092380672
HCC2108,11178236,-3.6455661628602742
NOMO-1,3025944,3.969971169930392
EHEB,2842253,6.477039888159031
Kasumi-2,54618164,3.8625919459899833
EHEB,104842,-5.697629761421609
HCC2108,5746,1.977916681532928
LXF 289,49793307,-1.960491877422628
OAW28,5281672,6.00346703144391
SNU-119,11152667,-1.7505046185564503
KMRC-20,SNX-2112-bortezomib (250-1 mol-mol),0.4424721588448694
RT-4,219104,3.5116723720438636
BT 248,6610216,3.912037893092857
HCC2108,navitoclax-piperlongumine (1-1 mol-mol),3.2345753523038536
NCI-H1339,637858,2.289025775873357
BT 328,241158,5.267624320159163
AsPC-1,2742550,5.133078791264603
KYSE-180,10074640,3.100626219289962
AU565,135440466,3.093480574806016
NCI-H1339,9936388,3.3861732240332314
HOP-62,54618164,5.192278696523286
NOMO-1,4521392,4.093982124965485
AsPC-1,11364421,-1.021042778985214
IST-Mes1,decitabine-navitoclax (2-1 mol-mol),4.382542969117623
Kasumi-2,JQ-1-MK-0752 (1-1 mol-mol),-0.4470190343146605
Mono-Mac-1,JQ-1-vorinostat (2-1 mol-mol),-1.1078457929866472
KMRC-20,16038120,1.6460192975899484
LXF 289,60700,2.2902498510351528
HuT 78,613000,1.4786721028886782
SNU-886,11964036,2.034434534905483
AsPC-1,969516,2.9281765712067447
PF-382,73707386,2.646630293561946
PF-382,navitoclax-gemcitabine (1-1 mol-mol),-3.611460525938325
CML-T1,71466445,2.0221424049362033
Mono-Mac-1,46215462,-0.6900076333947253
PF-382,16038120,-0.1734810985157941
SF539,53392493,1.7253246594854623
KMS-12-BM,136227924,1.841540408480291
HCC2108,135423438,4.347791872690299
SNU-119,44202524,1.6419079750813077
CML-T1,24785538,1.8797614633691848
Karpas-422,9907093,0.8832915232740778
NCI-H196,3689413,0.3068410473600975
BT 248,56963564,4.0439806336642175
ESS-1,56649450,2.890363396041127
ChaGo-K-1,4788,5.90494207062602
PF-382,selumetinib-tretinoin (2-1 mol-mol),4.149133041999036
RT-4,16065773,3.1312717151284155
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
RERF-LC-MS,11234052,4.094456859515875
BT 320,44507138,4.949888097685237
PE/CA-PJ41 (clone D2),5746,0.9508573023316716
MJ,25262965,-4.055624562220278
Becker,24951314,1.348289322869654
Panc 02.03,89928392,1.630028817710481
NCI-H929,24180125,2.4641763284453795
RKO,16013152,4.038378204585466
AsPC-1,49793307,-1.0458597957041098
WM793,969516,2.5069941114188485
NCI-H929,262093,-0.1267697569252451
IST-Mes1,135398516,1.9830137838908624
BT 248,25126798,4.2564362718884965
RKO,375860,-0.2095842697906711
PE/CA-PJ41 (clone D2),168313200,3.0210086537721574
HSC-3,135411,0.4070318982819898
ESS-1,9967941,4.268050907247004
BT 328,5329102,2.931007183375298
Kasumi-2,2729026,2.278256361901275
HSC-3,3854666,1.1819322162410355
ChaGo-K-1,7326481,2.958321983181722
BT 328,4917,3.0980779681660375
RKN,23635314,-1.997093039658799
KYSE-450,637858,3.2826178661178003
BT 248,216239,2.185733710507839
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
RKO,10302451,3.926970734642152
AsPC-1,54626689,5.229882111208764
IST-Mes1,3634881,3.096696127840678
MIA PaCa-2,10231331,2.934704407633453
NCI-H929,5311,0.6524822711391439
NCI-H1339,31703,-0.4400557205709002
AU565,168313200,1.787588028354966
KMRC-20,2729026,2.964214452435718
ESS-1,6918837,-2.928241796985352
Mono-Mac-1,135398738,5.903458005359669
NCI-H1339,49766530,0.922676999768476
KYSE-450,tanespimycin-gemcitabine (1-1 mol-mol),0.8586762777270994
SNU-423,5287969,-1.5815925133202535
KLE,3025986,-0.967724412977758
SK-MEL-5,6450551,3.017299477344576
LMSU,219104,4.323800749255201
SNU-213,1641662,3.634972560428031
Namalwa,24797083,-0.1749047261384438
IST-Mes1,44607530,1.064599314990069
Mono-Mac-1,24901704,1.857343620751862
BT 498,decitabine-carboplatin (1-1 mol-mol),4.946076038312435
NCI-H2030,doxorubicin-navitoclax (2-1 mol-mol),0.1120737931373815
ChaGo-K-1,54619267,3.9042384056884942
KMS-12-BM,46174525,2.6859136047743513
Namalwa,1566236,0.962108735319634
HSC-3,135984461,4.3923039521515985
AsPC-1,selumetinib-PLX-4032 (8-1 mol-mol),2.574223553479829
ESS-1,71751553,4.681072103352448
Lu-65,11427553,1.8001539504551751
IST-Mes1,25022340,4.432743731061051
Becker,49867930,4.438387902904834
Ri-1,3136844,3.150567247939398
SF539,5113032,4.5569437183020485
BFTC-909,637858,2.264716830291231
Mono-Mac-1,15953870,2.971889199477423
Namalwa,11214940,1.1706932474053011
ESS-1,148198,-4.109415572856481
Kasumi-2,46843906,1.3893397569967554
ChaGo-K-1,2828334,6.905279023540132
SW1783,44197249,1.0547858460239052
Kasumi-2,135440466,2.9310364314773376
KYSE-450,1641662,3.736286251526556
RKN,5566,3.4992110401170944
EHEB,JQ-1-navitoclax (2-1 mol-mol),-0.4814265909259828
ACC-MESO-1,44620216,5.38480031222097
BT 248,24748573,2.3039416185334556
Lu-65,3503,1.319082259857831
Karpas-422,navitoclax-MST-312 (1-1 mol-mol),0.954674009908166
CML-T1,54618771,0.285641515878807
SF539,24180719,2.4860980350614073
SNU-423,2871966,0.8863330694044053
KMS-12-BM,11427553,1.3856549566874048
SNU-213,navitoclax-pluripotin (1-1 mol-mol),-0.537091332254985
MIA PaCa-2,675434,3.942298358915322
BT 328,327653,3.5942697932581344
BT 320,25105715,3.591126909496077
RKN,5280436,4.161667428331563
Lu-65,9956119,4.2489471675785975
SF539,selumetinib-PLX-4032 (8-1 mol-mol),2.9753691858714575
Becker,445091,4.9889444875802464
MIA PaCa-2,3465537,1.2213186133491942
Mono-Mac-1,selumetinib-JQ-1 (4-1 mol-mol),0.1381126547939459
SF539,72199292,1.9939606105084
HSC-3,107985,-3.2412158645238893
SF539,5738263,3.647048629199091
BT 320,11626560,2.4160208902080713
SNU-423,crizotinib-PLX-4032 (2-1 mol-mol),1.5840192780701718
NCI-H929,46191454,-1.4087002661466548
KMS-12-BM,53245473,5.652555547777156
BT 328,24856436,4.552904501266461
IST-Mes1,2828334,6.0384225929755555
KYSE-180,24785538,2.7061039911851723
NCI-H1339,45279963,4.172949640647973
IST-Mes1,25150857,2.301198962208278
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
H-STS,6918837,-3.5766968439685662
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
Lu-65,49793307,-2.235561608271653
RKO,51039095,3.7257826703811014
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
CML-T1,168312962,-0.7219792388324245
KMS-12-BM,6505803,-0.6027320108546551
H-STS,9907093,4.221434191899145
Mono-Mac-1,208908,2.4390801171858327
SNU-119,decitabine-carboplatin (1-1 mol-mol),5.089069342690692
RKN,148198,-1.0178445286580065
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
RKN,3815108,2.827407220517517
BT 248,10074640,2.9402331094049265
RERF-LC-MS,9840324,5.508232790936476
PE/CA-PJ41 (clone D2),11507802,3.844244761379668
PE/CA-PJ41 (clone D2),1716436,3.6798676111614457
HSC-3,51037431,1.551679435860501
SK-UT-1,65628,4.642853879953485
KMRC-20,452548,1.1770836669609313
NCI-H209,20959075,-3.666427517945176
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
MJ,24180125,3.2687573062983484
KMS-12-BM,73707398,0.3620923628880652
SNU-423,carboplatin-etoposide (40-17 mol-mol),4.41939125050277
PE/CA-PJ41 (clone D2),7326481,6.5922799929982006
PE/CA-PJ41 (clone D2),56973724,5.008283021237775
SW1783,400769,1.007590054280138
WM793,44486219,4.341209426760334
LXF 289,54613361,1.2100808209747431
Ri-1,25062766,-0.0725185532276084
AsPC-1,44607531,1.5574724897590664
NCI-H196,17759555,3.3296273563754366
Mono-Mac-1,119607,3.615184398714216
BT 286,9803433,5.109975977606045
KLE,104842,-3.354831620063557
OAW28,25183872,-1.003855010480259
Mono-Mac-1,6918289,-1.537953506191046
HSC-3,452548,0.1992369898040848
SNU-886,5278396,3.692331874950952
BFTC-909,168313047,1.967772312792883
SW1783,54678924,1.5903593535652931
SK-UT-1,2858523,3.0356672469783
ChaGo-K-1,24797083,0.5545543122526493
SF539,45279963,3.2464007819640583
SF539,5311,1.7990759900663726
HuT 78,25126798,3.93002512253093
AU565,3854666,0.9438607721687704
EHEB,5280436,3.866090373293539
NCI-H1339,6918878,2.975408494274888
BT 248,11656518,0.6524098808252552
KMS-12-BM,navitoclax-piperlongumine (1-1 mol-mol),-0.5668023571576813
NCI-H209,doxorubicin-navitoclax (2-1 mol-mol),-1.980488433431222
SK-MEL-5,216345,4.294680632537732
CML-T1,44185566,0.9347798856606148
ChaGo-K-1,tretinoin-carboplatin (2-1 mol-mol),5.128629678798782
SW1783,322968,0.9146856362556636
AU565,17755052,-0.9729531204394496
BT 286,387447,-4.984845769910886
BT 248,11960529,3.73553983344596
OAW28,89928392,1.6809049325642302
KLE,44507138,1.5092224182482787
Namalwa,2729026,2.9646999473246125
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
OAW28,135999136,1.5944266420299655
ChaGo-K-1,46199207,2.6380266258494784
NCI-H929,44486219,3.7960191523770135
SW1783,11485656,3.310538702987134
Namalwa,9956119,3.303198891097498
SK-UT-1,9866186,0.9156760057280894
NOMO-1,5278396,3.0205756000124775
SF539,446155,1.5612752979886544
KLE,10302451,4.42053427640389
Panc 02.03,23582824,1.3457270338170706
CML-T1,441298,0.5187670078326817
SNU-886,107985,-2.815059265270472
Lu-65,5291,3.7552825058524184
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
KYSE-180,5311281,3.969841054896334
BT 328,10385095,1.6482003129933624
NCI-H929,3543504,4.657244806127615
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
RKN,6917907,-6.438038185084336
PE/CA-PJ41 (clone D2),25262965,-1.0517358381882034
SNU-213,3503,3.0772179743043253
KYSE-450,15983966,1.931035725285284
KLE,54618305,4.289261640342655
Mono-Mac-1,16722836,-1.2323126560129107
LMSU,11213558,1.28166790207028
EHEB,135875424,3.250653126047009
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
OAW28,24753719,4.434201172795376
AsPC-1,3503,2.1995832473977157
OAW28,71680916,5.167013104004298
Becker,25227462,2.4003945013421575
WM793,1641662,4.965953189176842
RT-4,675434,4.226250873257813
NCI-H2030,10385095,2.209603603161303
SF539,tanespimycin-gemcitabine (1-1 mol-mol),-2.9863403068380614
BFTC-909,6918328,0.6354681535452512
SK-MEL-5,11175137,3.02526064620366
BT 328,9903786,4.817171686681598
ACC-MESO-1,10231331,6.136184274550163
HuT 78,44491742,3.833204810123411
LXF 289,25102847,1.656353256373218
SNU-886,3025986,0.191528697071382
RKO,16741245,1.399079485469943
HEC-108,46199207,3.6826733270490646
SNU-423,675434,4.253270492704943
Kasumi-2,46943432,0.9724659287269805
KMS-12-BM,53392493,1.4932523405392888
NCI-H1339,11494412,1.0306883056063765
KYSE-450,24772860,-1.687862811669867
Namalwa,1716436,3.476053043060672
EHEB,9887053,2.923841050224105
NCI-H196,3543504,4.34188123098332
SF539,24771867,1.191281674737788
Mono-Mac-1,51039095,1.3547034147730423
LMSU,675434,4.968873655762188
MIA PaCa-2,72193861,1.772895681896366
Namalwa,984333,-1.466329732922578
SNU-886,3552672,3.544596634627867
BT 320,54649381,5.331321773509753
OAW28,12003241,-0.542287488877267
BT 248,12001922,0.9128950259060647
Lu-65,9884685,0.6868572515984375
BT 248,25183872,-1.6442953183353304
NCI-H929,23939,4.224811778291157
EHEB,136227924,2.586993854279513
ESS-1,11625818,4.257377389303946
RKN,387447,-2.9807645129134066
PE/CA-PJ41 (clone D2),6918328,0.3452251982206104
PE/CA-PJ41 (clone D2),46843906,3.732979270115668
MIA PaCa-2,54618164,3.936263034196557
LXF 289,969516,2.6399649875984355
LMSU,135875424,4.495921610081383
SK-MEL-5,19582717,3.136691731429188
Ri-1,ISOX-bortezomib (250-1 mol-mol),-0.9947623817494354
Namalwa,11719255,3.200352082125332
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955
BT 286,644241,2.213968846177929
SNU-423,24771867,3.564101413967203
SNU-119,10385095,1.2447707748514782
BT 498,16725315,5.273722715780474
KLE,11656518,-1.5343189257668943
EHEB,89928392,-0.0785047887437129
MIA PaCa-2,1641662,3.4395946979479906
HCC2108,42642645,0.687631636914302
SK-UT-1,JQ-1-vorinostat (2-1 mol-mol),2.752157861333336
BT 498,46907787,4.416353779526344
MIA PaCa-2,24978538,3.3706281437981023
KLE,969516,4.2636253983089984
Karpas-422,selumetinib-decitabine (4-1 mol-mol),0.4977391111196939
RERF-LC-MS,5311,1.7201713868016182
BT 328,51039095,3.5315864754377735
SK-UT-1,56649450,4.279287497438238
SNU-213,17755052,1.5850181646262569
SK-UT-1,53495165,1.179970512792514
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
KLE,5284373,-1.0664955605853337
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906
Panc 02.03,2708,5.654354843286421
HOP-62,6436223,-6.153690503126226
IST-Mes1,49793307,1.120791830462594
SK-MEL-5,4788,5.599702300257514
SNU-119,46398810,2.4146356603703527
PF-382,445455,3.8799836217704664
SF539,4477,-0.2990330117959373
Ri-1,5278396,2.4527389088774494
Kasumi-2,BRD-A02303741-carboplatin (1-1 mol-mol),3.1733704189118894
Mono-Mac-1,72734382,2.478752444995056
Kasumi-2,16736978,0.2987482410922295
SNU-119,9915743,-0.9461018440857424
SF539,6852167,2.369096859709367
BT 286,10302451,3.989436421266635
Namalwa,375860,-0.654511262615756
AU565,46174525,5.4998307146624255
SK-UT-1,45279963,3.814266670258307
Namalwa,docetaxel-tanespimycin (2-1 mol-mol),-6.910303489948078
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
BT 248,11257553,3.3794437157400754
HuT 78,3689413,-1.8719775604380453
HSC-3,4477,-0.923461709035426
Kasumi-2,24779724,5.733659143451784
SNU-119,568763,0.0507231945137797
RKO,5746,2.147448518007633
SF539,2874250,6.295568507703997
NCI-H2030,1242560,4.6842326187617624
KLE,24978538,-2.416214785508645
Namalwa,5479543,3.3225711466724324
KMS-12-BM,9549297,2.2758198611545035
BFTC-909,11427553,2.7610941057010754
AU565,11960529,4.91307375329511
RKO,135440466,3.093117295091816
BT 328,9908783,5.49619417239086
NCI-H2030,10410894,4.154952019474486
ESS-1,60750,-3.419429492485854
PF-382,23635314,-2.865470025294806
KYSE-450,3025944,4.332360551153181
HSC-3,44489367,4.725999442167047
PF-382,119607,4.835768261227938
IST-Mes1,25154868,5.0412707783574735
LXF 289,3062316,-3.851151802003845
Mono-Mac-1,11647372,0.3918687541673694
AsPC-1,6914657,-2.819399047423078
ACC-MESO-1,9935249,4.592258833593908
CML-T1,36462,-1.7431711247812498
Kasumi-2,327653,2.4977161394914953
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
SNU-119,5702613,2.9838920774559483
Lu-65,44607530,2.567077991420283
SK-MEL-5,25105715,3.094932274246352
Ri-1,322968,1.829437451733689
HuT 78,53495165,-2.7087413418511135
NCI-H2030,3815108,5.353671583033201
KLE,6918878,2.1026972133129616
BT 328,107970,2.1571810870296333
BT 248,9936388,1.117792201973615
RERF-LC-MS,46191454,1.934559197398404
SNU-213,409805,3.467553308221755
RERF-LC-MS,327653,4.17889189356682
SF539,25195348,1.0596246311568
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
Kasumi-2,tretinoin-navitoclax (4-1 mol-mol),-1.7233092596957704
KYSE-180,44491742,6.4799420322622305
Lu-65,119182,2.80605755326457
H-STS,6450551,1.5253926760198298
WM793,5282054,4.473294081689067
ESS-1,6914657,-3.5334126406740594
SNU-423,56963564,0.9363211448641164
HEC-108,54618305,5.558551802909847
ChaGo-K-1,24771867,3.5582145966940697
BT 248,4378219,1.4454405763629643
BT 498,136227331,4.544114350665722
RKO,46191454,0.9841477576830012
Becker,23635314,-3.772928939412857
Lu-65,51037431,1.5628873119577005
AU565,16065773,1.4318565791423328
KMS-12-BM,5284616,2.1225566255949047
KMRC-20,24901704,3.0273609194565276
LXF 289,10113978,1.6721223719755247
HSC-3,72193861,0.8237499088640272
AU565,24785538,3.4507965915778387
Karpas-422,3062316,-0.3473307121830488
AsPC-1,11719255,5.644609733763846
IST-Mes1,676352,1.6027795070012942
KMRC-20,6610216,4.741983793565595
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
Becker,1566236,1.7807841622280378
RKN,46199207,3.372714950884571
LMSU,11656518,3.057433571616044
PE/CA-PJ41 (clone D2),selumetinib-vorinostat (8-1 mol-mol),2.0198593804037475
NCI-H929,89928392,-0.45860298805955
Ri-1,6918878,0.3594446743212551
NCI-H929,135999136,4.255812797167961
HOP-62,5281321,-1.4991503511918276
Mono-Mac-1,52947716,-6.654817908600528
BT 286,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.8313547577027046
Lu-65,9936388,-8.009646164485344
Karpas-422,135411,0.9481856703320688
OAW28,135440466,2.5697421477630273
Ri-1,107985,-4.133158976783472
LXF 289,11507802,1.7765111516543377
AU565,1566236,1.7493429265082687
Namalwa,vorinostat-navitoclax (4-1 mol-mol),0.6445056951853491
MIA PaCa-2,9825149,2.044745621395805
ChaGo-K-1,24753719,4.520891779779164
AU565,24775005,3.4802015368768657
MIA PaCa-2,24856436,0.1423625732406639
Lu-65,5278396,3.729280751884731
BT 286,6917907,-6.473043481736071
Lu-65,168313200,3.8994737452267945
WM793,65064,3.5713682680127574
HEC-108,selumetinib-MK-2206 (8-1 mol-mol),4.526627272212327
KMS-12-BM,2945648,2.2840305648054833
AsPC-1,46843906,4.099754684530221
KLE,tretinoin-carboplatin (2-1 mol-mol),4.643010553497707
SF539,46191454,1.070261484173304
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
SW1783,44607531,2.045163268443033
HEC-108,2749,4.864852970303599
HEC-108,135411,0.6194051184569405
NCI-H929,54618164,3.87455268818749
NCI-H2030,24951314,1.9329833507416223
SF539,2749,0.9972456277180648
AU565,11955716,1.5670888997114951
ESS-1,11612883,3.2589568216623337
SW1783,navitoclax-gemcitabine (1-1 mol-mol),2.361367842252142
PE/CA-PJ41 (clone D2),3634881,3.643828975352439
BFTC-909,24785538,3.0409365635840433
HSC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.3128890682956813
SNU-886,10127622,1.388505353743375
Karpas-422,36462,0.1497993293193704
Lu-65,462382,0.8396815057149729
LMSU,25195348,4.0264247432996365
HuT 78,107970,1.6472037116063474
BT 286,3552672,1.7054946735285288
SNU-423,3854666,1.5881763460824465
HuT 78,25150857,0.8929430868058179
HSC-3,4261,2.5772280067300293
ACC-MESO-1,44607531,1.6516898403362088
RKN,6610216,4.220445612403551
SF539,selumetinib-JQ-1 (4-1 mol-mol),1.3049218182358
BT 320,136227331,4.5584663350036605
NCI-H929,73707386,0.8452841513210776
LMSU,5291,4.5569666616011
BT 498,alisertib-navitoclax (2-1 mol-mol),3.3650849812101544
BT 498,9911463,3.937995526968798
OAW28,10184653,1.1706980363621209
BT 286,73707398,0.9456567929994184
WM793,46224516,3.4822726042013055
RT-4,5351362,2.6254562857357646
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
Lu-65,11178236,-3.716931959445397
KYSE-450,11222830,1.7445073399277342
LXF 289,219104,4.555444774518925
HSC-3,3062316,0.7848248056146601
RERF-LC-MS,3689413,0.4263782886644774
HOP-62,SNX-2112-bortezomib (250-1 mol-mol),-0.1631695835975933
AsPC-1,16065773,2.935886834183449
NCI-H209,3384730,2.626651922378795
RT-4,44185566,2.540534847490806
AsPC-1,374536,-1.7506249493921369
HCC2108,5566,3.06575659173901
KMS-12-BM,241158,1.5195082823857844
NCI-H1339,984333,1.4866147707616064
PE/CA-PJ41 (clone D2),44607530,1.5651540354177746
HSC-3,387447,-4.149874850312051
SNU-423,148124,-5.293921885870976
SNU-886,5329102,1.596812622524428
Ri-1,52947716,-7.563694998491287
AsPC-1,3825829,4.335500071907528
HCC2108,44484440,3.875901941244504
Karpas-422,73707398,0.5334637120665475
MIA PaCa-2,6505803,-3.969520749405985
SK-MEL-5,6623618,1.9915835426594244
Lu-65,9952709,2.0015111957714424
BFTC-909,31703,-0.9928331583982526
Namalwa,3025944,3.875856836212888
RERF-LC-MS,151289,1.06337646711186
RKN,52947716,-5.912196482956353
NOMO-1,60700,-1.0021705320646457
HSC-3,6918736,-2.0241587603134468
KMS-12-BM,navitoclax-PLX-4032 (1-1 mol-mol),-0.94714190521785
BT 248,3025986,2.9298231166336297
NCI-H929,387447,-6.464991803110621
OAW28,168313047,2.064989846569142
PF-382,5978,-2.969199585988814
BFTC-909,9907093,4.635414583134371
NCI-H2030,5566,3.4824857655700328
ChaGo-K-1,11977753,-0.9113561720132052
LXF 289,2874250,5.409057432200043
KYSE-450,5282054,4.505957787336516
EHEB,5351362,0.8229401281543347
Ri-1,136227924,2.363884089308993
SK-MEL-5,25183872,-1.4190506694494895
BT 248,5460769,4.810999932000391
Mono-Mac-1,9907093,2.924657758065781
BT 320,9840324,5.908905325340882
Karpas-422,11497983,-3.582797451507803
SF539,navitoclax-MST-312 (1-1 mol-mol),0.2156471617471034
KMS-12-BM,451668,-4.0111672438300126
HOP-62,439501,-3.0300699988747333
ChaGo-K-1,tretinoin-navitoclax (4-1 mol-mol),4.3573110089788365
RT-4,6610216,4.294846652425395
SK-MEL-5,439501,-0.7759362068872153
Lu-65,216468,3.4441373873325714
RT-4,67156097,-2.3409564010950343
KYSE-180,136227924,3.113518519432139
AsPC-1,6917907,-5.50087073609159
SK-MEL-5,54618771,0.7093345512366925
SK-MEL-5,vorinostat-carboplatin (1-1 mol-mol),3.0622263342910507
RT-4,6852167,2.0895706527990376
LMSU,25161177,5.357505084661806
NCI-H2030,44185566,4.409465669932711
SNU-119,5328940,0.3494705393628248
NCI-H929,11626560,-0.3439403672463312
RKO,10127622,3.209405126939437
Karpas-422,16659841,3.690505948558723
WM793,10427712,4.81488735871317
CML-T1,151289,0.34759640697574
CML-T1,107985,-4.139753917879256
CML-T1,navitoclax-MST-312 (1-1 mol-mol),0.6606923209980897
AsPC-1,44493528,4.313387127964929
Becker,6918878,4.133877014709684
ESS-1,7251185,2.2330805866433834
RKN,71680916,6.446363106372924
NCI-H1339,2871966,2.5357996601271013
Ri-1,46199207,2.0638864462459305
RERF-LC-MS,11609586,3.546222239883878
AsPC-1,5282054,4.143624610165464
BT 248,73707438,3.693804860778579
Mono-Mac-1,2945648,2.7963825561825204
AsPC-1,60700,1.1964352024151823
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
SNU-119,10231331,4.363406465804169
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
ChaGo-K-1,73707371,4.824221553271621
KLE,107985,-4.625155684647364
SW1783,19582717,6.868976405767061
KMS-12-BM,9825149,-0.3079276938801488
NCI-H929,10184653,1.0865277300085363
BT 286,71729975,1.6702484611001218
Kasumi-2,tanespimycin-gemcitabine (1-1 mol-mol),-5.446919177897971
AsPC-1,24753719,4.618559637878285
Mono-Mac-1,3689413,-2.253738856829829
SNU-119,9907093,3.854419311028708
BFTC-909,6252,5.031852570794812
ACC-MESO-1,44491742,5.613898283692527
CML-T1,11612883,2.4336919382311253
ChaGo-K-1,66577038,3.1807983442187715
AU565,119607,5.010456243294951
HCC2108,25183872,1.312487478805732
NOMO-1,11175137,1.3676050257567425
HCC2108,5329102,2.0081576367450964
SK-MEL-5,2708,5.160333011661181
SNU-886,71466578,3.8028981862440343
RKN,16722836,2.340122812915413
WM793,4788,5.954303225972929
NCI-H196,409805,4.55561469724075
Kasumi-2,11317348,0.9834435800612674
SNU-423,6914657,-3.262772881758693
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
ChaGo-K-1,9935249,2.017228734725955
KYSE-180,126941,-3.004750085240848
RERF-LC-MS,46907787,3.883745984979501
RKO,409805,3.580644131410829
Lu-65,navitoclax-piperlongumine (1-1 mol-mol),3.0170876228722214
KLE,SNX-2112-bortezomib (250-1 mol-mol),3.268766111238186
LXF 289,72193861,1.9781400147016948
HOP-62,24748573,1.153820419307879
LMSU,navitoclax-pluripotin (1-1 mol-mol),-0.1706799905389637
AsPC-1,5311,1.9705564216623497
PF-382,46907787,-1.0517755055208098
ESS-1,9935249,3.3777402733386617
BT 286,89928392,0.4676933846077264
BT 320,2858523,3.05792743854883
Karpas-422,5278396,3.2041501178835414
SNU-423,5746,3.145468816022035
PF-382,selumetinib-BRD-A02303741 (4-1 mol-mol),5.510058878321319
Ri-1,168312962,-0.6145879740945622
LXF 289,9444,4.020808033871241
HSC-3,9903786,2.4966748748730025
CML-T1,46943432,2.522264418529326
NCI-H1339,9911463,4.3916675652750925
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
PF-382,6918289,-1.8568942087254432
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
RKO,100016,5.817852214634293
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
RERF-LC-MS,25062766,1.7296886540377192
RT-4,2828334,5.9208370423124554
LMSU,241158,4.2548793295703025
H-STS,3689413,-4.4758570940331515
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187
Ri-1,11977753,-4.917198176717717
NOMO-1,54649381,4.1030759428324455
KYSE-180,3384730,1.3990214479335077
KYSE-450,24785538,3.6513103906304942
KMS-12-BM,11612883,1.8629511117266817
SW1783,409805,4.510325829942446
IST-Mes1,11175137,3.00105789094782
SW1783,16065773,5.946044884546371
Kasumi-2,56973724,0.9281139851854971
SF539,71466380,4.199081692054065
HuT 78,9868037,2.4738144029909908
PE/CA-PJ41 (clone D2),6914657,-2.4889855415654223
Mono-Mac-1,JQ-1-carboplatin (1-1 mol-mol),-0.3034213126939502
EHEB,44259,0.6162293307337288
NOMO-1,46191454,0.6880471005756411
NCI-H209,11977753,-2.301420717847787
AsPC-1,11640390,5.159931420709134
OAW28,9840324,5.735695909737487
BT 286,5479543,2.409411999726575
SNU-213,9926054,2.110529432598139
KMS-12-BM,54649381,3.2424778032361186
HEC-108,20959075,-3.040145887697204
OAW28,vorinostat-navitoclax (4-1 mol-mol),-0.0627411194762238
KMS-12-BM,3676137,3.133967205799227
KMS-12-BM,navitoclax-gemcitabine (1-1 mol-mol),-3.5560923194390006
NCI-H196,selumetinib-UNC0638 (4-1 mol-mol),4.422806576622298
BT 328,60700,3.9480451882670424
RKN,17759555,4.047966260499275
ESS-1,3025944,4.241330613062884
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864
PF-382,100016,3.957595275699552
AsPC-1,613753,3.1774382169580355
IST-Mes1,67156097,2.0129233452386095
HEC-108,ISOX-bortezomib (250-1 mol-mol),0.3460694218807578
KMRC-20,11222830,2.077538911005185
Namalwa,9825149,2.0206272190302887
SK-UT-1,navitoclax-piperlongumine (1-1 mol-mol),3.105185528724131
Mono-Mac-1,644241,2.275828690099689
Karpas-422,10113978,3.2783736500447263
CML-T1,3825829,3.084807192466588
SNU-423,selumetinib-tretinoin (2-1 mol-mol),4.112042588554093
RERF-LC-MS,60750,-4.1612389836176
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
KMS-12-BM,44632017,-0.0018812054656874
SF539,10026128,4.850110020898141
HOP-62,navitoclax-piperlongumine (1-1 mol-mol),2.558154539746264
SNU-423,24180719,4.009058877663273
Ri-1,135440466,1.1729912767332191
SNU-423,67156097,-0.5877978282373478
OAW28,11152667,0.0990704789630026
KMS-12-BM,135398516,0.3252714266903287
ChaGo-K-1,6450551,3.266612737246024
KLE,60700,-0.7910024773146103
SNU-886,285033,-1.8858880502892013
RKO,56946209,-3.445993729976747
Ri-1,3038522,4.739795846773267
SNU-423,5281321,-2.4024956410686817
LXF 289,2746,3.190299829163617
SNU-423,4477,0.5093616133902202
IST-Mes1,9935249,3.876611894197404
KYSE-450,46398810,3.648883715738529
Mono-Mac-1,57330099,3.764598523152759
HCC2108,676352,1.822640586009688
IST-Mes1,24901704,2.6411672165981965
SNU-423,54618164,4.040713940867877
HSC-3,168313047,2.12803897774878
AU565,52947716,0.8422274137680903
SNU-886,25154868,3.4253449790012804
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
LXF 289,51037431,5.679407317259089
NOMO-1,73707438,4.2876330596581305
HEC-108,123631,2.3972749886256266
HOP-62,3136844,3.524389287742587
NOMO-1,2708,4.2098167660909525
Kasumi-2,1566236,1.00471674851072
WM793,119182,-3.1543080825396173
Mono-Mac-1,12003241,-3.167077714646063
HSC-3,44486219,4.38414181949899
H-STS,4261,-1.5298596443260053
ChaGo-K-1,SNX-2112-bortezomib (250-1 mol-mol),-0.1631401079810167
KYSE-450,23635314,4.2538404105785
ESS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.6491539318106514
BFTC-909,15953870,3.192835350037467
NCI-H209,navitoclax-pluripotin (1-1 mol-mol),-2.817778574206939
Kasumi-2,12003241,-2.245419673861097
NCI-H2030,12001922,2.618392132225964
CML-T1,5284329,2.20205002414717
WM793,23939,4.513894312283566
HEC-108,6610216,4.664785359409005
LXF 289,44819697,0.5606163889857397
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
IST-Mes1,11364421,-1.7965673619245748
AU565,57519531,1.889615726213954
HuT 78,1716436,2.3325786548339207
BT 328,25062766,3.0045654818886507
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
HEC-108,11612883,3.04097878516087
LMSU,100016,7.332455698517509
SNU-213,navitoclax-MST-312 (1-1 mol-mol),3.685779370841315
WM793,135875424,3.1604105075223656
SK-UT-1,100016,6.311695779547894
KLE,71304818,2.924630717517275
KMRC-20,216468,5.240233090076588
RKN,3038522,4.332475047921768
SNU-213,104842,-0.7066538476522156
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
H-STS,2749,1.0388085008681336
HuT 78,71304818,2.291662678403222
NCI-H196,doxorubicin-navitoclax (2-1 mol-mol),0.5112205720808501
EHEB,16720766,0.2436071662953463
PF-382,23939,6.138736968520051
Ri-1,2708,3.183708199317031
Becker,31703,1.0919022553440236
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
KYSE-450,5281321,2.0309467216777657
OAW28,159324,2.7212056331712584
OAW28,439501,-0.9322268226633188
SF539,57330099,3.5033572869669327
Becker,5287969,-1.95903417594286
EHEB,11507802,1.0533498675891693
SNU-119,4477,-0.101957157099522
KMS-12-BM,carboplatin-UNC0638 (2-1 mol-mol),1.757378560571638
HCC2108,17759555,3.761463468003181
Ri-1,2113511,3.984428046872122
RT-4,12003241,-1.8542714118634884
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385
Kasumi-2,68056272,3.4308739954935867
HSC-3,serdemetan-SCH-529074 (1-1 mol-mol),2.268504689753588
LXF 289,6450551,1.9915066986525345
SNU-213,327653,3.9341238423164127
SF539,selumetinib-UNC0638 (4-1 mol-mol),3.9589245906331314
NCI-H1339,11955716,-2.7317911742466285
SF539,322968,4.641648660199269
KLE,3038522,3.949469556770748
BT 328,11178236,-3.1111942702784092
RT-4,322968,4.646430873835076
Panc 02.03,49766530,0.9655059796360064
H-STS,753704,4.594437808877669
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
AU565,5280436,3.6175977861549473
Becker,16722836,2.963672271821801
CML-T1,6852167,0.9836314645814764
SF539,46398810,1.675879123276388
Kasumi-2,doxorubicin-navitoclax (2-1 mol-mol),-4.049414259936193
SNU-119,644241,2.7771526168962084
SK-UT-1,5287969,-1.264654811647733
Karpas-422,216468,2.361145468845441
SNU-423,5328940,2.374403241706306
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
AsPC-1,10296883,4.32215490848641
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
ESS-1,piperlongumine-MST-312 (1-1 mol-mol),0.6128133156835777
ESS-1,24856436,-0.1726658691519087
SK-UT-1,vorinostat-navitoclax (4-1 mol-mol),2.160306849194933
Kasumi-2,10302451,2.501538159290375
SNU-213,119607,5.874440203176763
LMSU,navitoclax-gemcitabine (1-1 mol-mol),0.2056426446886963
Mono-Mac-1,44589607,4.674636084948172
RERF-LC-MS,54678924,1.4734481784853186
SK-MEL-5,126941,-2.0410864203063244
CML-T1,navitoclax-piperlongumine (1-1 mol-mol),0.6324311645871261
SNU-213,322968,3.4615818853822127
NCI-H196,71466578,5.048301146086872
SK-UT-1,11222830,1.0435371315792576
NCI-H929,vorinostat-navitoclax (4-1 mol-mol),1.516172419894528
Namalwa,9933475,1.7779880022175991
MIA PaCa-2,25102847,1.798683379599451
LXF 289,20959075,-2.4089188058085
SNU-886,11317348,1.5463436352740425
HCC2108,56946209,-3.5616140091997397
PF-382,11612883,1.3339433579277435
Lu-65,11612883,3.0642065357892623
Kasumi-2,36462,-1.2000537391874553
BT 248,10302451,3.817813130063646
KYSE-450,selumetinib-PLX-4032 (8-1 mol-mol),5.261174592535557
NCI-H1339,11707110,5.363420889185477
KYSE-450,3503,2.083749354383258
KMS-12-BM,46224516,1.363965419553059
SNU-886,3689413,-0.3695618539773043
RT-4,135411,2.3178037837243166
AsPC-1,6852167,3.622461858977091
NCI-H929,10427712,4.4181705669387865
BT 286,36462,-0.1751673749960541
SF539,4578,4.594464802750392
SNU-423,702558,5.708440861926304
ChaGo-K-1,11964036,2.321636114711196
OAW28,6917907,-5.603755883192341
LMSU,11404337,0.046862413597458
EHEB,638278,3.110605019807073
NCI-H196,navitoclax-PLX-4032 (1-1 mol-mol),3.3889118353454704
KMS-12-BM,6918837,-5.957807567575875
Panc 02.03,16720766,4.473005389666903
PF-382,9866186,-0.181999891578736
MIA PaCa-2,1716436,3.209523428737418
NCI-H196,erlotinib-PLX-4032 (2-1 mol-mol),3.340004131800971
SF539,44607530,0.9511382642775598
HCC2108,168313047,3.002355785890527
KMS-12-BM,156414,0.8404794203086158
EHEB,doxorubicin-navitoclax (2-1 mol-mol),-3.104964273062398
HOP-62,136227924,3.3249367186884564
KYSE-450,71304818,3.197699947963966
PF-382,4261,0.6206870573702211
BFTC-909,5281321,-1.6266730162675118
Becker,10296883,4.31752254310815
Mono-Mac-1,56963564,0.1465814447816201
SNU-119,1242560,2.269349854429625
Kasumi-2,3081361,2.7656675201923555
LMSU,1641662,4.120981858702554
Kasumi-2,4521392,4.1748849427500625
CML-T1,19582717,1.9595186711365948
BT 498,6438330,1.9724723295366628
EHEB,54143018,-0.2425574036169623
OAW28,89183176,4.823946494889004
SK-MEL-5,25262965,-1.2315424629364211
OAW28,5329102,1.8792475137868745
ChaGo-K-1,46843906,1.9586607185407423
RKO,119607,4.75876667689532
KYSE-450,16720766,2.1902157415608836
LMSU,5287969,-1.920405728904364
SNU-423,5566,3.225192273921879
LMSU,selumetinib-decitabine (4-1 mol-mol),5.339480518693171
KMS-12-BM,25062766,1.5143080044468464
HCC2108,11497983,4.98436619743709
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295
Becker,10184653,1.6824622119630197
IST-Mes1,24753719,4.106786270688489
HOP-62,54678924,2.041879666308894
LXF 289,216345,3.67485776854348
SNU-213,11364421,1.2530815378633922
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
HuT 78,135440466,0.5263420458199721
KMRC-20,44589607,3.662166795510174
MIA PaCa-2,56973724,3.939860746778317
EHEB,11626560,1.520000059512031
AsPC-1,11222830,1.755039918901926
ChaGo-K-1,24901704,3.2868248459161538
RERF-LC-MS,448949,1.7883798522328354
KLE,168313016,5.53335411774071
PE/CA-PJ41 (clone D2),10231331,2.737757357175731
MIA PaCa-2,11657048,4.878585794682366
WM793,9936388,1.3359302595984517
Ri-1,753704,4.378804687168766
Mono-Mac-1,11683005,4.367072031055066
LMSU,1242560,3.6890056089090937
WM793,5311,2.1433101075982406
RERF-LC-MS,10302451,4.085913110869725
NOMO-1,10074640,3.0496099519927435
RT-4,11964036,3.812081086796839
Karpas-422,11404337,-0.752603119365503
SF539,71729975,3.876423931998654
AsPC-1,11626560,2.2683411612930637
BT 328,2858523,3.1475044170181996
NCI-H1339,46398810,3.698809091636484
NCI-H2030,3062316,-0.7983590245700212
NCI-H1339,5287969,-2.094492411794171
Lu-65,selumetinib-PLX-4032 (8-1 mol-mol),0.9230228492906724
HuT 78,10113978,2.521071548009062
NCI-H929,53232,1.3774173243264964
SNU-886,327653,2.660863736494067
Ri-1,135928012,2.2309450357468994
Becker,168313016,4.48609238913996
NCI-H1339,53495165,-0.4722640551033099
WM793,4378219,1.9547593472491875
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
RKN,10113978,4.430129932581481
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
AsPC-1,54626689,5.229882111208764
WM793,11609586,2.945181998270863
LMSU,11612883,3.4193736852271206
NCI-H2030,5329102,2.740425855579455
NCI-H1339,salermide-PLX-4032 (12-1 mol-mol),5.736856833548513
RKN,24964624,2.2448388370498704
SK-MEL-5,656346,3.708545747764347
WM793,10385095,0.6081370186912695
Karpas-422,151289,0.9778807831289208
PF-382,322968,1.8904688275492667
WM793,5460769,5.840780592325561
HEC-108,51037431,2.239611554360474
CML-T1,16038120,0.5708889366464743
Mono-Mac-1,selumetinib-MK-2206 (8-1 mol-mol),1.4468247405197736
BT 498,11396600,3.4855943403203704
Ri-1,67156097,-2.9960843721421107
AsPC-1,25262965,-4.011117827244764
SK-MEL-5,446155,3.759030292305935
MIA PaCa-2,16722836,1.1361163699698982
HuT 78,56949517,4.088339707137809
Kasumi-2,5282054,2.4598760030877553
Kasumi-2,24821094,1.7820431474601306
BT 248,57519531,6.254880017804167
ChaGo-K-1,148198,-4.908529159972166
SNU-886,9936388,-5.3251547250946825
LXF 289,322968,3.971478433961818
CML-T1,5470400,-2.3275269381266326
NCI-H1339,25227462,-0.3202555792543043
SNU-119,selumetinib-UNC0638 (4-1 mol-mol),3.591039220835182
MIA PaCa-2,24748573,2.471671606965887
KLE,11214940,0.7817459379434555
NCI-H1339,56946209,-4.9853882615502725
BT 328,navitoclax-pluripotin (1-1 mol-mol),-1.2977497604117467
AsPC-1,387447,-4.291846387154746
ESS-1,5329102,1.725733095868152
MIA PaCa-2,25195348,3.726807791554416
NCI-H196,44489367,4.4813360413597705
SK-MEL-5,9936388,2.3503506475790816
PF-382,vorinostat-navitoclax (4-1 mol-mol),-0.4263827729642097
Namalwa,3543504,3.3437849281345247
EHEB,135411,-0.07398268976703
HCC2108,10385095,1.3545455997149978
OAW28,54649381,3.786658613217657
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
HCC2108,5460769,1.78766929460534
MIA PaCa-2,5291,3.0537829500454614
ESS-1,24180125,3.331979674522133
MIA PaCa-2,25062766,2.214474129004581
AsPC-1,11404337,0.3809720735493328
BT 320,64971,4.224921006781723
AsPC-1,11977753,1.3763157806720072
SNU-213,613753,3.1734091192238503
SNU-119,49867926,4.1413838407199375
SNU-423,11178236,-5.066365028213152
Namalwa,25126798,3.8884375431248417
RKO,11964036,1.8153618806471208
NOMO-1,11404337,-0.1001889231988697
BT 320,52947716,3.1695176437652757
SK-MEL-5,5278396,3.5563438270192274
Kasumi-2,6914657,-5.1533998646952925
CML-T1,6505803,-0.3633146304142068
SF539,44819697,-3.4306992197500255
KMS-12-BM,26596,-3.7364157309734822
BT 328,2729026,2.3236347104871924
CML-T1,2130404,3.1458672398900425
SNU-119,tretinoin-navitoclax (4-1 mol-mol),1.7834789734876322
KYSE-180,16720766,1.7167051312732595
Kasumi-2,55508,1.5459922299360274
BT 498,piperlongumine-MST-312 (1-1 mol-mol),2.0235754447154353
IST-Mes1,54618164,4.8538718291352945
KMRC-20,5328940,1.6552901694758546
BT 328,navitoclax-piperlongumine (1-1 mol-mol),2.639428516957035
BT 328,selumetinib-BRD-A02303741 (4-1 mol-mol),6.07719627140778
SK-UT-1,11507802,0.5091133584540986
Kasumi-2,6918736,-2.315158162333665
Ri-1,2945648,1.0308232221327251
SW1783,24797083,1.3978272138606742
HOP-62,71751553,4.571888658933869
BFTC-909,36462,4.374665451212183
BFTC-909,15983966,-4.834157449814871
MJ,23635314,-4.748597421317521
SK-MEL-5,3503,2.718146130273396
SF539,119607,5.330074057823079
BT 248,2858523,2.3138600326756436
BT 286,5281321,-0.1981041613926186
NCI-H929,375860,-0.8805079289764249
Namalwa,52912189,-1.1471104729897783
ChaGo-K-1,136227924,2.8574479872364247
HCC2108,navitoclax-MST-312 (1-1 mol-mol),1.0917424387869863
NCI-H196,tanespimycin-gemcitabine (1-1 mol-mol),-1.8049409117597135
BT 248,12003241,-0.5635987052840526
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
MIA PaCa-2,46224516,1.6127588238587849
AsPC-1,60700,1.1964352024151823
ESS-1,11152667,-1.1144895141014577
NCI-H2030,12003241,-1.1383124397984303
Ri-1,11396600,2.305014362827753
SK-UT-1,5287620,-0.1399962541405603
PF-382,24180719,4.536989460755837
Ri-1,54618164,3.351620474259991
HSC-3,24772860,-2.421030928901566
LXF 289,16736978,1.6084503302226174
H-STS,44202524,1.3266978322273313
HuT 78,446155,1.49234207270104
RERF-LC-MS,11717001,4.567893424272946
PE/CA-PJ41 (clone D2),10127622,2.6959246171276625
RKO,5351362,1.5688417029382893
BT 320,selumetinib-MK-2206 (8-1 mol-mol),3.122937537933898
SK-MEL-5,navitoclax-gemcitabine (1-1 mol-mol),-2.451034866388519
ESS-1,1566236,1.5560500313895365
RKN,9911463,4.114615883902867
ESS-1,11494412,1.0604335653802026
NCI-H929,12003241,-1.2414676879861424
SNU-423,11404337,0.0022687984612849
AU565,25195348,3.492226581515367
AsPC-1,16659841,4.5181069426631
BT 328,6436223,-4.925516012264063
SK-MEL-5,6918736,-0.2565259857456182
ESS-1,5311,0.311650985953959
SNU-213,54619238,4.377932230506036
HuT 78,51039095,2.102033530869646
HOP-62,25102847,2.967758593907596
HuT 78,JQ-1-MK-0752 (1-1 mol-mol),-1.2241508901650953
KLE,navitoclax-piperlongumine (1-1 mol-mol),-2.7147471251118143
NCI-H929,16115403,-5.6578245507090905
Kasumi-2,11234052,3.910537949204277
BT 328,16219061,3.835550220565251
Ri-1,6918736,-3.10014909157418
WM793,448949,1.628822965430235
CML-T1,3503,1.2439697949752524
MJ,11455910,1.0370030045754386
ESS-1,54454,2.499886449492877
Panc 02.03,387447,-4.21908064053878
KYSE-450,6505803,0.925446652115482
KMS-12-BM,11234052,1.039776638758491
AsPC-1,44819697,-0.3025066533854976
RKN,9887053,4.324470541002337
SNU-119,5329102,1.9834591388005431
BT 498,24978538,1.086721793823347
ChaGo-K-1,ISOX-bortezomib (250-1 mol-mol),0.189557717286372
CML-T1,navitoclax-PLX-4032 (1-1 mol-mol),0.956704604832818
NCI-H1339,285033,-1.5807051815557247
SK-MEL-5,89928392,1.837778592471805
OAW28,25262965,-0.9519808245592094
Kasumi-2,1716436,2.2552230484948477
Kasumi-2,ISOX-bortezomib (250-1 mol-mol),-0.8608455854799354
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
HCC2108,446155,1.94698082724245
WM793,selumetinib-UNC0638 (4-1 mol-mol),2.385330899983246
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
RKO,969516,2.537841036798478
OAW28,54618164,4.207465894202405
ChaGo-K-1,46926350,-4.424960815511268
Namalwa,71680916,3.957958076797236
BT 286,16065773,1.7230000692404597
H-STS,53495165,-1.641069756041938
SNU-423,25126798,3.799827359638474
KYSE-180,5113032,5.165592461043619
ESS-1,44491742,4.277473074701454
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
Ri-1,tretinoin-navitoclax (4-1 mol-mol),-2.192947300647472
HuT 78,67291369,-1.2460432819903486
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
HuT 78,54613361,-0.8401705547778511
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
BT 286,navitoclax-PLX-4032 (1-1 mol-mol),1.6129490724419135
OAW28,3634881,3.2370607224140473
PE/CA-PJ41 (clone D2),11719255,3.630354595850525
KMRC-20,6505803,2.060614018584274
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
RERF-LC-MS,24889392,5.73600211591012
RERF-LC-MS,25126798,3.475546322259903
Kasumi-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9653989283259805
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
Namalwa,5282054,2.488758086873497
RKN,219104,3.4277527780329096
SK-MEL-5,49850262,3.835719127247764
EHEB,46199207,2.926466130058298
Namalwa,5702613,5.916482169691303
AsPC-1,168313200,3.2842521999758523
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
NCI-H929,9549297,1.69378915829561
HOP-62,4261,2.721798262464122
EHEB,44632017,1.189004229648695
PE/CA-PJ41 (clone D2),5566,3.1605313786079825
NCI-H1339,6918736,-2.7818792604398235
Kasumi-2,46215462,1.2219116069395664
MIA PaCa-2,25126798,3.924004652513405
BT 248,5278396,3.9189937549477545
LMSU,navitoclax-sorafenib (1-1 mol-mol),3.2151070813962286
SK-UT-1,15953870,4.0206121025368216
HCC2108,46398810,2.6632695646236773
RKO,6914657,-2.9196237708628505
HuT 78,2130404,3.85812044436517
Ri-1,5282054,1.736002290271582
HCC2108,3689413,-1.830632797435868
RERF-LC-MS,16065773,2.958049600168222
SNU-119,656346,2.524643522978163
BFTC-909,702558,5.601571619782522
MIA PaCa-2,9826308,0.6670683268194105
ACC-MESO-1,11364421,1.3421413429971474
H-STS,11455910,0.6438795438543947
KYSE-450,5328940,1.9152649667159072
MIA PaCa-2,44489675,3.7736935827734706
AU565,216345,2.670108206329082
HEC-108,3385,6.041983945648764
HuT 78,119607,5.154111912943426
HEC-108,3543504,4.706207337036549
SF539,54618771,0.9520052550930058
Karpas-422,selumetinib-JQ-1 (4-1 mol-mol),-0.3387810810596827
MIA PaCa-2,10172275,4.620213928756893
NCI-H196,4788,5.975435744717622
Becker,vorinostat-navitoclax (4-1 mol-mol),1.0402549716197431
Karpas-422,11625818,1.3819021943398546
SNU-119,SNX-2112-bortezomib (250-1 mol-mol),-2.290476264848759
KYSE-450,15547703,4.417668058274178
BT 320,119607,6.086126545734404
Kasumi-2,44507138,0.9761318750595236
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
SK-UT-1,49793307,-1.387353739951522
BFTC-909,107985,-3.700699007813787
OAW28,9840324,5.735695909737487
AsPC-1,73707398,2.3690176063372888
NCI-H209,9866186,-1.4908819729941871
Lu-65,25154868,3.911083549863155
ESS-1,25227462,-2.235408931429562
Panc 02.03,4788,6.040807258084593
RERF-LC-MS,135999136,4.400683337930441
KYSE-450,439501,-3.185322034462323
RERF-LC-MS,445643,4.345437949323675
NCI-H929,446155,1.246736711414303
ACC-MESO-1,446155,2.9941213249489063
NCI-H209,15953870,2.4365262020056195
MIA PaCa-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.9095756818952287
LXF 289,5329102,1.6667075021580833
HEC-108,10385095,1.228149017066595
NCI-H209,72376,-4.141163112569914
BT 248,72376,-0.6579483524735774
SW1783,9967941,5.280203655099816
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706
SNU-119,123631,0.6885393078398833
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
Namalwa,135984461,4.336205571620734
H-STS,6184667,4.225407258507326
OAW28,44493528,4.631141764792384
Ri-1,9444,3.077798333832145
BT 498,11364421,2.0232467845321125
KMS-12-BM,24951314,-0.6430805237393931
AsPC-1,637858,2.8111542457272605
Ri-1,126941,-2.3172631680827687
AsPC-1,6917907,-5.50087073609159
KYSE-180,676352,2.6978947803601057
PE/CA-PJ41 (clone D2),11494412,6.141663454426873
OAW28,60700,1.95920843974679
LMSU,3062316,-2.3200924553246183
PE/CA-PJ41 (clone D2),11228183,3.3949317736120546
Mono-Mac-1,ISOX-bortezomib (250-1 mol-mol),0.3219679032848082
HuT 78,vorinostat-carboplatin (1-1 mol-mol),1.4699381378496317
NOMO-1,54618771,-0.7336388686704796
SF539,11719255,2.415885825794134
ESS-1,16013152,5.626524469878935
AsPC-1,25150857,2.720712035994173
NCI-H2030,4261,2.035787894419823
Karpas-422,60700,-1.504917229120135
Karpas-422,44202524,1.2512598284574767
HuT 78,10302451,3.5523158684911764
KMRC-20,selumetinib-decitabine (4-1 mol-mol),6.46474564385979
NOMO-1,65064,5.083490310509571
BT 286,136227331,4.205096233968031
HuT 78,82146,0.1378074486168638
Kasumi-2,54618795,2.2160859361178624
Namalwa,salermide-PLX-4032 (12-1 mol-mol),5.130194684209192
HSC-3,9936388,1.0714511856923938
KMRC-20,navitoclax-pluripotin (1-1 mol-mol),-0.4667071263611014
HuT 78,26596,-1.9929249611117947
RERF-LC-MS,11626560,1.1998891680987491
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
Mono-Mac-1,5284616,1.041829592246337
MIA PaCa-2,25262965,-3.121356079036344
BFTC-909,11228183,3.298719229946038
RERF-LC-MS,984333,0.876742343627688
BFTC-909,60750,-1.7298046099952136
BT 328,9868037,5.326885818831123
SF539,10302451,2.624022513021108
BT 328,9549297,2.748428048509406
HuT 78,11222830,0.3543354397865786
NCI-H209,36314,-3.490565280489779
RKO,25195348,3.4491832635970585
KYSE-180,216468,3.656318392003096
CML-T1,9908783,6.154706718384333
NCI-H196,vorinostat-carboplatin (1-1 mol-mol),3.2545067268890446
BT 328,24964624,2.9431698803975324
BT 498,docetaxel-tanespimycin (2-1 mol-mol),0.8722065410112619
SF539,10184653,1.7813996446939269
NCI-H196,11404337,0.5983725190796483
HOP-62,10410894,2.567224758918039
Kasumi-2,25126798,3.908076551751955
WM793,36462,4.293096910683363
BT 286,24856436,1.1067701612857763
SNU-423,6438330,2.845782859540362
OAW28,262093,2.853078829548121
AU565,54618305,4.305835133395234
BT 286,72376,-3.16729090401154
KMRC-20,11609586,2.572780033443364
NOMO-1,19582717,2.563142509513499
Namalwa,3062316,1.228247623122234
Karpas-422,4788,5.537541042200492
ACC-MESO-1,17755052,3.468527757653984
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
ACC-MESO-1,44489367,5.824107451823484
KYSE-450,1566236,2.943712788473633
IST-Mes1,374536,3.187270781803884
NCI-H929,3136844,3.56413576716979
HOP-62,44491742,4.640090000896823
SF539,doxorubicin-navitoclax (2-1 mol-mol),-1.7413374971116728
BFTC-909,2113511,5.65564772398506
SNU-119,vorinostat-carboplatin (1-1 mol-mol),4.187778089555317
AU565,46907787,3.197599854412173
HuT 78,50905018,2.5901860875051144
AsPC-1,11656518,2.0782041289904845
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
ChaGo-K-1,44607530,2.2725472381038503
SK-MEL-5,71466445,2.1269711311282373
HOP-62,2733526,2.706309948771008
HOP-62,637858,3.261273294662145
HOP-62,123631,2.2603596444453116
CML-T1,11717001,4.07494523492724
SK-MEL-5,2858523,3.111072255115378
SNU-886,11626560,2.6362040536999514
HOP-62,9866186,0.6362395623867438
OAW28,44493528,4.631141764792384
Ri-1,44185566,1.1229828302850782
IST-Mes1,71466578,4.723128098465521
IST-Mes1,selumetinib-PLX-4032 (8-1 mol-mol),4.413511328522001
Ri-1,49793307,-4.547425498308136
HuT 78,11656518,1.0208848045852064
SW1783,44566777,2.310065302579828
KYSE-180,44819697,-2.483025029894288
Ri-1,675434,3.90496175093301
Lu-65,1566236,3.455735123137807
Ri-1,11485656,1.6570467994982818
AsPC-1,9967941,3.911764573168509
PE/CA-PJ41 (clone D2),5278396,4.12050417476776
PE/CA-PJ41 (clone D2),148124,5.794245590172473
BT 286,613753,3.3258744553617667
PE/CA-PJ41 (clone D2),navitoclax-PLX-4032 (1-1 mol-mol),3.1934376543337395
OAW28,4477,1.0036814180565996
NOMO-1,25183872,-0.6960845434284378
BT 248,24978538,0.997787879795877
NOMO-1,5281321,-2.1390969134868656
RT-4,54649381,5.182810489152522
Mono-Mac-1,60700,-2.5077544634616844
Mono-Mac-1,56649450,3.2410705398980864
BFTC-909,5278396,3.473037688340168
Ri-1,UNC0638-navitoclax (1-1 mol-mol),-3.130813752237708
NCI-H1339,72193861,1.3941268213904905
NCI-H929,123631,2.2312857610244827
Becker,16741245,3.954379733751191
AsPC-1,219104,4.54762024266609
CML-T1,25126798,3.796147395391691
BT 320,123631,3.381923883037432
SNU-423,753704,4.654692815537345
Lu-65,107985,-2.4100126884744015
HOP-62,11214940,4.302935020611148
RKO,72193861,0.7735395045157347
OAW28,54619267,3.96587417417148
HEC-108,67156097,-0.2232306565612508
PF-382,25102847,1.62616859805539
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
BT 286,2742550,3.3943072978834277
EHEB,4521392,4.976004028778806
RT-4,46843906,5.20167725568056
HOP-62,168313016,4.593663167068175
KMS-12-BM,9826308,-0.4519305046408473
PE/CA-PJ41 (clone D2),613753,3.226711686840519
LMSU,JQ-1-navitoclax (2-1 mol-mol),3.886973336392811
ESS-1,25062766,1.641098624401774
AsPC-1,25161177,4.641147259380914
EHEB,15547703,3.057077629561598
Ri-1,168313047,1.4794526918566904
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
RERF-LC-MS,25150857,3.1332692975488934
EHEB,675434,4.751173059410473
RKN,322968,3.2277505791227776
RKO,44507138,3.480554434186059
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
SNU-423,168312962,4.085540824042528
Panc 02.03,25126798,4.246913180768056
SF539,445455,5.827598780000013
IST-Mes1,5329102,1.6787488330100182
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549
EHEB,6918878,1.3489098367208612
KLE,5746,2.2077814730114373
KMRC-20,66577038,2.939049648949199
EHEB,decitabine-navitoclax (2-1 mol-mol),0.1121135025155182
SNU-119,969516,3.8713828709310256
SF539,23725625,5.199616438597248
Lu-65,1750826,-0.7879341098892302
HEC-108,JQ-1-vorinostat (2-1 mol-mol),2.7336649081261437
PE/CA-PJ41 (clone D2),2708,5.346353434531731
PF-382,54454,2.1316538534788196
MIA PaCa-2,11612883,2.6735044266109917
OAW28,2746,2.637952220594215
KMRC-20,5329102,2.310119092431828
OAW28,9915743,2.8675584787684456
WM793,24821094,4.44664829967469
WM793,10074640,3.0714713533769573
SK-UT-1,56963564,2.7705405230221967
Namalwa,5335621,4.013430994700431
AsPC-1,11647372,4.7024563360539675
WM793,44241473,6.43700199521037
IST-Mes1,11717001,4.337000636344965
Panc 02.03,1242560,3.876690059869664
HOP-62,53495165,2.032704303702465
SW1783,613753,4.7217707300915
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
HuT 78,2842253,5.94786669464028
KLE,44489367,4.867561911603137
KYSE-180,241158,4.333679160826191
AsPC-1,67291369,5.582806392200744
OAW28,44819697,-1.5562690526140308
LXF 289,65064,4.964411921317377
SNU-886,11214940,1.3041085761730546
NCI-H929,60700,-1.1580289283938754
CML-T1,5280436,4.11670865979611
RKN,1641662,3.781184529562369
Panc 02.03,24964624,3.328827283539013
Karpas-422,JQ-1-carboplatin (1-1 mol-mol),-0.5867346052444206
Karpas-422,navitoclax-piperlongumine (1-1 mol-mol),0.8534804042436965
BT 498,9952709,3.05743267810106
BT 328,selumetinib-piperlongumine (8-1 mol-mol),4.372590392700236
KYSE-450,4578,4.488057266772786
Mono-Mac-1,216239,1.788861131685611
Kasumi-2,11625818,2.3070585930223477
NCI-H929,54613361,-0.2364744908060287
SW1783,5278396,3.782003108499985
KMS-12-BM,10127622,5.364692191971256
HEC-108,6918736,-2.1205057865818633
SNU-886,42611257,3.550012838833151
PF-382,5746,-0.5974019482348806
HCC2108,327653,2.5162191828052713
KYSE-450,11404337,-0.7664225185438103
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
ChaGo-K-1,5470400,0.2648797109153149
HOP-62,24951314,0.9173922976891838
SNU-119,168313047,1.9562265924685545
SNU-886,24951314,1.1149346729448562
SNU-423,9825149,2.365990280587489
HuT 78,25062766,1.4308476674773298
NCI-H196,11647372,0.2932338575732979
Mono-Mac-1,23635314,-2.2093510638454443
SNU-119,444795,1.2975403527774965
MIA PaCa-2,46174525,4.06698670372721
KYSE-180,tanespimycin-gemcitabine (1-1 mol-mol),-0.7772592135179538
SNU-423,11396600,4.403909661334611
SNU-423,15953870,5.451798235524798
HSC-3,44241473,4.97517832627678
BT 286,46199207,1.811364952788779
SNU-213,selumetinib-navitoclax (8-1 mol-mol),0.185492688578574
NCI-H2030,51039095,3.777820295346348
ESS-1,65064,5.283025860998633
LXF 289,5460769,3.06478422280727
MIA PaCa-2,9935249,2.549119041340402
NCI-H209,11507802,-4.115441457622851
SK-UT-1,375860,0.2310503192742169
RKN,10385095,1.0188882527918253
WM793,3025944,4.634648353889454
ESS-1,135398738,5.75744142626397
OAW28,6918638,0.0048657249331401
NCI-H1339,54613361,-0.0549690451885617
AsPC-1,24748573,4.519934140177759
SNU-119,46224516,3.0258187740166083
LXF 289,54618164,3.0378434141224617
NCI-H929,969516,1.5005590932517423
CML-T1,46199207,2.0991647549590304
KMS-12-BM,3025986,-1.3403296282767831
RERF-LC-MS,25183872,-0.4545636564638026
Becker,25126798,3.953102552375253
OAW28,374536,3.018534312402979
OAW28,11497983,4.916879328733168
HuT 78,serdemetan-SCH-529074 (1-1 mol-mol),1.8219869196237213
HSC-3,176870,2.0282815166078523
HuT 78,156422,4.343521315297441
AsPC-1,11977753,1.3763157806720072
SF539,135999136,1.70209400272594
PE/CA-PJ41 (clone D2),44607531,0.8014998549696746
Karpas-422,46174525,4.10467072834266
HOP-62,3854666,3.243198417563859
HuT 78,4917,3.0693457272323825
SNU-119,327653,3.4048649042702364
BT 286,9929138,6.547331402872382
Lu-65,5460769,3.7972822070130494
KYSE-180,51037431,2.26453575909295
RKO,12003241,-0.2410566552434749
PF-382,tretinoin-carboplatin (2-1 mol-mol),4.943732821506593
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
ESS-1,6918736,-1.7029949901876988
AU565,49766530,1.448288738772077
WM793,25183872,-1.026450709028654
Mono-Mac-1,16736978,2.1360631840468898
HOP-62,carboplatin-etoposide (40-17 mol-mol),3.0329769796472
OAW28,24753719,4.434201172795376
CML-T1,11178236,-2.7580162479970634
IST-Mes1,46199207,3.629760005921771
LMSU,446155,-0.7885997290913209
ChaGo-K-1,135875424,3.8110724271208656
MIA PaCa-2,erlotinib-PLX-4032 (2-1 mol-mol),3.754648518897779
ChaGo-K-1,9903786,4.114689259573735
KLE,11612883,3.331847823409616
NCI-H929,navitoclax-piperlongumine (1-1 mol-mol),1.7457744317764834
AsPC-1,11494412,3.580103428724827
Karpas-422,702558,5.38036572824696
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
SW1783,5281321,-0.3453049143187137
KLE,6438330,2.393391106186865
Kasumi-2,11609586,-0.6223010091545076
SNU-119,135411,0.3740085311650424
SF539,374536,1.1024692735749633
PF-382,36314,2.7349440998972296
Lu-65,216345,4.515711815904248
NCI-H929,54618771,0.737310556758401
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704
SK-UT-1,6450551,2.944918696564172
HEC-108,44607531,1.840431852580758
LMSU,44589607,3.054254488130367
SK-UT-1,10385095,1.6809894125740852
ESS-1,selumetinib-JQ-1 (4-1 mol-mol),2.1651949829821353
AU565,285033,-2.964869253470222
BT 320,navitoclax-gemcitabine (1-1 mol-mol),3.195871969497656
BT 286,10322450,5.184244057340175
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
Becker,3385,6.743991470359075
CML-T1,445643,3.3065494006722327
NCI-H1339,439501,-1.6994812988125017
NOMO-1,9907093,3.6530797436282434
Mono-Mac-1,10127622,4.4929712725026505
HCC2108,9444,3.448443284867183
SW1783,9903786,4.362374850125049
BT 320,9444,6.119535049609411
ESS-1,selumetinib-PLX-4032 (8-1 mol-mol),4.921474213039296
RT-4,6918736,0.057811102641414
RERF-LC-MS,65064,5.274588293813746
NCI-H929,2858523,2.982891394222708
KLE,16741245,4.352629336159379
Kasumi-2,107970,1.3663131605888186
KYSE-180,selumetinib-tretinoin (2-1 mol-mol),6.206720364804737
AsPC-1,9907093,4.363482739155403
LMSU,568763,1.244726818384242
OAW28,71466578,4.4029072721322455
AsPC-1,11427553,3.0222816384498237
CML-T1,navitoclax-gemcitabine (1-1 mol-mol),-3.0033720863451467
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
KYSE-450,navitoclax-pluripotin (1-1 mol-mol),0.3166156605789935
KLE,11228183,-0.1439343669453544
LMSU,4259181,1.0604093757007595
Lu-65,25150857,3.0819218313756243
SK-UT-1,10074640,3.5856267596228713
OAW28,5746,2.6048591865024657
MIA PaCa-2,60700,-0.9449919961316452
KMRC-20,5280436,3.9328974141799615
BT 498,19582717,5.618555005089504
PF-382,5351362,0.8995545334729175
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
Mono-Mac-1,6505803,-1.0735015571845192
RKN,67156097,-0.5718675734992968
SK-MEL-5,24797083,1.0656460799543117
PE/CA-PJ41 (clone D2),969516,4.346091945294376
PE/CA-PJ41 (clone D2),salermide-PLX-4032 (12-1 mol-mol),5.637961880793886
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924
MJ,126941,-2.9129176545267055
ESS-1,vorinostat-carboplatin (1-1 mol-mol),3.745022747956192
RKO,168313047,1.9322709085928884
HOP-62,241158,4.371363298737313
HEC-108,9936388,-4.887528080420867
LXF 289,208908,1.975389940693236
KYSE-180,6505803,-2.0087833017185264
SW1783,73707398,1.417049584359394
WM793,11364421,-0.8939436431091912
BT 328,24951314,3.0926880274607753
BT 320,9933475,3.009143992406663
BT 286,262093,2.2473217807206916
SK-MEL-5,49766530,5.144736864268162
HuT 78,3825829,4.013992283960839
HCC2108,135875424,3.411556630339189
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
BFTC-909,42611257,4.384387627976705
RKN,89928392,1.2442310560485252
RERF-LC-MS,252682,6.464777279315186
Ri-1,10385095,0.3591008967084118
PE/CA-PJ41 (clone D2),216345,4.750574762289649
AsPC-1,400769,-0.2711365707281618
H-STS,tanespimycin-gemcitabine (1-1 mol-mol),-4.299307238751318
Namalwa,BRD-A02303741-navitoclax (2-1 mol-mol),3.7105553400958384
Kasumi-2,5284616,2.846557055185116
Ri-1,11640390,2.6738647112315888
SK-MEL-5,56649450,4.398184828401185
SNU-213,135440466,1.6712887821469151
BT 286,11707110,-5.9587050063679605
MIA PaCa-2,409805,3.7490389776997466
KMS-12-BM,227681,1.85871490335109
Kasumi-2,6610216,3.59110037414398
AU565,71751553,3.982904849419344
SNU-886,168313047,3.810150500353015
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
BT 286,6914657,-6.2929304393953975
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
RT-4,10074640,3.33667314177338
AsPC-1,285033,-0.5419823336362324
SF539,644241,2.736795870753983
HCC2108,53232,1.9986728385566
AsPC-1,11647372,4.7024563360539675
BT 286,11626560,1.3785689480454144
Becker,387447,-3.92218262413233
ESS-1,3825829,4.02803833382595
Namalwa,89183176,2.615366381833868
SNU-213,16741245,5.672249183986696
ESS-1,15953870,4.251182517456194
RERF-LC-MS,6918638,0.4520678244574614
Becker,11152667,-0.0638370344727879
SNU-119,selumetinib-navitoclax (8-1 mol-mol),2.401180921765086
AsPC-1,44589607,3.181986375917279
Ri-1,374536,1.215254129911067
HCC2108,136227924,3.562843531024723
Karpas-422,10184653,0.6496260208856843
KLE,54454,0.96963930140172
IST-Mes1,6852167,3.791716512628995
ACC-MESO-1,135398744,5.83972457285084
BT 248,3552672,1.5840638178238662
HEC-108,241158,3.683911292843857
HEC-108,25183872,-1.8518137093604925
KMS-12-BM,11167602,1.7675298654448677
RT-4,24180125,3.633157370927589
H-STS,9840324,5.735130502734432
WM793,10127622,2.6063340682647325
RERF-LC-MS,44489675,3.7548789887197183
Ri-1,439501,-2.801888786170529
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
OAW28,676352,1.7843387493833531
HOP-62,445643,3.769891604939145
EHEB,73707386,3.258970186799186
MIA PaCa-2,123631,3.2782041554498944
SF539,31703,-1.523395674641048
BT 328,148198,-4.14614868661324
SK-MEL-5,9903786,4.335376265950657
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
KMRC-20,erlotinib-PLX-4032 (2-1 mol-mol),4.001025542089447
Ri-1,387447,-5.205370002845584
SNU-119,25062766,2.2168629550530663
Ri-1,72193861,-0.0805566209959442
BFTC-909,6917907,-4.2174557642594035
ChaGo-K-1,54618164,3.816944034787713
SW1783,135875424,4.794068332474245
OAW28,9926054,1.976123345191561
ChaGo-K-1,3543504,4.252620977795733
AsPC-1,2858523,3.256128469853813
AU565,46398810,1.9802808058059196
NCI-H1339,25262965,-1.451773253208659
EHEB,3503,1.3671280774661785
RERF-LC-MS,9825149,2.3136516136403595
SNU-119,3634881,2.8282944940557484
ChaGo-K-1,9927531,4.39504142130407
NCI-H929,52912189,-1.2648597734935654
Mono-Mac-1,9956119,3.892925870265635
EHEB,46174525,4.557834321859672
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967
KMS-12-BM,3634881,2.6463615699611807
Ri-1,72376,-4.8920412183546
NCI-H1339,53232,2.307445546958286
AsPC-1,49793307,-1.0458597957041098
SNU-423,71466445,3.7020222675723646
AsPC-1,11609586,3.135544943212619
OAW28,9825149,1.8591620922463772
KMS-12-BM,5738263,2.600440253298569
KYSE-180,11152667,-0.8702132503194517
NCI-H1339,19582717,4.074457978506879
EHEB,5746,-0.445016034851696
Kasumi-2,136227924,1.9658135956042504
ACC-MESO-1,135875424,3.861508499056134
LMSU,11178236,-3.271286165721627
ACC-MESO-1,638278,3.50248621605198
MJ,135423438,2.050663035644961
OAW28,16065773,3.4526029247448973
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
Namalwa,11625818,4.000691082929696
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
Becker,54143018,0.9159558532527126
NCI-H929,10074640,2.9963817325731807
KMRC-20,60700,0.7111086892810461
KMRC-20,25126798,4.0465189677431646
RERF-LC-MS,2945648,2.437954541344266
NCI-H1339,3025986,-0.7108239777279446
H-STS,BRD-K55473186,4.025612277112804
HEC-108,124202324,3.003291050730973
MIA PaCa-2,6450551,2.264163954553481
SF539,3038522,2.057800880949275
CML-T1,3011155,1.2837041284349135
IST-Mes1,24785538,1.075792459113639
SNU-213,25154868,4.992321030185977
SK-MEL-5,44137675,4.284883260277097
Ri-1,46215462,0.2208615859518133
KYSE-450,11364421,0.1587398851119797
LMSU,navitoclax-birinapant (1-1 mol-mol),3.8096655259250167
AU565,11257553,-0.514738811981399
SW1783,126941,4.818238928893187
Becker,168313200,3.791120418398256
KMRC-20,5278396,3.577157973061421
HSC-3,5311281,3.0761228014048245
PF-382,5311,0.2704502980561536
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
BT 286,JQ-1-carboplatin (1-1 mol-mol),3.0626602949719226
AU565,6918736,-3.127988177088939
HSC-3,2708,5.023023521923633
Namalwa,107985,-4.241523948583442
NCI-H929,216239,2.215366899845667
Becker,676352,1.735579238816336
NCI-H1339,10427712,4.05819725251799
SK-MEL-5,15547703,3.136399381363894
HCC2108,25126798,3.42355668622167
SNU-423,JQ-1-carboplatin (1-1 mol-mol),4.402018355533478
BT 320,46843906,4.201274452576595
LXF 289,637858,2.285720521187594
Mono-Mac-1,11455910,1.2371744705316827
HEC-108,54649381,3.8371593577221255
RKO,25126798,4.002843113400742
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
Karpas-422,44493528,4.27188958418413
Karpas-422,11647372,-0.5156950059246161
SW1783,42642645,1.5180122548711477
NOMO-1,54678924,1.1055951494804663
SNU-119,637858,2.7399101747630867
BT 328,285033,-0.2548275745662432
Kasumi-2,10410894,1.8135964606255892
Namalwa,168313200,2.5159524673485074
SK-UT-1,135421197,2.4956722116312813
LMSU,5113032,4.833258964444667
AsPC-1,9840324,5.861158829716173
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
HSC-3,navitoclax-gemcitabine (1-1 mol-mol),-1.8598418032436657
KYSE-180,5278396,3.1226563629461705
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
ChaGo-K-1,16013152,4.057243427628333
HOP-62,49846579,1.8418614881366409
NCI-H209,selumetinib-navitoclax (8-1 mol-mol),0.4074969352699937
NCI-H209,24748573,0.014770013268607
HCC2108,11238147,2.303897319938246
LMSU,613753,3.288100775967615
Kasumi-2,44137675,1.606596454570492
LXF 289,135440466,1.0541158239349229
Kasumi-2,44566777,1.2078773885517011
NCI-H929,11213558,0.6823472924014866
Kasumi-2,BRD-K55473186,1.9287541942318225
Ri-1,11717001,4.512033854446696
RKO,24180719,5.308193040989237
HuT 78,6184667,-1.7510976513907253
AsPC-1,24180719,3.701309063973522
Mono-Mac-1,124202324,0.5742000490261943
ChaGo-K-1,24821094,3.1681477916504144
H-STS,135440466,1.636722926447895
Lu-65,49867930,4.634333542704757
Namalwa,53495165,-2.2218010443485627
SNU-886,969516,2.757505683401957
SNU-423,24180125,3.626785562106237
KMRC-20,4917,2.994813665263991
LMSU,252682,6.355540941087888
HEC-108,44259,1.4684609831763502
Ri-1,65628,2.1586840271379732
CML-T1,136227924,1.8923919385229255
IST-Mes1,5281321,-0.504099135222913
ChaGo-K-1,6610355,5.203089594311465
BT 498,25102847,3.5077914922175712
SW1783,11656518,1.104179519424249
Karpas-422,4917,3.0827412077879233
HuT 78,46907787,-2.3061129610788833
Namalwa,16736978,1.158404823156188
ChaGo-K-1,5284616,3.0899776435340027
BT 328,10427712,5.978304580808892
Kasumi-2,3543504,3.4583921680412413
AU565,11964036,0.1505437081667179
NCI-H929,20959075,-3.1953287844218417
LMSU,11626560,2.53911445992309
NCI-H196,44507138,1.669275276934409
PE/CA-PJ41 (clone D2),6918837,-3.248214905194486
LXF 289,984333,0.880488465949386
RT-4,44632017,1.2730155033067565
ESS-1,168313200,3.675041672586614
MIA PaCa-2,11494412,0.4238198089736678
NCI-H1339,selumetinib-PLX-4032 (8-1 mol-mol),4.614004496430995
AU565,66577038,2.656766135213886
NCI-H196,25183872,-0.1581676895244862
SK-UT-1,doxorubicin-navitoclax (2-1 mol-mol),-1.417611513602161
H-STS,selumetinib-tretinoin (2-1 mol-mol),4.002593719006082
Panc 02.03,984333,0.8671961837803726
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731
PF-382,15547703,2.5313681976208056
SF539,216345,3.6548053411240495
RERF-LC-MS,16038120,1.5599846769821624
RERF-LC-MS,67156097,-1.006688958645714
ESS-1,11977753,-1.6513872956899434
NCI-H2030,carboplatin-etoposide (40-17 mol-mol),3.9396863916898575
ESS-1,24901704,3.989977980383822
LMSU,7251185,3.0971316330728778
RERF-LC-MS,44185566,3.014427147988128
AsPC-1,3689413,-2.062701377390924
NCI-H929,25102847,2.528780215609897
HuT 78,71729975,0.9717002340056357
SNU-423,104842,0.5354825848611453
Lu-65,24772860,-2.8621529229367417
Kasumi-2,285033,-4.713748931161676
KLE,16722836,1.577901881910007
Becker,crizotinib-PLX-4032 (2-1 mol-mol),1.695188234860732
Becker,selumetinib-UNC0638 (4-1 mol-mol),4.645955748496869
BT 320,46199207,1.7709687668778378
Lu-65,151289,1.2132872341043388
HSC-3,3689413,-2.2600837113951497
SNU-119,4378219,1.466515976267717
SNU-423,11238147,2.877637999183568
HEC-108,2729026,3.096957715125247
SNU-423,9884685,0.0513758273382596
SNU-119,3676137,3.8101807796539298
KMRC-20,11485656,3.1191450490376673
Mono-Mac-1,2742550,3.3470269848726004
MIA PaCa-2,24901704,3.473377038111004
ACC-MESO-1,57519531,4.624518995494161
RKN,44202524,1.6880658914716755
HEC-108,17759555,3.905037779906696
HuT 78,24771867,-2.8492074914531407
ChaGo-K-1,219104,4.142543487513976
RKN,135984461,0.6080422026652917
SF539,erlotinib-PLX-4032 (2-1 mol-mol),2.8421126789574913
BT 328,66577038,3.3966345058951974
BT 248,5284373,1.9481267041892785
OAW28,135411,2.218427323792269
NCI-H1339,16736978,2.50497962887706
ChaGo-K-1,salermide-PLX-4032 (12-1 mol-mol),5.454543144681506
Panc 02.03,25154868,5.464083731960118
SF539,55508,4.727617915120432
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
LXF 289,10410894,3.939992216810496
SF539,54596558,5.2593841125490135
SNU-119,11656518,-1.0487494422596892
LMSU,carboplatin-etoposide (40-17 mol-mol),5.006172673673393
OAW28,5278396,3.588828047742794
CML-T1,135875424,3.5304182343940935
MIA PaCa-2,JQ-1-vorinostat (2-1 mol-mol),1.48518441266489
RERF-LC-MS,3825829,3.876424055067748
BT 498,serdemetan-SCH-529074 (1-1 mol-mol),2.9202400422580745
PF-382,erlotinib-PLX-4032 (2-1 mol-mol),3.234247711308871
Becker,135398516,2.479609320225028
Becker,107985,-2.6804749742466347
AU565,375860,-0.7785666069738753
NCI-H2030,409805,6.26321786552448
BT 498,selumetinib-vorinostat (8-1 mol-mol),4.296908663159793
Panc 02.03,16065773,3.1661848504472023
Kasumi-2,9868037,2.67651294484719
PE/CA-PJ41 (clone D2),65064,6.0820970563721835
ESS-1,6917907,-5.9598430612808455
ACC-MESO-1,navitoclax-MST-312 (1-1 mol-mol),0.9370622659916767
Lu-65,5746,1.255843467205462
Karpas-422,753704,4.670762479174696
Karpas-422,10410894,3.8052707227541194
Lu-65,23725625,4.934264541765965
NCI-H929,44632017,1.43603243468148
KLE,5470400,-2.677220539970202
IST-Mes1,10302451,1.9071808976959603
RKO,9823820,5.913042612438718
Kasumi-2,9927531,4.453654232617923
BT 248,53232,4.253838861384023
AsPC-1,46191454,4.573546152494067
EHEB,36462,-0.01305148556103
MIA PaCa-2,36462,1.2671989611626788
CML-T1,656346,-0.3506831167953311
BT 320,9952709,2.926036005886834
SNU-423,4705,3.684586446624816
Panc 02.03,753704,5.09544361232119
KYSE-450,676352,2.3888034274358536
AsPC-1,702558,5.7476960936684565
Lu-65,135875424,4.016301544047221
OAW28,46907787,2.388022074777516
Namalwa,2842253,3.7074389000842696
PF-382,4259181,-0.6205773881868614
KYSE-450,25227462,-0.8054559419348748
MIA PaCa-2,11364421,-4.9428281339026325
HOP-62,6184667,2.366883795259722
BT 320,SNX-2112-bortezomib (250-1 mol-mol),1.4191259031936097
KYSE-180,15547703,3.316205173217497
LMSU,4378219,1.9748882526366265
RT-4,piperlongumine-MST-312 (1-1 mol-mol),2.794941054913251
ESS-1,4521392,4.16442971067231
PE/CA-PJ41 (clone D2),5335621,4.800366392306084
KMS-12-BM,6610216,3.741234433073347
HOP-62,16720766,1.4150148120607713
AU565,67156097,-2.287523284177128
HOP-62,46215462,2.7155032630368443
PF-382,72376,-3.2964560616169587
NCI-H2030,44507138,3.9074279242795744
RKO,2708,5.0364138660049935
RKN,159324,4.081844329649501
SW1783,3552672,4.975646737829227
SK-MEL-5,selumetinib-PLX-4032 (8-1 mol-mol),2.720334370628281
MJ,1641662,2.6485771241185474
SNU-886,9825149,2.821873129999439
Namalwa,44632017,0.5371915846662842
Karpas-422,219104,2.0781563371385814
LMSU,409805,5.989527903576905
Mono-Mac-1,24180719,2.2518396015404174
SNU-423,156414,1.5595439535021
H-STS,navitoclax-piperlongumine (1-1 mol-mol),0.9655635349297744
SK-UT-1,4477,-0.1518162613562077
RERF-LC-MS,9926054,1.8051014319834384
BT 328,107985,-2.461939045328001
KYSE-180,selumetinib-UNC0638 (4-1 mol-mol),4.875323970784825
LXF 289,6852167,2.2044562779321635
NCI-H1339,selumetinib-vorinostat (8-1 mol-mol),3.4752897958657245
NCI-H1339,24785538,2.8561185149962456
KMS-12-BM,135398738,-0.0456622404629242
NCI-H929,6610355,3.3413826828309983
OAW28,11175137,3.6697867992343607
SW1783,24785538,4.897756498421733
H-STS,54613361,-0.8413528716163291
NCI-H1339,4578,5.067713769422355
PE/CA-PJ41 (clone D2),2733526,4.358750662295764
KMS-12-BM,208908,1.7484542711618651
OAW28,9926054,1.976123345191561
HOP-62,54454,2.939267875512383
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
SNU-119,54143018,0.8882121695154049
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
SNU-886,24785538,0.7681311411213433
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
MJ,9444,4.239360752969744
KMRC-20,44241473,4.734926633770504
NCI-H929,5284329,5.087247954769154
SNU-213,72193861,4.636092164190722
HEC-108,159324,3.617209831238773
LMSU,10074640,3.239182097688426
RERF-LC-MS,5311281,3.366561586065275
AU565,54613361,-1.6068695222158444
OAW28,208908,1.9779710002494069
NCI-H2030,135999136,3.784787341236107
SF539,alisertib-navitoclax (2-1 mol-mol),-0.0974409144974691
Ri-1,46398810,1.4854612845408548
Namalwa,10410894,2.360659903782703
KMS-12-BM,10113978,1.9839556331980863
SK-MEL-5,selumetinib-piperlongumine (8-1 mol-mol),3.4239328434426546
H-STS,66577038,3.1923549200255796
MIA PaCa-2,9926054,1.823118001934022
Ri-1,6610355,3.840292325756221
H-STS,107970,1.855553720240211
Panc 02.03,6505803,-1.93196111296706
ESS-1,44566777,0.5104790978676739
KYSE-180,9866186,0.5701832390810861
ACC-MESO-1,53232,2.123309987866441
Mono-Mac-1,JQ-1-navitoclax (2-1 mol-mol),-1.3007467584542969
HuT 78,9935249,1.327110293574704
ACC-MESO-1,168312962,-2.250253484188745
BT 328,637858,2.786285777963434
BT 498,selumetinib-PLX-4032 (8-1 mol-mol),5.785043307214588
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625
AU565,5287969,-1.6574542255158256
KLE,selumetinib-decitabine (4-1 mol-mol),3.7726080772360784
AU565,11485656,2.0156354686346174
ESS-1,46398810,3.012711144030241
Karpas-422,56649450,2.989450445379875
Mono-Mac-1,702558,6.913431597800472
SNU-423,135398516,1.3477258713042957
KMS-12-BM,25195348,1.3906161221402649
OAW28,25183872,-1.003855010480259
SF539,568763,-0.1587178935899355
EHEB,44607531,1.253327134816266
NCI-H1339,2708,5.014409852934372
SNU-886,24753719,3.844666745133929
NOMO-1,44493952,3.580250185381126
Becker,6918328,0.7436877244681701
BT 286,25126798,4.985091475140932
LMSU,387447,-4.878284727647071
BT 498,11175137,3.589277332996231
ChaGo-K-1,24775005,3.8919444347065344
AsPC-1,23725625,6.32859301599116
KMS-12-BM,56946209,-5.052101721159677
NCI-H196,9911463,4.433350594042992
LMSU,322968,4.855851656802344
AsPC-1,44137675,4.002233175780649
HuT 78,5287969,-1.62674651410725
CML-T1,984333,-1.4387494949343358
OAW28,25262965,-0.9519808245592094
HCC2108,5278396,3.8392308280377425
Mono-Mac-1,55283,2.711605788635057
SK-MEL-5,24951314,1.4790209915709416
SK-UT-1,241158,3.8222099850046054
CML-T1,5978,-4.3443825686600785
MIA PaCa-2,613753,3.093440383606966
AsPC-1,462382,1.1756614609859282
BT 248,19582717,6.9976074882401464
HEC-108,104842,-0.6030222866662514
Kasumi-2,219104,1.7742372806275355
KLE,49836020,-2.0520357560351714
NCI-H1339,selumetinib-MK-2206 (8-1 mol-mol),2.766531591740839
CML-T1,9956119,2.073633266475815
SF539,9826308,-0.4997268921639499
HCC2108,5280436,4.355594613728095
SW1783,24180719,4.7795575092347535
Ri-1,452548,-3.2717135557473376
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108
SNU-423,5311,1.94726746362996
KLE,JQ-1-navitoclax (2-1 mol-mol),-1.1752020177182094
SK-UT-1,9840324,5.285920653944741
SK-MEL-5,54649381,4.626873834001773
HuT 78,4788,5.194344825774489
LXF 289,5281321,-2.4870532876216487
NCI-H929,selumetinib-decitabine (4-1 mol-mol),2.969724213776984
RKN,5311,1.8833679583763572
KMRC-20,3634881,4.3387746647694545
SK-MEL-5,65064,5.630976284944332
SNU-213,navitoclax-piperlongumine (1-1 mol-mol),2.8810672171216085
HEC-108,5282054,4.01625624429958
SK-UT-1,11404337,0.3155392200884543
H-STS,24964624,0.7611885125245664
BFTC-909,375860,-1.1901103647211757
RT-4,25262965,-0.987005470802566
NOMO-1,6610216,4.0700997553747325
SNU-886,6610216,4.570931249301276
SW1783,10322450,4.230470764848986
PE/CA-PJ41 (clone D2),148198,-3.3597343554635652
AsPC-1,57519531,4.317220146110072
SNU-423,46398810,2.9075797324730135
HEC-108,3025944,5.148490920496766
CML-T1,16115403,-5.689263243746957
KYSE-450,docetaxel-tanespimycin (2-1 mol-mol),-3.366078664284114
CML-T1,54619267,3.062776009775362
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
PF-382,16725315,0.8059260614794377
PE/CA-PJ41 (clone D2),123631,3.305692644541571
SNU-119,9825149,2.245076319827961
OAW28,68056272,3.642995313586114
HOP-62,4096211,2.550558881488983
HSC-3,969516,2.431912353028137
ESS-1,135999136,4.050088319286221
BT 286,23725625,3.3137349163221415
BT 498,122327,5.198903507544806
KYSE-450,66577038,3.5261008260070232
BT 248,8515,3.628450909279232
Karpas-422,73707438,3.942643719433516
NCI-H196,2874250,-0.7115511680043887
BT 286,444795,5.07961620697437
Kasumi-2,navitoclax-sorafenib (1-1 mol-mol),-1.696804912117395
Kasumi-2,5738263,2.363328574896373
EHEB,6918289,-4.286720857258569
Mono-Mac-1,docetaxel-tanespimycin (2-1 mol-mol),-7.241912251281891
ESS-1,carboplatin-UNC0638 (2-1 mol-mol),3.6411517750033986
HOP-62,navitoclax-PLX-4032 (1-1 mol-mol),2.7748975941487273
NCI-H2030,16115403,-5.109862467449794
SNU-213,3062316,0.5853814592942461
AsPC-1,107985,-4.227741895863185
SNU-119,10074640,2.593103189576663
Mono-Mac-1,46224516,3.2819327915906005
Kasumi-2,6918328,-2.1918789082401355
HCC2108,44259,2.0867454916119077
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
ChaGo-K-1,46215462,1.7039822163377707
AU565,148124,-5.63717967948206
SF539,11238147,1.3297186459142216
Becker,24797083,1.1548920477152247
LMSU,1566236,2.090789851327695
LMSU,11507802,1.3946784970655006
SF539,81146,6.283283936863958
SF539,16720766,-0.1257805364307158
BT 328,25126798,5.564385085332987
KMS-12-BM,445643,2.943383383902934
HOP-62,16219061,3.3311422412461185
BT 498,5282054,4.48015487257215
RKN,49793307,-1.2643121180608
Mono-Mac-1,navitoclax-piperlongumine (1-1 mol-mol),0.8484355222187875
KYSE-180,10302451,1.5519577455009292
BFTC-909,400769,-0.3884900564724624
KMS-12-BM,400769,-2.0250605176070864
SNU-886,135875424,2.126718157354228
H-STS,crizotinib-PLX-4032 (2-1 mol-mol),1.0847078558510623
Kasumi-2,selumetinib-UNC0638 (4-1 mol-mol),3.1045685976717623
SNU-423,445643,4.312080284928333
MIA PaCa-2,11977753,-1.247147741906793
RERF-LC-MS,44607531,1.5104561529736475
AU565,9908783,4.7252597511686965
ESS-1,vorinostat-navitoclax (4-1 mol-mol),0.8107114414663552
HOP-62,135659046,3.835086594204883
HCC2108,107970,2.525568270617478
Ri-1,568763,-1.1108517100164117
Karpas-422,selumetinib-PLX-4032 (8-1 mol-mol),5.101056087927793
CML-T1,5351362,1.0869507822739353
BT 498,46398810,2.841976962151931
ACC-MESO-1,5280436,3.655257878531662
Ri-1,50905018,4.0972663844416255
SF539,selumetinib-BRD-A02303741 (4-1 mol-mol),4.342387271248252
HSC-3,2858523,3.403454274190548
SF539,3552672,1.9155568088960504
HuT 78,2742550,1.9478816710996465
KYSE-180,3038522,3.921557797457244
AU565,72376,-1.9935205494525805
NCI-H929,3038522,2.7996723936558943
SNU-119,5282054,3.91901589659366
SNU-886,9884685,0.7167053677402274
ACC-MESO-1,1641662,4.244033376768605
ChaGo-K-1,46398810,3.134133884392003
KYSE-180,60700,1.3499298515602995
RKO,6450551,2.9764230599456782
SK-MEL-5,6914657,-2.0624544709944113
KLE,676352,1.979256710786136
Ri-1,3634881,2.329895582823285
BT 248,71729975,1.811306833980593
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
SNU-119,439501,-2.3303537311085143
Becker,44137675,2.3212832651934043
RKO,11612883,3.106052261550285
Kasumi-2,3025986,-2.1480582997040325
Kasumi-2,10113978,2.7713645825563153
PE/CA-PJ41 (clone D2),navitoclax-birinapant (1-1 mol-mol),3.23386712784497
Namalwa,119182,-4.266706274657806
NOMO-1,227681,3.177880686522457
KLE,10127622,3.079839364113069
RT-4,969516,2.145135966433337
MIA PaCa-2,11152667,-2.2461765608848663
Karpas-422,107970,2.1264000948746555
KMRC-20,44486219,5.7591116026780815
H-STS,89928392,0.800005419398714
PE/CA-PJ41 (clone D2),1750826,2.319325081181221
ChaGo-K-1,vorinostat-carboplatin (1-1 mol-mol),3.971958802147907
PF-382,374536,2.6185584915406137
RERF-LC-MS,219104,4.628133490361187
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
ChaGo-K-1,25150857,2.9122993230235377
SNU-119,51039095,2.8116554470827086
NCI-H196,docetaxel-tanespimycin (2-1 mol-mol),-4.384424728938734
RT-4,15547703,3.010002143922484
KYSE-450,17755052,4.184551596541284
OAW28,446155,3.9986810531407486
ACC-MESO-1,44819697,-1.5954499982774353
Lu-65,702558,5.6246593295299
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
BFTC-909,54618771,2.8225313881877545
ESS-1,selumetinib-UNC0638 (4-1 mol-mol),4.619112844343245
KYSE-450,25150857,3.125664809349332
BFTC-909,66577038,2.856590203747272
BT 498,46191454,3.027040351794544
SNU-423,44819697,-0.9263578160695418
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
LXF 289,44486219,3.8558224358877298
HCC2108,107985,-3.038738614535184
Karpas-422,15547703,2.8004410697454687
NOMO-1,56649450,3.0749194455734012
NOMO-1,25150857,2.063048355345986
RKN,5460769,5.79272629497122
ESS-1,36462,-0.1255368808432747
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
OAW28,656346,0.8948255988542453
HCC2108,24951314,2.6304731468995457
Mono-Mac-1,serdemetan-SCH-529074 (1-1 mol-mol),1.0195185640061482
HOP-62,9911830,2.7524936884021223
HSC-3,6505803,-2.979370598270903
ESS-1,67156097,-1.3750835854420782
ACC-MESO-1,71304818,1.697730113527269
BFTC-909,445091,4.3207806819680625
KMS-12-BM,969516,2.2529798908048244
BT 498,11455910,2.7063920015971084
NCI-H196,11455910,1.326317749713535
BFTC-909,5746,0.5111824642409613
HOP-62,6914657,-3.9101561019120807
RERF-LC-MS,16725315,4.583339442818838
SNU-213,3689413,0.5464532854962126
Namalwa,navitoclax-gemcitabine (1-1 mol-mol),-4.909512690079978
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
PF-382,6438330,0.2212428462176163
NCI-H929,46907787,-2.2229329095691495
SF539,5291,3.503530356529322
AsPC-1,2749,1.937127114514975
AsPC-1,6918638,0.7071735542476161
EHEB,5278396,3.4775281227216936
AsPC-1,49766530,-1.5554439905221051
PF-382,11364421,-5.01539048557423
PE/CA-PJ41 (clone D2),1641662,5.7786463138338595
KYSE-450,135421197,2.3081928088852774
ChaGo-K-1,JQ-1-MK-0752 (1-1 mol-mol),1.6532654417593031
SNU-213,46199207,3.777420200975711
Kasumi-2,168313200,3.5619242662151342
SNU-886,selumetinib-PLX-4032 (8-1 mol-mol),2.129242673373235
RERF-LC-MS,10296883,4.230661493555322
ESS-1,46215462,2.1404151141829986
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
WM793,11640390,4.32157052643877
ChaGo-K-1,3825829,4.445461759620719
SNU-213,4259181,0.9824949084518934
Kasumi-2,448949,-0.5395388127141975
Panc 02.03,11964036,1.263021853424522
KYSE-180,168312962,3.1351492164159045
SNU-423,25227462,1.2332861285602368
KMRC-20,3815108,3.353399483495532
RERF-LC-MS,387447,-4.351660250848144
HOP-62,10127622,3.013635555271906
KYSE-450,148124,3.78473118264584
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136
EHEB,3385,0.9451951233490862
HEC-108,11626560,2.4526082617686793
SNU-213,44137675,2.701983719716649
BFTC-909,2841722,4.3094465275997536
AsPC-1,11175137,3.2351214827225956
KLE,72193861,1.934481049124771
LMSU,216468,4.5440038894644115
LXF 289,16065773,1.584092119185821
MIA PaCa-2,9903786,3.251255785633491
H-STS,148198,-3.664450029895992
MIA PaCa-2,16038120,0.1859845686132181
Becker,9907093,5.038379174054834
PF-382,9967941,3.320272765089539
ACC-MESO-1,9911463,4.148709224081578
MIA PaCa-2,56649450,3.735395641127426
Becker,24772860,-1.986740443990647
SK-UT-1,2708,5.491455066314142
Kasumi-2,11427553,1.2029720763459597
HOP-62,52947716,2.688391451350114
Karpas-422,4096211,1.5644137887158134
EHEB,JQ-1-MK-0752 (1-1 mol-mol),0.5958653616888636
NCI-H929,15983966,1.8742462336946937
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
NCI-H1339,126941,-5.139235423752655
Karpas-422,1566236,1.018431355816045
SNU-119,5287620,-2.0634192053301623
ACC-MESO-1,31703,0.0673520740882152
BFTC-909,54618164,4.281231487810877
ESS-1,613753,3.280704528327703
KYSE-450,24753719,4.912608563377894
LMSU,72376,0.2338050828767356
KMRC-20,9936388,1.9781775187030703
PF-382,5278396,3.0663374884499266
H-STS,11485656,0.1079902200809361
LMSU,216239,2.7784961545541216
ESS-1,54618164,4.192374601121606
NCI-H2030,3025986,-0.2193329556503326
H-STS,3503,1.3838886795992438
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
LXF 289,36314,1.2391029615263165
SK-UT-1,262093,2.998836933826174
HCC2108,4259181,0.1536721114746798
Kasumi-2,227681,1.7835466743963533
CML-T1,409805,3.5817002644537683
SNU-213,51037431,4.174424071961102
EHEB,65064,3.0143976665527368
KYSE-450,53325874,4.377584660975113
KMRC-20,49850262,4.568150133018385
HSC-3,9956119,3.902686667761622
SF539,5287969,-1.7419223666366572
OAW28,46926350,-3.936437112233884
EHEB,44491742,5.293750317448726
Panc 02.03,19582717,5.117031119305748
MIA PaCa-2,4788,5.933145310837657
Lu-65,16038120,0.5019241155175782
AU565,135411,0.1136824900578053
Becker,4578,4.452563048211831
SF539,11152667,-2.173581814614824
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
RKN,135875424,3.6230459419726526
ChaGo-K-1,11657048,4.982961492034328
SK-UT-1,439501,-2.663904937582399
NCI-H196,72376,-0.477527805208171
Lu-65,445091,3.92858193162068
MIA PaCa-2,71466380,4.134783838185487
PE/CA-PJ41 (clone D2),5282054,4.186584535772045
LMSU,11964036,2.78018409031856
BT 286,49766530,0.4498348011542866
SNU-423,216345,4.297446622363854
OAW28,10302451,2.68651474445359
RERF-LC-MS,11964036,1.6707185338079893
RKO,25062766,2.7314931301361476
KLE,5291,4.081072995426117
BT 320,11404337,0.6966185269279856
PE/CA-PJ41 (clone D2),3025944,5.40545678004527
RKN,4788,5.902938799554125
KLE,11427553,3.3715856930539316
ChaGo-K-1,4378219,2.361959907819356
PF-382,107985,-3.9923551873687497
Mono-Mac-1,135398516,1.6736296018854304
ChaGo-K-1,637858,1.5063352286209188
Karpas-422,3689413,0.6826110279753447
RERF-LC-MS,2746,3.2731211053052647
KYSE-180,2113511,7.401895265754639
BT 248,9927531,4.7076279917818225
SNU-423,9866186,1.8570452912107576
NOMO-1,46907787,-1.215006340822028
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
OAW28,52912189,1.8010258653688298
PF-382,2858523,2.2172889178765733
WM793,68056272,3.787649254718563
HCC2108,9926054,2.5765466804926445
IST-Mes1,45279963,3.842534876522704
RT-4,66577038,3.0506588017384635
SNU-423,selumetinib-PLX-4032 (8-1 mol-mol),4.134751066727683
MJ,53495165,-2.457565715339927
PE/CA-PJ41 (clone D2),16736978,2.372818675587023
HCC2108,31703,-0.3826417360031045
LMSU,44137675,3.873281140485592
KMRC-20,31703,0.9785031203773554
SK-MEL-5,51039095,2.8198767912934617
AU565,9952709,2.716124716701941
NCI-H929,60750,-4.1339317564443965
PE/CA-PJ41 (clone D2),6438330,3.358991898439142
Mono-Mac-1,66577038,3.474147051168979
NCI-H929,72376,-2.0403577805803637
OAW28,11364421,1.0555351676055402
SK-MEL-5,56946209,-3.269494146912073
LXF 289,11152667,-0.4789950074309144
WM793,3038522,3.898471306442064
HuT 78,4096211,1.1112538350998973
Karpas-422,JQ-1-MK-0752 (1-1 mol-mol),-0.5305291148680019
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
Ri-1,1750826,-4.869262928717968
AsPC-1,448949,1.7535133746232512
KMS-12-BM,vorinostat-carboplatin (1-1 mol-mol),0.7008192168713556
AsPC-1,16038120,0.5677006157285766
MIA PaCa-2,25154868,4.812022238902172
ChaGo-K-1,9926054,1.8139091606673228
HuT 78,5284616,0.3056845634963596
SK-MEL-5,44507138,3.312693142083379
KYSE-180,24964624,3.1608590023354712
HOP-62,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7687331733710137
SK-MEL-5,11152667,1.6641946386501631
NCI-H196,36314,-2.9149684646195624
SNU-213,6918328,0.0948868684210311
SK-MEL-5,6918289,3.341650767010156
KMS-12-BM,9956119,2.7211618813495257
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
SF539,11317348,2.653231871522483
SW1783,9936388,2.9056540363277796
RERF-LC-MS,6610216,4.063402980130349
BT 286,2729026,1.1931369747850211
Karpas-422,241158,2.526232566496073
PE/CA-PJ41 (clone D2),erlotinib-PLX-4032 (2-1 mol-mol),2.956437823485526
HEC-108,44819697,-1.05954599286061
PE/CA-PJ41 (clone D2),53481919,4.4896734978648505
SK-MEL-5,23635314,-1.8855584102441283
ChaGo-K-1,3384730,3.6213619982801895
KYSE-450,44819697,-0.2732564479087796
KMS-12-BM,56649450,0.982928705692675
Mono-Mac-1,salermide-PLX-4032 (12-1 mol-mol),4.403514285485615
NCI-H2030,969516,2.9415471646637186
MIA PaCa-2,421610,1.6474550079189487
H-STS,15983966,-4.061111130827075
HuT 78,16725315,3.3290051312719284
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
HSC-3,5280436,3.640312984510688
PE/CA-PJ41 (clone D2),5280436,2.0981550433518947
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
CML-T1,208908,1.88775844056814
SK-MEL-5,24856436,1.066299696532792
Namalwa,JQ-1-navitoclax (2-1 mol-mol),-0.9649533324047836
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
CML-T1,56963564,-0.6939066710243597
CML-T1,11497983,1.5281324652658594
KYSE-180,73707398,1.6922150122396675
BT 320,11364421,3.2966905188906717
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433
SNU-886,135928012,0.9415972865486992
BT 286,208908,2.223006881461146
Lu-65,JQ-1-navitoclax (2-1 mol-mol),1.6809303944234784
SK-UT-1,168312962,-2.178754145996638
HuT 78,23725625,5.900572836007656
ESS-1,5479543,3.502329300494909
Lu-65,2749,1.4261505855725336
PE/CA-PJ41 (clone D2),25150857,3.0802622094811176
KYSE-180,71304818,2.610394222514715
KMS-12-BM,salermide-PLX-4032 (12-1 mol-mol),4.711885987308765
SNU-886,44137675,2.6120412235311856
ESS-1,3552672,1.6370770083868251
Ri-1,5280436,1.738295922392693
Mono-Mac-1,7326481,2.5894382859741625
SK-UT-1,ISOX-bortezomib (250-1 mol-mol),0.217311614583509
Panc 02.03,46398810,3.420081587494409
BT 328,409805,5.840944403536212
BT 320,89928392,3.842726131224359
Kasumi-2,3385,2.4314400955221576
AsPC-1,24797083,1.5655308519339004
Kasumi-2,9935249,-0.6704419087402653
PE/CA-PJ41 (clone D2),6610355,5.506554656769886
LMSU,25154868,5.828737682964474
RERF-LC-MS,54619267,3.9836959677109354
ESS-1,5284616,3.0410604134986405
Panc 02.03,44185566,3.1312758482446976
LXF 289,3854666,2.0847029854583377
AsPC-1,65064,5.237570806440869
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991
PF-382,375860,-0.9454794315487792
PF-382,15983966,-4.881243933970009
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
BFTC-909,89928392,2.1120581393996116
Lu-65,selumetinib-MK-2206 (8-1 mol-mol),0.5653370026157463
BT 248,24779724,5.957496049021181
KLE,136227924,3.154327848580928
NCI-H209,52912189,1.270838689300851
Lu-65,crizotinib-PLX-4032 (2-1 mol-mol),1.337779445328492
ESS-1,9907093,4.140542010053599
KMS-12-BM,219104,2.1179947044049396
SK-MEL-5,11238147,2.4714738225484947
Becker,navitoclax-pluripotin (1-1 mol-mol),0.2111715680577011
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278
HSC-3,3503,2.2677536339528044
ChaGo-K-1,12003241,1.029111103028103
RERF-LC-MS,11178236,-5.98494163410248
SNU-423,66577038,3.060627668659738
HEC-108,2841722,7.354178437919021
PE/CA-PJ41 (clone D2),89928392,3.005689968748253
KMS-12-BM,36462,-0.0282673998252453
NCI-H1339,148198,-2.9438729710882963
WM793,24856436,4.423556463104999
KMS-12-BM,4096211,0.0697159534999253
RERF-LC-MS,53232,1.207294902086358
OAW28,123631,1.649178742735097
AsPC-1,24180719,3.701309063973522
BT 498,4378219,1.6877979414326845
ChaGo-K-1,148124,-2.510637409875074
NCI-H196,9866186,2.281672090063059
IST-Mes1,11507802,2.196367921071978
BT 286,119182,-1.2057998884515009
AsPC-1,9956119,2.16125044927063
MIA PaCa-2,4477,0.266407248170907
SK-UT-1,44566777,0.4643066266972094
WM793,6918837,-0.893478746769829
KMS-12-BM,72193861,-0.3059555505997974
HOP-62,10296883,4.184861943544038
AU565,9887053,5.902090445564702
BFTC-909,11612883,3.5324782187628827
KLE,4788,5.329574441575628
HuT 78,52912189,-0.7415735278682234
RKO,216468,3.08027711257304
HOP-62,4477,0.4859776870229825
SNU-119,5278396,2.5454097325647904
NCI-H1339,44137675,3.1401606981690646
H-STS,26596,-2.569417697964928
LMSU,119607,5.586825661807856
BT 286,73707438,3.831264447880484
BT 248,135398516,2.090653291947233
ChaGo-K-1,444795,4.90712509154543
BFTC-909,6918736,-1.9066217610366931
BT 286,carboplatin-UNC0638 (2-1 mol-mol),2.636766097165947
AU565,46215462,1.837951563203271
NOMO-1,151289,1.0922355572005962
HuT 78,3038522,2.0525522612169813
Mono-Mac-1,71680916,6.133858126249924
SK-MEL-5,72193861,2.262524849088693
BT 248,10184653,1.5665149744328004
KYSE-450,erlotinib-PLX-4032 (2-1 mol-mol),3.596980184500655
BT 320,56963564,5.490825870792066
SNU-119,50905018,4.442332120900816
AsPC-1,6450551,4.162604073037061
Karpas-422,docetaxel-tanespimycin (2-1 mol-mol),-5.263561049867699
Kasumi-2,46199207,3.5720995907025803
Ri-1,11175137,1.4705980177352482
MIA PaCa-2,2874250,4.325876303213778
PE/CA-PJ41 (clone D2),carboplatin-etoposide (40-17 mol-mol),3.538007302832437
Namalwa,31703,-3.2423376321614996
Lu-65,984333,-0.592717922586905
Lu-65,241158,4.2277525357675705
HEC-108,400769,-0.3836243025224323
SK-MEL-5,135411,0.7753321282520284
OAW28,24785538,1.1869022382798196
MIA PaCa-2,25161177,3.85496737061916
SNU-886,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1159003486040796
PE/CA-PJ41 (clone D2),10296883,4.236451814997899
NCI-H2030,54619238,5.583163368588451
KYSE-450,9911463,4.540289012412596
HuT 78,4705,4.420154035532244
MIA PaCa-2,4096211,1.982360073504129
BT 320,9887053,4.397401387197895
KMS-12-BM,119607,3.6226525677646313
HuT 78,44589607,1.1336903613451157
KLE,327653,1.7943752773136603
SNU-886,26596,-1.4881272997493236
MIA PaCa-2,12001922,1.5564360891917508
KYSE-450,3825829,4.738351974491715
RKO,25105715,3.388469834531371
KLE,salermide-PLX-4032 (12-1 mol-mol),5.565306669496566
BT 248,54618771,0.8718785044821341
ESS-1,2733526,5.879363294342396
Lu-65,11214940,4.598307339532426
RT-4,10127622,3.667218475131435
HEC-108,2874250,5.591629636654944
Mono-Mac-1,piperlongumine-MST-312 (1-1 mol-mol),1.1779929114188603
SF539,46943432,2.0271543904998746
H-STS,6252,1.236462961602802
Karpas-422,crizotinib-PLX-4032 (2-1 mol-mol),0.9999200358144872
LMSU,5566,3.0603699915448015
LMSU,984333,0.4760983232851017
ChaGo-K-1,3634881,3.518956616921623
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
BT 328,448949,2.700509720099411
HEC-108,4259181,0.4931043474853455
KMS-12-BM,42611257,2.4160280183147913
MIA PaCa-2,19582717,4.60477521845353
NCI-H929,52947716,-4.644393709847638
Namalwa,66577038,3.005730564471273
KYSE-180,446155,1.8141725427218347
AsPC-1,216345,4.477392842458871
BFTC-909,9825149,2.463033939289578
BFTC-909,11609586,2.9417391320909134
HSC-3,23725625,4.627515506200981
NCI-H196,2708,6.724723846319038
Mono-Mac-1,2842253,3.804079975263365
PF-382,11626560,-0.1561430168366412
HEC-108,6917907,-4.71711933146506
WM793,44589607,3.080108180448729
ChaGo-K-1,5281321,-1.8819785009117511
NCI-H929,selumetinib-piperlongumine (8-1 mol-mol),2.46209131947828
BT 498,25183872,0.1229262427220635
PE/CA-PJ41 (clone D2),53232,2.816121278001021
MIA PaCa-2,54613361,0.4679102497568742
SK-MEL-5,selumetinib-navitoclax (8-1 mol-mol),3.0996146071399093
LMSU,4521392,4.5371268680912715
H-STS,11625818,2.7941108082935755
SNU-886,3634881,3.0881138995018107
NCI-H2030,216345,4.536107937609808
HSC-3,2828334,6.4248099303253605
BT 498,439501,-2.816531814980934
Mono-Mac-1,327653,2.35680812589116
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
OAW28,25154868,4.5321266568460805
HuT 78,6918837,-5.480154932078149
KYSE-180,20959075,-3.178555830663627
SNU-213,6623618,2.3332354524548835
PF-382,439501,-2.5741395884768377
RKN,25262965,-0.5506090189051945
Ri-1,4917,2.03951216141433
HSC-3,135421197,2.8710443540281756
OAW28,23582824,0.6142488529896691
Ri-1,446155,3.1357563975714036
SK-MEL-5,452548,1.4563398029709325
BT 286,25154868,4.894925288023734
Kasumi-2,piperlongumine-MST-312 (1-1 mol-mol),0.99360798269259
OAW28,11497983,4.916879328733168
PF-382,24785538,-0.3675574083063133
NCI-H929,15953870,2.0316293430847594
KLE,9956119,2.1756146990139893
HSC-3,9825149,2.288348548385444
KYSE-180,SNX-2112-bortezomib (250-1 mol-mol),-2.01002465261766
CML-T1,44543605,3.785822858271075
RT-4,carboplatin-etoposide (40-17 mol-mol),3.317167056326169
ChaGo-K-1,54678924,2.2307192214046903
LMSU,11364421,1.7536295583512325
KYSE-450,72967,3.7351940397417023
SNU-213,9911830,2.5887674571936827
BT 286,9927531,5.383522650777723
Kasumi-2,25062766,0.6905738640208902
AU565,11317348,4.006750700524709
ESS-1,3025986,-1.587368137911761
HSC-3,16736978,3.722635885718807
MIA PaCa-2,5328940,1.3715341713371223
SF539,25154868,4.846757922777188
Mono-Mac-1,5335621,4.625887085201477
NCI-H1339,serdemetan-SCH-529074 (1-1 mol-mol),2.9330051590353583
Namalwa,24753719,3.8228113675826063
ChaGo-K-1,9823820,4.154977738904327
MJ,JQ-1-navitoclax (2-1 mol-mol),0.5482971466923605
BT 328,3025986,-0.1303666559009026
SNU-119,BRD-K27188169-navitoclax (2-1 mol-mol),3.038273734124671
SNU-119,16720766,2.4248018282214283
NOMO-1,54143018,-1.1216489579847602
RKN,6438330,1.1013294242613172
BT 498,9927531,5.612738328284819
KLE,2733526,3.099087274855166
SNU-423,31703,0.0890706535618343
SNU-119,1750826,-5.069173879827324
KYSE-180,5311,1.7867284684655886
BT 286,4261,6.4796291982462675
RKN,72193861,2.3331130274465313
IST-Mes1,11178236,-2.2337214332221023
BT 498,16065773,3.101291116370222
Ri-1,9868037,1.6681879870423917
HuT 78,23635314,-3.2203205513382023
HOP-62,44589607,4.744731792767849
RKO,176870,5.862868084879783
SNU-423,25105715,3.517866626039398
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
HuT 78,54618771,-0.2261201753145263
Mono-Mac-1,1566236,1.6378087380099338
H-STS,doxorubicin-navitoclax (2-1 mol-mol),-4.029519086979923
NCI-H209,568763,-1.9106467846038149
NOMO-1,44137675,1.7607667559168472
MIA PaCa-2,49766530,-2.3545367349028097
RKN,65628,4.337575078598336
Karpas-422,11964036,-0.5881564027256297
SF539,375860,-0.4378698388059482
WM793,25262965,-0.5623706777584844
LXF 289,46907787,-0.1426698074457199
RT-4,9936388,-6.517969541343547
OAW28,4917,3.0899334279272046
SK-UT-1,219104,4.058043606422707
Ri-1,54678924,1.162364883135177
SW1783,44543605,3.70035976615173
RKO,3815108,2.4813915623878264
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
ESS-1,5460769,-0.3251379363550979
KMS-12-BM,9840324,5.159975426829893
MIA PaCa-2,126941,-4.274207418052814
PF-382,73707440,6.113676619987129
OAW28,46398810,2.3633613380182386
MIA PaCa-2,46191454,1.026049198507862
WM793,107970,2.3599025930331368
EHEB,54613361,-0.7006236829490292
BT 328,9926054,3.720062864226824
SF539,46215462,1.5811922555633615
EHEB,10410894,2.894743254709859
NCI-H929,66577038,3.051859645281257
KLE,1750826,-1.5621795259056923
BT 248,702558,5.9883095131036495
Mono-Mac-1,168312962,1.743961844717124
H-STS,374536,1.4789763498998243
IST-Mes1,carboplatin-UNC0638 (2-1 mol-mol),3.3529895985097675
ESS-1,navitoclax-gemcitabine (1-1 mol-mol),-3.147832073684123
RERF-LC-MS,15547703,2.8085711207925015
SK-UT-1,5311,2.5232548896464824
IST-Mes1,53392493,1.914417087858707
OAW28,219104,3.640461878438656
SK-MEL-5,3825829,3.883151083406129
LMSU,11717001,4.418665943257039
SNU-213,46398810,2.362902483781062
KMS-12-BM,441298,3.3874000284739028
ESS-1,11955716,-2.238673877316504
OAW28,24821094,3.6183900250040497
KYSE-450,31703,1.0169298465386034
AsPC-1,36462,3.6552458214160506
HOP-62,9868037,3.695700187533532
SK-UT-1,60750,-4.1322168678971956
OAW28,3081361,1.8855664708831448
RKN,262093,2.5285063130840344
IST-Mes1,navitoclax-gemcitabine (1-1 mol-mol),-2.5828122357465144
HSC-3,262093,2.860040873457059
BT 286,JQ-1-navitoclax (2-1 mol-mol),1.691250716820441
HuT 78,9884685,0.1724524998439705
RERF-LC-MS,44462760,4.251912039026111
ChaGo-K-1,135659046,3.4410165185967743
AU565,24772860,3.3222909323637455
Becker,44493528,4.387044567791122
WM793,24797083,1.5845720068425453
SK-UT-1,3062316,3.08976408403466
HuT 78,54618164,4.24138057284203
OAW28,969516,2.7253654251657573
NCI-H1339,11178236,-2.640399828152474
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
HuT 78,16659841,-0.357838633597325
ChaGo-K-1,9911463,3.7968497419655094
Kasumi-2,24964624,-0.4292953548999766
PF-382,9868037,2.2881920680680756
BT 320,644241,3.936570500455286
KYSE-180,702558,5.1302684030030905
Kasumi-2,12001922,1.274437651383908
NCI-H196,5746,2.0463177301204616
KMS-12-BM,44493952,5.238647579582932
SNU-886,3676137,3.017985964934311
PF-382,3025944,3.98071208263538
SK-MEL-5,20959075,-1.933058848264935
Panc 02.03,11178236,-2.8028080099743624
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
H-STS,46191454,1.9033796822973523
HEC-108,54613361,0.1609074083651108
LXF 289,54618771,-0.5375230222620658
ACC-MESO-1,54454,2.2105554463598924
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
BT 286,54618164,4.321497968648174
KYSE-450,702558,5.8139297537708
SNU-423,16038120,1.4003538126035056
BT 248,25195348,5.391578709053811
RKN,16725315,3.256745916563384
SNU-213,72376,-0.8991790133219716
CML-T1,11964036,0.6626338262041811
Karpas-422,tretinoin-navitoclax (4-1 mol-mol),2.3839667409839063
BT 248,3543504,4.235039119755324
EHEB,6252,0.1933342673652495
Becker,selumetinib-BRD-A02303741 (4-1 mol-mol),6.881234663908775
SNU-423,568763,0.9972810479944874
BT 286,2126,4.4745148481835235
LMSU,5278396,3.836734271411514
SW1783,51039095,4.654055453172231
Namalwa,24951314,0.4623180672040747
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863
HuT 78,36462,0.7819646320410331
MIA PaCa-2,76446078,4.284259753564461
KYSE-180,66577038,3.3144658202336945
Namalwa,23725625,3.168532097227349
RERF-LC-MS,5351362,3.2669953777859493
ESS-1,5351362,1.0632420043003554
BT 286,135421197,2.331823163871174
AsPC-1,462382,1.1756614609859282
SNU-119,11640390,2.9384325633103026
SK-MEL-5,71466578,3.722137827995549
RKO,216345,4.0768365061219525
HOP-62,107985,-3.8044998203346383
HSC-3,alisertib-navitoclax (2-1 mol-mol),0.6022178387515709
BT 286,9911463,3.0735360087935364
H-STS,5282054,2.573359833272533
KMS-12-BM,10296883,2.976049270226853
RKO,9956119,3.3077949428120195
BT 328,44819697,-1.602072753607262
HSC-3,216345,4.289127923460728
HSC-3,6610355,4.654791000572877
NCI-H1339,44566777,1.0860363171374443
EHEB,25126798,3.800307973895597
NCI-H1339,vorinostat-navitoclax (4-1 mol-mol),1.6362880651435705
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
KYSE-180,selumetinib-navitoclax (8-1 mol-mol),5.444648861161274
Lu-65,2113511,5.91913102712555
OAW28,675434,4.444033298399729
Ri-1,5738263,2.2065663042204844
SK-MEL-5,46199207,3.4414275272252137
PE/CA-PJ41 (clone D2),11364421,2.0982795896653834
Lu-65,44185566,3.028319442619555
AsPC-1,123631,3.3144447888973048
NCI-H1339,24797083,1.4150886054909655
BT 248,400769,-0.0166923245796401
RT-4,6450551,2.2362160436961314
NCI-H1339,1716436,3.037375145615222
HSC-3,104842,-3.919620834903339
BFTC-909,126941,-2.0975077483758415
MIA PaCa-2,216345,3.471588700144882
NOMO-1,135875424,3.068632733482165
SNU-886,selumetinib-tretinoin (2-1 mol-mol),2.050620006893266
KYSE-450,11152667,0.9209824146572594
OAW28,11178236,-3.057015425639644
KMRC-20,148198,-1.1031106323256945
IST-Mes1,24180125,3.710624760267412
EHEB,219104,3.08550903293029
PF-382,72193870,1.048942272028045
RERF-LC-MS,3854666,0.8294073497518095
Karpas-422,51037431,4.098391545359284
SF539,448949,0.5600320112814784
HCC2108,3825829,4.6343664994608496
Karpas-422,6917907,-5.654366357922142
EHEB,JQ-1-vorinostat (2-1 mol-mol),0.2631441629277845
KMS-12-BM,5291,3.1050299402444095
Namalwa,2126,3.4152061939625136
HuT 78,24772860,-3.0726220135578353
SNU-213,638278,3.3592322377614363
HEC-108,46191454,0.932122354999318
SK-MEL-5,15953870,5.041877344086934
ChaGo-K-1,JQ-1-vorinostat (2-1 mol-mol),1.2329864056769342
Lu-65,3136844,3.9390005430833184
BT 328,11656518,4.018032711371447
BT 320,57519531,6.301542560729613
KMS-12-BM,51039095,1.746743438142051
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
NOMO-1,136227924,2.5449106490851263
HOP-62,216345,4.191400178728098
LMSU,9936388,2.8786407463456656
AU565,36462,0.154728470238132
MIA PaCa-2,168313200,1.759366617697624
KMRC-20,104842,-2.088943206569887
AU565,168312962,1.8906319972872971
BFTC-909,5291,3.495280995080932
BT 248,1641662,4.808188715890419
BT 498,2729026,2.5400165852939196
NCI-H929,tretinoin-navitoclax (4-1 mol-mol),-0.4664155813684951
Panc 02.03,9911830,3.8856260346392903
AsPC-1,25150857,2.720712035994173
BT 286,navitoclax-MST-312 (1-1 mol-mol),0.9465292199095277
Karpas-422,89928392,0.7937418388010543
SNU-119,25183872,-0.5002243893820045
KMS-12-BM,navitoclax-birinapant (1-1 mol-mol),-0.785030684423409
Kasumi-2,4261,-0.415942894249068
KMRC-20,51037431,3.686624478209352
Ri-1,25262965,-4.2714913167069835
WM793,crizotinib-PLX-4032 (2-1 mol-mol),1.8719851046729632
KLE,23725625,2.7746440048356
RKO,11625818,4.5581118700811105
KMS-12-BM,10410894,1.7534583743773589
SNU-119,60700,-0.1085854321234963
Becker,11364421,-5.867324857945357
OAW28,71466445,4.188405368682896
Namalwa,216345,4.441431133973052
ACC-MESO-1,alisertib-navitoclax (2-1 mol-mol),0.7857690269167803
RKO,2729026,2.3662843020346753
PF-382,54618771,-0.2642287573533248
NCI-H929,36462,0.845260564861955
RERF-LC-MS,10427712,4.250983789220692
HuT 78,135398516,3.648200603857496
Becker,9826308,0.0658327796307835
AU565,3038522,2.241670788617941
HSC-3,5566,2.855912953749529
SNU-886,216239,1.293630546683639
AU565,3689413,0.8257687517728082
KYSE-180,123631,1.841294475412796
AsPC-1,44202524,5.110549363526631
RKO,241158,4.5302703569847305
Kasumi-2,71751553,4.151047970892257
MIA PaCa-2,135875424,3.180139545836177
BFTC-909,54613361,0.5481358040879688
SF539,3062316,-1.76598803310592
HuT 78,decitabine-navitoclax (2-1 mol-mol),0.5260270362971856
EHEB,16725315,3.5389292854080505
SK-UT-1,11152667,-1.0251821128308043
HOP-62,409805,5.513075555987367
NCI-H1339,60750,-4.602537649686373
Namalwa,16038120,1.0132909592473565
LXF 289,46843906,2.101940493524925
AsPC-1,11178236,-3.0731642515052098
HSC-3,46174525,4.198953944320053
OAW28,54619267,3.96587417417148
HuT 78,208908,2.8130928881015422
NCI-H929,11427553,0.419395277417347
KMS-12-BM,16736978,-0.4930730722396533
PE/CA-PJ41 (clone D2),31703,-1.1740452115890814
NCI-H929,44489675,3.656307412577015
SW1783,10302451,4.263014004956648
HOP-62,selumetinib-piperlongumine (8-1 mol-mol),3.458683839970051
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286
ChaGo-K-1,9866186,1.9654387369279056
PE/CA-PJ41 (clone D2),19582717,4.700549622049601
NOMO-1,6918837,-4.687337521865761
Becker,44185566,3.0765843891002547
SNU-423,24797083,1.3709546558320778
HCC2108,tanespimycin-gemcitabine (1-1 mol-mol),0.2372099864187673
Kasumi-2,9903786,1.7296917357536032
NCI-H929,702558,5.133204411961539
NCI-H929,11404337,-0.6691193705825791
HCC2108,44185566,2.949072119702921
LXF 289,11640390,5.398484732926136
EHEB,serdemetan-SCH-529074 (1-1 mol-mol),1.3155569018374509
SK-MEL-5,10410894,3.059644403817
SNU-423,12003241,-1.4382544514663564
HuT 78,71466380,2.9398406998655395
KMS-12-BM,3025944,3.1800470659597284
KMRC-20,piperlongumine-MST-312 (1-1 mol-mol),2.9533358433546444
KMS-12-BM,17755052,-0.7211534532736694
KYSE-450,11955716,-2.223741431662978
HOP-62,ISOX-bortezomib (250-1 mol-mol),0.9515306322664672
Ri-1,serdemetan-SCH-529074 (1-1 mol-mol),1.4624553326223522
SNU-886,navitoclax-pluripotin (1-1 mol-mol),-8.136657717634877
BT 286,11152667,1.278732358262165
WM793,doxorubicin-navitoclax (2-1 mol-mol),-0.741764803207122
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015
AsPC-1,31703,0.7807561035178269
MIA PaCa-2,carboplatin-etoposide (40-17 mol-mol),2.457685275331116
OAW28,168312962,3.352489814007426
PF-382,44589607,0.7007325594590731
HSC-3,219104,4.05954551765257
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
RKO,151289,1.190219151105647
IST-Mes1,3825829,6.080187468224706
PE/CA-PJ41 (clone D2),135411,0.8293994588997935
ChaGo-K-1,462382,0.9099733724752056
Panc 02.03,6852167,4.143336119644561
BT 328,702558,5.711275260817638
PE/CA-PJ41 (clone D2),56949517,4.369609998916364
NCI-H1339,selumetinib-UNC0638 (4-1 mol-mol),4.735041004813278
AsPC-1,9952709,5.897814669584309
Ri-1,36314,3.2158141028558083
WM793,54626689,6.182066538200824
SNU-213,9911463,3.827165589896959
BT 498,44185566,3.051411567565442
Mono-Mac-1,452548,-2.4901637647281847
HOP-62,erlotinib-PLX-4032 (2-1 mol-mol),3.2366767860483145
BFTC-909,5329102,1.9658448878596055
BT 328,46398810,2.9413062884147014
BT 286,9915743,1.1038828678808648
RT-4,54619267,4.475901221652596
HOP-62,72199292,2.0893543654643403
BT 248,11317348,2.524808263877468
PF-382,selumetinib-navitoclax (8-1 mol-mol),0.0511061030946494
EHEB,20959075,-3.303490374431417
KMRC-20,16741245,3.9826803312414527
RKO,439501,-1.8401322759847645
AU565,11977753,-1.5018138963846497
ChaGo-K-1,52912189,2.09928070426417
WM793,6852167,3.317398724097228
KMS-12-BM,navitoclax-MST-312 (1-1 mol-mol),0.0074530885526159
RT-4,72193861,1.6093035569826073
MIA PaCa-2,135398516,1.9665175565302655
WM793,9911830,2.975609583515234
RERF-LC-MS,16722836,2.4162442447682193
NCI-H1339,10296883,3.881669394748239
RKO,49793307,-1.4433237106321422
BT 286,11612883,1.7976038545897062
CML-T1,637858,1.454745710944211
KMS-12-BM,3038522,3.0774694723408036
BT 498,navitoclax-MST-312 (1-1 mol-mol),0.6566975328936648
Namalwa,71466380,3.6089451461716
Ri-1,10127622,5.1327863724648095
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567
SF539,6918638,1.218816827551867
Namalwa,44543605,5.038599911094309
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
HuT 78,11178236,-3.136781933116147
HuT 78,44202524,1.902464587959626
ESS-1,6918328,-0.1703669492376587
RKN,51037431,2.467401650082352
SF539,65628,3.9792533711127582
PF-382,selumetinib-MK-2206 (8-1 mol-mol),1.294147913599038
Ri-1,637858,0.8978114122705031
SNU-423,107985,-4.181882942370829
AU565,5335621,4.583819394214033
SNU-213,10074640,2.758568829113537
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
SF539,carboplatin-etoposide (40-17 mol-mol),1.5231255103181107
SK-MEL-5,9967941,2.0132409445112707
BFTC-909,5280436,4.2143472852581025
RKN,10410894,1.511663597063748
Namalwa,6610355,3.6186379138370017
SF539,126941,-2.8509530485587065
RERF-LC-MS,25227462,0.8140348385016122
PF-382,12001922,1.3621804177433754
ACC-MESO-1,36462,2.9779299416618237
PF-382,16741245,3.010878138090118
IST-Mes1,5738263,4.045528078129119
CML-T1,54143018,-0.824314936779772
BT 328,10184653,3.731010322665131
SNU-423,54618771,0.8845738276291084
ChaGo-K-1,24889392,5.7134252534785075
PF-382,selumetinib-JQ-1 (4-1 mol-mol),-1.2412031100333754
RKO,15547703,3.988071110220001
ChaGo-K-1,11238147,3.908632567260728
Panc 02.03,54454,5.027619058009229
SW1783,44491742,3.6997355499837217
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
Karpas-422,44137675,-1.3828937962979793
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
HOP-62,selumetinib-vorinostat (8-1 mol-mol),1.8094917487163475
RKO,11427553,3.456895276763714
RT-4,71304818,2.636098080172375
NCI-H929,3384730,2.4908246089676385
Karpas-422,51039095,2.7059855927348706
OAW28,6918878,3.220005605820797
SNU-423,54678924,2.1389201541521405
SK-MEL-5,168313047,1.975290985697176
BT 328,selumetinib-tretinoin (2-1 mol-mol),5.411953573942954
KMRC-20,49793307,-1.1812176037357236
RKO,3025986,-0.6013959236761957
Mono-Mac-1,1750826,-3.0480548093833053
EHEB,54619267,5.440652083155126
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
OAW28,2749,3.2113189756487683
Karpas-422,2871966,0.3090239295442658
LMSU,9926054,1.9493229998791417
BT 248,44241473,4.372252470027867
SNU-119,5978,-4.047164032584213
Kasumi-2,11364421,-5.792134203695654
LXF 289,10302451,1.735451917587997
Mono-Mac-1,11625818,2.7738715371544407
IST-Mes1,11485656,3.5408910362273835
BT 248,241158,3.909930885156875
SNU-213,5113032,4.529210101778295
Lu-65,JQ-1-MK-0752 (1-1 mol-mol),3.396249910599845
HuT 78,11507802,0.6434442936513365
Kasumi-2,44491742,3.800345149395397
RKO,159324,3.5523933893017583
H-STS,56946209,-4.578784798240611
PF-382,navitoclax-PLX-4032 (1-1 mol-mol),-0.0589134631644863
Namalwa,5460769,2.4239066035753054
AsPC-1,135999136,4.3448843965381965
BT 286,107970,1.9511501669936515
SF539,24180125,3.915045335194428
OAW28,11396600,3.5740319462685535
SK-UT-1,1317464,3.8102371333241023
WM793,15983966,-0.2219786467978368
SNU-886,441298,0.5019863351835324
SF539,tretinoin-navitoclax (4-1 mol-mol),2.6465654261890617
BT 286,53392493,1.7738214073447722
SNU-886,445091,2.7467604761461097
HCC2108,navitoclax-pluripotin (1-1 mol-mol),-1.5801642437599936
H-STS,selumetinib-piperlongumine (8-1 mol-mol),2.659030814623116
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
ACC-MESO-1,46199207,3.4428384584430303
AU565,6610355,3.967539400054512
KYSE-450,24771867,3.24164368139856
RKO,8515,4.32265921632429
Namalwa,carboplatin-UNC0638 (2-1 mol-mol),3.639633422658992
NCI-H929,4788,5.842901865932074
Lu-65,1242560,4.017707407743541
SNU-423,navitoclax-PLX-4032 (1-1 mol-mol),2.701511272036536
HEC-108,452548,2.7369645386651307
PE/CA-PJ41 (clone D2),60750,-1.2354534688999257
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
BT 248,9911463,2.7908107916357436
RKO,24901704,3.90150667551114
PE/CA-PJ41 (clone D2),54626689,4.875473167492311
HuT 78,selumetinib-vorinostat (8-1 mol-mol),-4.277294994055841
ACC-MESO-1,BRD-K03911514,4.424297284892215
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943
Namalwa,54619267,3.686644648242005
Lu-65,675434,4.6985998957044774
AsPC-1,5738263,4.8764899816054905
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
KYSE-180,654092,0.3510982053718326
SNU-119,445091,4.135214962682557
NCI-H209,44607530,2.40492464566077
BT 248,119182,0.6885021238666414
Panc 02.03,4477,0.984097917718396
RERF-LC-MS,73707398,2.0319367406190483
NOMO-1,11719255,2.6566855899212944
BT 286,9840324,5.923668609002887
KYSE-180,8515,4.449202894378201
LXF 289,16741245,5.010251526780332
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
PF-382,126941,-3.067039026453267
Becker,46907787,3.975901887649669
HSC-3,675434,4.441932850910441
HOP-62,15547703,4.560533258663546
ESS-1,6450551,2.4356422182289106
Lu-65,11152667,-1.8224670022620897
RERF-LC-MS,25262965,-1.1343637554659964
ESS-1,54618771,1.2318880484657342
KLE,426756,4.4338865892288295
NCI-H196,6610216,4.943661751084643
Ri-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2329470107135907
AsPC-1,11494412,3.580103428724827
HSC-3,16115403,-5.41980643687828
Ri-1,89928392,-1.6393201076464738
EHEB,3025944,4.323656262321947
ESS-1,444795,3.9723378710264985
KYSE-450,11640390,4.647540881608271
IST-Mes1,3081361,1.9096346363157353
Namalwa,72376,-3.07685992530759
KYSE-180,11175137,2.9654350002556873
SW1783,107970,3.037635999927972
Becker,56963564,0.0372017803501728
SW1783,4917,3.480222092567203
MIA PaCa-2,46199207,3.3310599597253843
Ri-1,3689413,-2.346816387466721
HuT 78,11719255,1.766568320704254
KMRC-20,serdemetan-SCH-529074 (1-1 mol-mol),2.30805961058782
KMS-12-BM,9444,3.443513988010703
NCI-H209,42642645,-0.6980833637264824
MIA PaCa-2,119182,1.3201769074657816
BT 248,24772860,-1.8114686790878316
Karpas-422,2708,4.388605602289197
HEC-108,5280436,4.260553189863144
IST-Mes1,72376,0.3576615812024088
SNU-886,23725625,4.310392340682066
SNU-119,3815108,1.8360895016279837
MIA PaCa-2,9911463,3.5885490135085663
BFTC-909,448949,2.818327130228084
AsPC-1,135984461,3.722049898583642
SK-UT-1,6918638,1.3984076220807655
PF-382,262093,0.5149344400111652
Kasumi-2,9803433,4.641295101837652
SNU-886,9868037,2.869419012431549
HuT 78,6918328,-2.2367447807827405
LMSU,72734382,6.104130077489303
HSC-3,docetaxel-tanespimycin (2-1 mol-mol),-2.9988743376183575
BT 498,241158,4.164187123770961
CML-T1,400769,-1.2523952078832103
BFTC-909,104842,-1.584917163766509
NCI-H2030,387447,-2.9646513764291726
BT 248,11178236,-4.1971988945266965
SF539,6918328,-0.3520383633660662
KMS-12-BM,4705,2.431122737655679
NCI-H929,168313016,5.007996140484685
MIA PaCa-2,11222830,1.3825683444330394
SNU-119,11626560,1.6667374543655389
IST-Mes1,24856436,3.396810776549086
SK-MEL-5,613753,3.2985063698452826
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
MIA PaCa-2,4261,1.9783874519377245
MIA PaCa-2,17755052,2.071011142750117
SK-MEL-5,53232,2.3078145894982893
CML-T1,613753,3.0468922998366357
SNU-119,10184653,0.0248827318699143
KLE,135875424,3.394401628511705
OAW28,66577038,2.5027239379183666
RERF-LC-MS,11612883,2.474683430971872
HSC-3,16722836,1.7284043741706685
RKN,3689413,-4.085525957083088
CML-T1,654092,-1.9909155078044125
AU565,16720766,2.906162391657848
Karpas-422,5287620,-4.326710186438937
BFTC-909,3062316,2.03384364484094
BT 498,11427553,3.765674202927968
KYSE-450,6917907,-5.14733530155551
SF539,387447,-5.002674810102925
LXF 289,387447,-4.093727880786265
Kasumi-2,445643,3.712609595977314
RKO,135411,0.3039750611139232
KLE,5335621,6.0454813938491405
SW1783,24951314,2.5031295891577083
SW1783,3854666,3.296513769962362
Karpas-422,49793307,-4.95469591758221
RKN,216468,4.351451769225332
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
Kasumi-2,2949965,2.010544177145751
Lu-65,selumetinib-JQ-1 (4-1 mol-mol),-0.4610963672816198
Karpas-422,44607531,1.274772844929052
CML-T1,168313016,4.15358640853123
NCI-H929,6505803,-1.240454682973536
HuT 78,11977753,-0.8983403403257315
LMSU,11427553,2.2667679897186757
RKO,6252,0.5352436981906653
SW1783,16725315,5.184633472906502
RKN,3854666,2.132003481112045
Panc 02.03,54619267,4.6873070757127335
SNU-213,374536,4.5761002458249695
PE/CA-PJ41 (clone D2),135875424,2.9357060771459245
AsPC-1,6438330,3.2823568933486196
EHEB,11404337,0.0364567319098325
BFTC-909,16219061,3.736019824418232
NCI-H1339,11404337,0.2277853658172252
PE/CA-PJ41 (clone D2),11178236,-3.5733613875059262
WM793,9907093,5.490749105587387
HEC-108,60700,1.732447929158594
H-STS,5746,0.9486967341675628
WM793,2828334,6.191612506266247
Lu-65,11640390,4.172577765309866
AsPC-1,71680916,4.418583351869457
CML-T1,11485656,1.9899616795432975
KYSE-450,11455910,0.6287655004796859
CML-T1,2945648,2.7633194270668877
MIA PaCa-2,10296883,4.037005331930825
PF-382,tretinoin-navitoclax (4-1 mol-mol),0.5792978560561972
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
Mono-Mac-1,4096211,1.4458168023329625
KYSE-180,11626560,2.00053897353166
ESS-1,327653,3.2040700098938837
ChaGo-K-1,9933475,2.408030721375389
KMS-12-BM,24856436,-0.1996093117488152
ACC-MESO-1,654092,0.4220956302588627
Ri-1,5281321,-3.06997364503604
NCI-H196,5311,1.2798513187769205
KYSE-180,6918328,1.6181247370511698
MJ,6917907,-5.708175674485562
SK-MEL-5,24964624,2.9124247923536783
SNU-119,5311281,2.891953115435588
Kasumi-2,5311281,1.4543587988632989
ChaGo-K-1,4261,2.1016705661768684
BFTC-909,216345,4.226804426652683
Karpas-422,5738263,2.386980222939564
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
BT 328,72376,0.5320465754189707
BT 248,123631,2.103805835203493
ESS-1,decitabine-carboplatin (1-1 mol-mol),5.337587299103004
AsPC-1,24748573,4.519934140177759
MIA PaCa-2,135440466,1.742842838035012
OAW28,24901704,3.441244042276163
NCI-H929,17759555,3.669029016892366
SK-UT-1,9884685,5.1525602917749875
RT-4,25102847,1.6194464271831264
CML-T1,9823820,1.5491308586448294
LXF 289,71466380,3.888647536265504
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
Ri-1,5351362,-0.2436544124268334
BT 498,6918837,0.8299871100943732
HSC-3,11222830,1.881269114654764
CML-T1,5328940,-0.6883003462747955
AsPC-1,10385095,2.76496705920137
KYSE-450,73707398,1.7321370562114622
LMSU,11214940,4.711725342258078
WM793,66577038,3.1191342289924417
Mono-Mac-1,44819697,4.760065022955159
WM793,4521392,4.34292186054555
KLE,5329102,2.881910158775446
BT 498,10302451,4.23204741279201
HOP-62,JQ-1-navitoclax (2-1 mol-mol),0.645936379150377
H-STS,135398516,1.890546081861667
AsPC-1,24951314,2.0738112971970275
HSC-3,3025986,-0.4532276268650599
PF-382,49850262,2.873386319481207
KMS-12-BM,54454,3.3056700898570277
PE/CA-PJ41 (clone D2),10302451,2.698134533156883
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
ESS-1,54613361,0.2104463314777853
ESS-1,9884685,0.689834242395422
SNU-213,135984461,4.435605101205859
HSC-3,446155,2.7370474852392346
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
Mono-Mac-1,11626560,0.7319803190138492
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644
Ri-1,6252,-0.4804929147517275
ESS-1,72376,-3.01301826130781
Lu-65,tanespimycin-gemcitabine (1-1 mol-mol),-1.4852703394729607
ESS-1,44197249,5.299862122462015
KYSE-180,3503,2.347380717343577
KMRC-20,4521392,5.860934935010035
AsPC-1,42611257,3.6284330949745094
OAW28,11152667,0.0990704789630026
PE/CA-PJ41 (clone D2),4378219,4.605247392620583
MJ,439501,-3.472446137047906
IST-Mes1,crizotinib-PLX-4032 (2-1 mol-mol),1.4798286107475835
Becker,5311,1.7921665195219072
KYSE-180,5328940,1.5841327354029733
EHEB,11396600,3.4241723821303314
RERF-LC-MS,25154868,3.293982375318642
IST-Mes1,1242560,3.612096070768593
WM793,46191454,1.3645728185603727
NCI-H2030,46199207,3.2278610843944313
BT 248,54626689,4.44361910749143
Karpas-422,374536,2.0966843525351173
KMS-12-BM,11152667,-2.0033121328533054
ESS-1,11964036,1.685679354186414
HEC-108,11964036,3.068027447156284
AU565,9967941,3.769081839228565
SNU-886,2841722,5.058350864200372
KYSE-450,5329102,3.4097073656415615
KLE,638278,2.977843699594415
AU565,1641662,2.8108586385203234
CML-T1,10385095,0.9719029483379856
BFTC-909,11222830,1.7098036316197358
Mono-Mac-1,613753,2.716265313942883
Namalwa,11455910,-0.4529585092669797
IST-Mes1,5113032,4.841043294054768
SK-UT-1,5351362,2.3369266208176556
Kasumi-2,24772860,-3.0702303943568197
BT 286,24775005,3.227465140595902
Mono-Mac-1,60750,-0.2214723919691935
Namalwa,71751553,4.989934392817737
BT 498,219104,4.156833951191354
BT 286,42642645,0.4820370250639494
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
SF539,docetaxel-tanespimycin (2-1 mol-mol),-4.4379333242133
RERF-LC-MS,44241473,4.536869636330491
Panc 02.03,11626927,4.481877662185247
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
Namalwa,15953870,2.955206613456957
HEC-108,6184667,5.152766799175181
RERF-LC-MS,23725625,5.011639185934848
Mono-Mac-1,UNC0638-navitoclax (1-1 mol-mol),0.713076461951265
SNU-886,decitabine-navitoclax (2-1 mol-mol),-8.577955246496893
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
LXF 289,753704,4.962227230589067
ESS-1,46224516,3.2167819229259447
KYSE-180,5281321,1.5873257175067956
PE/CA-PJ41 (clone D2),9952709,3.673274575880338
HSC-3,11507802,1.06595538315282
Karpas-422,vorinostat-carboplatin (1-1 mol-mol),1.8240625772492975
HCC2108,2749,3.7407563708836102
ChaGo-K-1,374536,0.6604540670834225
HEC-108,11404337,0.7883165010808656
SNU-423,5351362,1.1925295534620222
RT-4,44819697,1.9904234220349264
Kasumi-2,65064,2.9473106091456467
Mono-Mac-1,4917,3.0045902586541713
Kasumi-2,15953870,2.7617758274096404
IST-Mes1,44491742,4.903550558956352
PF-382,71466578,2.892192903824988
NCI-H1339,25102847,3.622460842241946
Karpas-422,71680916,4.106507626467137
PE/CA-PJ41 (clone D2),16038120,1.5447880430004386
NCI-H929,136227924,1.899057841083653
NCI-H1339,2742550,4.5254309197539735
SK-MEL-5,46398810,3.127286082204237
EHEB,3543504,5.334270443674065
ChaGo-K-1,441298,1.668083723590158
ChaGo-K-1,23635314,5.83207100789115
BT 286,216239,2.296063009751389
LMSU,439501,-3.1304465735998153
SNU-423,12001922,2.3385317619154353
SNU-119,57519531,5.7777697645171795
Ri-1,246676,4.619716207885173
SK-MEL-5,375860,0.3634288608432608
Karpas-422,60750,-4.565045356168419
Becker,ISOX-bortezomib (250-1 mol-mol),0.428200248169345
BFTC-909,71466380,5.267829049221599
Panc 02.03,11485656,5.602754460209725
Karpas-422,5978,-4.397865794233498
RT-4,3385,4.126461688410087
KMS-12-BM,JQ-1-vorinostat (2-1 mol-mol),-2.5260495197970525
IST-Mes1,135421197,1.925463420817299
Mono-Mac-1,44486219,3.9337809212248382
PF-382,6918878,-0.2369499162228823
HOP-62,24964624,3.1243711395082543
NCI-H196,4261,0.7892412084491274
SW1783,4705,3.473081250569121
SF539,3689413,-2.2250008276513107
KMS-12-BM,135999136,1.7056569950210811
ACC-MESO-1,10074640,3.497274494427276
PE/CA-PJ41 (clone D2),387447,-3.919842712569756
SNU-119,126941,-2.8871019003996574
PE/CA-PJ41 (clone D2),9967941,3.5242615732915534
H-STS,15953870,3.89259126645257
Ri-1,1242560,2.284731901733303
Kasumi-2,3689413,-2.6905586087263043
HuT 78,148124,-4.9142161440271135
AU565,4705,1.275846161151896
Namalwa,JQ-1-vorinostat (2-1 mol-mol),-0.8440437734227959
HOP-62,11657048,4.01244988008706
LMSU,3025986,-1.1384200565557423
Kasumi-2,44819697,-2.5261102007933154
BT 286,5287620,-2.4250248709269124
SK-UT-1,54618771,2.629062811355061
KMRC-20,4096211,2.631082680972026
SK-UT-1,9907093,4.521774895830979
KMRC-20,11214940,0.9068953612442124
HOP-62,387447,-3.823160514435493
Karpas-422,3503,1.3324407002806058
SNU-119,72376,-2.5899020632208742
ACC-MESO-1,17759555,4.251515989904748
AsPC-1,5278396,3.912005463923024
ChaGo-K-1,11234052,4.170735457945669
AsPC-1,56973724,5.500241353025212
PF-382,53232,2.4647050421770005
Panc 02.03,241158,4.402915180139186
KLE,9866186,1.5006756729771336
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
KYSE-180,54143018,-0.6121199451945726
AsPC-1,5281321,-1.206156098851657
RKO,216239,1.9979551619375524
NOMO-1,15983966,-5.011559396504552
Karpas-422,11238147,1.4747635682905047
BT 248,55508,3.993579478299883
SNU-423,docetaxel-tanespimycin (2-1 mol-mol),-4.7254091536928104
NCI-H929,9868037,2.724281418576466
Namalwa,4705,3.621778373883038
WM793,carboplatin-UNC0638 (2-1 mol-mol),2.595896359447151
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
HCC2108,serdemetan-SCH-529074 (1-1 mol-mol),2.3033726270926
PF-382,2729026,0.5855884852341721
CML-T1,135928012,3.921778036516406
KYSE-180,5287620,-1.547969048447004
Karpas-422,25102847,2.7396004244892125
SNU-119,11167602,2.3286246928254335
ChaGo-K-1,52947716,2.4825337083096564
RERF-LC-MS,135875424,2.839581382146162
Panc 02.03,56946209,-4.513446270471167
NCI-H2030,11364421,0.5606861319843897
ChaGo-K-1,11178236,-3.285468505296693
LMSU,24753719,4.829555677738913
NCI-H929,409805,3.661820790042666
BT 498,11612883,4.017951205392113
Mono-Mac-1,100016,3.734497226962008
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
SNU-213,1750826,-0.3902581059910673
AU565,49836020,5.742264990221176
HOP-62,57330099,3.6921695700920862
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631
BT 498,7251185,2.57671304723101
SW1783,136227924,2.7676121780420364
HuT 78,19582717,2.6899137103246327
Becker,46199207,3.68158924353219
KMS-12-BM,68056272,2.2091741251856982
RT-4,445455,5.670983982398453
NCI-H1339,2746,3.2710965804253633
LXF 289,1750826,-0.5305094201812034
CML-T1,5566,2.203374574789853
Mono-Mac-1,2946601,4.595748556282713
MIA PaCa-2,navitoclax-MST-312 (1-1 mol-mol),1.14230691570943
NCI-H1339,6450551,3.0443618718545244
NCI-H929,637858,-0.3950607584941885
LMSU,5287620,-1.1667958498443185
ESS-1,54143018,0.807928117545995
KMS-12-BM,24901704,2.3878689097063424
Kasumi-2,1750826,-5.270023181988586
AsPC-1,5280436,2.0433035906644696
Ri-1,JQ-1-navitoclax (2-1 mol-mol),-3.4544449292269586
HEC-108,135398738,5.1700626311097935
OAW28,445455,5.326899909172617
HuT 78,71466445,0.6237805812301164
HSC-3,123631,3.70813832669854
LMSU,5282054,4.011761884092238
ChaGo-K-1,216239,1.9174193091465608
Kasumi-2,10322450,3.5434418993684114
ChaGo-K-1,10231331,4.797062827822195
SNU-119,9967941,5.644960862211108
NOMO-1,54618164,3.731990472759892
MIA PaCa-2,54626689,4.534739947118546
KYSE-180,15983966,-3.249627780516399
SNU-213,3854666,3.663424826303367
OAW28,2858523,3.071437644261336
AsPC-1,76446078,5.483716778202627
NCI-H209,docetaxel-tanespimycin (2-1 mol-mol),1.9080282467878955
NCI-H2030,3503,2.737633424778545
SF539,702558,3.162113771527059
LMSU,5351362,1.3918765572974243
NCI-H929,216345,1.9065836273896417
KLE,24856436,-1.53848530026464
BT 328,alisertib-navitoclax (2-1 mol-mol),0.3590132286260764
SNU-423,10113978,4.025124345725794
KMS-12-BM,445455,3.345017046406881
RKN,11152667,0.0617927102225113
AsPC-1,219104,4.54762024266609
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
NCI-H1339,65064,5.348039511094046
BT 248,387447,-5.028656036950466
SNU-119,654092,-3.073300249988697
AsPC-1,53392493,3.5744228182767164
Ri-1,68056272,2.942516708587133
HOP-62,168312962,3.1091715829143216
KMRC-20,10074640,3.028506289108157
AsPC-1,9840324,5.861158829716173
Mono-Mac-1,375860,-0.4295713018664168
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
OAW28,44607530,1.1070032957823266
Ri-1,decitabine-navitoclax (2-1 mol-mol),-4.461207799698283
Becker,selumetinib-PLX-4032 (8-1 mol-mol),4.580169016551391
SF539,6252,2.539418639524388
Karpas-422,53232,2.9652087025502687
SNU-119,675434,5.343032629204847
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
BFTC-909,3136844,3.2427360302120403
OAW28,148198,-3.8662210541116977
CML-T1,4096211,0.5897034084412636
KMS-12-BM,23725625,4.892779562300822
SNU-119,49766530,-2.6347810345662785
PE/CA-PJ41 (clone D2),9825149,3.600795638985757
NCI-H2030,44589607,2.9694652404648547
Kasumi-2,11656518,-0.8040408639715576
MIA PaCa-2,serdemetan-SCH-529074 (1-1 mol-mol),1.810745795416243
CML-T1,6917907,-6.247910968385368
SNU-119,421610,2.8611579206364315
NCI-H1339,12001922,2.434231494820422
Lu-65,10302451,3.851828229272266
HEC-108,10074640,3.0709446672134946
H-STS,3136844,3.9456833945347833
KMS-12-BM,148198,-2.3401169496211778
Ri-1,148198,-2.551976890306858
PE/CA-PJ41 (clone D2),51039095,3.82696027623671
BT 286,53495165,-2.917577853080983
SNU-886,445643,4.49357862319239
CML-T1,89183176,3.024950752568636
BFTC-909,676352,2.5282943369079818
Panc 02.03,24951314,2.3006835537528585
SF539,15953870,3.263207389755282
PF-382,44632017,0.9401237974673988
Ri-1,46174525,2.671851467732814
CML-T1,4788,4.608482830288328
KMS-12-BM,10385095,1.107401404691538
HuT 78,2945648,3.150096975155089
Becker,46398810,3.659842106831334
NCI-H2030,76446078,5.365957574929404
Namalwa,49867926,3.871708467281813
H-STS,11427553,1.5169535049673049
EHEB,6918328,-0.9331880587360782
SNU-213,969516,2.999480362119821
ChaGo-K-1,107970,1.9284648709268049
OAW28,49793307,-1.8076729764727852
EHEB,11609586,1.2753249269460478
PE/CA-PJ41 (clone D2),11485656,2.035669448740327
Namalwa,4477,-0.3247155167185905
RKO,227681,3.9032876810461814
Ri-1,49846579,-5.783613255423313
Kasumi-2,31703,-3.912318367279324
SK-UT-1,BRD-A02303741-navitoclax (2-1 mol-mol),5.142165719819776
KYSE-450,57330099,4.469167864214201
KMRC-20,135398516,5.837743145524966
SNU-119,selumetinib-MK-2206 (8-1 mol-mol),2.741948442476576
SNU-119,10322450,3.771322180088625
MIA PaCa-2,5351362,1.024245072191309
AsPC-1,24901704,4.152315193440913
HuT 78,11455910,0.0216709312460527
ESS-1,16736978,2.6908591982967645
Mono-Mac-1,2828334,5.6358472407180695
SNU-886,17755052,1.4860081485560532
LMSU,5470400,3.850959102601626
Karpas-422,675434,4.111382767941029
KYSE-180,151289,0.6004966681509784
BT 328,ISOX-bortezomib (250-1 mol-mol),1.5922800813403362
KYSE-180,135398738,4.479498150489159
HOP-62,JQ-1-UNC0638 (2-1 mol-mol),1.583491465804524
Mono-Mac-1,969516,2.650184266608886
HOP-62,UNC0638-navitoclax (1-1 mol-mol),2.4690733929057385
ChaGo-K-1,4917,3.3620383707745662
Panc 02.03,3634881,5.203302993958793
KLE,24785538,1.6849105600387455
EHEB,72376,-2.605248149465708
OAW28,9935249,3.684332158484572
HuT 78,135984461,1.9427901339992903
HOP-62,1285940,3.1997778552050895
HSC-3,44493528,4.631982422980787
RERF-LC-MS,1716436,4.437154842045929
SK-UT-1,107985,-4.193387591911345
SF539,2729026,2.548731779898503
AsPC-1,6918328,0.3822733035015269
MIA PaCa-2,24951314,0.8451751507215038
EHEB,3136844,4.591447211361851
PE/CA-PJ41 (clone D2),5287620,-0.7845756481007433
ESS-1,2945648,3.5685871452412137
SNU-886,5281321,-2.4775522134293846
HEC-108,15983966,2.2350760521339024
BT 286,vorinostat-navitoclax (4-1 mol-mol),1.1734217347995668
SNU-886,2842253,5.3530946546481815
KMS-12-BM,6918328,-3.473135115653443
KYSE-180,3689413,3.064535959483158
BT 286,1750826,-0.130592970617936
LMSU,49766530,-0.1291663690745916
NCI-H1339,crizotinib-PLX-4032 (2-1 mol-mol),2.596594679687944
Kasumi-2,4705,3.579279614719375
Lu-65,53392493,3.827142623727452
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
WM793,124202324,3.2510114503738894
OAW28,285033,-1.6788024908058845
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609
KMRC-20,57330099,4.053303525305033
H-STS,24797083,1.5630657554706655
CML-T1,3854666,0.73725489161191
KLE,11152667,-1.6090314572433455
CML-T1,135421197,0.9317392273651705
SF539,24797083,0.4526611461759284
OAW28,5335621,5.136061685098042
HCC2108,6918837,-2.190970663092924
RERF-LC-MS,45279963,3.7797867340420215
KLE,2828334,4.827132086641668
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
PE/CA-PJ41 (clone D2),11612883,4.335668949701792
Namalwa,tretinoin-carboplatin (2-1 mol-mol),4.711706284787402
RT-4,11497983,5.0525297457562335
Karpas-422,8515,3.8543440231436135
NOMO-1,23635314,-2.3321691272104697
Mono-Mac-1,216345,3.019133822225676
Kasumi-2,9444,3.998890232290453
NCI-H196,alisertib-navitoclax (2-1 mol-mol),0.6580146352998756
NCI-H929,19582717,2.600948271168246
KLE,156414,1.5892150248130086
ACC-MESO-1,docetaxel-tanespimycin (2-1 mol-mol),1.2731409547027943
HEC-108,docetaxel-tanespimycin (2-1 mol-mol),-4.808010092677581
HOP-62,448949,1.84106276173181
Lu-65,54618305,4.948052353708299
KYSE-450,5291,4.139799755765828
SK-MEL-5,17759555,4.048629860745806
HOP-62,2858523,3.0590549447697275
Namalwa,54618164,3.970816819204835
NCI-H1339,71466578,4.86926698619994
BT 328,15983966,3.6622955294931865
OAW28,4788,5.61832216329738
NCI-H1339,54619267,4.355528234226246
AsPC-1,9935249,3.639166614114404
RT-4,44137675,4.764559708105059
ACC-MESO-1,168313047,3.680243112419498
Karpas-422,selumetinib-UNC0638 (4-1 mol-mol),1.8652233950787973
EHEB,1750826,-3.083056512698404
Becker,11955716,-1.4968569931897069
SNU-423,9911830,2.1086837652762473
SK-MEL-5,9825149,2.3906358989800163
SF539,1242560,3.791681789864431
H-STS,46926350,-4.349495266854958
Kasumi-2,5460769,1.467216518279754
HOP-62,10184653,2.0915708533115587
AsPC-1,24785538,0.8298650260870277
Mono-Mac-1,2708,2.725116801773413
AsPC-1,81146,4.947223766743442
Lu-65,44202524,1.40083991712789
HuT 78,409805,4.736359437343851
AU565,9927531,4.912755977802547
ChaGo-K-1,16725315,3.255226634029485
SW1783,11214940,3.7998857791777287
IST-Mes1,11222830,1.7720886037954378
SW1783,3825829,4.196997387332537
Kasumi-2,8515,3.2781378887974775
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
SNU-213,navitoclax-gemcitabine (1-1 mol-mol),2.580873398185735
PF-382,3825829,3.5943460783681207
H-STS,216239,0.9162079464609584
PF-382,89928392,-0.2076371550725149
WM793,135440466,3.4729537866645828
LMSU,71304818,3.266059532186748
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
Kasumi-2,2742550,3.256021563602066
NCI-H929,24753719,4.216810454357832
H-STS,9866186,-0.0944353973133468
OAW28,65064,5.229460149894731
OAW28,25062766,3.2225198305631464
HEC-108,25150857,3.0835964658841246
H-STS,60700,-2.8002918740934044
BT 248,24775005,3.1653639365719553
LMSU,piperlongumine-MST-312 (1-1 mol-mol),1.415881107955257
NCI-H196,4259181,0.9744150084112732
SF539,445091,3.820067439228608
Mono-Mac-1,11396600,1.2647728617805982
SNU-213,11612883,2.207970532635057
PF-382,3038522,2.759643282415116
BT 286,135440466,0.9125155825882112
HOP-62,9927531,4.3195662996069855
EHEB,10427712,4.001167017482681
H-STS,11507802,0.4528511080463978
SF539,57519531,1.493804886958663
OAW28,216345,3.8770767977792913
NCI-H1339,54454,3.7472624418631617
SNU-119,24856436,-0.7380975951321199
IST-Mes1,5281672,4.409062773089972
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417
SNU-886,20959075,-1.9195531644083397
Ri-1,135984461,2.0671055438536547
MIA PaCa-2,JQ-1-MK-0752 (1-1 mol-mol),0.7789496627710616
MJ,71466380,5.818114341591543
Lu-65,5978,-3.596221870039605
ACC-MESO-1,135421197,1.1131712845559925
NCI-H1339,676352,2.5885839758095592
KLE,25183872,1.4445815878101878
KMS-12-BM,6438330,0.9422197844346454
MIA PaCa-2,54454,2.3541686076518253
SK-UT-1,9903786,5.78516391020833
PE/CA-PJ41 (clone D2),24797083,2.207629580437647
PF-382,6252,-3.946421345482259
Mono-Mac-1,9911830,2.1868049767694044
SF539,JQ-1-navitoclax (2-1 mol-mol),0.5515785836007664
NCI-H209,piperlongumine-MST-312 (1-1 mol-mol),1.7207029898692474
RERF-LC-MS,135421197,1.554065103888189
H-STS,ISOX-bortezomib (250-1 mol-mol),0.4695504712696665
BT 248,25150857,2.3784591591930635
SNU-213,11178236,-1.8376458893314875
Ri-1,46907787,-1.1077031577889345
OAW28,135398516,2.0767833136681437
KLE,107970,2.4969694624001546
BT 248,2945648,2.911977762170341
LMSU,107970,2.329788160301069
RT-4,104842,-2.837554052237836
Kasumi-2,23635314,-3.2137156100627973
WM793,168313047,2.1825025569441405
IST-Mes1,448949,2.0697752718967677
KMRC-20,9915743,2.261900740642606
ChaGo-K-1,5351362,0.7984355835079401
OAW28,20959075,-3.9569108449030295
BT 248,16038120,1.7409517230791791
NCI-H196,124202324,2.494260717218826
Mono-Mac-1,9826308,-0.3549450293788487
ESS-1,2126,5.022491020211577
SNU-423,445091,4.024034893293104
BT 498,9926054,3.200560952387037
RT-4,135398516,2.327932490402957
SW1783,6918328,3.3453228504618995
HOP-62,11626560,2.088889257155472
KLE,selumetinib-UNC0638 (4-1 mol-mol),3.976187739409722
KMS-12-BM,2733526,2.511527741006988
BT 328,374536,4.943552861027733
SNU-119,1641662,3.269862503326484
NCI-H1339,piperlongumine-MST-312 (1-1 mol-mol),1.2826174925611926
ChaGo-K-1,9907093,4.059324237981179
Kasumi-2,208908,2.161160996454662
NCI-H1339,6438330,3.671694196593789
Karpas-422,9887053,3.894192278074615
IST-Mes1,5311281,1.4883568311904505
Becker,25102847,2.1724805944053975
SF539,400769,-1.0115362811049124
Namalwa,25062766,1.6047548376295822
Panc 02.03,446155,2.721578883226381
Panc 02.03,568763,0.7660787595735656
MIA PaCa-2,selumetinib-PLX-4032 (8-1 mol-mol),1.6013326620809585
HEC-108,11222830,1.779874343530328
PF-382,3384730,1.4668655115256852
CML-T1,4477,-0.6676342393752774
MJ,doxorubicin-navitoclax (2-1 mol-mol),-3.4914578181494007
NCI-H209,54618771,0.4504113944457773
Becker,44607531,1.318290319409554
KYSE-180,2729026,3.0243505230230565
BT 328,11175137,3.2083588182965705
BT 328,4378219,2.241353375973062
NCI-H929,9911830,2.939236367729051
BT 328,24772860,-1.739359818332389
SNU-423,45279963,4.04517438276715
SNU-213,31703,0.5753594315199101
Kasumi-2,54613361,-0.9648217673530566
BT 286,16722836,1.8037687633845072
KLE,3025944,3.8646829194893546
OAW28,25102847,1.9718431113444057
NOMO-1,3062316,2.517026306117631
PE/CA-PJ41 (clone D2),44819697,0.0049812921739646
EHEB,16722836,1.130353250152493
BT 328,3634881,2.884291919608293
BT 286,51039095,2.127259435113009
NCI-H196,5351362,2.106735039915596
AsPC-1,10296883,4.32215490848641
KMRC-20,24951314,2.492306253507562
ACC-MESO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.089233445562891
HEC-108,navitoclax-birinapant (1-1 mol-mol),1.0122779025542474
HuT 78,54143018,-1.655797975805756
SK-MEL-5,6184667,2.419101173147099
KMRC-20,24180125,2.1292230700197874
IST-Mes1,327653,2.848745693869025
Ri-1,11404337,-1.810959317313917
RKO,11717001,3.92417498432234
BFTC-909,11404337,0.4468911705694049
SK-MEL-5,3689413,3.463644790263917
ACC-MESO-1,11178236,-5.172752088865678
EHEB,6438330,0.8032584071441157
Ri-1,5328940,-0.3334425744780813
SK-MEL-5,4259181,0.9764517115857632
SK-MEL-5,9866186,2.008250773590418
Panc 02.03,9926054,1.881153725115377
Kasumi-2,9933475,1.7570111474767809
WM793,piperlongumine-MST-312 (1-1 mol-mol),1.4459627223482716
HOP-62,5566,3.0329633334860246
ACC-MESO-1,24785538,2.771715835479783
PE/CA-PJ41 (clone D2),5328940,1.486645508379929
LXF 289,6505803,-2.367756082461904
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
SNU-423,1750826,-3.0329631786048923
BT 328,54618771,1.300712581347958
BT 248,11175137,2.43855252671782
SNU-213,11238147,2.964120806343807
BT 286,4705,3.0604993750879834
BT 328,9825149,2.1820811004987126
MIA PaCa-2,9549297,2.915653478367295
Panc 02.03,49793307,-1.288996397670963
MIA PaCa-2,11717001,4.308928886902068
RERF-LC-MS,969516,2.2498421794663095
BFTC-909,5287620,-2.871557478653834
Becker,5280436,0.2916845727306569
KLE,JQ-1-MK-0752 (1-1 mol-mol),2.9937546834772375
BT 320,448949,3.0267975144627894
PF-382,5566,2.4095985038819947
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
HOP-62,vorinostat-navitoclax (4-1 mol-mol),1.1061829362989206
LXF 289,44589607,3.4320685896186585
SF539,11234052,3.1104537569749353
Karpas-422,135398516,0.8464676443060564
CML-T1,71304818,1.5782846307483736
KMS-12-BM,9868037,1.5063019992906226
Mono-Mac-1,25262965,1.0629902073080637
Lu-65,57519531,4.867194285561449
NCI-H196,JQ-1-vorinostat (2-1 mol-mol),-1.4598355433927688
BFTC-909,46199207,3.2760821272908753
Karpas-422,46907787,-1.7872558374884018
AsPC-1,25183872,-0.8583413037674358
ChaGo-K-1,25227462,1.4432760051535278
AsPC-1,57330099,4.415374546363204
ChaGo-K-1,erlotinib-PLX-4032 (2-1 mol-mol),3.5306775519247746
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
KYSE-180,1750826,2.4925152788264726
LMSU,24797083,1.8363127025251853
SNU-119,452548,0.641037029070195
CML-T1,135999136,1.353337094400064
Becker,JQ-1-navitoclax (2-1 mol-mol),4.827296641390771
KMS-12-BM,57330099,3.2111991420002215
RERF-LC-MS,4477,-0.1141702320643991
HSC-3,15983966,0.0470426194362112
BT 498,3689413,1.8744771197995864
Karpas-422,49836020,3.572840137931533
SNU-213,24180719,4.112073754783821
H-STS,44462760,2.174167118730489
CML-T1,55283,-0.0221984323925449
HuT 78,5284329,2.4236179223209513
Namalwa,24856436,-1.4734170848625472
Kasumi-2,123631,2.0188728462797885
AsPC-1,4578,5.074011683523406
SF539,piperlongumine-MST-312 (1-1 mol-mol),0.3137797380658941
SNU-886,4259181,0.9120616711669954
ESS-1,4917,3.7890836888483626
OAW28,322968,3.926433659329745
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
NCI-H196,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304767119574239
IST-Mes1,5566,2.9881744281003373
ACC-MESO-1,44185566,3.81089645336787
EHEB,3552672,2.013023360686031
NCI-H2030,638278,4.046309354650408
Ri-1,16038120,0.0455465003903266
ChaGo-K-1,168312962,3.0507546612682823
NOMO-1,9884685,0.4754269892492985
PE/CA-PJ41 (clone D2),doxorubicin-navitoclax (2-1 mol-mol),-1.4596299758397953
LMSU,5460769,3.9630418347665857
HOP-62,decitabine-navitoclax (2-1 mol-mol),2.8967431057082806
ACC-MESO-1,23635314,4.805138762332019
RERF-LC-MS,246676,4.480243243269967
RT-4,25183872,-1.211160463214132
RKN,400769,-0.3685197718994141
PE/CA-PJ41 (clone D2),6852167,3.048314493941667
CML-T1,135984461,1.8956927240773784
BT 320,66577038,3.2847085574393557
SK-UT-1,24797083,-0.5976783400947587
HEC-108,151289,0.8721533950647946
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937
KLE,10385095,2.1345695418673354
Mono-Mac-1,4477,0.9858317647029236
CML-T1,3384730,0.9879066704986152
HuT 78,25262965,-1.2447606076305184
PE/CA-PJ41 (clone D2),25183872,-0.14942285161157
BT 328,9444,4.598160630608248
KMS-12-BM,100016,3.5545657198194873
NOMO-1,445455,4.303833401854377
ChaGo-K-1,11404337,1.1508536619225571
SNU-886,9967941,1.858584505430476
PF-382,216345,3.312440656550695
NOMO-1,24889392,4.281820029392572
IST-Mes1,JQ-1-vorinostat (2-1 mol-mol),0.3770936853030046
NOMO-1,11427553,1.1686106553832942
SNU-213,11640390,3.703838959573684
RKO,23725625,3.9986828157613616
HCC2108,119182,4.202789641454693
ACC-MESO-1,54613361,4.477829702351627
OAW28,24978538,-0.39276463694641
MIA PaCa-2,156414,1.6924569137824248
KYSE-450,9866186,1.0868221005132463
HEC-108,702558,5.741783323073097
BT 328,3825829,4.625111565622426
BT 320,54618795,3.6611780989616514
HCC2108,73707398,1.1119632364432313
Namalwa,54678924,0.7353468971102918
RT-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.18220229095385
Ri-1,11364421,-5.60623006121576
SK-MEL-5,16725315,4.671402704829768
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
CML-T1,24978538,-0.5146505107576096
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
MIA PaCa-2,5287969,-2.3681939301530455
LXF 289,3025986,-0.453776319374568
HuT 78,44632017,1.0845444881128212
H-STS,6917907,-5.810162038338551
KYSE-450,alisertib-navitoclax (2-1 mol-mol),2.776253910680575
NCI-H929,54639665,4.443848049019438
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
Namalwa,53481919,3.785858901194669
Kasumi-2,selumetinib-navitoclax (8-1 mol-mol),-1.4155555334459644
MIA PaCa-2,11175137,2.616995003058467
WM793,10231331,2.277080944837622
LXF 289,6918837,-2.0130943060067454
Namalwa,7326481,3.2837850445002483
Mono-Mac-1,156414,-0.6734994653601284
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
Ri-1,613753,2.7044868241849165
NCI-H209,53495165,1.0251739222665532
NCI-H1339,969516,2.528006193946809
SF539,216468,4.034624291224008
OAW28,51039095,2.7471743585791075
HEC-108,3825829,3.356859835270974
AsPC-1,5311,1.9705564216623497
EHEB,selumetinib-tretinoin (2-1 mol-mol),4.625312744108104
HSC-3,6184667,4.256789074152558
HuT 78,11612883,1.5245291666063423
NCI-H196,5280436,4.249264897117882
BT 328,71751553,4.608962030519419
KYSE-180,vorinostat-carboplatin (1-1 mol-mol),3.9189821803734577
Namalwa,16725315,4.579457546839429
MIA PaCa-2,4578,4.4453332581389535
Karpas-422,15983966,-2.597972132371412
MJ,46398810,2.7370882768174596
Ri-1,selumetinib-navitoclax (8-1 mol-mol),-1.125961619919062
AU565,2871966,0.5985779022023225
IST-Mes1,46843906,1.738626305357275
BT 498,51039095,3.6677678650771903
Becker,serdemetan-SCH-529074 (1-1 mol-mol),3.075542184320411
OAW28,1641662,3.6011202742070014
KMS-12-BM,5335621,3.708216955119463
IST-Mes1,navitoclax-piperlongumine (1-1 mol-mol),2.2991023643561115
LXF 289,9936388,-5.793518221083613
MIA PaCa-2,4917,3.10668536131689
HOP-62,10231331,1.3709968490270463
EHEB,25183872,-1.17879257651429
BFTC-909,44607531,1.7004331217528663
WM793,452548,1.1404647506174352
Becker,5746,2.3579978479166384
AU565,227681,3.7153411694983887
PF-382,10385095,1.1317259097020056
SF539,24748573,0.9472280680221892
KMS-12-BM,46191454,-0.8526827535334566
BT 328,3384730,1.2152683647278577
PF-382,409805,3.4085068464251997
NCI-H196,637858,3.0093076834066923
IST-Mes1,salermide-PLX-4032 (12-1 mol-mol),6.709164103992604
KMS-12-BM,44589607,1.1628348529963377
HEC-108,selumetinib-BRD-A02303741 (4-1 mol-mol),6.22303090572745
ChaGo-K-1,387447,-4.0313743226417875
OAW28,135928012,4.847644989583831
RKN,17755052,4.615024850417848
Karpas-422,5746,0.513145379443875
LXF 289,6914657,-2.1957863105134474
ESS-1,168312962,3.040527705732362
Ri-1,9887053,2.359250902526285
Becker,1716436,3.8374444305943514
H-STS,16741245,6.378704245448754
Panc 02.03,10296883,4.297264305827386
SF539,6184667,1.7310938600147268
BFTC-909,53232,2.9810373365160316
BT 248,24753719,4.394714770526552
NOMO-1,421610,4.35383474826381
HOP-62,135423438,1.5837123025968611
PE/CA-PJ41 (clone D2),44566777,1.4460436063371125
AU565,7251185,1.9736319172199277
HEC-108,1641662,3.2650548064529237
PF-382,4477,-0.0830303421102948
Kasumi-2,54143018,-2.3900299530010405
Karpas-422,44486219,3.855480246667008
SK-MEL-5,135421197,1.8346447693413537
Becker,11396600,4.49881996506653
KLE,9903786,3.130074514321622
BT 286,11317348,1.6450901998776757
Namalwa,10184653,1.1583544921124178
KYSE-180,ISOX-bortezomib (250-1 mol-mol),0.5668882301656226
ChaGo-K-1,56946209,-4.866978275420876
Mono-Mac-1,56946209,-4.758871933449349
LMSU,16065773,3.25664528889909
Ri-1,31703,-4.209857724033629
Panc 02.03,11427553,3.85172253134883
ESS-1,carboplatin-etoposide (40-17 mol-mol),0.969659746088125
AsPC-1,5351362,2.4874401689371033
SF539,salermide-PLX-4032 (12-1 mol-mol),2.8378152204226836
HEC-108,6914657,-4.042403483970356
HuT 78,16038120,0.7817739501159142
Karpas-422,4259181,-1.4276330915263615
Ri-1,4261,0.0314759848451894
SNU-423,216468,4.240235187700666
ESS-1,44137675,3.2480943550658576
KYSE-450,vorinostat-navitoclax (4-1 mol-mol),3.1121330202386974
RERF-LC-MS,136227924,4.560045704487339
Kasumi-2,445091,5.553993217061133
LMSU,selumetinib-piperlongumine (8-1 mol-mol),4.680339218702476
RKO,6610355,5.147293026177706
LXF 289,9967941,3.6599941581067057
BT 498,49793307,0.0294787754678871
Namalwa,374536,0.8945549847595208
Namalwa,46199207,2.7519500516222912
BT 248,5280436,3.4551701194558935
OAW28,16720766,3.888951908869231
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819
WM793,73707398,0.9042820542427616
CML-T1,12001922,1.44047939392769
H-STS,44632017,0.7308222143683922
Kasumi-2,11485656,1.64011250363507
HuT 78,10074640,2.6664319662154625
HOP-62,54626689,3.8543822457381687
AU565,15983966,1.7541662071439053
SK-MEL-5,5281321,0.508645730860985
AsPC-1,11955716,-2.13511164723979
PE/CA-PJ41 (clone D2),11396600,3.63156445822279
NCI-H1339,72734382,4.418833505137817
LMSU,25150857,3.1228438520338253
KLE,46398810,3.130465535353637
MJ,4096211,1.1855677594978866
SF539,46199207,2.5581705364942193
Mono-Mac-1,2749,1.219428226055154
MJ,3038522,3.33569699650525
PE/CA-PJ41 (clone D2),42611257,3.82431664602614
AsPC-1,5566,3.190935368909542
BT 498,119607,5.8425982216003405
CML-T1,1716436,3.108020123675437
SNU-423,135440466,2.852751796609215
AsPC-1,46174525,4.390753346499015
KYSE-180,4788,5.873750540393015
RKO,135875424,3.829354185480349
WM793,11238147,2.989890948344662
CML-T1,9967941,3.2676581028704503
Kasumi-2,5335621,4.247176943532892
CML-T1,9825149,1.6129799202532635
RKO,66577038,3.1469091340303637
MIA PaCa-2,969516,2.746520412230261
KMS-12-BM,46843906,0.1435996413551739
NCI-H2030,17755052,4.328898176318331
HCC2108,71466445,4.412506412183148
H-STS,375860,-0.6907889018597777
CML-T1,46398810,1.457844995716712
BT 320,42642645,3.0201339489728563
NCI-H209,24978538,-1.1799487785033067
LMSU,6918837,-1.4182367040159407
NCI-H2030,4788,5.845910727996914
PE/CA-PJ41 (clone D2),11964036,2.080788440495361
KMS-12-BM,5281321,-2.748905186924615
HuT 78,444795,-1.7173791831946914
SW1783,salermide-PLX-4032 (12-1 mol-mol),6.068207873844662
NCI-H1339,9911830,3.231454639260267
Ri-1,4705,2.754354482473573
RKO,25150857,2.5785304193211247
Mono-Mac-1,5328940,-1.985592469607955
ChaGo-K-1,44607531,1.465791535592978
HCC2108,5282054,3.0861306329764964
PF-382,6918736,-2.107719564435389
ESS-1,10113978,3.392450898705775
EHEB,46907787,0.323033594148826
Ri-1,crizotinib-PLX-4032 (2-1 mol-mol),1.439549368158699
EHEB,46943432,1.4009693182531664
PF-382,11497983,-3.782661101953355
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
HCC2108,25150857,2.994087068367986
RERF-LC-MS,11625818,4.251014876931036
EHEB,124202324,1.636771857102227
PF-382,44185566,1.017432682942044
NCI-H929,9866186,0.2477340085292711
HOP-62,73707398,1.728110403283316
Kasumi-2,151289,0.8385264971723331
RKO,11719255,3.406006587740275
HEC-108,11625818,4.313201084341855
ESS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.581305001836425
SNU-423,126941,-1.4095759658666385
AsPC-1,44462760,4.701078704400346
MIA PaCa-2,44589607,2.9560404415477533
SW1783,72193861,3.9823565234230314
SF539,23582824,-0.2198249685001801
ACC-MESO-1,5278396,4.0330276972141
Mono-Mac-1,53495165,-1.384513911752195
HSC-3,erlotinib-PLX-4032 (2-1 mol-mol),2.5171532957569864
WM793,6505803,-1.695252066312567
SNU-119,9884685,1.7075636021097025
KMRC-20,25150857,2.3131751126804616
BT 328,24797083,3.187781247629872
Namalwa,216468,0.3360162821959921
KLE,9935249,5.162792026951856
LXF 289,168313016,5.746715572468322
Kasumi-2,JQ-1-vorinostat (2-1 mol-mol),-0.9081345169636283
AU565,11626560,1.628517095800036
HSC-3,25062766,1.5460878624268062
PE/CA-PJ41 (clone D2),11427553,3.7565243742301617
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
Karpas-422,107985,-2.8458224127978733
CML-T1,9903786,2.526700219209825
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
NCI-H929,322968,-0.4532114476759251
PF-382,2113511,5.305319424437295
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
MJ,73707398,1.2722011507797648
MIA PaCa-2,5281672,4.326280360096159
H-STS,erlotinib-PLX-4032 (2-1 mol-mol),4.123094127064452
SNU-886,24748573,0.9987877672847516
WM793,3081361,2.8594902062102374
RT-4,3689413,0.3652230576391069
PE/CA-PJ41 (clone D2),16720766,1.1856728493123077
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
Kasumi-2,409805,3.7279902229812114
LXF 289,11485656,2.2610473771175847
HSC-3,9967941,3.1508151586249844
SNU-119,46191454,1.5208499646959712
BFTC-909,969516,2.723005004244225
HuT 78,24951314,-0.9560314989082764
CML-T1,135398738,1.6792363237461696
LMSU,44819697,-1.5946135282515452
HOP-62,16065773,1.872748547861876
RT-4,9967941,2.350248504826165
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
RKN,44493528,4.408823872302737
HCC2108,6917907,-5.24436050839449
SNU-119,46199207,2.9147124779042435
NCI-H196,9825149,2.985706018384809
HOP-62,1750826,-0.2990217230122637
RKO,1716436,3.795795915163565
AsPC-1,53325874,4.506725704395743
SNU-423,5738263,2.530771634166199
RKO,135999136,6.045591123054076
H-STS,387447,-5.130568890460207
LMSU,702558,5.700567867563839
SNU-119,25150857,1.966340721822474
OAW28,107970,2.4537130721494105
LXF 289,11238147,3.4273419568352006
Lu-65,60700,0.1842167213594187
RKO,11238147,3.3996395604326977
Lu-65,alisertib-navitoclax (2-1 mol-mol),1.9804624556752644
KYSE-450,11507802,4.680867496065348
WM793,3825829,4.563508127916012
KYSE-180,168313047,3.1175173804941307
Ri-1,219104,2.628053406762598
ESS-1,24951314,1.795276006384557
Mono-Mac-1,2874250,-1.2814848013351932
HOP-62,3384730,2.596455739523981
BT 286,2746,4.414216796759687
SNU-119,alisertib-navitoclax (2-1 mol-mol),-0.0715431732612024
ChaGo-K-1,4096211,1.2191968259267876
NCI-H196,15547703,5.48928690632669
RERF-LC-MS,216239,1.5111459083459036
KYSE-180,322968,4.83956254664213
HSC-3,16038120,1.4145642849720264
BT 498,71304818,2.894673989277281
AU565,11507802,1.2242731086346843
PF-382,702558,2.625780781007821
RERF-LC-MS,7251185,3.4578262740878976
KLE,9911463,3.5004519168580828
BT 328,JQ-1-vorinostat (2-1 mol-mol),3.553838421661415
CML-T1,327653,2.5732071532781866
Karpas-422,6438330,1.009867343899865
ACC-MESO-1,6450551,3.561931878479919
NCI-H929,156414,0.5091151756924145
SW1783,6610355,5.017799798077197
CML-T1,104842,-6.467154894462458
Namalwa,11167602,1.8297854280338213
SNU-119,11228183,1.025523846387519
PF-382,66577038,2.531906234689114
EHEB,36314,1.738223816404837
BT 286,675434,4.334118060963705
Namalwa,89928392,0.6743977588494114
HSC-3,100016,6.558832951826536
HOP-62,135440466,0.703284490040229
OAW28,16722836,1.5279923407751788
KMS-12-BM,89183176,3.5435448288108056
Karpas-422,11455910,0.7211757450052372
SNU-423,11964036,2.2479137081458203
Ri-1,12003241,-5.9425936829646435
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124
BT 328,9911463,3.726223215474182
HCC2108,17755052,3.0973240129693833
KMS-12-BM,4259181,-0.5634255522920182
LMSU,tanespimycin-gemcitabine (1-1 mol-mol),1.1507117487410143
ESS-1,4261,0.7524787521612106
SF539,2708,3.2874630457066103
SF539,UNC0638-navitoclax (1-1 mol-mol),2.2023146643666323
NCI-H196,31703,0.16997276013656
BT 498,262093,3.072055867790356
BT 286,568763,-0.0474884133388832
SNU-213,387447,-4.101875903510779
RKN,11404337,0.6786980557761386
BFTC-909,3815108,3.5118939741133075
Ri-1,vorinostat-carboplatin (1-1 mol-mol),1.3287966003987923
ACC-MESO-1,navitoclax-birinapant (1-1 mol-mol),1.2335149444368336
BT 328,5738263,4.558527530025055
PF-382,11222830,1.048169261061167
HuT 78,49867926,4.101314288502533
SNU-119,carboplatin-UNC0638 (2-1 mol-mol),3.434233494695521
AsPC-1,148198,-3.729188282050714
RERF-LC-MS,5460769,5.094680634820597
Ri-1,4477,0.9849203528472006
SK-UT-1,54143018,1.4978372615780644
SNU-886,42642645,0.8705530909872051
OAW28,135928012,4.847644989583831
HuT 78,25154868,3.748850122707697
MIA PaCa-2,alisertib-navitoclax (2-1 mol-mol),-0.2545467399902864
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
ESS-1,53495165,-2.215744312493367
Becker,53495165,2.7375596088041103
HCC2108,89928392,0.7050545298033302
Ri-1,72734382,3.3487101348360824
SNU-423,44185566,3.12747229468207
Kasumi-2,49793307,-4.053216594075624
HuT 78,71576739,-3.3283921388984155
SNU-213,46191454,2.292491387475712
SK-UT-1,3689413,-2.3572164451465105
NOMO-1,5746,1.3002002606442051
NCI-H1339,322968,3.982114951842054
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
NCI-H196,44607531,1.7206917376940007
HSC-3,15547703,3.1084945046177297
Kasumi-2,46224516,1.9043930771708657
RKN,135999136,4.319110081529012
KYSE-450,135875424,4.8684130020868235
SNU-423,1566236,1.8226515664509473
SK-UT-1,445091,4.399813328633606
SK-MEL-5,piperlongumine-MST-312 (1-1 mol-mol),1.8829016872652296
IST-Mes1,15547703,3.097349866450655
HCC2108,241158,3.0824386157377197
MIA PaCa-2,11507802,0.9401760079454452
SNU-119,387447,-4.116955767451351
IST-Mes1,11494412,3.57589790392084
Kasumi-2,984333,-0.6107639841292208
BT 248,9549297,1.6274014594604191
SK-UT-1,11175137,3.4203767191490724
SW1783,44493528,4.220460910824872
PE/CA-PJ41 (clone D2),9840324,6.5625963406787005
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
BT 498,24964624,2.135100588287655
BT 286,navitoclax-gemcitabine (1-1 mol-mol),-3.19115614959178
BT 498,carboplatin-UNC0638 (2-1 mol-mol),3.552975230735022
Ri-1,6438330,0.7863948150709156
SNU-423,10385095,0.9709432237153084
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
AsPC-1,135875424,4.124114476494282
SNU-213,71304818,2.05795076129124
ChaGo-K-1,24978538,3.0694714119392112
RKO,11214940,1.6564081526645635
BFTC-909,3634881,3.6308731463535704
Lu-65,23582824,0.2818334700004627
WM793,10410894,3.504687642816823
KMS-12-BM,BRD-A02303741-carboplatin (1-1 mol-mol),5.576574018385502
KMRC-20,3384730,3.9096966997308744
KMRC-20,387447,-3.930757262228924
SW1783,2871966,1.533691405345237
MIA PaCa-2,9907093,4.239063733882627
Mono-Mac-1,1716436,1.8382110406537744
OAW28,2708,5.3328257603707545
IST-Mes1,462382,1.0027449292382402
SF539,23635314,-2.6621769118066516
AU565,25227462,0.9575642046813388
AU565,25062766,2.0331930756167234
LXF 289,3689413,0.4542816941401804
HSC-3,46199207,3.7875254196691617
Panc 02.03,119607,6.223236877281167
H-STS,54143018,0.5439646012734883
RT-4,navitoclax-gemcitabine (1-1 mol-mol),-4.248755815605392
AsPC-1,44493528,4.313387127964929
ESS-1,BRD-A02303741-navitoclax (2-1 mol-mol),4.070395472210358
OAW28,72193861,2.7871547903709266
BT 286,10231331,-1.310629484482038
ACC-MESO-1,11485656,3.7436435043406
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
Karpas-422,5311,0.5747268386466993
LMSU,25105715,3.7531762313471466
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
PE/CA-PJ41 (clone D2),serdemetan-SCH-529074 (1-1 mol-mol),2.6683290169301346
EHEB,969516,2.488094363127618
Becker,11977753,-2.20370670195944
HSC-3,1641662,3.3023853436193256
HCC2108,6918328,-0.0809019219950942
NCI-H1339,navitoclax-sorafenib (1-1 mol-mol),4.7250529369838725
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
RT-4,11238147,3.737016422545975
CML-T1,11626560,-0.8907703496754931
AU565,11214940,0.9865925706012508
PF-382,11238147,1.430662922581268
HuT 78,24901704,-0.7514069981488459
SF539,122327,5.038371430182477
HCC2108,11152667,0.6161783395316693
NCI-H1339,5287620,-3.928120713935858
LXF 289,53495165,1.0389398894889437
Kasumi-2,24771867,-3.1023362721742607
CML-T1,148198,-3.9003291277504526
NOMO-1,44507138,0.557170216692965
Lu-65,19582717,4.909054003445902
OAW28,4096211,1.5501495805084426
BT 248,24951314,2.138284126904765
MIA PaCa-2,375860,-0.6403278633855397
EHEB,9926054,1.8810570858595552
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
RERF-LC-MS,44493528,4.358183394704722
BT 320,9549297,2.275077325933936
SNU-423,60700,1.632231011146198
Ri-1,44632017,0.5070203922812767
Karpas-422,72734382,3.992792587505708
NCI-H929,11683005,1.6623595675282548
SK-UT-1,navitoclax-MST-312 (1-1 mol-mol),0.81365218885664
SK-UT-1,6610216,4.443950873518219
BT 248,208908,1.7719462620560902
SNU-886,44185566,3.1834094102423083
NCI-H2030,71304818,2.458601205050272
PE/CA-PJ41 (clone D2),42642645,1.5712136673163746
SF539,2130404,3.7538105132797304
BT 498,11317348,2.1875513655438876
RT-4,navitoclax-PLX-4032 (1-1 mol-mol),-0.362810350442769
SK-UT-1,carboplatin-UNC0638 (2-1 mol-mol),5.634306420745063
AsPC-1,4788,5.925917601642537
Karpas-422,119607,5.478750501953686
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
WM793,5280436,4.679936736167119
CML-T1,135440466,1.4712310181015782
OAW28,446155,3.9986810531407486
BT 320,969516,5.171798432399237
Namalwa,selumetinib-UNC0638 (4-1 mol-mol),4.558272137526928
Kasumi-2,3825829,3.3479634665685167
BFTC-909,44819697,-0.8003395289407239
BFTC-909,2949965,3.0294119536880197
SK-MEL-5,216468,3.582933078212788
EHEB,23725625,4.849566011145166
OAW28,5287620,-1.6233190690502424
KMS-12-BM,65628,3.1283199596989624
MIA PaCa-2,448949,1.723715555169293
NCI-H2030,24964624,3.4158063313495393
MIA PaCa-2,42642645,0.3251150152649052
HSC-3,67156097,-0.140204998248407
PF-382,9907093,3.754844367394135
HOP-62,148198,-4.07466395157971
Kasumi-2,selumetinib-piperlongumine (8-1 mol-mol),1.718006716449046
RKN,3543504,4.234888347098623
PE/CA-PJ41 (clone D2),46224516,2.950334969022111
RKN,5287620,-2.679516494579474
Namalwa,613753,2.874891192816088
SW1783,25126798,4.288989102632611
AU565,71304818,2.0398490425817144
NCI-H2030,49793307,-3.2142989821735592
NCI-H929,6914657,-3.822913484179682
HOP-62,156414,1.5376490539390024
CML-T1,11625818,4.307055863962681
CML-T1,24901704,0.2948239854297986
BFTC-909,11626560,2.2197507332783735
PE/CA-PJ41 (clone D2),25126798,4.075940103267287
Lu-65,44462760,4.548896782935523
RT-4,5278396,3.4020225081996744
LXF 289,168313047,4.113002678801054
Namalwa,decitabine-navitoclax (2-1 mol-mol),-1.051646403003791
SF539,6918736,-1.352397505308771
ESS-1,5281321,-2.6789892941924034
Mono-Mac-1,25195348,3.3020482611967927
LXF 289,11427553,2.4541082171467368
BT 498,navitoclax-pluripotin (1-1 mol-mol),1.792235845906525
Mono-Mac-1,51037431,3.7216020490235624
SW1783,navitoclax-sorafenib (1-1 mol-mol),4.194590797982974
BT 248,76446078,4.2307608716074565
Namalwa,7251185,1.266481522188178
BT 498,3465537,2.67100305933086
HOP-62,5746,1.5783238510950015
KLE,119182,1.982009911849402
HOP-62,tretinoin-navitoclax (4-1 mol-mol),3.2080972792190017
ACC-MESO-1,selumetinib-JQ-1 (4-1 mol-mol),2.43285066252002
SK-MEL-5,JQ-1-vorinostat (2-1 mol-mol),2.0202682324830077
BT 286,6918736,-1.805383943708912
Panc 02.03,2858523,3.458791746781272
SK-MEL-5,135398516,1.9789586439354627
NOMO-1,11507802,1.1250810428603863
ESS-1,44543605,4.6000400414532505
Becker,3825829,4.088732787660409
H-STS,16736978,1.4661636218515657
SNU-886,10074640,3.87726874978677
BT 248,1714884,3.688077995610216
BT 248,24797083,0.3482207661961916
SF539,135423438,0.8139499502196877
NCI-H1339,44589607,3.107342644976079
BT 498,135411,3.2287003420197458
SNU-119,151289,0.6680539907323628
LMSU,crizotinib-PLX-4032 (2-1 mol-mol),1.7173193927866348
ACC-MESO-1,3025944,5.5965233945786865
RKO,16065773,3.3120716405166615
Namalwa,11228183,3.284342185048067
Ri-1,5113032,4.679412130425412
BT 286,441298,1.5194102888498262
SK-UT-1,9933475,2.6906239244816352
Ri-1,11497983,2.566309956988992
NCI-H929,44819697,-1.4685499411762664
BFTC-909,2733526,3.41724914482818
HCC2108,322968,3.4619795366418105
HEC-108,4261,2.7308504637450683
SK-UT-1,9967941,4.506671205621334
KMS-12-BM,5329102,1.2155421851150237
OAW28,4521392,4.353680801577448
BFTC-909,11647372,1.2423847125416496
Ri-1,44819697,-1.3296656427670626
LXF 289,11404337,0.1273620702572638
ChaGo-K-1,49766530,-1.5426741425236086
SF539,11404337,-0.0923032150573938
SNU-423,24772860,-1.7391670370922852
NCI-H196,176870,5.213807422921147
NOMO-1,16722836,0.125485002235246
KMRC-20,9907093,5.120567595099458
KLE,1716436,1.7262214726363108
NCI-H209,9927531,3.5477571143466156
NOMO-1,126941,-2.339513844414448
H-STS,6918736,-3.6487860531030702
ACC-MESO-1,11222830,2.54606187358561
Namalwa,6917907,-5.8599003249265555
PF-382,5394,4.4607333976243435
Panc 02.03,6450551,4.166761052507323
HOP-62,56973724,3.21471823934275
ACC-MESO-1,selumetinib-vorinostat (8-1 mol-mol),3.6513542751877313
KMS-12-BM,71304818,1.2685254858454966
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
KMS-12-BM,9926054,1.301975129823355
HEC-108,3689413,1.021712931431184
MIA PaCa-2,6918878,0.9930766335426112
BT 320,5328940,3.389766935980773
Namalwa,5113032,4.637348749632831
Namalwa,25262965,-4.400546903132476
BT 286,156422,4.3114640256828
RKO,3854666,1.2691133577357363
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948
SF539,71751553,4.845342915681748
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
SNU-213,11234052,4.331616153144613
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
ChaGo-K-1,54765302,6.273541453946622
BFTC-909,25262965,-1.7887871070762158
BT 320,vorinostat-navitoclax (4-1 mol-mol),3.086351264141679
NCI-H2030,44819697,2.8705865872962835
NCI-H929,44185566,1.267263970973427
OAW28,15953870,5.078636607909671
HuT 78,3634881,0.7628736071702301
NCI-H196,387447,-3.86918133998242
PF-382,decitabine-navitoclax (2-1 mol-mol),-2.1904802536786305
HOP-62,BRD-A02303741-navitoclax (2-1 mol-mol),2.8444726864007612
IST-Mes1,JQ-1-navitoclax (2-1 mol-mol),-0.6205173891711487
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
H-STS,1641662,3.378445220211116
LMSU,10302451,4.092585001279765
Namalwa,73707438,4.231902210564029
OAW28,675434,4.444033298399729
HuT 78,156414,0.7736660521630903
Becker,3025944,4.190319243036172
NOMO-1,3385,1.8227638422939128
IST-Mes1,44566777,1.465871694296859
ChaGo-K-1,11175137,2.6738271502007183
PF-382,67156097,-2.0916414621390387
PF-382,selumetinib-decitabine (4-1 mol-mol),-0.112942711472379
SNU-213,9903786,2.2891232968098887
BT 320,65064,6.551398782521052
AsPC-1,5281672,6.419333790815674
PF-382,9956119,2.18852743102483
Becker,4917,3.690734626467594
KMRC-20,10184653,1.8099581366329816
OAW28,637858,2.2776250733597085
HCC2108,439501,-2.3356100476768145
ChaGo-K-1,46191454,1.732064551306023
AsPC-1,25161177,4.641147259380914
NOMO-1,656346,0.9377734591624955
ESS-1,11222830,1.000273173568511
HEC-108,4788,5.901110925385162
NOMO-1,72734382,3.160209893803666
BT 328,168312962,4.074485851514308
MIA PaCa-2,selumetinib-decitabine (4-1 mol-mol),3.3034989346058397
Becker,selumetinib-MK-2206 (8-1 mol-mol),3.018075586447546
ESS-1,387447,-5.037795986549112
BT 320,vorinostat-carboplatin (1-1 mol-mol),4.235025979591699
SF539,421610,3.0034514922655817
SK-MEL-5,11626560,2.320856597589919
HuT 78,9825149,1.9871661414815665
PF-382,148198,-4.947878541405711
BT 498,448949,2.374656639146098
SNU-213,selumetinib-BRD-A02303741 (4-1 mol-mol),0.82373667635177
SNU-423,selumetinib-navitoclax (8-1 mol-mol),2.4281091642149475
NCI-H929,400769,-1.5124256482167764
NCI-H929,11175137,1.2036169120329363
BT 320,6852167,5.054396580410171
KLE,5738263,3.521072611240238
PF-382,24901704,1.4040004124632075
MIA PaCa-2,71576739,4.483139378007073
EHEB,168313047,2.145249955872484
PE/CA-PJ41 (clone D2),122327,4.362025797266764
BFTC-909,10113978,3.8739618499623094
OAW28,452548,1.2278646078369797
AsPC-1,54618164,4.187549957668634
HCC2108,135411,0.8115668550852202
Namalwa,3689413,-2.4943268400148715
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
PF-382,25150857,0.9357192544570664
SF539,5746,0.7777386338638989
PE/CA-PJ41 (clone D2),462382,1.0378209469483948
EHEB,71304818,2.7376303187441966
KMRC-20,168313047,2.207569694794804
ChaGo-K-1,carboplatin-etoposide (40-17 mol-mol),3.333007724933194
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854
Mono-Mac-1,72193861,0.5225127451155739
KMS-12-BM,5479543,3.250022203761556
EHEB,9908783,5.71177990312006
RKN,9911830,3.6623648245681744
PE/CA-PJ41 (clone D2),208908,3.026569932345668
WM793,56946209,-4.12818494071316
Lu-65,6918736,-0.6279560102878885
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
HuT 78,24775005,3.660301435771245
Lu-65,44486219,3.92826981701093
AU565,46191454,1.308540851634407
SW1783,374536,1.729044945983793
Karpas-422,31703,-1.45582270104394
ChaGo-K-1,16038120,0.9722602056316896
HuT 78,6436223,-5.212835622139217
H-STS,73707398,1.2106724937411937
BT 286,1716436,2.8152439824486244
LXF 289,25126798,3.2757893610597923
PE/CA-PJ41 (clone D2),11238147,5.476916752075203
HuT 78,2708,0.286348811973392
NCI-H1339,SNX-2112-bortezomib (250-1 mol-mol),-2.3734966856408883
SK-UT-1,2729026,3.1641569062038997
NOMO-1,46224516,2.27353152393119
HOP-62,71680916,4.399993359816238
NCI-H929,135984461,1.9075332391524664
BFTC-909,11364421,-5.034674750215906
OAW28,51039095,2.7471743585791075
Becker,6918837,-2.985823176035118
Mono-Mac-1,54619267,1.8356475642400525
RKN,89183176,6.327700475537756
BT 248,72199292,1.1105829108074048
Karpas-422,148198,-3.5709854147128843
Ri-1,24753719,2.417177193104349
Kasumi-2,3465537,0.5812514796989715
Kasumi-2,241158,2.967162139629707
Kasumi-2,5566,3.0024962406609874
KMS-12-BM,124202324,0.0272958362457217
HEC-108,2828334,6.315620913516899
HOP-62,5951923,3.7670098609397336
OAW28,10385095,1.310156197215646
OAW28,409805,4.888216855585461
HOP-62,tanespimycin-gemcitabine (1-1 mol-mol),-1.4683521467310283
BT 498,5470400,2.7488625160963824
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
IST-Mes1,637858,2.1376990366589905
ESS-1,10427712,4.097612541596862
BT 498,9935249,2.416260478208693
RKN,984333,1.094463938199557
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
RKO,24797083,0.8657042008278414
Ri-1,9967941,2.161012496352715
KMRC-20,crizotinib-PLX-4032 (2-1 mol-mol),2.3477359340418587
HOP-62,66577038,2.1262593150280966
KYSE-180,selumetinib-MK-2206 (8-1 mol-mol),4.332919329436686
Kasumi-2,451668,-1.101171086852316
SNU-119,135423438,2.0179604003543288
AU565,156414,-1.7188953203880928
NCI-H2030,124202324,3.552041324911957
ESS-1,23582824,0.5465688177901259
Kasumi-2,9823820,3.05022407511669
PE/CA-PJ41 (clone D2),11626560,2.6434106801081265
ChaGo-K-1,17755052,3.6386676398619224
Namalwa,5470400,5.015667749445751
AU565,6918328,-1.0169109160359904
RKN,11396600,3.670395083293249
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
SNU-886,6918878,0.4224764612922807
RERF-LC-MS,16659841,3.453543705685564
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
Lu-65,navitoclax-gemcitabine (1-1 mol-mol),-1.4233092303710124
HEC-108,selumetinib-vorinostat (8-1 mol-mol),3.960684910603258
NCI-H929,57519531,1.5644006725496582
SNU-886,9823820,0.0175156920594608
NCI-H2030,5311,1.826556505271368
BT 248,11427553,3.5134734510694687
Karpas-422,168313016,4.1332698119868265
HuT 78,2858523,3.1169604415364303
Kasumi-2,vorinostat-navitoclax (4-1 mol-mol),-2.345570206946048
Mono-Mac-1,54626689,3.913673897382288
KLE,72734382,3.5646775287439505
OAW28,3689413,-1.4375749125930504
Panc 02.03,462382,1.1832417961450334
NOMO-1,11625818,1.7683333213472852
EHEB,25262965,-0.476476540262067
Karpas-422,448949,1.746149355007417
NCI-H929,11640390,-3.3259312039438216
HSC-3,navitoclax-pluripotin (1-1 mol-mol),-0.9987365285156716
Lu-65,9911463,3.1807959522129905
NCI-H1339,vorinostat-carboplatin (1-1 mol-mol),3.7601817566263818
PF-382,65628,3.430221294092043
LMSU,11955716,0.1089430802506861
HOP-62,11396600,3.498863261816077
Panc 02.03,10184653,2.526680989613479
OAW28,1716436,3.318226269910468
RERF-LC-MS,44632017,0.7768655843829712
NOMO-1,439501,-2.35226533453039
ChaGo-K-1,3136844,3.608639859706436
RT-4,11175137,3.2600224234362796
NCI-H196,11964036,1.981444132546761
KYSE-450,135440466,3.4784789863702112
OAW28,25195348,5.036760517156048
Lu-65,45279963,3.542981128293979
KMS-12-BM,SNX-2112-bortezomib (250-1 mol-mol),-3.02097095985075
MJ,19582717,5.308710561122589
SK-UT-1,5113032,5.060629024627444
ESS-1,44185566,3.0308522030936667
SF539,selumetinib-navitoclax (8-1 mol-mol),2.7228502818299556
RT-4,12001922,1.7739058895208752
BT 320,2828334,6.462824713587457
AU565,10296883,3.47614106437246
IST-Mes1,11612883,3.500237916670588
Panc 02.03,6918837,-1.2317043962492993
BFTC-909,100016,5.8134150302243865
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
LXF 289,4477,1.125394938272502
SNU-119,9444,4.392660959332783
HuT 78,56963564,-0.3875963553009233
KMS-12-BM,5278396,2.1546808929463164
BT 286,5470400,-2.2970279935898033
RKO,9903786,4.184024439899693
NCI-H196,44137675,5.149945093178445
PF-382,124202324,0.9608672552424454
SNU-119,5280436,3.876478127021692
BFTC-909,44486219,4.380685277356905
Kasumi-2,9911463,3.4999156831259524
HuT 78,36314,-5.690425807572839
KMS-12-BM,9887053,-0.448618862637891
Namalwa,11497983,4.414210935166738
BFTC-909,984333,1.0937084793466407
Panc 02.03,25062766,3.7424097220448207
Kasumi-2,24180719,3.447908092121991
NOMO-1,54454,3.4949720971193083
KYSE-180,25154868,3.555107240815876
NCI-H929,2841722,4.211619881266404
PF-382,568763,-0.4200136453948588
HEC-108,72376,-2.7240450345568905
EHEB,10113978,2.77276539003515
PF-382,73707438,4.86482182399275
NCI-H929,selumetinib-navitoclax (8-1 mol-mol),2.7472624638867766
Mono-Mac-1,44607531,0.4504172572847592
IST-Mes1,5746,2.704326416379231
NCI-H929,31703,-2.722564633295698
NCI-H1339,9933475,2.906210693951244
BT 286,2828334,6.031620597313496
AU565,56649450,1.7738933823843377
SNU-423,2130404,3.7015735691590623
MIA PaCa-2,25105715,3.4465386312083734
LXF 289,16722836,0.8079280065417594
NCI-H196,11396600,4.033022120096851
ESS-1,25022340,0.9618153764188746
NCI-H929,11238147,1.9557398811989737
Panc 02.03,71751553,4.925944110140211
BT 320,135440466,3.8135283916877625
Becker,docetaxel-tanespimycin (2-1 mol-mol),-6.393493307906233
SK-MEL-5,5280436,3.174001621654815
HuT 78,9826308,-1.5248554066187403
Mono-Mac-1,6184667,2.8246190436164453
SK-MEL-5,44819697,0.0744475735891143
RKO,9840324,5.302067215897717
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
Panc 02.03,6914657,-4.005158687469553
MIA PaCa-2,71304818,2.5129056072181113
BT 286,25262965,-1.0999928306967477
CML-T1,44632017,0.7838820876699769
PE/CA-PJ41 (clone D2),322968,4.827437551622912
SNU-213,400769,-0.2995381710407024
Namalwa,5746,-1.3078798882420877
SF539,10074640,2.2789640038336394
Becker,11625818,4.324027571559308
HSC-3,73707398,1.0290894823159855
AsPC-1,374536,-1.7506249493921369
BFTC-909,42642645,1.561027146692027
SF539,9915743,0.9219479584552366
ACC-MESO-1,navitoclax-gemcitabine (1-1 mol-mol),0.0530863875319522
KMRC-20,11364421,1.2660239724990872
NCI-H1339,100016,8.285361450373896
OAW28,51037431,5.214608262969992
SF539,BRD-A02303741-navitoclax (2-1 mol-mol),2.7425485852442866
BT 286,25022340,6.1397690085034915
ESS-1,navitoclax-birinapant (1-1 mol-mol),-5.210357307930014
CML-T1,451668,-2.1837981176470738
HuT 78,46199207,3.332923671335415
NCI-H2030,25102847,2.1233040695404486
BT 286,984333,-1.1632809313667252
HCC2108,54618305,4.9170237432018435
Lu-65,9825149,1.987488121708482
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
Mono-Mac-1,carboplatin-etoposide (40-17 mol-mol),0.946614563265474
H-STS,24901704,3.405459257701186
KLE,5311281,3.4471397801732477
SNU-423,3081361,3.1308652078280104
NCI-H929,selumetinib-PLX-4032 (8-1 mol-mol),3.606448116077345
SF539,11427553,1.911717552312056
IST-Mes1,24821094,3.7341606082149776
NCI-H2030,5351362,2.185216793526661
NCI-H929,24772860,-3.485705594224342
CML-T1,44507138,0.8933545312764144
MIA PaCa-2,selumetinib-tretinoin (2-1 mol-mol),0.3935924528272985
AU565,68056272,3.4490660549666425
MIA PaCa-2,31703,-1.8338416127618913
ChaGo-K-1,24856436,-0.1076929992200115
Namalwa,36462,-1.022429039126246
MJ,285033,-3.775120913328887
BT 320,5282054,5.407913205549652
HOP-62,11485656,2.83083000651899
NCI-H2030,1714884,3.7040002436428394
Lu-65,selumetinib-navitoclax (8-1 mol-mol),0.9088068792801124
SK-UT-1,selumetinib-UNC0638 (4-1 mol-mol),4.7391323910259935
NCI-H2030,104842,-1.6635448144651332
SK-MEL-5,44491742,4.058095878540579
BT 248,6918837,-0.6138774965830072
HCC2108,4477,-0.2147784559751654
HuT 78,53392493,1.254063263001093
Lu-65,54143018,1.3160828330251422
WM793,serdemetan-SCH-529074 (1-1 mol-mol),2.1116726629279747
LMSU,24821094,3.02517753591971
BT 286,71751553,4.3381123592050015
RT-4,135421197,2.4643711937197756
NCI-H929,25150857,1.5927885501879306
Kasumi-2,7251185,0.9050560163252253
MIA PaCa-2,selumetinib-MK-2206 (8-1 mol-mol),0.8333069562699312
HEC-108,44589607,3.4353145741514557
SK-MEL-5,67156097,-0.100012625717114
SW1783,445091,3.700343726063664
Mono-Mac-1,71304818,2.050057377960679
SNU-886,24772860,-3.3986263976004913
SK-MEL-5,104842,-2.299697057796787
SNU-886,6438330,2.3407499785849524
HuT 78,5278396,2.15665743131779
Mono-Mac-1,49793307,-4.32207267885748
ChaGo-K-1,6918638,0.8510727110172542
NCI-H1339,216468,2.5099668441276006
EHEB,65628,3.796785261187004
KYSE-450,72376,0.4386506850457716
HuT 78,9549297,1.1531452884135298
HuT 78,6918878,-1.0659334174257225
KMRC-20,44491742,5.411645351023098
RERF-LC-MS,44202524,1.2785968032229695
Becker,16659841,3.7149025743042703
H-STS,11222830,1.7144208699256454
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
WM793,24180719,3.9443550279133186
Kasumi-2,11222830,0.4757152299010318
SF539,decitabine-navitoclax (2-1 mol-mol),2.637439217970881
SF539,11396600,2.4945499602014487
Becker,6918736,-3.597074061250567
MIA PaCa-2,71466445,3.52941204584422
SK-UT-1,400769,-1.5923135433790303
HOP-62,44462760,6.082940310622514
OAW28,5746,2.6048591865024657
SNU-423,3025944,5.553712511515966
BFTC-909,3384730,4.46542670181497
SW1783,9866186,2.9884922789438444
PE/CA-PJ41 (clone D2),73707398,2.4931970679708972
KMS-12-BM,navitoclax-sorafenib (1-1 mol-mol),-0.3529677445590104
Ri-1,3384730,1.0748430565234326
Kasumi-2,2746,1.0036072682129122
BT 286,24978538,0.9384657669866732
OAW28,71751553,5.303505748888211
AsPC-1,4705,5.582464580618905
SW1783,1750826,3.2712130388919856
NCI-H1339,9935249,3.107250994389658
HOP-62,24779724,5.1203173517940135
KMRC-20,1750826,-3.609233849414064
PE/CA-PJ41 (clone D2),11955716,-1.9630087475563516
BT 320,285033,5.611549861739741
Karpas-422,25150857,1.000258872901277
KYSE-180,24180125,4.03262772641334
HSC-3,444795,5.012644187656376
SNU-886,serdemetan-SCH-529074 (1-1 mol-mol),2.464759395102203
SW1783,9907093,4.435721436933663
SNU-213,68056272,3.686200404295785
Ri-1,46843906,1.47284812548098
KYSE-450,25195348,3.344057018387479
SNU-119,176870,1.4867362217138953
BT 248,5284616,2.1714532824885473
BT 248,2949965,2.620236046838219
MIA PaCa-2,15983966,-4.265990163763759
IST-Mes1,6917907,-4.257425330675956
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507
PE/CA-PJ41 (clone D2),24180719,4.2890339364841505
KLE,selumetinib-navitoclax (8-1 mol-mol),-0.4039228772243814
HuT 78,11609586,3.1698799239466857
AsPC-1,25227462,2.9060868065293195
Mono-Mac-1,3025944,2.9896268645900483
AU565,24180125,2.1910645714042634
NCI-H2030,9926054,2.071654789099982
Becker,246676,4.322247201161359
HuT 78,erlotinib-PLX-4032 (2-1 mol-mol),4.780125064629265
OAW28,327653,3.155680016062074
KYSE-450,46926350,-4.1870362089493804
PE/CA-PJ41 (clone D2),selumetinib-decitabine (4-1 mol-mol),4.162814575364819
NCI-H2030,5311281,3.3563177503628276
MIA PaCa-2,10302451,3.7253784601245945
SK-UT-1,53392493,1.8561003470526265
OAW28,5287620,-1.6233190690502424
LMSU,168313200,4.186982561512388
BFTC-909,135440466,2.535274686795805
RKO,135398516,4.318914396092429
NCI-H2030,24785538,3.3209864186545377
BT 320,BRD-K55473186,3.858960180173933
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
Lu-65,11364421,-2.73779838513083
EHEB,4917,2.7157925783041073
PF-382,23725625,4.463043593784131
EHEB,5281672,5.758571308107243
SK-UT-1,crizotinib-PLX-4032 (2-1 mol-mol),2.7419345363185608
AsPC-1,72734382,6.119259394736332
LMSU,serdemetan-SCH-529074 (1-1 mol-mol),2.8216668636447313
KMRC-20,55283,3.082017581412527
KMS-12-BM,374536,-3.694674622373437
Lu-65,65064,5.373865875652577
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
NCI-H2030,3543504,4.420171280073458
KYSE-180,57519531,3.399978539206015
Lu-65,6917907,-5.890074381403312
RERF-LC-MS,36462,1.1230283698314445
WM793,44819697,-0.03600588144364
ACC-MESO-1,5746,2.848145912679028
SNU-423,56649450,3.705931646214938
NCI-H2030,9936388,0.4850325164954482
Kasumi-2,5291,3.833785516332381
SNU-423,selumetinib-JQ-1 (4-1 mol-mol),2.511686996120453
SNU-213,168313047,2.8352682390823234
OAW28,12001922,1.8847589611064504
Kasumi-2,24951314,-0.5780068322267972
AU565,11494412,-0.7938994603064
NCI-H1339,107985,-2.3926548683095885
Mono-Mac-1,73707386,2.736178467367938
Becker,6610216,4.575848391008017
RERF-LC-MS,23635314,-3.639251677232653
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
CML-T1,6252,-3.9112690302721265
Lu-65,216239,1.7183510968964233
PE/CA-PJ41 (clone D2),4259181,1.7662808489331707
NCI-H196,12001922,1.8660420195191385
Lu-65,SNX-2112-bortezomib (250-1 mol-mol),-2.8589416478019403
H-STS,3825829,3.5499806421209854
ACC-MESO-1,702558,5.575552464926079
HSC-3,36462,2.0858436100123847
RERF-LC-MS,44819697,-0.3406635094896507
KMRC-20,36462,3.67134556506655
CML-T1,36314,-5.131510797683319
CML-T1,10077130,2.746402588915116
ESS-1,9911830,2.1910771619648077
NCI-H929,49766530,-2.4737600180853385
SNU-213,100016,6.954868306659309
BT 248,10427712,4.022427006719253
PF-382,46943432,0.0711232205860505
BT 328,serdemetan-SCH-529074 (1-1 mol-mol),2.5091917299328315
IST-Mes1,31703,-0.6384703159849433
Karpas-422,637858,1.0915898497737888
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563
KYSE-450,54626689,5.089860588921688
ChaGo-K-1,10427712,4.586347903058592
HSC-3,11404337,-0.7786873247989411
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
PE/CA-PJ41 (clone D2),3825829,4.527338573645581
HSC-3,49793307,-2.517203900284079
LXF 289,23725625,4.938564251049365
RKO,46224516,2.430810450928805
HSC-3,54618164,4.361792769190993
H-STS,3025944,4.171325659510201
SK-UT-1,216345,4.640105934271291
OAW28,409805,4.888216855585461
ESS-1,23725625,4.356874799520387
HCC2108,9911463,3.889332679655138
KMS-12-BM,46398810,1.728920729166526
OAW28,5311281,1.8509970799423736
KYSE-450,selumetinib-MK-2206 (8-1 mol-mol),3.9509923248068928
Mono-Mac-1,5282054,2.9932927644562053
KMS-12-BM,11717001,5.884192823277555
NCI-H929,24964624,-4.598319176525677
Ri-1,9903786,-0.2937603570790111
SNU-213,49793307,-1.7137170581408678
AsPC-1,4259181,1.083384461798112
AU565,446155,4.298434988536317
HOP-62,44507138,2.604389889395895
KLE,262093,2.3874885119076668
Kasumi-2,9825149,1.9223862209950433
RT-4,vorinostat-navitoclax (4-1 mol-mol),0.3971975472076162
LMSU,10296883,4.275438301361486
BT 320,crizotinib-PLX-4032 (2-1 mol-mol),2.9020632961686537
SW1783,9911463,3.515685844560525
KLE,5280436,4.013094882120016
AsPC-1,44491742,4.429887143828186
Panc 02.03,11222830,1.865607722872823
KMS-12-BM,2126,3.610569458867974
IST-Mes1,49867930,4.491137344342606
ESS-1,9926054,1.828443058535804
SNU-213,10127622,-0.4888185859398967
Becker,4521392,4.384697789712053
SNU-119,31703,-1.023889627752851
Mono-Mac-1,10322450,2.242206847932455
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
KYSE-450,67156097,3.411841611974051
OAW28,3025944,4.579278298637093
ChaGo-K-1,6918328,0.4455436396012512
ChaGo-K-1,6918837,-3.3217715787792064
NCI-H196,73707398,1.4930546062583872
Mono-Mac-1,24978538,0.6361846953537684
AsPC-1,11612883,5.278069767960674
SNU-886,6852167,1.7356740395835049
Mono-Mac-1,2733487,4.00561651175431
Lu-65,9967941,2.1259265391153157
Karpas-422,4477,0.4453815636384887
BT 498,5287620,-2.66292935604836
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
SNU-423,73707371,4.995198662873275
HCC2108,5311,1.3772121830259485
Ri-1,navitoclax-PLX-4032 (1-1 mol-mol),-2.9137015839307265
Lu-65,10074640,3.7287414773273655
BT 248,11238147,1.7431248737974965
KYSE-450,navitoclax-MST-312 (1-1 mol-mol),1.0440074090451137
KMRC-20,241158,6.296391412542069
Panc 02.03,5329102,3.1751218779490404
SNU-886,11612883,1.6070499462687953
BT 286,10410894,2.24933683770091
Becker,tretinoin-carboplatin (2-1 mol-mol),4.919710353741397
KYSE-180,11234052,4.637440527326196
KYSE-180,46199207,3.0515921936822092
BFTC-909,3025944,6.464154930724253
KMRC-20,42642645,1.4773611251579275
NCI-H196,49793307,-2.562819319116333
WM793,2729026,2.380057317950378
BT 286,25102847,2.006913594269484
NOMO-1,16720766,-1.891739380903732
BT 498,73707398,4.023335284833002
NCI-H196,6505803,-2.584709085122825
NCI-H1339,10410894,3.449598840011211
BT 320,44607530,2.9331646844346015
SNU-213,44241473,4.380911531659556
SF539,136227331,3.3252279599925085
Mono-Mac-1,44491742,3.632264372511232
BFTC-909,3689413,0.9841636034152118
KYSE-450,53392493,3.727068470803864
OAW28,24951314,0.5571772807313425
Ri-1,448949,1.2663271999958974
KYSE-450,2749,3.233270096277708
NCI-H929,6918289,2.8956061350920796
KLE,24901704,2.3973635656707204
Becker,72734382,4.483386097403077
KMRC-20,5351362,2.3053530473648776
RERF-LC-MS,2871966,0.0193381278585586
Lu-65,4917,3.035155518535288
HOP-62,3689413,-1.4977119259076146
Karpas-422,451668,0.3348454552678767
ChaGo-K-1,4705,3.918553629962962
EHEB,carboplatin-UNC0638 (2-1 mol-mol),3.0000584339231655
H-STS,135411,0.6360583946211977
Kasumi-2,176870,2.2683953361762166
LXF 289,11396600,4.152956454399736
ChaGo-K-1,11626560,2.009486144157491
HuT 78,5113032,3.627590183655839
LMSU,JQ-1-vorinostat (2-1 mol-mol),2.553257799343416
AsPC-1,1716436,2.9196038383716205
HuT 78,46398810,2.0725080388247927
MIA PaCa-2,5460769,2.8270884799697833
CML-T1,5278396,2.8291940129393054
ESS-1,3689413,-0.979855371465586
RKN,51039095,3.7797830340785694
Mono-Mac-1,selumetinib-PLX-4032 (8-1 mol-mol),3.3595379048000016
MIA PaCa-2,JQ-1-carboplatin (1-1 mol-mol),-0.0764118739989751
BT 320,53495165,1.9791180905331631
Ri-1,216468,0.3321468769751489
MJ,5566,1.0904788098650933
SW1783,25150857,3.7084233172602543
OAW28,46199207,3.397949359639469
NCI-H209,navitoclax-MST-312 (1-1 mol-mol),-1.744735354858028
Panc 02.03,10231331,3.962628244123872
NOMO-1,11964036,-1.1045639043109698
NCI-H1339,3081361,3.920928785225322
SK-UT-1,11497983,5.637939301868167
SNU-213,10302451,1.063572133551757
BT 328,2949965,3.033023429372895
BT 498,3062316,3.575496868301237
WM793,11152667,-0.0685864179324616
NCI-H1339,JQ-1-UNC0638 (2-1 mol-mol),1.853432296866984
Namalwa,alisertib-navitoclax (2-1 mol-mol),-1.1691420603669722
LXF 289,24753719,4.56569970094865
SNU-886,5284616,2.6710721615639765
Namalwa,4788,5.300896204344617
Karpas-422,89183176,2.312208291072324
Karpas-422,10296883,3.4516705884612704
Ri-1,15953870,1.4105014554932769
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
BT 248,4917,1.8494335305709009
BT 248,11640390,5.783520002908773
HOP-62,6852167,3.1179431190301226
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
NOMO-1,6918328,-2.206625897840938
ESS-1,11364421,-5.252170636700316
KMRC-20,11626560,2.2175468532986353
KYSE-180,9911830,2.764203258021631
AsPC-1,46843906,4.099754684530221
BFTC-909,421610,2.763760389372973
KLE,72376,-2.1064714455436855
BT 286,15953870,3.897211275702576
SNU-886,17759555,4.113713798253048
MIA PaCa-2,16659841,4.320188843200875
BT 498,3543504,5.593933324078399
ESS-1,568763,-1.0434791743348584
KYSE-450,44185566,3.113770819226177
LXF 289,11625818,3.3628594045115805
LXF 289,46224516,3.632609368126253
CML-T1,BRD-A02303741-navitoclax (2-1 mol-mol),1.3394174355089614
PE/CA-PJ41 (clone D2),445091,4.262366084021789
SK-MEL-5,5978,-3.2421152375449656
SNU-423,168313200,4.217782003449994
RKN,654092,-2.299209260296745
BT 286,148198,-5.76188834046235
PE/CA-PJ41 (clone D2),9866186,0.8086133009925387
Mono-Mac-1,46907787,-0.5681517995940845
ESS-1,JQ-1-navitoclax (2-1 mol-mol),-0.1704578961514246
IST-Mes1,5282054,4.276236228318484
RERF-LC-MS,445091,4.218142840499499
RKN,16038120,2.2721636156695357
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
Karpas-422,11955716,-2.575404342374506
SK-UT-1,5278396,3.7471831605219665
Becker,46224516,3.0790320889380376
SNU-119,4261,2.6486100655772407
NCI-H929,24785538,-4.700293187910172
AU565,51039095,3.3315580468624795
ChaGo-K-1,docetaxel-tanespimycin (2-1 mol-mol),-5.262192441392657
BT 328,11257553,2.5148124289145217
PF-382,151289,0.3016891931318033
SK-UT-1,25183872,-1.299930208238578
HEC-108,6610355,5.333623813086721
OAW28,44489675,3.928609606447794
IST-Mes1,12003241,-1.7187710036837192
HEC-108,25126798,3.8368047255927937
BT 286,4259181,0.6646990868644945
EHEB,216468,1.5463895294433374
BT 498,3634881,2.0541278251409967
SNU-886,322968,1.7797157277210858
OAW28,11964036,1.3272537866850969
Lu-65,6918837,-1.5228157707828325
BFTC-909,49793307,-2.946331542038894
BT 328,2828334,7.045901610155557
NCI-H2030,11626560,2.673199757356022
HuT 78,10322450,2.3335862951913726
IST-Mes1,44819697,0.965138597180618
SNU-886,25062766,2.1597541933468176
H-STS,docetaxel-tanespimycin (2-1 mol-mol),-7.723560174899757
KMS-12-BM,89928392,-0.4987831925576881
Panc 02.03,24821094,4.183998590604807
LMSU,445091,4.667050820468158
LMSU,156414,1.5302250641749746
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
KMS-12-BM,11977753,-3.492184366851405
SK-MEL-5,11977753,-1.7055633614852417
Lu-65,15547703,2.7015957132035235
Mono-Mac-1,4259181,0.0400691688405866
SNU-423,6918878,2.1961765683595824
HOP-62,alisertib-navitoclax (2-1 mol-mol),2.154425400396672
HuT 78,piperlongumine-MST-312 (1-1 mol-mol),0.3660386442956273
NCI-H2030,tanespimycin-gemcitabine (1-1 mol-mol),1.9623173242369956
Mono-Mac-1,135999136,5.618936483472871
LXF 289,71466578,4.726723075051965
HuT 78,5951923,5.985995138810963
LXF 289,46398810,1.8383298322371264
ChaGo-K-1,3465537,1.3270593672392677
Karpas-422,16038120,0.9032962171449342
HCC2108,44819697,4.4512579007259605
HOP-62,51039095,2.57567623107321
ChaGo-K-1,selumetinib-tretinoin (2-1 mol-mol),5.3341429737585235
KMRC-20,76446078,4.8666377437919985
Mono-Mac-1,5351362,0.6625592378948421
SF539,selumetinib-vorinostat (8-1 mol-mol),3.0121970622277248
SK-UT-1,SNX-2112-bortezomib (250-1 mol-mol),-2.387755678466967
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
NCI-H929,3025986,-2.370688030167058
NOMO-1,5291,3.5817896511091862
HEC-108,969516,3.1177295269090664
NCI-H2030,400769,-0.4492735508687972
BT 286,doxorubicin-navitoclax (2-1 mol-mol),-4.326574011981579
WM793,24753719,4.8266947199238786
SW1783,446155,0.9196184562402074
SNU-213,9825149,1.6899494716129702
Namalwa,46398810,2.631129060708828
SK-MEL-5,10302451,3.6618185056536574
HuT 78,46901937,3.36235026237692
NCI-H196,439501,-2.4399998682634023
LMSU,168312962,4.105800122245941
NCI-H929,16722836,-0.2091076703747729
BFTC-909,6918289,3.427790661189136
Ri-1,241158,1.4314385956610491
KYSE-450,44137675,3.8479858767038944
BT 286,selumetinib-vorinostat (8-1 mol-mol),-2.316984046450598
NOMO-1,135421197,1.2386186938920458
LXF 289,409805,5.2068809837223435
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
BT 286,decitabine-carboplatin (1-1 mol-mol),3.3032754794024783
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
BT 498,JQ-1-vorinostat (2-1 mol-mol),3.377257047018318
Panc 02.03,5746,2.615751109567445
NCI-H196,6918837,-2.8537078535104583
LXF 289,5287620,-2.3080718171081385
BT 248,44185566,1.9117845458549376
MIA PaCa-2,49867926,4.1553717841567215
RKN,2828334,5.965623907482328
Kasumi-2,navitoclax-piperlongumine (1-1 mol-mol),-3.156994425462095
SNU-423,BRD-A02303741-navitoclax (2-1 mol-mol),3.25284280837799
MIA PaCa-2,6610355,4.178666278984774
Namalwa,4259181,0.072491305186228
BT 328,6914657,-4.350943519439018
LXF 289,24772860,-1.828128181459349
HCC2108,selumetinib-tretinoin (2-1 mol-mol),5.736477688995886
AU565,5281321,-1.6701173206544262
BT 286,44607530,0.996307301304738
HCC2108,JQ-1-vorinostat (2-1 mol-mol),1.5555198543953237
NCI-H196,11364421,-2.6143973725469105
SF539,navitoclax-piperlongumine (1-1 mol-mol),1.805753462968184
AsPC-1,72193861,3.428817244246792
SNU-423,6852167,2.5596210289916765
SNU-886,9903786,2.951492144984292
KMS-12-BM,55508,1.5916377605400036
KMS-12-BM,25262965,-2.9423224876958525
SK-UT-1,984333,0.8652999578170681
H-STS,135421197,1.21674084203813
Becker,25262965,-3.2984826575287567
BFTC-909,6914657,-4.61933610547547
BT 248,4259181,0.8166391520482507
BT 328,11238147,2.054089677039581
HCC2108,2858523,2.774928001952886
BT 248,16219061,2.5057647005845354
Namalwa,448949,1.3938539452302794
BT 286,46843906,3.946750094075013
SK-MEL-5,16720766,1.2054685868185928
BT 320,46224516,3.0907007884048636
LMSU,44491742,4.063120482610564
MIA PaCa-2,11609586,2.31009126134966
KYSE-450,9911830,2.46681001783931
ESS-1,71466445,5.77037971840281
SNU-886,16038120,0.7187516548960445
Lu-65,5566,3.0755263242303528
SNU-213,4096211,4.225121711422805
IST-Mes1,60700,-0.0817355864677207
IST-Mes1,285033,-1.625614851116669
SNU-119,11178236,-5.208015951508076
RERF-LC-MS,53495165,1.4938275665549956
KYSE-450,11612883,5.465517956514392
CML-T1,25195348,1.1650045100950834
MIA PaCa-2,JQ-1-navitoclax (2-1 mol-mol),-0.3337062531421545
KMS-12-BM,56963564,-1.528308653494457
NCI-H1339,navitoclax-MST-312 (1-1 mol-mol),0.9103160746312428
Namalwa,16065773,1.7637307024944335
BT 248,1716436,2.58950342299198
RKN,5113032,5.131058822839954
HEC-108,16038120,2.2224846611744957
ESS-1,2733487,7.1971924455192955
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
SF539,327653,3.3770394007544953
Kasumi-2,9884685,-1.7492969798518767
KMRC-20,89928392,2.0741009557442487
HuT 78,5311,-0.4427844433748262
BT 498,25150857,2.6595117105682298
AsPC-1,6918837,-2.7365580441764155
OAW28,54618164,4.207465894202405
NCI-H1339,3062316,3.21375908835857
ACC-MESO-1,25183872,0.7454056301967538
PE/CA-PJ41 (clone D2),9911830,2.474692527897134
ACC-MESO-1,16741245,1.697213973554462
BT 328,9956119,4.461775202302022
HuT 78,2749,0.3933024099015727
NCI-H1339,6610355,4.7012470310276875
EHEB,31703,-2.7035431722217744
LMSU,15547703,4.748920610126263
ESS-1,148124,-6.743563487136813
Namalwa,10302451,0.420511059814922
RT-4,44607531,2.8716913439843803
PF-382,654092,-2.265760863591032
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
SF539,25183872,-1.8165850981931693
KMS-12-BM,25105715,2.85606918803758
EHEB,3062316,0.0300315004197751
KYSE-180,11625818,4.6401032525686
Karpas-422,5335621,3.688273816665903
Kasumi-2,25227462,-2.512802493882235
KYSE-180,10127622,5.464942572598225
AU565,56963564,-0.3705062094323867
HOP-62,24771867,2.21478649865432
CML-T1,16741245,3.55536863016822
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
BT 286,1566236,1.6712159772486277
BT 286,72193861,1.711789672532825
NCI-H1339,262093,3.4716839644219246
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
BT 248,11455910,-0.0312737668402554
LMSU,3038522,2.183221848979368
Lu-65,5287969,-1.6782757581231496
HOP-62,10302451,2.804324049095648
SNU-119,72193861,1.9875714401022249
PE/CA-PJ41 (clone D2),53392493,3.504289946236342
BT 328,387447,-3.18043057197166
NCI-H929,107970,2.2964601738289687
ESS-1,73707398,0.9452333213652502
SNU-886,11507802,1.52809997396743
NCI-H196,89928392,1.4109494619621703
Kasumi-2,15983966,-4.769110499873103
LXF 289,12001922,1.5738020993239468
SF539,16722836,1.315642485980416
AsPC-1,25154868,4.981069474579037
NCI-H2030,676352,2.9901891656883683
SNU-423,52947716,3.098528991071038
SF539,16659841,3.270548926893477
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335
EHEB,6610355,4.225572519993169
BT 498,44566777,-0.1124506153493127
ESS-1,7326481,3.8932312053689873
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
Karpas-422,135440466,2.948344321983633
SNU-886,11455910,-0.4283095081187237
HuT 78,702558,5.694592487661442
BT 286,5328940,1.8588280079046673
SNU-213,3038522,4.259011590979997
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
HEC-108,49793307,-2.56694084675293
Karpas-422,44632017,0.8686663662207279
SF539,135398516,2.131078137574097
OAW28,4521392,4.353680801577448
NOMO-1,11640390,1.5691640408186416
AsPC-1,11364421,-1.021042778985214
NCI-H196,9936388,-3.664647197542574
PF-382,44137675,2.4985862116087283
ACC-MESO-1,2841722,4.126179141670728
RKN,6918328,0.5495182279950256
SNU-119,122327,4.167274545692746
CML-T1,7326481,2.1414014754107735
MIA PaCa-2,9911830,2.066034374401692
KMRC-20,44259,2.7583820903803695
RKO,984333,1.1849980625737155
KMS-12-BM,6918878,0.6296559584919736
SNU-119,vorinostat-navitoclax (4-1 mol-mol),2.3396657030551684
NCI-H1339,9927531,5.416434112117517
LXF 289,15547703,4.3915240757493565
MIA PaCa-2,46215462,1.498613405861276
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
SNU-886,24771867,1.589817907725939
NCI-H929,51039095,0.5625919712885992
HuT 78,25161177,3.1402397670522877
BT 328,11427553,3.9535129095984054
Ri-1,20959075,-3.551913416843835
NOMO-1,73707398,0.2786764614411772
HSC-3,carboplatin-UNC0638 (2-1 mol-mol),3.049969024774373
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252
KMRC-20,JQ-1-UNC0638 (2-1 mol-mol),2.8287414261232744
CML-T1,11167602,0.5863351465273275
SK-MEL-5,969516,2.7494090939853804
SNU-119,navitoclax-piperlongumine (1-1 mol-mol),1.89121393785076
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
NCI-H929,5281672,4.191985707125186
NCI-H196,2729026,3.1386730408201187
BT 320,15983966,3.4202708205912087
HEC-108,36314,3.0566190608483015
Ri-1,3025944,3.3507725240035864
Lu-65,4261,0.8426070626178986
IST-Mes1,126941,-2.6873860553959754
NCI-H929,JQ-1-vorinostat (2-1 mol-mol),-1.9493300173988888
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658
Ri-1,71466578,3.32101497363571
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
NOMO-1,10385095,1.0593467546243338
BT 286,salermide-PLX-4032 (12-1 mol-mol),4.140353758250688
KMS-12-BM,11719255,0.7474259860262262
PF-382,6505803,0.1218702134100329
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
PE/CA-PJ41 (clone D2),445455,4.423683569648825
PF-382,17755052,0.5460645234403898
MJ,5394,2.8816454661396698
OAW28,54649381,3.786658613217657
SK-MEL-5,11364421,0.3059082232055436
SK-MEL-5,JQ-1-UNC0638 (2-1 mol-mol),3.706409053077637
HSC-3,60700,-0.4613248471359459
HOP-62,9926054,1.899267170249981
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006
ChaGo-K-1,25105715,3.5734509146637032
BT 286,7251185,1.6595733363638832
HOP-62,2871966,1.1314603098656817
KMS-12-BM,50905018,3.0779303184533076
SNU-886,12003241,-3.694795257520175
ACC-MESO-1,135398516,3.573192480677428
BT 286,12003241,-0.6969940125697452
LMSU,5328940,2.811876730497891
NCI-H929,65628,3.950811987229233
NCI-H1339,2749,2.6760815783008787
Lu-65,4788,5.124191932628282
RT-4,3815108,3.2555557052481
Becker,51037431,2.3347522905676037
EHEB,11656518,-0.4921898134750562
Kasumi-2,44462760,0.6612462691358557
H-STS,25126798,3.914537201699023
BT 248,135421197,1.5349499708791383
HSC-3,doxorubicin-navitoclax (2-1 mol-mol),-0.4787085696617523
SNU-423,8515,4.7137159265579225
ChaGo-K-1,3025944,4.403252616983074
ESS-1,9956119,4.049525614029127
AsPC-1,439501,-1.6009280184427317
H-STS,12001922,1.5454673867103017
SW1783,crizotinib-PLX-4032 (2-1 mol-mol),3.4336355505770317
SW1783,24964624,3.0506533345729245
SNU-213,10184653,0.2023790634763856
RKN,11175137,3.1657803092866224
SK-UT-1,135398738,5.687512813913111
HOP-62,52912189,4.806129419715892
BT 498,135875424,3.150429417088691
H-STS,vorinostat-navitoclax (4-1 mol-mol),1.152799818591655
IST-Mes1,135411,1.0362911335756892
IST-Mes1,9840324,6.735519666210419
NCI-H1339,10302451,4.201130344992501
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
NCI-H196,5113032,4.880688917429165
Lu-65,11404337,-0.485331944829254
BT 248,24180125,1.9773901044414168
RT-4,24964624,3.0687805889747977
CML-T1,753704,4.085313154725238
Namalwa,6918878,-0.0380235771387645
Namalwa,24771867,-1.506492255683234
BT 328,46224516,3.135960011776331
HuT 78,25102847,2.213703306492941
Namalwa,11494412,-0.23219160030294
KMS-12-BM,11404337,-1.6165924780935808
PF-382,10184653,0.9152232637437828
IST-Mes1,navitoclax-pluripotin (1-1 mol-mol),-0.6633970571557571
SNU-119,3081361,1.3460457927796947
SW1783,54618771,3.657201070811366
KLE,54618164,4.225211860569233
BT 328,4096211,3.6600455300853154
Karpas-422,9840324,5.92160025158539
SK-UT-1,969516,2.241121714943991
NCI-H2030,168313047,3.7381994867050703
SK-MEL-5,262093,3.0272532373657848
KYSE-180,15953870,2.8572759517399677
KMS-12-BM,54613361,-2.0656544481167085
BT 286,3384730,0.7645214338465928
NCI-H929,JQ-1-navitoclax (2-1 mol-mol),-1.7995914527242012
HSC-3,51039095,3.0016489760435294
Lu-65,25126798,4.1024131872823055
NCI-H929,107985,-4.785949324647598
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216
BT 286,16219061,2.6372151747686954
MIA PaCa-2,67156097,-1.2297933208564042
HCC2108,637858,1.810315688111992
RT-4,9907093,5.696541057936112
MJ,tanespimycin-gemcitabine (1-1 mol-mol),-2.1107286873488356
H-STS,25227462,-1.51229280635868
KYSE-180,67156097,-0.5044651468589622
HEC-108,vorinostat-carboplatin (1-1 mol-mol),3.8874971320983143
HEC-108,654092,0.6558774071347439
Kasumi-2,16065773,1.6844864290683614
BT 320,selumetinib-PLX-4032 (8-1 mol-mol),4.7621521702079175
PE/CA-PJ41 (clone D2),5287969,-1.8325693318378895
KLE,9826308,0.0278909201933885
KYSE-180,54613361,-0.6142200008025552
RT-4,25126798,3.4225327599877096
ESS-1,16659841,3.2976235988863554
HOP-62,54649381,3.909621773040776
AsPC-1,568763,2.040921390287386
Mono-Mac-1,6918328,-2.339991136558335
ESS-1,6438330,2.0697444258880173
PF-382,46174525,2.636073374054482
NOMO-1,5311281,1.2143454060885572
SNU-886,241158,1.2144772988451973
RERF-LC-MS,24901704,2.6292316786888295
MIA PaCa-2,10385095,0.818601661096134
ESS-1,selumetinib-tretinoin (2-1 mol-mol),5.525028519961577
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
IST-Mes1,24951314,2.196137261882708
CML-T1,9936388,-6.3994005254305995
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
PF-382,5281321,-2.364322655239298
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
OAW28,44489675,3.928609606447794
PE/CA-PJ41 (clone D2),5281321,-1.4532998106593589
Karpas-422,11228183,1.4854836377169958
HCC2108,44241473,4.848973928948178
NCI-H929,44137675,0.5857297222034469
BFTC-909,51037431,4.63288955594681
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
NCI-H196,107970,2.3706951810586068
AsPC-1,327653,4.351823995090995
HuT 78,227681,1.5978856071996634
ACC-MESO-1,119607,5.522701718625694
KMS-12-BM,2742550,3.02175924738708
AU565,53392493,1.7262495119460306
SF539,148124,-5.79726265481526
NCI-H196,452548,1.1867613213126158
SNU-886,11647372,1.0041621658196034
HuT 78,5494449,0.26098093907273
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
RT-4,3038522,5.726431253424827
NCI-H1339,445455,5.209347585146279
Ri-1,71466380,3.5240850403725426
Panc 02.03,439501,0.4668648826805023
LXF 289,11222830,2.2114905387790755
SF539,46843906,2.6895390724819253
MIA PaCa-2,1750826,-3.667978190943184
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759
NCI-H196,46224516,2.3441046962939622
H-STS,10184653,1.7921408702106925
RERF-LC-MS,446155,1.000000375050646
RKO,613753,3.427719504210608
SNU-119,24889392,3.5636549899822194
RKN,5328940,2.201806852003849
KYSE-180,10385095,1.0867111286980162
KMRC-20,216345,4.461604453697398
SF539,24775005,3.2878443565215987
KYSE-180,409805,5.709174911109602
AU565,216239,2.683840039589205
Lu-65,vorinostat-navitoclax (4-1 mol-mol),0.9928473166705348
NCI-H1339,135398738,5.033311384632643
SK-UT-1,107970,2.916039273405532
KYSE-450,navitoclax-sorafenib (1-1 mol-mol),2.514511411707921
SNU-423,JQ-1-navitoclax (2-1 mol-mol),1.222088007808966
KYSE-180,5460769,3.044274290576871
BFTC-909,374536,2.594742723017773
Ri-1,444795,2.8789748064532823
H-STS,16659841,4.209446171340807
KMRC-20,44819697,1.1580347805946598
SNU-119,54618164,3.949548457526877
HCC2108,5287620,-1.7107453647651585
NCI-H1339,11214940,4.423314112627096
Mono-Mac-1,crizotinib-PLX-4032 (2-1 mol-mol),1.1974443887432722
NCI-H929,168313047,1.9193676847223529
OAW28,119607,5.347849335106357
SNU-423,6918736,-1.750514789581466
BT 286,60700,-3.766952299365687
SK-UT-1,2874250,6.155994559300563
SNU-886,5566,3.303161938775539
HOP-62,5328940,2.0909155724009287
WM793,24772860,-1.904667330479004
OAW28,72193861,2.7871547903709266
HuT 78,441298,1.9970992526454237
RT-4,135928012,3.02526945611553
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
NCI-H1339,11396600,3.0711399080961934
Namalwa,148198,-5.5603375502023
MIA PaCa-2,9915743,0.7812754347673511
SK-UT-1,46843906,3.6979645993744032
SNU-213,5460769,1.7717518807864931
LMSU,107985,-1.9062813049718328
HOP-62,navitoclax-sorafenib (1-1 mol-mol),1.723589528182747
KYSE-450,11178236,-2.864393215026398
BT 328,73707398,2.390014521827579
HOP-62,11222830,1.3014701308472565
AsPC-1,52947716,3.328482082087177
NCI-H929,3503,1.25684257431255
AsPC-1,16219061,4.6595447221902955
Lu-65,6438330,4.885617436818886
SK-UT-1,3025944,4.81857732958154
CML-T1,crizotinib-PLX-4032 (2-1 mol-mol),-0.082010794969092
BT 320,72376,3.3397736941212433
EHEB,984333,0.8159443893987631
Mono-Mac-1,17755052,0.0767939682825722
OAW28,23725625,6.509051762822527
Lu-65,navitoclax-MST-312 (1-1 mol-mol),0.9653028056890602
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
AU565,9926054,0.9817648939808896
H-STS,1566236,1.8552051664221092
Ri-1,44137675,-1.093711141379852
Lu-65,6852167,2.6497392225444103
OAW28,5566,3.0868855994062137
MIA PaCa-2,387447,-4.141831839994585
RKO,54678924,1.753529637740366
LXF 289,5351362,2.37199640031851
MJ,168313200,3.5794941200353514
OAW28,53495165,3.30177539085494
IST-Mes1,piperlongumine-MST-312 (1-1 mol-mol),2.506000344733661
LXF 289,10074640,2.806214579062189
ACC-MESO-1,6610216,4.642819431262072
SNU-423,9936388,-4.810408284387772
BT 286,10127622,-1.2732169388544852
BT 248,644241,1.8454939937856112
RT-4,selumetinib-vorinostat (8-1 mol-mol),2.4962461169474084
CML-T1,6610216,3.6071739537574863
BT 328,docetaxel-tanespimycin (2-1 mol-mol),-0.9357205348249352
CML-T1,11234052,1.4016611587884042
BT 498,1716436,3.5174688270474923
LXF 289,17759555,2.434653643868842
PE/CA-PJ41 (clone D2),56649450,2.1051297783430187
KMS-12-BM,656346,0.20048229693813
RKO,5329102,2.192208184281935
SK-UT-1,135999136,1.6451873526214251
Namalwa,16013152,3.948657270974704
NCI-H929,10410894,3.741769756077017
Namalwa,126941,-4.3558657962175396
CML-T1,carboplatin-etoposide (40-17 mol-mol),-0.8203492199596885
AU565,3676137,4.605193047317769
BT 286,9967941,4.666112297990241
H-STS,72734382,4.174468427359164
Namalwa,81146,4.387935606174053
Lu-65,9935249,3.101131829236005
ChaGo-K-1,tanespimycin-gemcitabine (1-1 mol-mol),0.5067754366627312
Ri-1,56946209,-5.333405443135551
RKO,5311,2.326095881991792
SW1783,52912189,3.916642045529953
AsPC-1,11497983,4.51017072011312
EHEB,327653,2.436506136039934
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
NCI-H196,selumetinib-navitoclax (8-1 mol-mol),4.633179682093875
KLE,decitabine-navitoclax (2-1 mol-mol),-1.0020457102212554
PF-382,10074640,2.4256064634454884
KMS-12-BM,613753,2.6976812863702277
SNU-886,72199292,0.8312064221987397
OAW28,4788,5.61832216329738
RKN,44185566,3.394049733904779
KMS-12-BM,3062316,1.283927819580485
HSC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.001735081038066
KYSE-450,4259181,0.2433830255631184
SNU-886,2733526,4.210800511502518
MIA PaCa-2,5479543,3.424758886953834
ACC-MESO-1,387447,-3.5837310917006384
KMS-12-BM,11964036,-0.4657573927084836
Namalwa,135421197,0.8963594643304925
MIA PaCa-2,9884685,0.7084207681532095
KLE,navitoclax-pluripotin (1-1 mol-mol),-4.415890697426241
BT 286,216468,1.073793666658399
ChaGo-K-1,72193861,1.1879509711321792
BFTC-909,11656518,3.71751997684089
HSC-3,navitoclax-birinapant (1-1 mol-mol),-1.4061179827525565
NCI-H196,54649381,4.303776340582988
Mono-Mac-1,24951314,0.195026284018331
Kasumi-2,702558,4.897760229735286
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
KYSE-180,46191454,1.2517200441796488
BT 328,227681,3.8990040378810544
SF539,3136844,3.725452843586701
AU565,16736978,1.4090353018278403
BT 328,9803433,4.554547423924098
NCI-H929,638278,2.7948371949110205
AU565,46943432,5.0196372017891555
SF539,selumetinib-piperlongumine (8-1 mol-mol),3.2935785565458424
SF539,11964036,0.8812555480716474
BFTC-909,16725315,4.495652912061774
NOMO-1,9911463,3.1879476164010243
SNU-119,11364421,1.6270559776007496
SF539,6505803,-2.26727491960267
SK-UT-1,135440466,3.5602856179357327
OAW28,9907093,4.094861416701174
H-STS,400769,-1.1927584059737322
HOP-62,11719255,5.763967823522321
Becker,8515,4.701222217711314
SNU-213,44819697,-0.0885228429048293
RKN,3025986,-0.1432368238740909
SNU-119,6918837,-0.1720170696149332
ChaGo-K-1,126941,-6.179924649296775
MIA PaCa-2,15953870,2.730980253379173
H-STS,135928012,3.8653043239054976
ACC-MESO-1,135999136,6.41791740965286
BT 248,25262965,0.9142276489527752
SF539,6610355,4.186308559739079
Becker,89928392,3.138737458608371
NCI-H1339,2828334,5.983574272220661
SK-MEL-5,8515,4.00227623893396
BFTC-909,5738263,3.1091802601858185
HuT 78,2126,1.4144801662515558
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
HCC2108,54618771,2.799542688239582
Mono-Mac-1,9884685,-0.2142901784268321
SNU-886,navitoclax-piperlongumine (1-1 mol-mol),-7.772241665279227
OAW28,285033,-1.6788024908058845
ACC-MESO-1,10127622,5.935815768092786
BFTC-909,23725625,7.000464253417552
BFTC-909,613000,3.1980696015333137
PF-382,5113032,5.313987207149933
HOP-62,2126,3.9968391108859063
RKO,285033,-2.0365968290915393
Mono-Mac-1,3081361,1.9126925710117495
SK-MEL-5,25150857,2.2941529310638877
KYSE-180,11485656,1.9289585779871232
KMS-12-BM,9911463,2.0749809508981256
NCI-H929,11364421,-2.397738455551311
AU565,2842253,5.995707097044385
HuT 78,5287620,-2.72818029260661
PF-382,10410894,2.6681125550608025
Lu-65,2874250,6.215177714586098
NOMO-1,637858,1.0893367728071195
HCC2108,10231331,3.026437227257123
ChaGo-K-1,89928392,2.9195597645126945
HuT 78,57519531,1.7150629071467791
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
NCI-H196,2841722,5.547130593063546
NCI-H196,4917,3.669562562302993
BFTC-909,56946209,-2.8280109825858943
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
Becker,969516,2.296759639012105
NCI-H929,4259181,0.6476848617762108
PF-382,3634881,2.1354287574506117
SNU-886,9926054,2.2284003182480774
Namalwa,25154868,4.619245763975098
HSC-3,409805,5.892445537848464
PF-382,4917,2.62124804307342
AU565,11228183,3.2105327090314133
Panc 02.03,448949,3.46549633046868
HEC-108,89928392,1.8334971858898483
NCI-H196,9911830,5.051951455628038
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
Ri-1,11683005,3.8644579101571663
Ri-1,5311,-0.1594609946430047
HCC2108,3815108,3.7436297083403938
ACC-MESO-1,JQ-1-vorinostat (2-1 mol-mol),1.9444643692658088
CML-T1,375860,-0.8039918924580166
BT 498,135659046,3.899086642972748
HOP-62,5351362,1.162394565524452
OAW28,25126798,4.214847534438453
AsPC-1,4521392,4.0696198883268275
HuT 78,637858,0.0090449520272635
Karpas-422,24772860,-2.5980734738396567
Lu-65,46843906,3.4533673258167954
IST-Mes1,44487872,4.402175961022997
EHEB,3634881,2.279328443256432
Namalwa,9967941,3.9551429015919
H-STS,25102847,2.763833752411945
HOP-62,216239,1.9534304158746405
HuT 78,11485656,1.3035734242835073
WM793,322968,3.984805339497546
Ri-1,JQ-1-vorinostat (2-1 mol-mol),-1.3537009805514455
KYSE-450,168313200,3.958386537902572
HuT 78,148198,-3.964995663982544
SF539,42611257,2.369438053162354
BT 248,753704,4.567621051188063
LXF 289,135421197,2.6553019911408056
BT 248,46215462,2.381699206499341
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918
HEC-108,doxorubicin-navitoclax (2-1 mol-mol),-1.1181452203598452
SK-UT-1,46926350,-4.372914941162361
PF-382,navitoclax-pluripotin (1-1 mol-mol),-4.412096991385023
RERF-LC-MS,89928392,3.2509495975064193
PE/CA-PJ41 (clone D2),104842,-2.4434720439613127
LXF 289,11612883,1.9814919247106189
NCI-H1339,219104,4.587065461273761
NCI-H196,65064,4.372824187509945
HCC2108,11485656,2.4652137706419137
NCI-H1339,375860,-0.3541433845632409
HOP-62,42642645,-0.4674089233275948
NCI-H929,151289,1.2109794778223528
KLE,49850262,3.3302068182628393
ChaGo-K-1,16720766,0.9883407566157564
ChaGo-K-1,9825149,2.134765038111806
HOP-62,23582824,-0.2188858267384983
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
IST-Mes1,119607,5.839609606963759
SNU-213,11485656,2.091894408723056
BFTC-909,44259,1.3269924163099676
Mono-Mac-1,219104,2.665185592268247
HOP-62,navitoclax-birinapant (1-1 mol-mol),2.4233787895619487
HuT 78,4578,4.42076549518963
ACC-MESO-1,135440466,2.2679972756943987
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
LXF 289,9840324,4.681234496405457
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091
KLE,crizotinib-PLX-4032 (2-1 mol-mol),3.0491582374844723
RKO,5280436,4.655813696583822
AsPC-1,10231331,1.7826677656602696
ChaGo-K-1,10302451,4.275291921166029
Mono-Mac-1,2126,3.9956645703631666
AsPC-1,9967941,3.911764573168509
WM793,67156097,1.6522934388361206
Mono-Mac-1,25126798,3.343794523028253
BT 286,1242560,3.590885965949965
HCC2108,piperlongumine-MST-312 (1-1 mol-mol),1.4523587020205275
HSC-3,6918328,0.3384783511123991
HSC-3,5746,0.0203057913802775
OAW28,400769,-1.4620594490922918
NCI-H1339,4477,0.5176181920473496
ChaGo-K-1,4259181,-4.05678240495267
NCI-H1339,51037431,4.307498887080274
AsPC-1,126941,-0.909933311518488
HCC2108,60700,1.0851578183191786
SNU-213,2749,2.01271461042932
NCI-H929,46199207,3.0580701159443766
AU565,176870,1.580958212812136
Karpas-422,25154868,5.247703712225478
WM793,613753,3.3762732235563733
Becker,81146,4.883737622281325
AsPC-1,12001922,2.2862775547931675
KYSE-450,ISOX-bortezomib (250-1 mol-mol),0.3236912354061821
RERF-LC-MS,1641662,3.403538628142178
OAW28,123631,1.649178742735097
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
ESS-1,24964624,3.0338116933926735
KYSE-450,462382,0.9133555690572344
Mono-Mac-1,9903786,0.9536797288397608
BT 286,135659046,3.5488699738704432
WM793,3503,2.6868893579078006
SW1783,44185566,3.100049600805726
Karpas-422,322968,2.538876581792157
LMSU,8515,4.269991680871031
MIA PaCa-2,selumetinib-navitoclax (8-1 mol-mol),2.356546555669427
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
Panc 02.03,10302451,3.706546166543765
SK-MEL-5,568763,0.9376173789152876
HOP-62,3825829,4.170218994796182
ESS-1,44607531,1.6327452604769903
PE/CA-PJ41 (clone D2),24856436,1.5751990412346553
MJ,2749,1.2624455241951358
Mono-Mac-1,11214940,2.191892992947718
SW1783,tretinoin-navitoclax (4-1 mol-mol),5.880695853154788
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
RKO,15983966,1.976330033309676
BT 286,15983966,1.706586921281891
SNU-119,5284373,1.050197910759818
KLE,135984461,1.6662233005465323
BT 328,3503,3.047903158140159
SW1783,46191454,4.39093757555096
Kasumi-2,11640390,2.994278179386077
CML-T1,445455,4.626862894514658
NCI-H929,148198,-3.717368743483661
OAW28,9884685,1.3567472374362477
Karpas-422,JQ-1-UNC0638 (2-1 mol-mol),-1.394772143472039
NCI-H929,124202324,1.4595728205494207
CML-T1,9887053,1.7753443459725933
Becker,44819697,-0.6778092127374704
RKN,9967941,2.6996754619948065
AsPC-1,2729026,3.0501658646319796
PE/CA-PJ41 (clone D2),53495165,-0.6517072813998595
BFTC-909,25105715,3.3944682152224455
NCI-H2030,9911463,4.399921690700774
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
SF539,72734382,5.710474447466601
PF-382,54613361,-0.7673282016613778
CML-T1,salermide-PLX-4032 (12-1 mol-mol),4.618653772046038
Lu-65,89183176,5.539944953304831
RKO,11396600,3.504834935214814
BFTC-909,82146,3.493415453952883
SNU-213,selumetinib-MK-2206 (8-1 mol-mol),-0.2586478319753106
Kasumi-2,4578,4.103424218787652
NCI-H1339,25105715,3.779280194220663
KMS-12-BM,44202524,0.8101877803602248
MIA PaCa-2,16736978,1.1146080849337705
IST-Mes1,5311,2.113640627204962
ChaGo-K-1,6852167,1.9816298194521569
AsPC-1,262093,3.2992304028365926
ChaGo-K-1,400769,-0.9998240126612606
NCI-H929,11625818,1.510489676264857
BT 248,3854666,2.6170510866367955
PE/CA-PJ41 (clone D2),54678924,3.100957634297122
Lu-65,446155,0.5614057813043029
CML-T1,638278,3.0153915179905098
SK-MEL-5,148198,-1.053859411744173
NCI-H1339,135440466,2.8677664758976538
NCI-H929,676352,1.778414026340849
Ri-1,2828334,5.647865236669552
SF539,24785538,1.1616917641832667
MIA PaCa-2,2708,5.768507038607672
MJ,5746,-0.072159634538125
SF539,637858,1.5175949767978318
HEC-108,44185566,2.966044024818036
OAW28,107970,2.4537130721494105
PE/CA-PJ41 (clone D2),3465537,3.306521730536944
Lu-65,135440466,0.7027414116594601
BT 286,9935249,1.1744552926242438
BT 320,375860,4.032556785404055
HOP-62,46174525,5.003008160940451
SW1783,25161177,4.268571653873596
SNU-886,5351362,1.18697411300336
RT-4,107985,-3.170589180041932
SW1783,46174525,4.2531961544847885
HOP-62,11964036,0.1349768729321491
OAW28,10427712,4.195688642509306
NCI-H196,navitoclax-gemcitabine (1-1 mol-mol),0.0406343766358786
PF-382,159324,-2.108239526563577
AU565,400769,-0.800888344050601
MIA PaCa-2,107985,-4.172242964909647
HCC2108,46191454,1.2793271361980716
Lu-65,46174525,4.719153428448135
RKO,1566236,3.4833841973625725
BT 320,6917907,3.364777316338114
Namalwa,135659046,3.012855120581617
Ri-1,123631,1.8918959386766108
Becker,135875424,4.35709039626534
SW1783,11964036,1.4624651747986186
BT 498,246676,4.408890433497639
WM793,25126798,4.114576992305207
NOMO-1,9840324,6.741383080584752
SF539,16219061,3.124474327572297
RKN,44589607,3.09715941328701
SNU-119,16219061,3.5319077719330885
HuT 78,6438330,0.788518681331833
RT-4,navitoclax-piperlongumine (1-1 mol-mol),1.919426217940122
OAW28,135398516,2.0767833136681437
Karpas-422,5329102,1.479846875546867
PF-382,5284329,4.993412059506353
AU565,57330099,4.7929461834362606
Kasumi-2,135398744,8.02054113805855
ESS-1,637858,1.315760041448024
SF539,441298,1.510728884927333
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
ACC-MESO-1,76446078,4.183302819310867
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787
Kasumi-2,72376,-3.459838502439841
SNU-423,3689413,-2.448438848320713
HSC-3,11238147,1.6158665960047474
RERF-LC-MS,613753,3.34976336152667
BT 328,1716436,3.653949071950038
BT 498,44607530,1.702028923848098
ChaGo-K-1,10322450,2.8130717345361336
CML-T1,9911830,-1.528510322337235
H-STS,56963564,-0.0472332493661748
AsPC-1,5281672,6.419333790815674
BT 286,156414,1.5712991446224744
KMS-12-BM,126941,-5.220907783111232
MIA PaCa-2,3503,2.1121016304173468
AU565,3503,2.743681155949089
HOP-62,5738263,4.049243215173011
KYSE-180,107970,2.4041035075192196
PF-382,44489675,3.595955687856044
KLE,24748573,2.547641121756725
SNU-119,5351362,0.9137342384395012
MIA PaCa-2,24821094,3.7530351784505234
HuT 78,54626689,4.7254586853376175
WM793,71466578,5.303096396012995
BT 328,selumetinib-UNC0638 (4-1 mol-mol),5.206465568197119
LMSU,15983966,1.8709586957084512
MJ,11507802,0.1827831368767201
LMSU,54618771,1.0017714306772694
SNU-423,erlotinib-PLX-4032 (2-1 mol-mol),4.135123666689958
NCI-H196,446155,2.4623098053751677
BT 320,15547703,5.516273739658597
Lu-65,36462,1.7650112764581103
Karpas-422,375860,-0.2340212994929422
SW1783,3689413,0.540292166648154
HuT 78,10184653,1.1494734571444012
BT 498,72193861,3.1486454761975917
ESS-1,67291369,3.683100317554582
Namalwa,5280436,1.768996655798306
HuT 78,11625818,3.646817685983461
Karpas-422,3385,3.70826421332824
Karpas-422,selumetinib-tretinoin (2-1 mol-mol),4.3301952364803915
Ri-1,navitoclax-MST-312 (1-1 mol-mol),-2.913946311421581
HSC-3,3384730,2.4690621301166926
HEC-108,65064,5.34082663858378
Kasumi-2,24978538,-3.812533145701136
SF539,25161177,5.227921335860274
Lu-65,613753,3.4021482681658393
SF539,9823820,1.6245183308883937
MIA PaCa-2,73707398,0.9717738640313962
Karpas-422,46943432,0.9846326291416436
H-STS,71680916,3.817960068109933
ACC-MESO-1,11427553,2.389819749095902
KMS-12-BM,11214940,1.3088229833339329
Mono-Mac-1,2949965,2.609351900169026
ESS-1,5311037,3.6560576458162295
SF539,56949517,4.748779906195386
Lu-65,10127622,1.511770058636235
KMRC-20,11404337,0.8151706043014814
SK-UT-1,25102847,3.856160399391282
MIA PaCa-2,637858,1.1483651516118356
ChaGo-K-1,71304818,1.816739783520312
KYSE-180,107985,-3.532250408088534
AU565,44607530,-0.2063452249558506
NCI-H1339,5978,-3.09040269698192
LMSU,25227462,1.468686757541464
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
EHEB,46191454,0.8192064691223043
BT 286,5329102,1.7447783077398489
ACC-MESO-1,322968,5.3153065954738326
Becker,11404337,1.8814700373648592
ChaGo-K-1,5280436,1.6029209874008523
SF539,73707438,4.098722810092626
HEC-108,409805,5.771065107307232
HOP-62,5291,3.833370883851296
NCI-H929,2828334,5.894238913273239
BT 248,6505803,-0.8385222866943476
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
SK-UT-1,637858,2.463996188946881
CML-T1,6918878,-0.7643857619236708
ChaGo-K-1,119607,5.482633007693178
RT-4,3854666,3.7100044962154506
KYSE-180,262093,4.394400122480356
LXF 289,400769,-1.8947060859446272
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
IST-Mes1,3384730,4.026476803757859
BT 248,2708,3.971792549478314
SNU-423,25102847,3.0694416219969876
PE/CA-PJ41 (clone D2),9915743,0.2241511570918921
HOP-62,selumetinib-PLX-4032 (8-1 mol-mol),2.4428399643658603
Becker,11178236,-3.172073747487462
SNU-213,176870,4.17726922356707
RKO,9908783,5.5436232623995805
LXF 289,25262965,-2.558275633709226
HCC2108,4261,0.8119370263303683
KMS-12-BM,9967941,3.0004287957561875
H-STS,42642645,0.4333051661235175
Mono-Mac-1,136227331,4.247854438913471
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
BFTC-909,5282054,4.21714099973987
OAW28,1566236,3.486252592676433
IST-Mes1,4521392,4.383284740471391
Mono-Mac-1,54454,2.2047312672861676
RKN,10184653,1.939164173873933
ACC-MESO-1,salermide-PLX-4032 (12-1 mol-mol),5.911303184857687
PF-382,5281672,3.504573563810081
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
Becker,3689413,0.4493271202500121
KYSE-450,446155,3.327914204468242
BFTC-909,11214940,1.666026285351028
Becker,54619267,4.626572213417588
Mono-Mac-1,9929138,7.711944602530317
CML-T1,5291,-1.725219795873105
EHEB,carboplatin-etoposide (40-17 mol-mol),0.7214068333239794
NCI-H2030,JQ-1-UNC0638 (2-1 mol-mol),1.861719916285668
PF-382,navitoclax-sorafenib (1-1 mol-mol),-1.747600817008782
ESS-1,135440466,2.7026954574197424
WM793,11485656,2.688663515558037
AsPC-1,3825829,4.335500071907528
OAW28,5113032,5.506773811436986
OAW28,5329102,1.8792475137868745
NOMO-1,44607530,2.1799605259844914
BT 498,73707438,3.8032973142746944
RT-4,3503,2.674693598756191
Lu-65,31703,-0.7957665797454153
NCI-H196,54618305,5.68839138137451
NCI-H1339,doxorubicin-navitoclax (2-1 mol-mol),-0.8830700703229586
HOP-62,11238147,2.977850239032067
OAW28,6918328,-0.6493981710218658
NCI-H929,54686904,2.5438684398285996
IST-Mes1,613753,3.190229377917506
MIA PaCa-2,3081361,1.8008604148856877
Kasumi-2,11152667,-1.6921100461719016
IST-Mes1,6918638,1.4350648787515894
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393
PE/CA-PJ41 (clone D2),3503,2.850031755363566
KMS-12-BM,5746,0.0880156660447664
SNU-886,613000,2.2202815860905822
NCI-H2030,10427712,5.726847799338336
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
Becker,11626560,1.902962201079582
NCI-H2030,6917907,-6.031841495353539
SK-UT-1,1566236,1.7242203991960865
OAW28,25227462,0.9824255132553372
WM793,2746,3.494212158504219
SNU-423,16065773,3.3258076403763415
Karpas-422,6610216,4.297042652021984
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
PE/CA-PJ41 (clone D2),72193861,3.673729386606365
SK-UT-1,5329102,3.5213520964338207
NCI-H1339,445091,6.107545506766502
LMSU,49867930,4.439231756123768
ACC-MESO-1,51039095,2.5717576118399577
NCI-H196,11626560,2.389103282911341
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
OAW28,12001922,1.8847589611064504
KMS-12-BM,73707386,2.349774634710614
LMSU,400769,0.2687008392096283
PE/CA-PJ41 (clone D2),25062766,3.3062311369970137
SF539,3025986,-1.0860147813868546
HuT 78,selumetinib-MK-2206 (8-1 mol-mol),-3.652138343341758
Namalwa,5311,0.3963470202077738
SNU-423,53495165,0.0371718834478377
Lu-65,2708,5.479352175899552
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
KYSE-180,52912189,6.205067529093029
KYSE-450,44589607,3.132602917923117
MIA PaCa-2,piperlongumine-MST-312 (1-1 mol-mol),1.1891376220003034
Becker,462382,1.302780642835376
BT 328,piperlongumine-MST-312 (1-1 mol-mol),1.83335233808469
HOP-62,piperlongumine-MST-312 (1-1 mol-mol),1.588875271586378
BT 286,44185566,0.9763246934051132
EHEB,11485656,2.717011543878295
Panc 02.03,6917907,-5.450554920776264
SNU-119,6610355,4.422886164754199
SNU-213,65064,5.569795489228084
Namalwa,carboplatin-etoposide (40-17 mol-mol),0.1635376118774288
SNU-119,24978538,0.7616052232036742
AU565,219104,2.449004695507307
AsPC-1,56649450,2.958633157592254
ChaGo-K-1,42642645,1.188286091204559
CML-T1,72193861,-0.1877801569331633
KMS-12-BM,9952709,1.973172777433049
SNU-886,644241,2.771156867357371
ACC-MESO-1,73707398,1.5001086563583304
HCC2108,67291369,1.6270621345157394
EHEB,vorinostat-navitoclax (4-1 mol-mol),0.5492722372244424
HCC2108,72376,-2.554295384171075
SNU-423,262093,3.077382051759327
RERF-LC-MS,24964624,3.0594292113466515
BT 498,46926350,-3.9030297935889737
RKO,6438330,2.4839059464581785
LMSU,6918328,1.1714083340130723
RKN,71466380,6.199959456698308
NCI-H929,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497346861051973
SF539,11609586,2.890542664621997
SNU-423,25262965,-3.8107470635875007
NCI-H929,54649381,3.9072363732080535
BT 320,5978,5.361358451203573
MJ,400769,-0.147050073653482
HOP-62,5460769,2.443615735481444
SNU-423,6917907,-5.559529881879768
Lu-65,5470400,0.5460431386615598
OAW28,45279963,4.210324099066774
BT 498,11626560,2.542570965173451
SNU-886,navitoclax-sorafenib (1-1 mol-mol),-7.4083537328702365
BT 320,5281321,2.315886758261944
CML-T1,54686904,3.622967709931094
HCC2108,12001922,1.7040984021547378
MIA PaCa-2,11707110,-3.540833689463187
AsPC-1,4788,5.925917601642537
RKN,15547703,3.1395613683678287
KYSE-450,5280436,3.3266706371790264
LMSU,selumetinib-MK-2206 (8-1 mol-mol),3.140399649431559
WM793,9887053,4.971798307876137
KMRC-20,25183872,-0.3631829438506245
BT 248,44589607,2.2150317514642635
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
HEC-108,5978,-1.7034022834061815
BT 320,168313200,3.0477072720221936
RKO,10184653,1.6814092199651305
LMSU,44185566,3.2605987232959035
HEC-108,65628,4.442011228839073
SNU-119,4788,5.600954059003079
SNU-423,navitoclax-gemcitabine (1-1 mol-mol),-0.7752835571487771
EHEB,44202524,1.2346784446145649
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
PF-382,448949,1.3962904970520496
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
SNU-423,11485656,3.131370831257297
SNU-213,60700,1.9168120227571512
ESS-1,135411,0.5252983253091638
RT-4,124202324,3.016060322906711
HCC2108,24964624,3.042744623925763
PF-382,11234052,3.0504434330399883
ESS-1,375860,-0.234699059648963
Kasumi-2,25161177,3.916701757551495
BT 286,375860,0.1606437193581575
PE/CA-PJ41 (clone D2),JQ-1-vorinostat (2-1 mol-mol),1.551802384723893
Kasumi-2,3136844,3.733604332390159
MIA PaCa-2,322968,4.188739410962973
SF539,54618795,3.1497169107131944
AU565,24797083,1.2091873523376886
Ri-1,51039095,1.9057143183426843
NCI-H1339,81146,4.4779522522382305
BT 328,2749,4.811351487491957
PF-382,5311281,0.0181022265462825
SNU-886,5282054,3.1814794510018514
CML-T1,23635314,-1.5423479854884166
LMSU,6917907,2.90407541957411
KMRC-20,5282054,4.2383021010346065
PF-382,54618164,3.241191825495517
HuT 78,16013152,3.8354573431378185
OAW28,11455910,2.4986666790908583
Kasumi-2,6610355,3.4850778191475342
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743
AU565,73707398,1.1644887368044523
Panc 02.03,123631,3.5560371664842325
BT 320,3854666,3.86904800273952
HOP-62,53392493,3.6394168789685706
LMSU,6610216,5.122726082721053
SK-UT-1,5978,-1.5541444209487143
PE/CA-PJ41 (clone D2),25154868,5.390664458057599
ChaGo-K-1,81146,4.46891312687106
Namalwa,selumetinib-PLX-4032 (8-1 mol-mol),4.791848826949847
NCI-H929,71466578,2.486095138204317
NCI-H196,89183176,-2.228939888416075
OAW28,135875424,4.470041991889524
SNU-213,3385,5.795373664597125
BT 286,24748573,1.9402593533465669
KMS-12-BM,9884685,-1.5036404450716507
KMRC-20,3543504,4.387857873550899
HOP-62,122327,5.042080848521016
NCI-H2030,637858,2.3348665143276843
BT 328,11404337,1.5843001055688009
Becker,5281672,5.170616475815027
NCI-H1339,71304818,2.557154987327623
KYSE-180,9936388,-5.3897473887689
EHEB,216345,1.2200668921328206
KYSE-180,25262965,0.0419540229516487
HuT 78,17755052,0.1532683017086964
PE/CA-PJ41 (clone D2),11317348,4.636596301807158
NCI-H1339,252682,6.483729619076123
RKO,24821094,3.7157598247146977
ChaGo-K-1,984333,0.9481175577146016
RT-4,6610355,4.842396120436743
HuT 78,25183872,-2.0170798191492634
SNU-423,1641662,3.703023072171153
BFTC-909,3465537,1.8561429441463555
RKN,12003241,-0.3350096455718494
AsPC-1,24951314,2.0738112971970275
Kasumi-2,11214940,0.2886545067447796
Mono-Mac-1,49850262,2.484321321634945
KYSE-450,49766530,0.7642756518369849
HSC-3,11609586,3.4480340554706284
EHEB,54618164,4.264105290178519
H-STS,24951314,0.6840074671900861
SF539,36462,1.0067932013019132
AsPC-1,262093,3.2992304028365926
RT-4,51039095,3.6513947715077135
AU565,2949965,1.8156290557963255
IST-Mes1,11964036,1.5284066254046933
HEC-108,16725315,4.671671470713106
NOMO-1,5470400,0.2862684612003833
RT-4,2749,3.2785054841162022
NCI-H209,selumetinib-piperlongumine (8-1 mol-mol),2.1280942303913197
BT 286,6610216,4.050396966302166
KYSE-180,56946209,-3.779813924696878
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
Mono-Mac-1,3634881,2.4944168079015134
Lu-65,11609586,2.7049330243878584
KLE,441298,1.608704823737003
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
ACC-MESO-1,24901704,3.483315834042047
BT 286,26596,0.1662425719802319
NCI-H1339,5460769,-0.265386406275254
BT 320,9911463,3.706038906545982
KYSE-450,10385095,1.1558983027763154
PE/CA-PJ41 (clone D2),11609586,3.386208915344469
NCI-H929,2749,1.0943201778081362
KYSE-180,3025944,4.407646494118587
KYSE-180,26596,-0.879665743021705
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
BT 248,11647372,0.9807519416972552
IST-Mes1,11955716,-2.3343063309165095
ACC-MESO-1,452548,0.999951222582263
KMRC-20,46224516,2.3490422835427944
HSC-3,44137675,3.228104265957375
MIA PaCa-2,50905018,4.410833032676193
LXF 289,68056272,4.660756431297166
NOMO-1,31703,-1.8429032714500968
ChaGo-K-1,25126798,3.881957924411908
KMS-12-BM,52912189,-1.6763978674189333
BT 498,crizotinib-PLX-4032 (2-1 mol-mol),3.453127992243518
ESS-1,46174525,4.298251988925839
Kasumi-2,71680916,3.663022593238377
Karpas-422,16065773,2.8753471194811433
KMS-12-BM,BRD-A02303741-navitoclax (2-1 mol-mol),1.0941472093440388
BT 320,4788,6.027753085231011
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
SNU-886,387447,-3.9367278767128617
SNU-423,6610355,5.092253202079039
Becker,24753719,4.281079864002637
BT 320,navitoclax-sorafenib (1-1 mol-mol),2.857010837113841
RKO,46907787,4.104881837237831
BT 286,6505803,-2.395900359039176
SNU-119,9866186,2.2038278212817652
HCC2108,568763,-0.0032676468194757
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
IST-Mes1,25126798,3.982374188902535
Mono-Mac-1,5329102,-0.8933301485342183
MIA PaCa-2,3634881,3.25947656124529
Mono-Mac-1,46398810,0.3910224062096548
BFTC-909,4096211,2.208598833058293
SF539,44462760,4.654163176504964
OAW28,89183176,4.823946494889004
Ri-1,9956119,1.7305193093233373
LMSU,9444,4.315048701595099
KMS-12-BM,4917,2.744184399982424
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
KLE,24951314,0.9154688182188032
NCI-H1339,9903786,4.835064182647526
KYSE-180,navitoclax-sorafenib (1-1 mol-mol),1.4243310506512128
AsPC-1,56649450,2.958633157592254
NOMO-1,10427712,4.067466468396052
PF-382,400769,-1.377370522308466
ChaGo-K-1,53392493,1.973130575864384
RKO,168312962,-2.5117583451491012
AsPC-1,6914657,-2.819399047423078
HEC-108,54619267,5.275779209173027
EHEB,374536,2.309110674045564
KMRC-20,selumetinib-MK-2206 (8-1 mol-mol),3.8802648290187225
SNU-213,46224516,2.251156317264964
AU565,637858,2.0174799842455364
OAW28,60700,1.95920843974679
PF-382,docetaxel-tanespimycin (2-1 mol-mol),-5.687046056145867
Becker,60700,0.0779655693307388
Lu-65,4578,4.325365526086933
AsPC-1,5282054,4.143624610165464
PE/CA-PJ41 (clone D2),2945648,3.0815607397196207
HuT 78,46843906,0.7162246400250988
KLE,5278396,3.889356862405411
EHEB,crizotinib-PLX-4032 (2-1 mol-mol),1.830977421252466
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
LXF 289,1641662,3.640483694902119
BT 286,11507802,1.483541301011614
BT 328,439501,-3.1360046964577983
BFTC-909,15547703,3.647732910564925
AsPC-1,4917,3.701934006694463
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
Becker,26596,-2.013233579681989
Namalwa,51039095,1.869745632471808
RKO,54619267,4.028311361432676
MIA PaCa-2,6914657,-3.194339390431366
Ri-1,1566236,0.746437074488416
CML-T1,selumetinib-decitabine (4-1 mol-mol),-0.3389481007221296
KYSE-450,168312962,-1.1635814375740514
BT 286,2858523,2.9856997635440803
H-STS,11238147,1.8768672024064708
HuT 78,66577038,2.508658596603646
BT 248,444795,4.817055384579841
AU565,89928392,2.1536851128845904
AsPC-1,135984461,3.722049898583642
Karpas-422,135421197,2.168063446429243
SK-UT-1,3503,1.0072553452312891
HuT 78,doxorubicin-navitoclax (2-1 mol-mol),-0.8174100340859971
SF539,serdemetan-SCH-529074 (1-1 mol-mol),2.2539127331776077
Panc 02.03,5287620,-2.132468814908427
Lu-65,25227462,-2.994823242761513
RKO,441298,2.3183923582018107
RT-4,54678924,1.2087543441917363
BT 286,BRD-K55473186,2.9341926558853784
AU565,156422,4.303267692822867
OAW28,44486219,3.976522680156617
Becker,49766530,0.5239013848654858
SF539,11656518,1.229269486951703
Mono-Mac-1,44607530,0.7163266856169314
HSC-3,9926054,2.205728912393848
EHEB,11964036,0.5022634413862269
MIA PaCa-2,selumetinib-piperlongumine (8-1 mol-mol),2.0711294667177516
SK-MEL-5,6438330,2.7940741044591126
SNU-213,654092,0.3556134430950528
HEC-108,219104,3.940802724544765
Ri-1,11626560,0.685551544754032
H-STS,selumetinib-JQ-1 (4-1 mol-mol),1.7397587853483405
NCI-H2030,9444,3.598421183891499
HOP-62,9884685,0.5036019018396981
ESS-1,6610355,4.793916265981142
Kasumi-2,11257553,-0.3952076481824682
NCI-H1339,446155,2.168467694487421
SF539,15983966,-3.97733563141033
RERF-LC-MS,11955716,-2.426679724944883
PF-382,54143018,-0.5673202131057219
PF-382,JQ-1-MK-0752 (1-1 mol-mol),-3.722439254577736
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187
Mono-Mac-1,54618305,4.078084902520956
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
PF-382,11609586,2.2064607585026006
LMSU,6918638,1.4149573073550044
AsPC-1,10184653,1.884059851333118
KMRC-20,23939,4.421386297224866
BFTC-909,452548,0.7682850038212578
BT 286,4378219,1.3689305744165488
Kasumi-2,navitoclax-gemcitabine (1-1 mol-mol),-5.447760787137567
PF-382,46398810,1.1284565194471994
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
RT-4,9911463,3.5197462916355073
BT 286,46907787,3.635470224586541
H-STS,135984461,1.3384437031548353
Becker,navitoclax-MST-312 (1-1 mol-mol),0.542067489060191
SNU-213,SNX-2112-bortezomib (250-1 mol-mol),-1.4533865129200167
LXF 289,159324,2.685439807189008
WM793,selumetinib-navitoclax (8-1 mol-mol),2.773218065087456
Karpas-422,6918837,-5.3439308234208065
KYSE-450,24951314,3.0584617604997058
SNU-423,10322450,4.431866174300737
Namalwa,54765302,3.978814795169302
Becker,984333,0.835843884651037
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864
HEC-108,31703,-0.7744900613716049
HuT 78,24821094,3.2631800653476017
HOP-62,25150857,2.9059675286732864
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
Mono-Mac-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.6827347262468866
H-STS,46843906,3.4319919456792296
Karpas-422,6918736,-0.9495569711563258
ChaGo-K-1,12001922,1.4825695444436542
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
Namalwa,navitoclax-birinapant (1-1 mol-mol),3.1548931611021898
PF-382,3689413,-3.8661032289286488
Becker,9884685,-0.0960658377350512
NCI-H196,selumetinib-vorinostat (8-1 mol-mol),2.502166357099755
SNU-119,2733526,3.002199231384174
Ri-1,107970,1.039511049799593
AsPC-1,11427553,3.0222816384498237
IST-Mes1,24964624,2.9505066533460464
RERF-LC-MS,107970,3.001301355490032
KYSE-180,159324,3.323934124765763
EHEB,5460769,-1.3281679410072365
KLE,568763,0.509610011546881
ChaGo-K-1,4578,5.530144890731415
BT 498,UNC0638-navitoclax (1-1 mol-mol),2.7043329045361393
OAW28,1641662,3.6011202742070014
RT-4,135440466,1.5975390058414984
PF-382,60750,-4.575665185057959
KYSE-180,119607,5.519962897909222
Namalwa,135411,-0.3844815221234907
MIA PaCa-2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7898327574016281
Kasumi-2,54626689,4.779746030866953
NCI-H196,16722836,1.435247078840738
Mono-Mac-1,71466578,3.003674036562798
Karpas-422,5311281,1.673971319714702
SW1783,252682,7.233019917696589
OAW28,702558,5.716785737298097
SNU-423,24856436,0.8656773751864265
MIA PaCa-2,navitoclax-piperlongumine (1-1 mol-mol),2.098278284226177
HOP-62,44484893,4.694286333214486
OAW28,11404337,-1.5682838378564492
NCI-H1339,9840324,6.07304514189999
NCI-H1339,44632017,1.0152846867592873
AU565,135875424,4.732736146663846
BT 328,25102847,3.596555529465503
MIA PaCa-2,11647372,1.8214453136696007
AU565,107985,-3.572249289009051
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
OAW28,9956119,4.544482925716663
RKN,3825829,4.2934517576030276
RKO,24964624,3.0430796891613903
Namalwa,65628,3.512710693266535
Kasumi-2,11228183,-3.3606954683588057
BT 498,327653,3.5489603001727477
Lu-65,2746,3.448286012693329
PE/CA-PJ41 (clone D2),16065773,1.8609668807275996
SNU-119,159324,3.0008353242690045
BT 498,1566236,3.668153571841636
AU565,6505803,-0.7592801042803803
RKO,9825149,2.459088339864112
MJ,6918638,-0.2004138762975409
IST-Mes1,387447,-3.626604128124616
SW1783,15953870,3.727401815787135
OAW28,6918837,-3.92509053266304
AsPC-1,327653,4.351823995090995
OAW28,11364421,1.0555351676055402
NCI-H1339,24753719,4.233509766860094
KYSE-450,5113032,4.607851328424312
SK-UT-1,71751553,5.981983562576585
KYSE-180,11364421,-2.9692931824369864
OAW28,53392493,2.314719178940984
BT 248,16725315,3.27587483179283
Becker,216345,4.415529131137277
OAW28,11719255,3.92549874892824
RERF-LC-MS,6450551,1.967154760545028
HuT 78,9823820,3.0138958683813537
SNU-423,65064,5.2614156203806735
BFTC-909,54619267,3.991913685478571
Ri-1,24180719,3.165444216400886
Namalwa,piperlongumine-MST-312 (1-1 mol-mol),1.0108057304725468
Panc 02.03,66577038,3.3089612685646985
HCC2108,11175137,3.2094968416883827
Kasumi-2,53392493,1.5560274267449214
MJ,3385,2.025237733510993
Kasumi-2,24856436,-1.5154163657154227
KLE,11609586,0.7062994369280325
HEC-108,5287620,-1.2592050187487678
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
HCC2108,49793307,-2.77688699099991
Becker,2749,2.963090834179414
ESS-1,9911463,4.377027533841143
BT 320,9926054,4.941319925063275
Mono-Mac-1,46199207,2.723327941357597
KMRC-20,doxorubicin-navitoclax (2-1 mol-mol),0.9051296535641696
NCI-H929,5328940,1.4271750635710874
AsPC-1,89928392,1.5669078555551634
Mono-Mac-1,89928392,-0.1187995872067037
SF539,6438330,1.6386797479013289
HEC-108,1750826,1.2012751309541916
KLE,65628,4.416189153864011
PF-382,9927531,5.462558018035092
RERF-LC-MS,3543504,3.1700226881436193
IST-Mes1,8515,4.272788297141445
CML-T1,49766530,-2.849769761760908
HCC2108,104842,-1.1232837273374026
HSC-3,10302451,2.6157222782287795
BT 286,3025986,-0.9461508297615284
ChaGo-K-1,156414,1.5604886005920922
AsPC-1,11625818,4.311821961769238
NOMO-1,72193861,0.7304873005319745
ACC-MESO-1,JQ-1-navitoclax (2-1 mol-mol),0.2263973859128728
RKO,3543504,4.836700902585943
SF539,46907787,0.2074640579250286
Kasumi-2,6438330,0.3381981879114322
Mono-Mac-1,24821094,1.2547339239391515
RT-4,5978,-0.8712015854260087
LXF 289,9908783,5.689655754809611
NCI-H196,1750826,-0.6704286653908172
Namalwa,241158,1.6214493925930429
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
PF-382,3025986,-1.4825966428556414
PE/CA-PJ41 (clone D2),135398516,2.8056220354575676
ESS-1,72193861,1.305557473991512
Lu-65,11175137,3.3632758039989277
SF539,49793307,-4.242973153830116
ESS-1,82146,4.445932191029335
Karpas-422,53495165,-1.4820588452950412
PF-382,11228183,0.289303450699542
NCI-H2030,vorinostat-carboplatin (1-1 mol-mol),4.06983462737207
Mono-Mac-1,JQ-1-MK-0752 (1-1 mol-mol),-0.3425960696296795
BT 286,56973724,2.44646115047201
SF539,24772860,-2.3648669148494856
Becker,6917907,-5.4473174275012886
AsPC-1,9911463,3.4970941612274693
RERF-LC-MS,51037431,2.0455212647735364
AsPC-1,17755052,1.5687054045124371
Ri-1,3825829,3.218260810941893
HEC-108,135999136,4.441314867436916
BT 328,24180719,4.750415959710981
CML-T1,702558,3.0833664933254235
LMSU,docetaxel-tanespimycin (2-1 mol-mol),-0.129764308689889
SF539,241158,3.806550538894245
SK-MEL-5,9926054,2.75949424585879
HEC-108,9866186,0.8605945036267506
WM793,docetaxel-tanespimycin (2-1 mol-mol),-1.36432681223834
BT 286,16736978,0.9709442496573794
SW1783,54618164,3.832878612817737
NCI-H209,navitoclax-sorafenib (1-1 mol-mol),-1.0259538473904688
PF-382,44197249,4.457184218022553
SNU-886,54613361,0.1365764016308465
OAW28,11214940,1.4072727029323666
SNU-886,tanespimycin-gemcitabine (1-1 mol-mol),2.0847122709866097
HuT 78,10410894,2.2762155045304295
SNU-886,54618771,-0.5899639628082597
NCI-H929,11612883,0.7981291863125404
OAW28,6918837,-3.92509053266304
EHEB,135999136,1.8833962574329148
BT 498,135423438,1.8216974125096568
SNU-886,5328940,2.5802660020848696
NCI-H196,168313047,3.552426610249759
CML-T1,73707386,2.9358077283853974
KYSE-180,5738263,3.136309383400005
SNU-423,71466578,4.7810266206946945
Kasumi-2,9952709,2.8950386128563985
BT 248,3038522,2.764297682711703
ACC-MESO-1,135984461,6.029797163877839
AsPC-1,11609586,3.135544943212619
LMSU,54613361,5.3504383264150235
HOP-62,24797083,1.208432344733137
NCI-H929,5284373,-1.7427436127229046
AsPC-1,11152667,-0.9426796832875202
Panc 02.03,1750826,-0.0877771412327358
MJ,2858523,3.220847662201125
Kasumi-2,446155,3.789762475260846
SNU-886,11427553,2.479878788580837
CML-T1,72734382,3.1811123479261276
BT 498,9549297,1.944333767833654
NOMO-1,25126798,3.9519848152055848
BFTC-909,6623618,2.802037410677928
SF539,151289,0.9968622519335693
Mono-Mac-1,6438330,1.7309353539073105
NCI-H2030,3038522,4.390336919265978
H-STS,1750826,-4.772155717820538
EHEB,100016,6.596024177667571
HuT 78,navitoclax-piperlongumine (1-1 mol-mol),-0.4618726000146174
SW1783,56649450,2.1130846621058756
Panc 02.03,6610216,4.56797737488032
ESS-1,25126798,3.845580054250281
KLE,UNC0638-navitoclax (1-1 mol-mol),-2.745432149551299
HSC-3,9907093,4.434110272404288
NCI-H929,11178236,-4.166985560553255
HOP-62,6917907,2.3888384264440816
KMS-12-BM,135984461,1.7287315424792562
HuT 78,selumetinib-UNC0638 (4-1 mol-mol),-2.012028836437227
RKN,2708,5.19327789915259
MIA PaCa-2,156422,4.184482659143903
CML-T1,docetaxel-tanespimycin (2-1 mol-mol),-5.351471523499181
MIA PaCa-2,135928012,3.7841811685806337
KYSE-450,6852167,3.693304163934065
AsPC-1,6505803,-1.959385905579291
HuT 78,4259181,-0.3142311669352864
KYSE-450,piperlongumine-MST-312 (1-1 mol-mol),1.338613375106185
BT 248,439501,-2.3411963573363104
Namalwa,9926054,1.683884099727144
RT-4,16038120,1.2849695111816888
HOP-62,3465537,2.2363453693957536
NCI-H1339,5738263,3.75824578425613
MIA PaCa-2,135411,0.8482732025592005
EHEB,11640390,3.640025607015964
KMS-12-BM,3825829,2.160644220643388
KLE,73707398,0.4840000511633914
HSC-3,54454,1.5891555650857276
NCI-H1339,11455910,0.5713481488212533
H-STS,72376,-2.162494963695944
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
SK-MEL-5,54619267,3.938676828232531
H-STS,11640390,4.3138571775142855
PE/CA-PJ41 (clone D2),10410894,5.555061016937591
NCI-H196,42642645,1.4168604332758885
HuT 78,6505803,-1.3012174270497974
Namalwa,6450551,1.7730795901303054
OAW28,216345,3.8770767977792913
Lu-65,4705,2.2628868276979404
KYSE-450,46191454,2.021198534281789
OAW28,15983966,1.5707780698474574
KMS-12-BM,409805,3.008136654369979
SF539,11228183,3.1050293541734475
KMS-12-BM,7326481,2.7761421195772544
Kasumi-2,53495165,-3.989635350263354
ESS-1,11455910,0.1046831634026344
BT 498,decitabine-navitoclax (2-1 mol-mol),3.07792952169354
AU565,3825829,3.6732705699214105
RKN,16741245,1.555254881894904
NOMO-1,1641662,3.174576963224712
NCI-H929,selumetinib-JQ-1 (4-1 mol-mol),-1.4418974567272833
SNU-423,53301938,4.291386023792434
AsPC-1,613753,3.1774382169580355
BT 498,3503,1.2954687242486842
IST-Mes1,67291369,1.9412797776758044
KYSE-180,9911463,4.116935332494812
RKN,24951314,1.3743916622304369
AsPC-1,4917,3.701934006694463
BFTC-909,122327,4.590877432942681
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714
SNU-213,25150857,2.2886972845490576
Ri-1,11214940,1.364775390900072
Karpas-422,445455,4.469696048434685
Namalwa,10385095,0.4710651537039255
MIA PaCa-2,119607,5.2591327300907835
HSC-3,107970,2.329842902304128
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
KYSE-450,3062316,2.5043987549881725
HOP-62,9825149,2.2210675279898897
IST-Mes1,11640390,3.2581579646920966
RERF-LC-MS,56649450,3.38813984116235
Ri-1,44486219,3.9245812935437794
ACC-MESO-1,5460769,5.633127442709169
AsPC-1,387447,-4.291846387154746
Panc 02.03,135411,0.8368106867561712
PE/CA-PJ41 (clone D2),49793307,-1.9834196995445272
WM793,400769,-0.3284339771877358
KMS-12-BM,54618305,3.825029881117321
CML-T1,2742550,2.9758871773228366
Lu-65,176870,3.853210265700402
EHEB,5282054,3.0969047421141584
KMS-12-BM,24821094,2.863970661783892
SK-MEL-5,15983966,2.497430173814158
HuT 78,16219061,1.2984020773766147
Ri-1,4521392,3.929629680901149
BT 328,5494449,3.740729289137561
NCI-H1339,24901704,4.008825025425333
BT 248,5494449,3.476308084030369
Namalwa,10427712,3.814538105116573
EHEB,107970,2.1350318268920776
SK-UT-1,613753,3.318153471243221
BT 320,navitoclax-MST-312 (1-1 mol-mol),1.1316480984239057
EHEB,6917907,-5.860529942502672
PE/CA-PJ41 (clone D2),10184653,-0.8548111367788473
NCI-H929,5281321,-2.264984865592431
Lu-65,11707110,-4.197253533392251
ACC-MESO-1,11152667,1.137280520783936
WM793,16725315,3.226655824606768
HEC-108,11175137,3.357797200724247
KMRC-20,24964624,2.981124341507829
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
AsPC-1,5287969,-0.8371135357044818
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
LMSU,36462,2.6264812061116127
WM793,16720766,1.530656675591024
MIA PaCa-2,11964036,1.3569409365148226
HuT 78,54678924,2.190206987497857
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
EHEB,49766530,-1.6427312921557593
AsPC-1,49766530,-1.5554439905221051
CML-T1,55508,2.709114480954857
Mono-Mac-1,6252,0.8274718864145973
Kasumi-2,vorinostat-carboplatin (1-1 mol-mol),1.2501182531177977
HCC2108,969516,2.879700977011491
EHEB,1242560,2.6348256954742757
PF-382,navitoclax-piperlongumine (1-1 mol-mol),-0.2817270531493807
HuT 78,49867930,4.292430272792475
SF539,136227924,2.8154987155907905
PF-382,216239,2.163237785332069
SF539,44241473,5.236379084530278
Panc 02.03,327653,3.634511095206161
AsPC-1,3503,2.1995832473977157
PF-382,119182,-3.7281285699674873
LMSU,BRD-K55473186,4.503625931723464
RKO,104842,-2.5196749638548
BFTC-909,6505803,-2.7076869289136147
Mono-Mac-1,262093,2.3689622956108107
ESS-1,10184653,2.852659542055244
BT 320,11178236,-2.5149680405736095
EHEB,BRD-K27188169-navitoclax (2-1 mol-mol),5.0776573503309
Panc 02.03,176870,4.923826321280428
LMSU,11222830,1.917017236141016
Ri-1,9825149,1.4325053245443746
SK-MEL-5,4521392,4.360009001043505
BT 328,1242560,3.7217728648483552
SF539,10296883,3.7658288303305976
SNU-423,119607,5.357124425124211
CML-T1,9927531,3.1672020542525674
Karpas-422,10302451,2.97293319769233
Kasumi-2,439501,-3.441659601561783
H-STS,6914657,-2.765637177138319
ChaGo-K-1,10385095,0.7525502719591264
SNU-886,11175137,2.2177679587104935
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
SNU-119,71304818,1.7575129370546083
PF-382,2828334,5.600053849858772
Kasumi-2,5978,-3.933681438293164
OAW28,46843906,3.2241568449076556
SK-MEL-5,2729026,2.1390901716806865
EHEB,5281321,-1.964184492535214
OAW28,3062316,-0.5042902382709098
BT 498,11222830,1.8322344159731312
NCI-H2030,navitoclax-pluripotin (1-1 mol-mol),-1.1596715614648436
SF539,11626560,1.8375334326150123
Lu-65,104842,-1.667070260430244
NCI-H196,675434,5.131658227650978
HOP-62,1566236,4.388769459301917
Ri-1,5566,2.004549606027771
BT 498,89928392,1.833655397128451
ACC-MESO-1,9903786,5.156493229165983
Kasumi-2,135411,-1.6102115279025644
ESS-1,24821094,3.503483475384322
ACC-MESO-1,374536,3.768869201315052
HOP-62,17755052,2.482423793609025
HOP-62,6610216,4.033430969864694
ESS-1,3385,5.777226471096733
Panc 02.03,4917,3.7856869354758342
BFTC-909,16722836,1.424017650466323
BT 286,tretinoin-navitoclax (4-1 mol-mol),3.1238797688457978
AsPC-1,445643,4.30663769172778
SF539,9887053,4.243548054334724
Kasumi-2,36314,4.106836250050073
WM793,46199207,3.3538268783703895
KYSE-180,navitoclax-gemcitabine (1-1 mol-mol),2.062581087909213
Karpas-422,54678924,1.4366135782104994
NOMO-1,11977753,-1.9426292333262003
RERF-LC-MS,24951314,1.4075693116182684
Karpas-422,16720766,0.6661379613872315
HSC-3,6623618,2.2678621841397644
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
SF539,72376,-2.558258632142047
SF539,3634881,2.419481014685841
AU565,9933475,1.5968241540352486
Mono-Mac-1,54618771,1.1455775902832934
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448
BT 328,969516,3.8664962726625416
SNU-886,ISOX-bortezomib (250-1 mol-mol),1.1872724485340942
AsPC-1,2749,1.937127114514975
Mono-Mac-1,vorinostat-navitoclax (4-1 mol-mol),-0.0754914405518991
NCI-H929,3062316,1.7563437367831485
Becker,11494412,0.142625338466196
SNU-423,71680916,4.325393035834424
RT-4,16725315,3.7919214509937977
KYSE-180,36462,3.219917830306027
Kasumi-2,46926350,-4.426429724391801
ESS-1,46191454,2.1127704272389805
HEC-108,BRD-A02303741-navitoclax (2-1 mol-mol),1.0152806773342118
Namalwa,5351362,0.7383034640998063
SK-UT-1,51037431,1.6639996533413053
SK-MEL-5,25062766,3.029124686982392
SNU-423,24785538,1.9416648635593148
LMSU,123631,3.4845106075088763
PF-382,71304818,1.2599854334325824
SK-UT-1,25126798,4.142879524330263
NCI-H1339,409805,5.836206098158848
HOP-62,8515,4.458909571137292
AsPC-1,5291,4.446798964395248
SNU-423,67291369,3.047724729546425
ESS-1,24771867,2.6208219680257328
BT 498,409805,5.970409290821295
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432
H-STS,54678924,1.1797889556191294
Kasumi-2,72734382,3.1758679904650715
Namalwa,5328940,1.0182998554643874
NOMO-1,54613361,-1.5441782746277026
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159
AU565,136227924,2.2371309282915184
KLE,11404337,-0.1549034777249487
Namalwa,5311037,3.6814678393714617
SNU-119,135398516,2.000123320648024
Karpas-422,11640390,3.2653656586739084
NCI-H196,25150857,2.434166901288255
RKO,6505803,-0.9276151073099124
Ri-1,46943432,0.5214586687647272
SK-MEL-5,7326481,2.442811680167144
H-STS,54618771,0.7523066402016166
Namalwa,44486219,4.008979005623025
MIA PaCa-2,6610216,4.225429520822784
NCI-H1339,11507802,1.2916680643182958
LMSU,676352,2.426612440121004
BFTC-909,24951314,2.3445794180209565
MIA PaCa-2,168312962,3.279024851833566
ChaGo-K-1,676352,1.608582687112449
EHEB,navitoclax-MST-312 (1-1 mol-mol),0.6175908191033533
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
AsPC-1,9825149,2.485133390345911
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
Karpas-422,5113032,4.470757133109911
SF539,9927531,4.183842431586729
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
AsPC-1,57330099,4.415374546363204
KLE,25105715,3.782155123781723
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
KYSE-450,285033,-1.7116882105667988
PE/CA-PJ41 (clone D2),9956119,4.236330934104538
MIA PaCa-2,151289,1.9491714685560824
SK-UT-1,136227924,4.460190875137593
ChaGo-K-1,44491742,3.5931231049771126
Mono-Mac-1,11364421,-5.714614376132776
SK-UT-1,11964036,2.7372114325499055
Kasumi-2,72193861,0.1525951303543335
MJ,24821094,3.517633488156914
BT 248,65628,4.438815715072134
MIA PaCa-2,5566,3.1307632964005663
Panc 02.03,16722836,2.9028860212849565
KYSE-450,56963564,2.961228752582631
OAW28,374536,3.018534312402979
Karpas-422,alisertib-navitoclax (2-1 mol-mol),-1.6367289046584168
AsPC-1,216468,5.354333542051531
KYSE-450,1716436,4.321900870881558
Kasumi-2,6918638,-1.1951505869280743
SNU-213,676352,1.9316561146461328
H-STS,2871966,-0.6937217649488046
SNU-213,JQ-1-UNC0638 (2-1 mol-mol),3.293883125689118
EHEB,6914657,-4.098891510643266
KMS-12-BM,6918736,-1.7905560703377923
IST-Mes1,6450551,1.123519877762822
HSC-3,49850262,4.538780600428152
Lu-65,71466380,3.872217675145991
NCI-H1339,119607,5.442601852865253
BFTC-909,10385095,0.9839595624316404
RKO,6852167,3.601912647929868
RERF-LC-MS,71304818,2.1402027844306986
ChaGo-K-1,2729026,2.395257991695926
HuT 78,4261,-0.4546763762816934
KMS-12-BM,24748573,1.031059985436439
RT-4,11234052,4.441535600719637
LMSU,carboplatin-UNC0638 (2-1 mol-mol),4.1197571889036455
LMSU,3825829,5.912113214968355
AsPC-1,2708,5.587707055847425
EHEB,654092,-1.857578615070723
SF539,676352,1.6554067162537418
HSC-3,23635314,-1.4139768262692471
ESS-1,9840324,5.937640700336064
IST-Mes1,16659841,2.7339021092282527
ESS-1,25150857,2.554300661987261
SNU-423,462382,0.9019532186956488
AU565,54143018,-0.7127893506095456
PF-382,5335621,3.7996740659180688
SF539,24779724,4.8810531030455415
MIA PaCa-2,1566236,1.8703719885196528
SF539,25062766,1.2381389436565498
NCI-H929,54143018,-0.1441434705872438
Mono-Mac-1,89183176,3.560555620335071
SK-MEL-5,168313016,6.194351632392148
SF539,11640390,3.628112258998275
Ri-1,9935249,2.110817780838048
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112
CML-T1,5281672,4.316508820409711
WM793,2708,5.5820491292106516
BT 320,71304818,2.914725517037444
PE/CA-PJ41 (clone D2),6610216,4.420679698302765
RERF-LC-MS,462382,0.9319597157341816
BFTC-909,54649381,4.487285574329416
RT-4,11507802,2.274211340245079
HOP-62,2828334,6.524051840329246
RT-4,3081361,2.257643054417338
ChaGo-K-1,135398516,3.2001379900675357
BT 328,25195348,5.638362277561031
ChaGo-K-1,2871966,0.7471035022397239
RKO,24753719,3.882573791668401
Namalwa,252682,5.816097793824885
SNU-119,148198,-2.509458516530883
WM793,11626560,2.3104279907190124
SF539,24978538,1.3983076300277495
Karpas-422,25183872,-1.8512729311509144
NCI-H929,11717001,3.5813087305608575
Ri-1,51037431,2.2135682846198543
AU565,44819697,-0.774785052988496
KMS-12-BM,11497983,2.267788359318396
Panc 02.03,5311281,4.827416145020449
SF539,11494412,-0.7610024681264586
Ri-1,445455,3.7143584213767777
SK-MEL-5,10385095,1.0393957169918682
SK-UT-1,9936388,-5.820733292214098
SW1783,5746,0.5250942021656682
SNU-213,selumetinib-piperlongumine (8-1 mol-mol),2.037048591352688
SNU-119,44185566,1.946638032582097
ESS-1,5287620,-2.0869622348593624
AsPC-1,25062766,3.1635616497742283
KYSE-180,387447,-4.108861459218713
HEC-108,25262965,0.7530764000502068
Kasumi-2,BRD9876-MK-1775 (4-1 mol-mol),0.2372012332768771
Namalwa,135398516,1.579840615104451
SNU-119,9823820,3.989816323435888
SNU-423,5291,3.88942094627468
BFTC-909,2842253,5.585220688564769
Panc 02.03,1716436,3.766168811644757
MIA PaCa-2,5280436,2.0338405377694806
BT 320,5494449,4.096191424375148
SK-UT-1,7251185,2.9981286588919303
Lu-65,135421197,2.266142941564523
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
HCC2108,9907093,5.193371437314048
SNU-213,4917,2.9300331249390226
HOP-62,9952709,2.3634226717159805
IST-Mes1,66577038,2.5150906013236423
SK-MEL-5,9956119,4.059324967715587
BFTC-909,9444,3.603329432205708
CML-T1,5460769,1.000954417912476
Ri-1,navitoclax-gemcitabine (1-1 mol-mol),-5.665001564745378
SNU-213,selumetinib-tretinoin (2-1 mol-mol),0.7321149203948827
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617
BT 286,selumetinib-navitoclax (8-1 mol-mol),-1.915867243382919
SNU-213,54618305,4.384098644621688
Namalwa,vorinostat-carboplatin (1-1 mol-mol),1.7606445191986038
NCI-H196,11656518,3.2090738426987477
RERF-LC-MS,52912189,3.970931922009392
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772
Kasumi-2,9926054,1.3771704127752784
Kasumi-2,alisertib-navitoclax (2-1 mol-mol),-2.881127323252466
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
ChaGo-K-1,65064,5.311703145942276
RKO,6610216,3.958403220086871
SK-MEL-5,11404337,-0.86554047446545
NOMO-1,46943432,0.592792127892358
SNU-119,25154868,4.579751406552007
Lu-65,55283,4.17804485585188
LMSU,445455,5.438135882086382
KMS-12-BM,24180125,1.472923036280714
OAW28,53232,2.960609854482466
NCI-H929,44202524,1.214176399548459
Lu-65,168313016,6.388486365629365
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
CML-T1,24771867,0.0964586614823225
RT-4,637858,2.2211102524324717
ACC-MESO-1,5282054,3.9636673696002593
OAW28,6610355,6.153508691776863
SF539,25126798,3.558928885650203
KLE,54626689,4.672839373899824
OAW28,65064,5.229460149894731
SK-MEL-5,16741245,2.8689553776613494
NCI-H2030,51037431,2.706088429950605
LMSU,11175137,2.5387478659601324
OAW28,11609586,2.8574541529278883
SNU-213,12003241,-1.127561281071067
BT 286,11396600,2.040730461375106
RKN,285033,-0.0275118271199953
BT 328,24785538,0.2054381662017833
RKN,2858523,3.2318364946727653
AsPC-1,107970,2.236934549480267
RKN,4261,1.529955054772996
EHEB,2729026,2.652912157322486
WM793,3025986,-0.3370576533498906
AU565,4378219,1.7809295710052302
PE/CA-PJ41 (clone D2),24901704,5.573857851352778
BT 320,1566236,4.371560124605876
KLE,11396600,3.656351561000123
PF-382,9908783,6.451315520536067
SW1783,docetaxel-tanespimycin (2-1 mol-mol),2.8206189802593733
Namalwa,BRD-A02303741-carboplatin (1-1 mol-mol),5.328421612608537
NCI-H929,selumetinib-vorinostat (8-1 mol-mol),1.6351341952434315
BT 498,4477,1.03565930318758
KYSE-180,148198,-3.2204698770091653
BT 328,5470400,1.931366636892646
SW1783,9926054,2.85460969526429
NCI-H196,16725315,4.056507781587541
SNU-423,17755052,2.0274211843455907
RKN,5311281,3.300248210659573
Namalwa,selumetinib-tretinoin (2-1 mol-mol),4.718693062265593
NCI-H1339,25150857,3.1189812048347796
CML-T1,2708,2.830885116766648
H-STS,11955716,-2.312998810387399
SF539,613753,3.180215487125264
SF539,46926350,-4.3784915774606175
IST-Mes1,17755052,1.8699185860343792
CML-T1,54613361,-1.4794949633252166
PE/CA-PJ41 (clone D2),6918638,0.5938730898283403
BT 286,11427553,1.8654884790282549
NCI-H209,439501,-3.220511958386942
HSC-3,246676,5.897694948115853
SNU-213,25262965,-1.4177959479680335
HEC-108,5746,2.057736968957512
SNU-119,6917907,-5.873983095672985
NCI-H929,6918328,-1.4176016400848788
AsPC-1,16065773,2.935886834183449
CML-T1,navitoclax-sorafenib (1-1 mol-mol),0.8856526530243491
SW1783,15983966,1.9735277014133552
H-STS,46174525,4.112955577900159
BFTC-909,57519531,3.2286550647211025
LMSU,135398516,3.1825333446331547
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
CML-T1,25102847,0.4234360383549997
CML-T1,9926054,1.696565612874625
KMS-12-BM,15547703,2.7013494250638614
KMRC-20,54454,3.590685195653472
HuT 78,119182,-0.4026937660621582
SF539,5284373,2.3802646906930485
SNU-886,446155,-1.7757385621733988
RKN,3503,2.6546301780010144
NOMO-1,148198,-5.33573798573566
H-STS,119607,5.558084402470166
LMSU,44607531,1.6909486121434856
ESS-1,56963564,0.4189689637772429
SNU-886,2113511,6.091216991292669
SK-UT-1,54613361,0.5908991855322304
CML-T1,176870,2.5950096151434345
SK-MEL-5,3815108,3.389102935160336
AU565,135999136,4.178255303593246
SNU-119,24748573,1.250225793254589
Lu-65,44137675,3.671350913807576
WM793,1242560,3.830743442552037
NCI-H196,44185566,3.19732340662783
RKO,44185566,2.4837284923488063
PF-382,452548,-2.9455036686626657
LMSU,9908783,4.430691687580579
MJ,2746,3.266657890633373
Karpas-422,5291,3.768859180081126
AsPC-1,10127622,2.6030187662085384
KYSE-180,44486219,4.201637826044419
NCI-H929,salermide-PLX-4032 (12-1 mol-mol),5.56611074354939
BFTC-909,25126798,3.8219929141120166
LMSU,46843906,3.905857502626125
HuT 78,168313016,3.837657248427472
BT 320,6610216,4.229919303269505
PF-382,11485656,2.17330616168877
WM793,753704,5.060805642150714
HuT 78,676352,2.2606140524406984
HOP-62,3543504,3.0589841179466264
Ri-1,navitoclax-birinapant (1-1 mol-mol),-3.80942516814163
H-STS,navitoclax-sorafenib (1-1 mol-mol),1.7549262144899889
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147
Namalwa,24821094,3.0030570338350153
KMRC-20,3062316,1.6707904711783064
SK-UT-1,6918736,0.0102936907283031
OAW28,5460769,4.044755256654475
HuT 78,65628,5.4520261644264165
CML-T1,6914657,-6.7918120052462685
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
ESS-1,107970,3.021792385864846
HEC-108,3854666,0.9548518440486092
OAW28,11612883,3.952715585132085
MIA PaCa-2,24775005,3.3138581445981106
ESS-1,151289,1.069450318701332
KYSE-450,5746,2.912407446662149
MIA PaCa-2,44202524,1.484255372060884
NCI-H929,3081361,2.990825939445924
HSC-3,4917,2.997958577945977
HOP-62,selumetinib-UNC0638 (4-1 mol-mol),2.92656902471884
RERF-LC-MS,123631,2.7610356359897104
SK-MEL-5,984333,1.0316499260206258
Ri-1,23725625,3.8050378563052702
BFTC-909,6610216,4.898578232775107
Mono-Mac-1,6610216,3.235922016233304
KYSE-450,5351362,2.5381052639488715
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
OAW28,44607531,1.5392912313773788
LMSU,vorinostat-carboplatin (1-1 mol-mol),4.433531570096117
LXF 289,11455910,1.909862916296106
Kasumi-2,148198,-6.27183434225638
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834
KMS-12-BM,3385,3.988129125134885
BT 320,5566,3.007077893151021
HuT 78,navitoclax-gemcitabine (1-1 mol-mol),-2.9372402673732205
SNU-119,156414,0.2348404717120807
SF539,6914657,-6.2311827891537295
SNU-423,107970,2.9468491759606303
SK-MEL-5,4261,1.841323007747508
LXF 289,452548,0.2436004430663324
ACC-MESO-1,445643,4.1355040989789025
SNU-423,11507802,1.2328580377251226
BT 320,5329102,3.0266079626967928
PE/CA-PJ41 (clone D2),crizotinib-PLX-4032 (2-1 mol-mol),2.663673400146886
RT-4,11364421,2.211361780662556
SNU-119,44259,0.785845765764312
BFTC-909,8515,4.73152093133166
AU565,421610,2.258686960610045
BFTC-909,10074640,3.0053798884123837
KLE,vorinostat-carboplatin (1-1 mol-mol),1.9329749700220415
SNU-119,9868037,3.103417825493656
OAW28,44137675,4.561686598527574
Mono-Mac-1,24964624,0.6349800606366015
RKO,5460769,5.660789679983863
BT 248,568763,0.252168352363544
HCC2108,374536,3.656255875705604
HuT 78,445643,3.9069827228558234
RKO,3384730,1.0492755436091918
SW1783,23725625,5.078273673319168
BT 286,54613361,-1.8400709728794231
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
Lu-65,53232,1.761486710748555
RKO,5282054,3.8735499096789856
HOP-62,12001922,2.1949882095207225
NCI-H1339,24772860,-1.8879714728988064
Mono-Mac-1,53325874,4.409017818896257
BT 286,322968,3.816277861601749
KMRC-20,6918328,1.7545350572530505
KMS-12-BM,71680916,2.263503265107647
KLE,9549297,3.198164194460754
LXF 289,5978,0.6093029371771528
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
LMSU,57519531,3.754499553388688
AU565,2126,4.335330080531479
NCI-H929,49836020,2.30560189930029
Panc 02.03,53232,6.367991743549877
NCI-H929,4917,2.9629665385410227
Namalwa,1239801,3.4041628695786432
KYSE-180,49793307,-3.1171537464519186
SNU-119,navitoclax-pluripotin (1-1 mol-mol),-1.1228674398646514
RKN,15983966,-2.847635435689191
SNU-886,44507138,2.788331490062725
KMS-12-BM,20959075,-3.73832330619988
Kasumi-2,52912189,-0.393622705419007
SF539,JQ-1-UNC0638 (2-1 mol-mol),0.3445992267657
PF-382,11213558,1.6003517541111008
SNU-886,4261,-0.0852092865807919
KLE,11485656,3.08308998793154
Namalwa,5287969,-2.4617636559658593
Karpas-422,16013152,4.291888200698237
BT 248,54596558,3.9995548839878503
BT 498,4788,5.870824964650662
HuT 78,11167602,1.7844027861507523
MIA PaCa-2,49836020,4.16350045307359
KMS-12-BM,444795,2.0247311602920415
BT 320,387447,-3.873135040539017
KLE,613753,3.1630835497956884
BT 286,46926350,-4.263889446024459
ACC-MESO-1,3676137,6.061513328745112
EHEB,135440466,1.7844203552470492
WM793,49850262,4.533978488158691
BT 498,9936388,2.0435440687928614
SNU-886,6918328,-0.0533986128601594
Kasumi-2,613753,2.4327594137588235
Karpas-422,5743,-5.574243862705145
NCI-H1339,56649450,3.8809889102274777
OAW28,25062766,3.2225198305631464
RERF-LC-MS,10113978,3.210216765519601
BFTC-909,5328940,1.2290524134113243
ChaGo-K-1,selumetinib-vorinostat (8-1 mol-mol),2.615914600490853
NCI-H2030,53232,1.866580630651426
PE/CA-PJ41 (clone D2),168313016,6.324441458081494
AsPC-1,25262965,-4.011117827244764
Kasumi-2,11167602,2.198810465874189
Kasumi-2,119182,-4.8733294561059255
Mono-Mac-1,3543504,4.1625450552704875
HCC2108,124202324,2.908828368060783
Ri-1,6505803,0.1421500129584279
RT-4,10410894,2.6613455189649913
SNU-423,25183872,-1.1443314850386328
SK-UT-1,4788,5.266389502617288
LXF 289,36462,2.912637639845359
AU565,53393127,4.519828407362072
PF-382,72734382,3.7745831304753894
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
HuT 78,44507138,1.1414703687130772
SNU-213,5311,1.6195658531629902
Namalwa,9823820,3.368866662810968
NCI-H209,5978,-2.9776109822230565
SNU-119,3025986,-1.122362641201654
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
KYSE-450,56946209,-4.220503618005704
MJ,375860,-0.5648982341601144
NOMO-1,3543504,4.095340640265792
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
OAW28,11719255,3.92549874892824
Panc 02.03,216239,3.7763245170365183
Panc 02.03,2729026,3.1511226959620715
RT-4,4261,2.418492483102545
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982
PF-382,5329102,1.0797765060108404
SNU-886,66577038,3.44647688682178
SF539,JQ-1-MK-0752 (1-1 mol-mol),0.6318948649394762
KMRC-20,676352,2.4695752697730056
KYSE-180,5280436,4.019735307251945
HOP-62,navitoclax-gemcitabine (1-1 mol-mol),-2.339180571105395
PE/CA-PJ41 (clone D2),52947716,3.214276450173903
RKN,5351362,2.529766574998156
BT 286,16038120,0.3961753230479998
HuT 78,46191454,0.2646394750770171
BT 248,54613361,5.122685224165604
AU565,44507138,1.5217719455679517
HSC-3,4096211,3.965550570092238
AU565,322968,2.504214157528526
BFTC-909,23939,4.493588141952023
PE/CA-PJ41 (clone D2),11656518,2.318391318734742
NCI-H1339,10127622,5.877682943538906
KMS-12-BM,vorinostat-navitoclax (4-1 mol-mol),-0.3192913755194076
EHEB,11625818,2.7353109359046615
SF539,168312962,3.6488542113401614
OAW28,9933475,1.6622343224708085
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
Becker,613753,3.3713137872968906
SNU-119,9936388,-1.2994148300283177
SNU-423,322968,4.058645946597137
BT 498,426756,4.604365420016062
SNU-119,104842,-1.1389094996160742
KYSE-180,51039095,3.462973951569757
SK-UT-1,4096211,5.814618826658096
KLE,168313047,2.8113927253020203
BT 328,doxorubicin-navitoclax (2-1 mol-mol),-0.3035540353070404
OAW28,67291369,5.503883029091299
MIA PaCa-2,42611257,3.5896213916046165
KLE,675434,4.244667851386391
ChaGo-K-1,selumetinib-decitabine (4-1 mol-mol),5.44157099070074
Ri-1,5284329,2.556131317651745
HOP-62,selumetinib-decitabine (4-1 mol-mol),5.718310393718077
KMRC-20,4788,5.828719135556259
SF539,BRD9876-MK-1775 (4-1 mol-mol),-0.024962409910424
BFTC-909,11152667,-0.3524603871752078
BT 328,11396600,3.7528560222461858
Ri-1,erlotinib-PLX-4032 (2-1 mol-mol),2.5965247245213434
Kasumi-2,2858523,3.136381143278692
HCC2108,11222830,1.6798861627317594
SNU-119,24785538,1.16814557127363
KLE,9927531,4.8057879583658405
BFTC-909,9866186,1.150003196853964
BT 328,44589607,2.897724961441205
KLE,6918328,-0.4270629798657607
Becker,3634881,3.7005490899104374
NCI-H196,216345,4.55519625209409
Ri-1,11152667,-3.7285428023246943
NCI-H196,3503,2.7199080939505427
NCI-H929,135411,0.3622558435964065
HOP-62,16722836,1.3353272495590989
SF539,25227462,1.1630748735531866
KYSE-450,doxorubicin-navitoclax (2-1 mol-mol),0.7817120569576905
ChaGo-K-1,10113978,3.5588806520341283
Namalwa,11707110,3.659331859404194
AU565,9803433,4.3672163986823085
LMSU,16722836,2.691296467692663
CML-T1,60750,-4.308471121020489
SNU-119,73707398,0.7345911888158907
RERF-LC-MS,11977753,-0.575574044510787
NCI-H196,135999136,4.3823476311898855
Becker,72376,0.2339482318167731
Namalwa,navitoclax-pluripotin (1-1 mol-mol),-1.959124206150004
LXF 289,23635314,-2.0420734326640253
Karpas-422,11977753,-4.357975408639603
PE/CA-PJ41 (clone D2),ISOX-bortezomib (250-1 mol-mol),1.316043804584087
NOMO-1,327653,2.81345515165661
HSC-3,53245473,3.709031325799373
AsPC-1,11964036,1.5618628535664978
Namalwa,676352,1.5925385443412192
SNU-423,11214940,1.835230705261515
BT 328,2708,7.776890663910961
HOP-62,6505803,-0.0366684489798773
PE/CA-PJ41 (clone D2),carboplatin-UNC0638 (2-1 mol-mol),4.040525542410768
EHEB,6852167,1.7579387732994172
RKO,44202524,1.4476976505001866
PF-382,46224516,1.3839719713771603
SF539,44202524,1.2344769857738371
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
BT 498,31703,1.193610486864811
NCI-H929,65064,3.1158427845285215
KYSE-180,16741245,1.8564307397104032
HOP-62,73707438,4.879888857078066
OAW28,46174525,4.143540766033049
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
RKO,5281321,1.9988379902215376
Kasumi-2,5479543,2.6831620827512004
BT 328,24775005,3.5424710463828624
KYSE-450,148198,-3.4919685284150876
SK-UT-1,3634881,3.231814398730286
ESS-1,10127622,5.583352628786162
BT 286,5311,2.9174041274412095
RKN,24856436,1.2279395925477072
Lu-65,10410894,2.9338236415664913
LMSU,11485656,2.410376154528579
Mono-Mac-1,72199292,0.6330197013887235
RKN,12001922,2.582060834791438
Kasumi-2,BRD-A02303741-navitoclax (2-1 mol-mol),-1.941760845574772
NCI-H1339,56963564,0.5367795839570972
SNU-119,3503,2.1114931973526425
HCC2108,46199207,2.9189708638806313
BT 286,24797083,-0.0799742333023719
KLE,piperlongumine-MST-312 (1-1 mol-mol),0.99514194367968
KLE,9823820,3.7832200192550047
NCI-H2030,44484440,3.521549989015301
LXF 289,3038522,4.104388560491244
NCI-H196,selumetinib-PLX-4032 (8-1 mol-mol),4.604890036629208
SW1783,3503,1.7276989845578277
HuT 78,375860,-0.3004561584408421
Karpas-422,navitoclax-PLX-4032 (1-1 mol-mol),3.265668039915953
RKN,11214940,-1.342915177510304
ESS-1,9887053,4.577592103187429
SF539,46174525,5.071115867258652
ESS-1,5978,-3.0981583425056787
BT 248,31703,-0.7981868387763399
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
AsPC-1,4261,2.35820288641389
RKN,60700,0.8209474049972991
SNU-119,piperlongumine-MST-312 (1-1 mol-mol),1.9759808399995944
Mono-Mac-1,73707438,4.288707884159042
Karpas-422,6918638,-0.9922508328121828
SK-UT-1,702558,5.233915547215681
KYSE-450,23725625,7.184930321255073
HCC2108,24180719,3.7452058347449033
PF-382,16736978,2.1192377766227355
AsPC-1,409805,5.083096669481897
ESS-1,4259181,0.7076598943715965
BT 328,9952709,3.885158695523131
KMRC-20,654092,-1.274296745742125
HuT 78,216345,3.2083234120467004
PF-382,9911830,1.7810920372451895
HSC-3,52912189,2.1489213461057424
MIA PaCa-2,24964624,2.7455097221801963
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
NCI-H929,SNX-2112-bortezomib (250-1 mol-mol),-3.169119515826122
HuT 78,71466578,1.9923030103429336
Ri-1,65064,2.4955274691972624
KMS-12-BM,984333,0.8199562104848779
LXF 289,2749,2.818144236178911
SNU-119,selumetinib-vorinostat (8-1 mol-mol),2.4531148017097726
BT 498,selumetinib-UNC0638 (4-1 mol-mol),4.90022051040507
PF-382,25183872,-2.3437313264330433
MJ,11213558,2.02705556252861
SW1783,10296883,3.940377993774996
KLE,16038120,1.5676746205851106
PF-382,49793307,-4.049648642852728
RT-4,11609586,3.0565970282052475
HCC2108,1242560,3.356321570563672
Lu-65,42642645,0.9193657310014032
SW1783,16659841,3.197521836887965
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057
NCI-H2030,navitoclax-MST-312 (1-1 mol-mol),1.17233719687161
BT 498,135421197,2.801881228152874
OAW28,16659841,4.936500838241895
KMS-12-BM,5284329,2.246794069285595
KMRC-20,11427553,3.4952779275874826
EHEB,15983966,-3.458477351874515
BT 498,selumetinib-JQ-1 (4-1 mol-mol),4.316550369510256
KLE,322968,2.787841827259593
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
Kasumi-2,6436223,-4.213376684231403
AsPC-1,11396600,3.3240147605355506
ChaGo-K-1,56649450,3.184271746518033
SF539,156414,1.5385171897873895
Becker,44462760,5.965848986366406
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
RT-4,31703,-0.972901161484085
SNU-423,11455910,2.439649543978504
ESS-1,25195348,3.4553614671814903
SK-UT-1,selumetinib-navitoclax (8-1 mol-mol),6.349573563603245
Lu-65,4477,0.0654724816795039
Kasumi-2,5281321,-3.5035572972621916
Karpas-422,45279963,3.778546245126845
Ri-1,53392493,0.5057181719967727
SNU-886,637858,1.4418078006770565
PE/CA-PJ41 (clone D2),2828334,6.340821215170622
KLE,36462,1.5319564725809691
AsPC-1,6918837,-2.7365580441764155
NCI-H929,71466380,3.795978498823376
PE/CA-PJ41 (clone D2),24771867,3.741688569493883
OAW28,6610355,6.153508691776863
RERF-LC-MS,6914657,-3.1593675222943896
HuT 78,JQ-1-UNC0638 (2-1 mol-mol),-1.5524452367081547
NCI-H929,5951923,6.150668957534198
SNU-886,9911463,3.862708319776098
RKO,9444,4.448790979485227
Lu-65,erlotinib-PLX-4032 (2-1 mol-mol),3.032800279318878
RKO,9911463,3.963116579454927
Mono-Mac-1,656346,0.8395847680643302
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
NCI-H929,54619267,3.6660361188352306
KYSE-450,60700,2.353056656519086
MJ,11152667,-1.2121300476072767
ChaGo-K-1,5566,3.0668549969604424
SF539,12003241,-2.026733754371074
SF539,208908,1.982441475653256
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
EHEB,135398516,1.2491473291998236
AU565,52912189,3.2475583793468994
BT 286,11455910,-0.3413435906946745
AsPC-1,3634881,3.56845743908184
Namalwa,1750826,-3.77700215521952
ChaGo-K-1,2746,5.131732167485152
EHEB,107985,-3.431566617096362
SK-MEL-5,216239,1.7796395684770618
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
AU565,9915743,-3.6885201415408098
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
EHEB,452548,-2.012657575306965
KLE,124202324,2.798176787230371
RKO,46843906,3.289277038806309
Kasumi-2,9907093,3.255145953057051
Ri-1,2874250,4.4080910823074015
CML-T1,126941,-3.100237153288417
SF539,8515,4.265018963639613
Karpas-422,3854666,1.0831762818043358
NCI-H1339,46926350,-4.1465404502416146
KMS-12-BM,675434,3.718693309292293
KMS-12-BM,6852167,1.232935409292076
SNU-423,46907787,4.032406628203726
AsPC-1,11152667,-0.9426796832875202
BT 286,11494412,1.6157020309527923
NCI-H196,6918878,3.7948272154638825
OAW28,54618771,1.1011370240470315
PF-382,9915743,0.1930622386086079
KMS-12-BM,72376,-4.576610051960773
SNU-423,navitoclax-pluripotin (1-1 mol-mol),-0.4289266734837184
CML-T1,445091,4.10308804654236
Mono-Mac-1,446155,1.9950711341343337
RERF-LC-MS,5470400,2.5584942331402623
NOMO-1,9926054,1.6113291347040215
Karpas-422,613753,2.8960805608319244
NOMO-1,52912189,-0.5265680930430634
SK-UT-1,52912189,5.034004666881923
LMSU,5280436,2.317492118597427
SNU-423,71466380,4.294535058973081
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
BT 286,71466380,5.082668290524384
KMRC-20,136227924,3.298573049161518
SNU-886,24978538,-8.014318851835679
Ri-1,9915743,-1.2170005610109595
BT 320,67291369,4.380585752028441
Namalwa,135423438,1.9520788575137753
SNU-886,SNX-2112-bortezomib (250-1 mol-mol),-2.93847148542514
ChaGo-K-1,selumetinib-navitoclax (8-1 mol-mol),4.9648562061893395
WM793,navitoclax-pluripotin (1-1 mol-mol),-0.4661023572804197
NOMO-1,285033,-2.4289999699368923
WM793,16722836,1.9523853795205277
Ri-1,656346,0.6144452864067766
BFTC-909,9936388,1.702123766125507
Becker,navitoclax-PLX-4032 (1-1 mol-mol),3.456000253563137
SK-UT-1,navitoclax-sorafenib (1-1 mol-mol),1.7980583949597466
KLE,3815108,3.3721583314849695
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
NOMO-1,4705,2.5023829157060926
SK-MEL-5,400769,-0.4151349609753891
ChaGo-K-1,44185566,2.9413507138853943
ESS-1,53232,1.8155260046975692
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
NOMO-1,6918878,0.4522523514749809
NCI-H1339,3854666,1.1163933455881117
BT 498,387447,-2.1725153128348547
WM793,selumetinib-JQ-1 (4-1 mol-mol),1.649848066078306
Namalwa,6918328,-2.1802160819991943
Mono-Mac-1,24856436,-2.470151993177535
ChaGo-K-1,1566236,2.038584840253616
KMRC-20,3825829,4.552870179452752
PE/CA-PJ41 (clone D2),9935249,3.298572074942043
CML-T1,31703,-3.375342626899218
HuT 78,11626560,-0.0583952728146231
CML-T1,11640390,3.08306987111381
WM793,11455910,1.0189470974054349
MIA PaCa-2,UNC0638-navitoclax (1-1 mol-mol),2.8894676156365
IST-Mes1,446155,1.803889787209672
RT-4,3543504,4.339418344926718
RKO,60750,-2.2331483998906654
Kasumi-2,44185566,0.8464196954941686
HCC2108,54613361,-0.9116007524668512
HOP-62,36462,1.2556592517294145
Lu-65,9840324,5.622509691828773
Namalwa,selumetinib-BRD-A02303741 (4-1 mol-mol),5.907304131340107
SK-UT-1,tanespimycin-gemcitabine (1-1 mol-mol),-2.178654952286891
NCI-H1339,5328940,2.364550013342955
NCI-H929,9926054,0.4409605375156073
ChaGo-K-1,123631,3.4556827131054
HCC2108,613753,3.4104972330481615
H-STS,3854666,0.1561624900748555
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
Ri-1,135999136,4.203993475326129
EHEB,16741245,4.711370152707264
Panc 02.03,4521392,4.25988041093388
SNU-119,216345,3.614862183808471
PE/CA-PJ41 (clone D2),568763,1.0096666551502742
Panc 02.03,409805,5.9877775932277615
NCI-H196,carboplatin-UNC0638 (2-1 mol-mol),3.541252771410712
SNU-213,6852167,2.322505898014435
HOP-62,11497983,5.1549735187421275
CML-T1,135398516,1.062716502546658
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
RERF-LC-MS,54618771,0.9955970244631366
PE/CA-PJ41 (clone D2),46199207,3.5307806574812046
OAW28,10074640,2.8656652346665545
Kasumi-2,3025944,3.902952987709838
OAW28,46199207,3.397949359639469
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
Namalwa,6184667,1.9403980705347172
MJ,5329102,2.173311571701512
EHEB,9911830,3.0366000052999893
HCC2108,11626560,1.2483680324780997
NCI-H2030,16741245,3.551000644564588
BT 248,72193861,2.013908806167315
SNU-213,56946209,-3.0832917036517475
NCI-H2030,107985,-3.4072882201526515
NOMO-1,5329102,1.5937414073922636
NCI-H1339,119182,-2.9193060131920405
NCI-H196,11609586,4.6494437662664465
Becker,5335621,4.427331566156457
Becker,selumetinib-piperlongumine (8-1 mol-mol),4.766670876498908
RT-4,10113978,3.079983585040923
KLE,6852167,2.751103786046217
ESS-1,448949,2.571296753427842
Ri-1,654092,-1.552094077000309
IST-Mes1,1566236,1.9315527075511711
NCI-H929,vorinostat-carboplatin (1-1 mol-mol),1.7849297289104662
OAW28,6852167,2.294169410796982
AsPC-1,5287969,-0.8371135357044818
LMSU,135999136,4.828023886470807
BT 498,9444,4.218280041925912
Kasumi-2,5280436,2.9235164089126884
SK-UT-1,126941,-4.3077723126369944
AsPC-1,44566777,0.4941234322675649
Kasumi-2,3503,1.0805615825532868
NOMO-1,1716436,2.6410194121109773
CML-T1,11364421,-5.082505847469849
IST-Mes1,2749,1.654199391381554
KLE,168312962,2.4682903625486077
KYSE-450,613753,3.352975816171232
Mono-Mac-1,25154868,4.051983982032292
SNU-423,439501,-3.458666497477645
ESS-1,44486219,4.319485753082415
MIA PaCa-2,11228183,3.414312638187762
IST-Mes1,42642645,0.3467837133172653
AsPC-1,2871966,-0.1237405253519755
KMS-12-BM,119182,-2.8670798945659617
Kasumi-2,49836020,6.151495097204233
Ri-1,46224516,2.535525926322653
Ri-1,11719255,1.9146528709587665
Kasumi-2,serdemetan-SCH-529074 (1-1 mol-mol),0.2929627524168506
ACC-MESO-1,54619267,4.83150874109993
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
MIA PaCa-2,2858523,3.008435530858324
KYSE-180,vorinostat-navitoclax (4-1 mol-mol),2.04555281689964
ESS-1,216468,-0.8835255749902827
LMSU,2729026,3.1039498249859183
ESS-1,439501,-2.0978778954241215
LMSU,44566777,0.4597072613973534
Karpas-422,JQ-1-navitoclax (2-1 mol-mol),-1.4008867544394668
OAW28,49766530,-0.5315014966120291
CML-T1,9444,4.326131103147221
EHEB,71680916,4.542174615812289
AsPC-1,72193861,3.428817244246792
BT 328,89928392,1.451353651421501
KYSE-450,262093,3.266752988649651
BT 286,168313200,1.66103693738852
SNU-423,4261,1.6127122663674172
RKO,448949,2.722052887717566
ESS-1,navitoclax-MST-312 (1-1 mol-mol),0.1700305380207872
HSC-3,46398810,2.2474004259842584
BT 328,135659046,3.8583019402961343
ChaGo-K-1,9911830,2.4299534095194084
NOMO-1,26596,-2.074766602044621
KMS-12-BM,159324,-2.1850115101348
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
SF539,56963564,-0.1880547909604584
Karpas-422,decitabine-navitoclax (2-1 mol-mol),0.2837209997925243
CML-T1,17755052,2.353347963272661
ESS-1,8515,4.728832630346152
Becker,24821094,3.775477955133952
RT-4,2729026,2.8165603599873306
SNU-119,448949,1.6770558610697637
SK-MEL-5,54454,2.090497805945611
ACC-MESO-1,24856436,4.2649128901645605
OAW28,44185566,1.918306011480311
OAW28,135440466,2.5697421477630273
RERF-LC-MS,135440466,2.007932851474071
RERF-LC-MS,6918736,-1.8242544668906209
CML-T1,119182,-4.6073645657146285
NCI-H1339,9866186,0.8819529179959803
Kasumi-2,11238147,1.8873340406507049
SK-MEL-5,10427712,4.3012034852444
AU565,24821094,-3.121521346886189
Kasumi-2,11955716,-2.6016781088205665
Karpas-422,71466445,2.788648588655379
IST-Mes1,51037431,5.172794571797409
HSC-3,5951923,3.085598804572914
Panc 02.03,73707398,1.687012904299387
KLE,66577038,4.579092184923065
KYSE-450,3689413,-0.3124621453247139
BT 328,11609586,3.6463226315951225
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
WM793,676352,2.515815978900982
RKN,5282054,3.624299707956654
Karpas-422,9884685,-1.8579964706591168
Ri-1,24797083,-0.1682916491575397
OAW28,135421197,1.4901490212875883
NCI-H196,156414,2.0892379474459037
HSC-3,124202324,3.390137695130575
H-STS,6438330,0.2327591369771806
PF-382,salermide-PLX-4032 (12-1 mol-mol),5.272425832636036
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
NOMO-1,107985,-4.118574275669005
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
RT-4,10231331,3.499380927126235
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
BT 328,135875424,3.085389187382682
SW1783,24779724,3.9128595943603544
IST-Mes1,11427553,1.720147340773497
Namalwa,4578,4.251470718867193
SK-UT-1,31703,-1.1985979493610477
Ri-1,124202324,-0.3559734542715176
NCI-H929,selumetinib-MK-2206 (8-1 mol-mol),-0.3553721950271566
KMS-12-BM,11175137,1.8406353702051843
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
SK-UT-1,71304818,1.4453829824044986
SF539,9825149,2.2900366045202674
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
HSC-3,16720766,0.1935986019014492
SNU-213,alisertib-navitoclax (2-1 mol-mol),4.251686417889072
LMSU,135440466,2.4580470994052916
LMSU,3552672,1.9414918603747835
BT 320,erlotinib-PLX-4032 (2-1 mol-mol),4.456521882362605
SK-MEL-5,4705,2.45435106083484
Namalwa,135440466,1.047510792241919
KYSE-450,135411,0.9240917820052414
Becker,5282054,3.7183306925435167
BT 328,16038120,0.9793977548017024
KMRC-20,10302451,3.571501385736242
SNU-423,24964624,2.37850111488742
BT 286,9825149,1.2617601682397392
SNU-886,702558,5.095529116539229
Lu-65,2729026,3.1489264055636164
SNU-423,23725625,5.944584513695728
SNU-423,11612883,3.406869193670429
SNU-886,3503,1.4984016938588718
SNU-423,alisertib-navitoclax (2-1 mol-mol),-0.7020457415756507
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292
OAW28,10296883,4.314409366833216
PF-382,446155,1.656597721830262
KYSE-450,107970,3.4899067291718717
SW1783,selumetinib-decitabine (4-1 mol-mol),5.3087613304483225
KMS-12-BM,5311,-0.4045600227605066
Lu-65,52912189,2.4478972750798587
KLE,11455910,3.332048563725763
NCI-H929,11485656,1.7872822459041733
ACC-MESO-1,216345,4.569735867855644
RKO,44589607,3.597229089573096
Ri-1,2858523,2.761311128229238
NCI-H2030,serdemetan-SCH-529074 (1-1 mol-mol),3.1997041761285834
HOP-62,16725315,3.3332717418500155
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
SNU-119,24779724,4.340610631668066
KLE,216239,3.024053239186479
SK-MEL-5,navitoclax-birinapant (1-1 mol-mol),3.7438137761587287
BT 320,53392493,4.061896393500848
SNU-886,46191454,2.868449433002464
H-STS,JQ-1-UNC0638 (2-1 mol-mol),1.212466073546629
RT-4,tanespimycin-gemcitabine (1-1 mol-mol),-3.611548867798562
HOP-62,49793307,1.9032662120533077
RKO,4259181,-0.4049041326260317
ESS-1,26596,-1.5335330182559344
ChaGo-K-1,2708,6.0017156260200375
NCI-H1339,135421197,3.8934160378835054
IST-Mes1,3503,2.9550990055374413
H-STS,11396600,3.334455384541719
Kasumi-2,24748573,1.468920481488018
MJ,11214940,1.554079945659114
Namalwa,4096211,1.0256721526458017
EHEB,753704,4.57215255992242
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
SNU-119,3025944,4.367446555553435
Ri-1,24772860,-4.365675374144319
ACC-MESO-1,25062766,1.64302611578302
BT 286,ISOX-bortezomib (250-1 mol-mol),0.3407126531024899
BT 328,568763,1.8540976735744827
ChaGo-K-1,644241,2.384389937346898
ChaGo-K-1,25183872,-0.0943535025043812
SNU-423,56946209,-4.392308882184761
SK-UT-1,24785538,2.9370151695629985
NCI-H1339,5470400,1.0062090619219264
Kasumi-2,2842253,5.767696299842194
KLE,11238147,4.019419041110989
HEC-108,16741245,3.4879989323714713
BT 248,9866186,3.3997152825838515
ACC-MESO-1,11626560,2.83142802841304
H-STS,107985,-3.371812219101193
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
EHEB,25062766,1.0202887553204696
KYSE-180,54618305,5.290256883782679
MIA PaCa-2,5738263,2.6368998007843456
SW1783,3062316,3.7843864001460585
Ri-1,15547703,1.021239227044065
KMS-12-BM,11626560,0.494949626901472
BFTC-909,44507138,2.8704731321552734
KYSE-180,969516,2.4529447975335117
SNU-886,53245473,3.705172438832396
SK-UT-1,24772860,-2.1685737338015505
ESS-1,5746,0.0804906650229093
EHEB,51039095,2.793639508249939
EHEB,44185566,1.5991961670911994
HOP-62,10074640,3.0888797836888053
BT 328,3552672,2.1088972193148146
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
NCI-H1339,4917,3.747173592434861
LXF 289,42642645,0.485507292149712
KMS-12-BM,11455910,-0.5978210432128618
Lu-65,16736978,1.5327388647399771
HCC2108,doxorubicin-navitoclax (2-1 mol-mol),-0.6309858314473922
NCI-H2030,60700,1.034141125582276
SNU-119,5479543,5.507463423789633
NCI-H929,46398810,2.168604614407646
ChaGo-K-1,11609586,3.37979827578237
AU565,16038120,1.417918520815656
Ri-1,navitoclax-pluripotin (1-1 mol-mol),-6.091181145598441
Namalwa,44493528,4.097758002058851
CML-T1,alisertib-navitoclax (2-1 mol-mol),-1.6309921665617133
SNU-423,7251185,2.0978048773368823
CML-T1,73707398,-0.0310412376393591
BT 248,16736978,2.1942612442020484
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
ACC-MESO-1,3038522,4.864795904430629
MIA PaCa-2,5311,0.9776668834294896
PF-382,3815108,1.747404185306998
CML-T1,159324,0.3275039904336689
Becker,tanespimycin-gemcitabine (1-1 mol-mol),-0.4424544755014754
Kasumi-2,71729975,0.1244547207122276
SF539,5470400,1.793905767243159
ESS-1,1716436,3.7627823141372874
MIA PaCa-2,984333,1.281535756123921
SNU-119,1716436,3.1005632385597237
HSC-3,6610216,4.3028162807700365
KMRC-20,54618771,1.1098897337437623
KMS-12-BM,4261,-0.5795047711854386
Mono-Mac-1,151289,0.6331917318262559
MIA PaCa-2,25150857,1.2289089337297283
Becker,168312962,-1.1419404426539477
PF-382,65064,3.049277713091966
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
MIA PaCa-2,4259181,-0.2210176227464965
NCI-H209,2749,1.5190087226766276
SW1783,selumetinib-MK-2206 (8-1 mol-mol),4.242449786456935
SNU-119,2742550,2.8976089932934883
BT 248,9884685,-0.279602051509792
BT 320,9825149,2.6279121601862676
NCI-H2030,11964036,1.7484747301817396
AsPC-1,15953870,5.362858272792295
SK-UT-1,66577038,3.2613537535167874
SNU-886,selumetinib-JQ-1 (4-1 mol-mol),2.185309080254947
IST-Mes1,219104,4.071310239310072
LXF 289,4788,5.213081732847737
IST-Mes1,2858523,3.245314531932087
CML-T1,49850262,2.3003389318393404
SNU-119,44819697,-0.6073475651500764
SNU-213,10113978,3.0551192339322784
NCI-H1339,462382,1.2176103463091026
ESS-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.9725488510506712
KYSE-450,753704,5.119991159407921
SNU-119,262093,2.598697839644185
KMRC-20,2841722,4.772278882478543
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
BFTC-909,7326481,3.4905195575106527
ChaGo-K-1,16736978,2.0946881293148376
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
RERF-LC-MS,11497983,4.204546577264711
HOP-62,2949965,2.889476445152641
Panc 02.03,54618771,1.0884531427161812
ESS-1,4477,0.5531720696297147
SK-MEL-5,46191454,2.492923802582545
BFTC-909,3552672,4.498195948808332
KMS-12-BM,3384730,0.2737397742242424
BT 286,426756,1.913868896716008
CML-T1,216468,0.1350088901202253
HEC-108,216468,0.5077016894807419
IST-Mes1,36462,4.9786696220654845
NCI-H2030,11625818,4.920098770684147
SF539,25262965,0.0170335462798406
PE/CA-PJ41 (clone D2),2871966,-1.530676226190852
KYSE-450,16038120,1.4472769553293552
H-STS,5281672,5.306153738631839
H-STS,2858523,3.0091153865210103
HOP-62,6918638,0.8791129287698843
Ri-1,16725315,3.0875224510373016
Namalwa,19582717,2.3448185040183622
CML-T1,10427712,1.89618534848285
LMSU,navitoclax-PLX-4032 (1-1 mol-mol),3.8157620441746833
Lu-65,5394,4.420956778785719
PE/CA-PJ41 (clone D2),36462,2.2016180933991594
SK-UT-1,246676,5.689307282465742
SK-MEL-5,navitoclax-MST-312 (1-1 mol-mol),1.0759478439480712
ESS-1,2742550,4.194579887734085
EHEB,alisertib-navitoclax (2-1 mol-mol),-1.9971610366443435
SNU-119,124202324,4.249664634956003
SNU-119,2126,3.7232553571891143
SK-UT-1,44185566,3.0890330795466125
Lu-65,selumetinib-tretinoin (2-1 mol-mol),-0.9758707789928271
BT 286,31703,-3.5254505333334594
NOMO-1,6610355,3.932739350210071
NCI-H196,24951314,1.598865298962579
SNU-119,11404337,-0.1265251374759644
NCI-H1339,51039095,3.6896681502531585
LXF 289,10296883,3.609856485747645
Becker,73707398,1.456292128842472
HEC-108,71304818,2.263440211327266
Mono-Mac-1,5291,3.566758148465558
EHEB,5329102,1.796828248778677
IST-Mes1,4788,5.898872389352922
PF-382,57519531,1.1953154667352015
AsPC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9702112350407297
Kasumi-2,1641662,2.7685254402742183
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
SNU-119,65064,4.58104500437737
H-STS,44137675,1.4047344665850907
Mono-Mac-1,navitoclax-sorafenib (1-1 mol-mol),-2.8345587791213727
ESS-1,5566,3.65596879307383
OAW28,969516,2.7253654251657573
RERF-LC-MS,3503,1.2198018250646854
AsPC-1,676352,1.9564823338284063
SNU-423,6184667,3.1994764745463304
Panc 02.03,5460769,1.6540560754425335
KMRC-20,25195348,4.57665452186817
AU565,123631,0.0519428975879534
NCI-H929,54454,1.0391277721640106
BT 328,5287620,-1.6650936654034112
LXF 289,2828334,5.402872149224608
NOMO-1,136227331,3.913043208951298
HEC-108,46398810,3.0484074002567287
HSC-3,54618771,0.6642536113718133
H-STS,16722836,2.295773784833407
Kasumi-2,6252,-4.69021119640851
HuT 78,3503,2.594592779968663
SNU-423,89183176,6.316481371266781
Becker,1750826,0.1399288732745424
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
BT 328,tanespimycin-gemcitabine (1-1 mol-mol),-0.0824560105444719
SNU-213,carboplatin-UNC0638 (2-1 mol-mol),3.219769925540834
NCI-H1339,25195348,3.198414569671987
IST-Mes1,5978,0.1624820602578698
AsPC-1,439501,-1.6009280184427317
RKN,49766530,-3.8574490235665584
HuT 78,122327,5.365599791501648
BFTC-909,168312962,2.436518653578315
Karpas-422,3025986,-1.6736184897187318
NCI-H2030,31703,0.2472817555604013
PE/CA-PJ41 (clone D2),11640390,3.953492019863505
AsPC-1,8515,4.986545700595871
NCI-H2030,11178236,-2.556772760717576
ACC-MESO-1,16725315,4.549788243222949
BT 498,984333,1.6558618711250384
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
Panc 02.03,24771867,4.320948526904658
Ri-1,2729026,1.3989648629345883
RT-4,119182,-0.6626417510702334
NOMO-1,49793307,-3.1091933140229
HSC-3,322968,3.758052812431369
NCI-H196,2858523,3.100768547477784
MIA PaCa-2,15547703,4.29520313125994
SF539,73707371,2.192047905744571
OAW28,3025986,-0.5681838773369163
Karpas-422,navitoclax-pluripotin (1-1 mol-mol),-0.031614077340192
BT 286,3503,0.7822186863791739
NCI-H1339,216239,3.528390744524712
SNU-213,16722836,1.1537884204596969
BT 286,81146,4.651385786966362
AsPC-1,24753719,4.618559637878285
PF-382,52947716,-1.076920291398276
NCI-H196,16038120,2.220488644828489
RKO,10427712,4.823698606341804
Mono-Mac-1,56973724,1.687151407906093
HEC-108,BRD-A02303741-carboplatin (1-1 mol-mol),4.399669755507875
ChaGo-K-1,11364421,0.7626665652731202
LMSU,9933475,1.3920899137371403
WM793,1750826,-0.77104860711207
H-STS,9915743,1.4562053378516668
SF539,409805,5.790114720226367
Karpas-422,56949517,1.4379353462298257
NCI-H1339,3825829,4.0280644624374435
ACC-MESO-1,11640390,5.7204309821765715
BT 320,4259181,1.858689674297262
CML-T1,448949,0.9677195275785144
RKO,123631,2.6120370559458155
BT 286,55508,2.1421401977564245
AU565,5494449,3.8187307918252262
AU565,5284616,2.6982931675931914
BT 328,selumetinib-MK-2206 (8-1 mol-mol),3.5375003025596596
RT-4,5311,2.127982619731648
BFTC-909,46398810,2.674147192871529
AsPC-1,44137675,4.002233175780649
Kasumi-2,26596,-3.0246532529835273
MJ,15983966,-4.500116759610759
AsPC-1,11214940,2.3233429785878443
LMSU,3081361,2.668477326227084
SNU-119,52947716,2.3236850993344285
SK-MEL-5,71466380,3.8965003815329906
BT 286,439501,-3.2145304071914844
RERF-LC-MS,216345,4.25766275770173
HuT 78,400769,-0.7325888332601455
BT 328,44484893,4.396363776297363
AU565,54596490,4.681317358630495
MJ,24779724,5.157647123549832
Lu-65,445643,4.085540954686197
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
Lu-65,44491742,4.485926174539046
NCI-H196,piperlongumine-MST-312 (1-1 mol-mol),1.4023349702680732
HuT 78,24797083,1.4167690374824495
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
Becker,71304818,1.6005732292475567
NCI-H929,6918837,-4.507848633334324
SK-MEL-5,11609586,2.982945620933936
NCI-H929,3689413,-2.331613234092956
ACC-MESO-1,vorinostat-navitoclax (4-1 mol-mol),0.9028362531018698
NCI-H196,2828334,6.824622539446005
HSC-3,25262965,-1.2196052378955902
ACC-MESO-1,421610,5.247671500966904
HuT 78,11214940,1.6478986529716984
ChaGo-K-1,11455910,-0.3769194241823518
ChaGo-K-1,613753,3.0329005548779864
IST-Mes1,49836020,4.276541253138442
SK-MEL-5,89183176,4.253397892442645
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481
Panc 02.03,5566,2.8367562997211815
SNU-886,89928392,0.8718165666636013
Ri-1,9826308,-0.8124183287153022
BT 328,54678924,4.095049817388681
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
EHEB,135984461,4.428627188495882
Panc 02.03,46199207,3.8452319744534886
KMS-12-BM,11222830,0.3420058811643648
Karpas-422,123631,2.844969571562552
Karpas-422,3634881,3.1102850261434805
HOP-62,6918328,-1.6775257144322653
ESS-1,6505803,-2.0071033756271106
OAW28,71304818,3.062868675930112
LMSU,9884685,1.8441382051797008
CML-T1,168313047,1.9633067789473095
CML-T1,16725315,3.685793664289718
SNU-213,24856436,1.6786280884983995
EHEB,44819697,-0.6865336192844265
Panc 02.03,104842,-1.6275579890051994
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
BT 498,44507138,4.476922300600167
Mono-Mac-1,4261,-0.1747295903201891
SK-MEL-5,3854666,2.922871568885423
PF-382,selumetinib-piperlongumine (8-1 mol-mol),2.6362885856450724
Ri-1,26596,-3.083821338619051
RKO,71680916,5.910552922648844
EHEB,11612883,2.202439191099921
EHEB,375860,-0.9049347764221136
AU565,5113032,4.518377698044194
SF539,5280436,3.2977322800026463
BT 286,3854666,0.3675459578647432
KMS-12-BM,16722836,0.1078471440950463
SNU-886,9927531,4.416743823533711
ChaGo-K-1,6438330,2.487418493930481
Karpas-422,6450551,2.30422397059455
BT 320,11222830,2.3629400148118354
AsPC-1,5746,2.3674241916356755
ESS-1,135421197,2.603718676668537
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
Karpas-422,56946209,-7.918567186496904
BT 248,5282054,3.4340814823816324
ESS-1,tretinoin-navitoclax (4-1 mol-mol),5.435469154170702
SNU-423,44566777,-0.8182000419835486
LXF 289,71304818,2.1201305139291033
BT 498,10184653,2.419934801281735
RERF-LC-MS,11707110,3.327368501952155
RKN,24772860,-0.333409077824626
Ri-1,8515,1.7161399430410786
H-STS,5460769,1.2422964505231244
RT-4,168313047,2.65705548195288
NCI-H929,navitoclax-birinapant (1-1 mol-mol),3.0660069376670065
NCI-H2030,25183872,2.0534030913447174
Panc 02.03,285033,-1.023489563814438
AsPC-1,107985,-4.227741895863185
BT 248,4705,2.6318547262793386
NOMO-1,24901704,1.738276567126731
NCI-H929,9915743,0.0759555072139175
SNU-423,984333,0.69154556302042
RKO,53392493,2.7606647137416616
KYSE-180,11404337,-0.9460930401604244
MIA PaCa-2,208908,1.9500660669416612
Panc 02.03,2113511,6.868929428825361
ESS-1,445643,4.277333724215148
Karpas-422,36314,4.062786595955015
ESS-1,9915743,1.8900363437156489
OAW28,42642645,0.9360886571737812
SK-UT-1,docetaxel-tanespimycin (2-1 mol-mol),-3.9315857495546735
HuT 78,9915743,-0.3205464670121912
OAW28,4261,1.5275003221448853
WM793,9911463,3.794379463406426
ESS-1,57519531,1.5158364649894671
Namalwa,decitabine-carboplatin (1-1 mol-mol),-0.3427123891632673
Becker,6505803,-1.1443258225494983
Panc 02.03,3689413,0.2165954212360822
LMSU,3503,1.6210474530909185
KMS-12-BM,60750,-3.781170987438112
BT 248,15953870,3.6832035377423216
SNU-119,66577038,3.3366072908443756
BT 248,54678924,1.5069949057557903
LMSU,26596,2.3008598244356935
IST-Mes1,322968,3.0930404941453933
NCI-H209,9967941,2.470617171151905
BT 498,46199207,1.8437430927098404
H-STS,16725315,4.449964499354371
Panc 02.03,16741245,4.354855972582246
KYSE-450,241158,4.285328470501583
IST-Mes1,11404337,-0.5180157624887997
Ri-1,17759555,2.301771456031875
LXF 289,135875424,3.2815298243266553
MIA PaCa-2,doxorubicin-navitoclax (2-1 mol-mol),-2.304183042067753
SW1783,45279963,3.6721383023604095
SK-MEL-5,445455,5.188541554233024
NCI-H209,135411,0.7970408532487251
RKN,676352,2.5860960344205175
HOP-62,3676137,3.3254005331924725
Karpas-422,24180125,1.2333390816210612
NCI-H929,24901704,2.6576899414441897
Namalwa,44819697,-3.151735066093753
BT 248,10385095,1.1706577035646757
LMSU,5311,4.122063566653656
SK-UT-1,selumetinib-MK-2206 (8-1 mol-mol),3.6848335310272495
KMS-12-BM,1239801,3.0053615870296753
Mono-Mac-1,400769,-0.1377248267804078
Lu-65,3825829,3.880703687258769
HSC-3,25126798,3.3699831224465604
Namalwa,11640390,3.4518080924768952
OAW28,73707398,1.2451215877479735
NCI-H929,4261,0.6477410637199463
PE/CA-PJ41 (clone D2),107985,-2.5138911601110254
RT-4,24797083,2.4952556091999347
Ri-1,9926054,1.5974379061435915
HCC2108,135984461,3.878993075429708
BT 286,44819697,-3.4653794468599117
ESS-1,JQ-1-vorinostat (2-1 mol-mol),1.066705942118914
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904
SNU-886,25183872,0.04916046112461
SNU-886,36314,-4.506581052227643
SNU-423,42642645,1.572075409923546
Mono-Mac-1,53232,2.497204294555262
HEC-108,6623618,3.02110008293671
LMSU,5329102,2.020452826888572
ACC-MESO-1,ISOX-bortezomib (250-1 mol-mol),1.554730838176437
Karpas-422,46843906,1.03468307378118
ChaGo-K-1,10074640,3.6205577288554394
NCI-H1339,7326481,2.9042986781727596
NCI-H929,2733487,7.111048494668631
SNU-119,9903786,3.393165032525661
NCI-H2030,JQ-1-vorinostat (2-1 mol-mol),1.2465457151300732
ESS-1,16038120,1.529167469529828
WM793,123631,2.8618988617204253
NCI-H929,656346,1.0360928512144068
HSC-3,17759555,3.5917299026109375
IST-Mes1,2113511,6.40207592921409
NOMO-1,66577038,2.985459327680272
BT 248,5311,3.0798190942417363
AsPC-1,5566,3.190935368909542
HSC-3,11612883,4.26819604770761
HuT 78,3543504,5.689885557286378
Lu-65,24964624,2.8804147061404075
SK-UT-1,42642645,1.4382792591793798
SK-MEL-5,3025986,1.0315417341364177
BFTC-909,107970,2.2861723254681774
Mono-Mac-1,16219061,0.7140738799397371
Mono-Mac-1,322968,2.235320264259914
KLE,2113511,5.3070368791783915
SF539,9933475,0.5324953409576078
Mono-Mac-1,5311281,3.37380571795301
SF539,54143018,-1.099127333554906
BFTC-909,1750826,-0.1726466566192349
ChaGo-K-1,67156097,-0.5727402535165194
SF539,3025944,4.088264008981447
CML-T1,89928392,0.2335848320544615
BT 248,445091,5.158109648340294
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
KYSE-450,44486219,4.896382772199078
RKO,11455910,0.1271196393609195
KLE,54649381,3.9923802992632687
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
EHEB,17759555,3.693788336759982
SW1783,10427712,4.612980278868
Mono-Mac-1,135411,-1.165468414197589
Mono-Mac-1,11964036,-0.102972472767287
PE/CA-PJ41 (clone D2),selumetinib-tretinoin (2-1 mol-mol),3.593635705218729
IST-Mes1,25102847,1.8280194065910471
Karpas-422,11222830,1.5173095522321836
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
HOP-62,444795,4.062660222672805
KYSE-180,637858,2.310022745659766
WM793,159324,3.425736366761861
SNU-886,2949965,3.980374171773664
Namalwa,46943432,0.650701651867592
BFTC-909,54626689,4.365294423210906
CML-T1,44589607,0.9502853682806348
Karpas-422,10026128,4.471871279969492
SK-UT-1,89928392,1.5133465040909966
BT 286,54596558,4.09108298890371
BT 248,122327,5.08009478305936
BT 328,16722836,1.9860843246282325
Mono-Mac-1,44493528,3.807460562047893
PF-382,25262965,-1.7427075899260709
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
KMRC-20,446155,3.8428728494703432
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
LMSU,5738263,3.8344484007304063
IST-Mes1,119182,0.8525106306178227
ChaGo-K-1,60700,0.6299469520284973
SK-MEL-5,2746,2.5702716912932337
SNU-423,selumetinib-BRD-A02303741 (4-1 mol-mol),4.623650435815717
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
KMRC-20,969516,3.471126157495644
RT-4,176870,3.685175817332376
HOP-62,446155,1.0940351919742453
KYSE-180,72376,-2.661600784164128
EHEB,135421197,1.2947733633872678
Lu-65,375860,-0.0242259972210493
Panc 02.03,10385095,1.3097039910351371
HEC-108,11507802,1.3993540262685686
WM793,SNX-2112-bortezomib (250-1 mol-mol),-1.3644142128989931
EHEB,6610216,4.931191689693455
KYSE-180,12003241,-0.805265861116592
IST-Mes1,selumetinib-UNC0638 (4-1 mol-mol),3.472834598034016
CML-T1,322968,2.5082577681036473
Karpas-422,135999136,3.6937273176122294
LXF 289,3815108,3.5075214319549683
KYSE-450,25126798,4.042128905943723
KYSE-180,5329102,2.581374775055639
OAW28,148198,-3.8662210541116977
AU565,613000,0.5241513608694668
BFTC-909,10410894,3.671861694905457
EHEB,10385095,1.253390881214325
ChaGo-K-1,5328940,1.1886194190450794
Becker,7326481,2.0225268509287253
OAW28,46843906,3.2241568449076556
Namalwa,10322450,3.877307531453308
MIA PaCa-2,6918837,-4.665998901916337
IST-Mes1,1750826,2.0701004204652778
MIA PaCa-2,9927531,4.662028210048159
Namalwa,60750,-4.795998727085379
RERF-LC-MS,262093,3.104487938727744
KYSE-180,36314,2.411334755990669
AsPC-1,71466380,6.178949844697013
OAW28,9915743,2.8675584787684456
ESS-1,15547703,2.140429677940592
SK-MEL-5,67291369,2.77281330357191
CML-T1,3543504,3.744639287704583
IST-Mes1,9936388,2.2275468363886763
HCC2108,11964036,2.450976446990399
OAW28,168313200,4.298133692275281
Karpas-422,3384730,1.9052527031441604
SK-UT-1,387447,-4.561746078529997
NCI-H929,26596,-1.2167182000669836
LMSU,24901704,3.2406983382817387
SK-MEL-5,4096211,2.3960357631286326
Lu-65,11955716,-2.4331112872150893
RKN,4378219,1.9905206425028277
RERF-LC-MS,44491742,4.380479941679622
ChaGo-K-1,322968,4.114664124130711
MIA PaCa-2,52947716,1.6425946184377718
ACC-MESO-1,10184653,2.2423096516125143
LXF 289,216468,2.2889797638929683
OAW28,753704,4.708152366597851
NCI-H929,3854666,0.9590353539059504
HSC-3,10184653,0.3696496653889782
HSC-3,12001922,1.7016354189742475
IST-Mes1,44589607,3.0309009389458605
SNU-119,441298,2.074764290405071
HuT 78,decitabine-carboplatin (1-1 mol-mol),2.461978095459001
H-STS,2828334,6.0228832587508006
RT-4,71466445,5.089577793908251
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
BT 286,5460769,1.8515527065353563
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561
RT-4,107970,2.3841738823851255
EHEB,9903786,1.657877258917439
BT 498,44819697,-0.3777975924200397
HOP-62,4259181,1.6890698920595109
Karpas-422,439501,-2.968319248514649
MIA PaCa-2,navitoclax-pluripotin (1-1 mol-mol),-0.3437181769375965
KMS-12-BM,446155,2.3535681188168476
BT 320,10074640,3.68399538142115
Karpas-422,selumetinib-navitoclax (8-1 mol-mol),2.054969232289055
RT-4,135999136,6.151607962032574
CML-T1,5335621,4.035243944386916
Kasumi-2,2126,3.96137914347523
AsPC-1,6505803,-1.959385905579291
KMRC-20,3025944,4.366878976688431
ChaGo-K-1,3689413,-1.075301905965469
SNU-886,56963564,0.781074966857933
HOP-62,82146,3.1920840849402805
CML-T1,10127622,3.755726914771393
KLE,11640390,2.1380206941615514
HCC2108,2113511,6.206167164976693
SNU-119,25195348,3.2417646819599444
Mono-Mac-1,227681,3.3122059805096185
NCI-H929,JQ-1-MK-0752 (1-1 mol-mol),-3.6559725672275394
Kasumi-2,56946209,-4.865772879743349
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
ChaGo-K-1,11396600,3.1968353669128637
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
MIA PaCa-2,2126,5.698167859697367
EHEB,ISOX-bortezomib (250-1 mol-mol),0.0742448904105083
PE/CA-PJ41 (clone D2),5738263,4.071016994612923
RT-4,erlotinib-PLX-4032 (2-1 mol-mol),3.2445039768018624
LMSU,6914657,-3.5331603162899707
HEC-108,54619238,5.029653380643683
SNU-886,selumetinib-piperlongumine (8-1 mol-mol),-0.4939497647937791
SF539,67156097,-1.6249990290252014
OAW28,11625818,4.459236282412159
MIA PaCa-2,3384730,3.900659511222064
HuT 78,6917907,-7.494534936281525
SF539,54619267,4.325836901582148
IST-Mes1,44185566,3.025290337876495
ESS-1,107985,-4.436359650155883
Karpas-422,984333,0.9643586289419676
KMS-12-BM,753704,4.548989794941243
HuT 78,72193861,0.6888403740474174
PE/CA-PJ41 (clone D2),5284616,3.399079248697445
HEC-108,637858,2.449708151119433
BT 248,25154868,4.640538278810453
H-STS,676352,1.5630553052267655
WM793,12003241,-0.659721194491695
KYSE-180,46398810,2.9758827771155003
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
NCI-H209,11404337,0.938734555574242
SW1783,1716436,2.7857036486954567
ACC-MESO-1,navitoclax-pluripotin (1-1 mol-mol),0.0190140508303161
Ri-1,1716436,1.3694183290635549
SNU-119,JQ-1-MK-0752 (1-1 mol-mol),1.0166640461128336
HCC2108,3062316,3.16488906574129
Karpas-422,9803433,6.366400015677791
NCI-H1339,1566236,2.281112121085828
Kasumi-2,445455,4.224989809831099
AsPC-1,10074640,3.638861482782184
Kasumi-2,10296883,1.6134498936175832
KMS-12-BM,10302451,3.4855488172991924
SNU-423,54613361,-0.0593712811961012
ESS-1,11640390,3.6623137422227607
EHEB,vorinostat-carboplatin (1-1 mol-mol),1.7793348056073373
LXF 289,3543504,4.042070583449167
SF539,100016,5.965471494853995
SNU-213,2858523,3.0248572714746853
BFTC-909,6852167,2.133526407129769
H-STS,24856436,0.4197930634847036
NCI-H1339,6252,-0.4207585995125426
HOP-62,crizotinib-PLX-4032 (2-1 mol-mol),2.0744297613100375
MIA PaCa-2,400769,-0.5001352159542624
HuT 78,241158,3.345962703014529
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
H-STS,49793307,-5.0868612084063995
WM793,11507802,2.1513003303084592
Mono-Mac-1,126941,-2.3144424159721
H-STS,navitoclax-gemcitabine (1-1 mol-mol),-4.788943462701537
RKO,6917907,-7.36544436443182
ESS-1,71304818,2.8292725688978986
IST-Mes1,vorinostat-navitoclax (4-1 mol-mol),2.4210379040593972
AsPC-1,11234052,4.540853045838434
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
SK-UT-1,10113978,3.4066925150008864
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
Ri-1,57519531,-0.0573484837377726
BT 286,2708,2.460649932488337
BFTC-909,5566,2.8568699448622263
NCI-H929,5282054,1.6993370124309537
RERF-LC-MS,6505803,-0.6931241555509828
AsPC-1,11238147,2.0906654911229796
PF-382,122327,5.887975915813721
EHEB,16038120,1.550937492892113
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
SK-UT-1,1641662,3.5811505263635235
PE/CA-PJ41 (clone D2),2749,1.4001288103335976
AsPC-1,1641662,3.9838157290035
SNU-423,57519531,1.7803888021546357
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323
SW1783,2858523,2.7249015392010425
KYSE-180,54454,2.017904173526763
ESS-1,445091,4.768128875501155
OAW28,53495165,3.30177539085494
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
Becker,5351362,1.5904741458166467
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
NCI-H1339,46174525,4.357687715736806
SW1783,71304818,3.413551155589458
OAW28,135875424,4.470041991889524
HCC2108,675434,4.657843907712605
SW1783,11626560,2.73995450904139
SK-MEL-5,107985,-2.7442566338787473
PE/CA-PJ41 (clone D2),46926350,-4.147494245167489
Mono-Mac-1,24748573,1.5404241948644124
RT-4,54618164,3.1267558882512803
MIA PaCa-2,navitoclax-birinapant (1-1 mol-mol),3.251928877119314
ESS-1,216345,4.629850284617237
H-STS,216345,2.2143657283557854
SF539,262093,2.0596515913386786
AsPC-1,11625818,4.311821961769238
BT 286,selumetinib-PLX-4032 (8-1 mol-mol),0.2510040812507161
HEC-108,148198,-2.2464200337513587
MJ,9866186,-0.7019525908206407
SK-UT-1,16720766,0.6075309431652871
SW1783,6918837,0.7485271513756125
IST-Mes1,2874250,4.337377448058327
RT-4,3025986,-0.629141422701896
NCI-H1339,3025944,4.2584671750779615
NCI-H2030,72376,-2.1157661371890044
Kasumi-2,66577038,2.680052495523132
CML-T1,vorinostat-carboplatin (1-1 mol-mol),1.2674452804454217
HEC-108,51039095,3.663645596248864
SNU-119,navitoclax-sorafenib (1-1 mol-mol),2.4601153144436045
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
KYSE-450,2828334,6.299741287777087
Karpas-422,9967941,3.787920675391452
RERF-LC-MS,24772860,-2.3078196081029136
EHEB,24785538,2.1074242406827044
AsPC-1,53232,3.925663364010775
LXF 289,5470400,3.745756378340341
HOP-62,72376,-0.6435309634126237
BT 320,16065773,4.123538520669632
SK-MEL-5,448949,2.5992925847880155
EHEB,10302451,2.5081035375606295
LXF 289,67291369,3.4412292386368746
ESS-1,3384730,2.888530811754609
NCI-H2030,1750826,0.9676784509807878
NCI-H929,46174525,3.514748643502036
EHEB,piperlongumine-MST-312 (1-1 mol-mol),1.299458892155912
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
ESS-1,31703,-3.4275082307518807
HOP-62,2945648,3.444698948827361
Karpas-422,2746,1.689970111701259
HuT 78,9926054,1.4431118641564118
NOMO-1,46199207,2.5514936314753434
NCI-H929,219104,1.172196270408648
Karpas-422,57519531,1.4841127416839142
HSC-3,10427712,5.181090366625566
ESS-1,409805,3.6702401515474135
ESS-1,1285940,5.086751580497306
RERF-LC-MS,36314,3.6884025033565897
KLE,68056272,3.842115579712106
BT 328,53393127,6.034881823049704
BT 248,3689413,-0.3734654016267222
AU565,36314,-7.774521242942876
MIA PaCa-2,3038522,2.485908488942159
KLE,5281321,-2.410398691037867
ChaGo-K-1,53232,4.008670122627816
Ri-1,11234052,2.0881087098511872
WM793,9840324,5.828227085394811
LXF 289,73707398,1.5723760999376108
Lu-65,2742550,4.528880941958593
LMSU,SNX-2112-bortezomib (250-1 mol-mol),-0.6329010440725568
CML-T1,44486219,3.9826752825954306
RKN,66577038,3.4891743358782104
BT 286,46398810,1.741988220933819
OAW28,984333,0.3792215902143511
EHEB,12003241,-2.0597430880681062
SNU-886,3465537,4.952996907212378
SNU-886,67291369,0.2726616209500875
AsPC-1,71680916,4.418583351869457
KLE,51039095,3.662417805217731
LXF 289,11364421,-2.6687395721676577
Ri-1,3062316,-4.680369659310852
Kasumi-2,44484893,-1.5195002495763423
ACC-MESO-1,selumetinib-tretinoin (2-1 mol-mol),5.795682849308936
Karpas-422,24901704,3.470448454583004
KMS-12-BM,ISOX-bortezomib (250-1 mol-mol),-0.4496875645415525
NCI-H929,docetaxel-tanespimycin (2-1 mol-mol),-5.802184770793407
NCI-H209,54639126,3.775629749799949
Ri-1,carboplatin-UNC0638 (2-1 mol-mol),3.0584033044093277
Ri-1,9884685,-4.0721071535449065
SF539,25150857,2.307908802702035
NCI-H209,53392493,2.3383319571831023
OAW28,11404337,-1.5682838378564492
BT 286,753704,4.971153206041931
HCC2108,159324,4.9915636231764005
AU565,46843906,2.01919943296107
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
PE/CA-PJ41 (clone D2),24180125,3.647059315463406
CML-T1,3815108,1.7472513397157303
Lu-65,5311,2.276911477754005
HOP-62,11612883,1.7191799143900155
RKO,54618164,4.0326978900214705
ChaGo-K-1,16722836,2.223487579942238
Panc 02.03,24180719,3.694319415808187
BT 286,216345,1.230005134011574
IST-Mes1,375860,0.4088289358172842
OAW28,9911830,2.567685352724645
OAW28,52912189,1.8010258653688298
SNU-119,3689413,-2.887862499697321
Karpas-422,9911830,2.3048839894494653
SNU-119,53232,1.8966224291818248
SNU-213,44507138,3.2200176081148224
HSC-3,25154868,3.1280580624042416
HuT 78,alisertib-navitoclax (2-1 mol-mol),-1.6997195751754324
HOP-62,4788,5.159973748153675
RKO,148198,-2.1467795088860875
KMRC-20,4259181,0.4653117276954742
H-STS,5278396,2.5022643900173707
Kasumi-2,57330099,4.668594265491518
AsPC-1,89928392,1.5669078555551634
HuT 78,24753719,4.53725590635391
Mono-Mac-1,20959075,-3.38453219938367
KMS-12-BM,49867926,3.4280203306526524
HSC-3,119607,5.3722262785741055
RERF-LC-MS,11427553,2.91041132641442
BT 320,676352,2.325208402765908
SNU-423,71304818,2.419735008623708
KLE,11234052,3.5359444822792896
Panc 02.03,25102847,3.3458680072040603
SNU-886,selumetinib-UNC0638 (4-1 mol-mol),2.5204736993113968
KMRC-20,24771867,3.994101826039686
SW1783,55283,4.5857048643674005
ESS-1,4788,5.85778957294441
KMS-12-BM,53495165,-2.246082698996139
HOP-62,44607530,1.7731789756813656
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
SNU-119,crizotinib-PLX-4032 (2-1 mol-mol),2.378023446596204
HSC-3,5282054,3.7905589736364647
NCI-H929,10231331,2.673485705852421
NCI-H929,9825149,-1.6436750133006153
HOP-62,45279963,3.745399813788082
HCC2108,219104,3.718593761594277
WM793,2749,2.5461703794044452
RKN,124202324,3.704376342602573
CML-T1,4259181,-0.9247208790621684
HOP-62,89928392,2.9587285225742477
SNU-213,11964036,0.9260625837749188
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
ChaGo-K-1,216345,3.946288356324136
ESS-1,11609586,3.461790355650639
Kasumi-2,46907787,-1.0712711351942366
RT-4,5460769,0.3645225539442671
KYSE-180,2874250,4.41639153643559
H-STS,36462,-1.1706487337003968
WM793,135984461,3.5730556754970175
OAW28,6610216,3.9661844518771185
OAW28,3503,2.6573145013500743
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671
LMSU,5311281,1.1859008880059876
CML-T1,1641662,2.8295390269831464
NCI-H929,tanespimycin-gemcitabine (1-1 mol-mol),-3.1675537812544516
NOMO-1,25262965,-2.043358942198166
LXF 289,15983966,-1.3187435990338214
SK-MEL-5,3384730,2.478323893384318
SF539,66577038,2.975973060606957
BT 498,322968,4.296939625448221
NCI-H209,JQ-1-navitoclax (2-1 mol-mol),0.3443784292512838
SK-UT-1,5291,3.873544658482056
Kasumi-2,60750,-5.618830215487252
SNU-213,44589607,3.464882112143256
Namalwa,25105715,3.6831853039250033
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
Kasumi-2,5746,-4.326746041624573
Ri-1,16722836,-0.0556472902275583
KLE,135440466,2.96482384763011
BT 286,67156097,2.119338660379996
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
HCC2108,10184653,1.422898929180728
RT-4,9935249,3.446453833049965
SW1783,54619267,3.631106969239044
RERF-LC-MS,11507802,1.168612691302407
NCI-H1339,24771867,3.8469201935046815
LMSU,alisertib-navitoclax (2-1 mol-mol),2.7596802469800026
ChaGo-K-1,piperlongumine-MST-312 (1-1 mol-mol),1.266782615898129
HOP-62,72193861,3.0602211877315364
Kasumi-2,4096211,1.078024917290252
BT 248,42642645,1.464081071598135
KMRC-20,9926054,2.16526453404653
EHEB,89183176,4.165917160627171
RKO,36462,3.4370564574699185
HuT 78,5746,-1.2054540829216351
ACC-MESO-1,24753719,6.460305862241897
H-STS,31703,-3.181617009980154
PE/CA-PJ41 (clone D2),5291,3.994121753282621
SNU-119,54454,1.8992360561821908
Becker,3854666,0.4017122764286526
SF539,2945648,2.8527116162154353
Namalwa,6918638,-1.4599496749108598
SF539,navitoclax-gemcitabine (1-1 mol-mol),-3.026639158537806
OAW28,53232,2.960609854482466
HOP-62,2708,4.639919882442816
IST-Mes1,9911830,1.5716425903239464
KYSE-180,crizotinib-PLX-4032 (2-1 mol-mol),2.1918539304937332
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
ESS-1,1242560,3.6553625997250143
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
PE/CA-PJ41 (clone D2),11647372,2.2083238406890473
BT 248,6918638,2.3802175448525844
Panc 02.03,216468,3.8655539989600176
OAW28,54596558,4.423614985335385
SNU-213,selumetinib-vorinostat (8-1 mol-mol),1.4256342092692729
AsPC-1,11238147,2.0906654911229796
NCI-H929,135440466,-1.839012232533784
Karpas-422,9935249,3.5194679685123695
LMSU,53232,0.1669358057766225
NCI-H929,11964036,-1.4756093749186814
BT 286,2871966,0.9709949836637652
SNU-423,72376,-0.5003659093552222
ACC-MESO-1,72376,-0.3966714785591665
OAW28,4477,1.0036814180565996
KMS-12-BM,24978538,-1.4319691213923784
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
BT 328,11485656,2.729036955069127
NOMO-1,5978,-2.430694050184869
RERF-LC-MS,4521392,4.229663793191115
Karpas-422,carboplatin-etoposide (40-17 mol-mol),1.0968345901116812
EHEB,navitoclax-piperlongumine (1-1 mol-mol),0.5125225467542266
AsPC-1,5351362,2.4874401689371033
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
NCI-H196,10184653,1.7255647355935626
AU565,54596558,3.073830584555768
MIA PaCa-2,44137675,3.4223653989045593
IST-Mes1,25227462,1.492895446731939
HCC2108,44607531,1.6757338761058749
MJ,107985,-2.8858164405295015
Lu-65,9927531,5.027796470849251
BT 320,2126,5.543243224179777
Ri-1,25183872,-2.275946767134655
SNU-886,11404337,1.5055907567781088
OAW28,702558,5.716785737298097
Lu-65,46191454,2.14257536499012
BT 286,44632017,1.4023340573889953
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
HOP-62,24978538,1.5301767800646526
NOMO-1,16038120,-0.1786929053902652
IST-Mes1,409805,5.880779442140838
KYSE-180,216345,4.057216202518236
AsPC-1,44185566,2.682305355629655
SNU-213,53232,4.908727917257865
Kasumi-2,168312962,2.3104598884340515
RERF-LC-MS,5278396,3.382202757419261
HEC-108,6918837,-1.8871962922774617
LXF 289,16725315,3.2486511295045677
RERF-LC-MS,445455,4.41080153827665
RT-4,selumetinib-JQ-1 (4-1 mol-mol),2.9367807248544233
Namalwa,11609586,-0.2919718897632319
BT 498,56946209,-2.201109347231142
AU565,72199292,-0.5217195589045935
BT 320,44486219,4.486546687955142
HEC-108,439501,-2.3418750446111347
NCI-H929,23725625,4.820953347318842
MIA PaCa-2,36314,-5.219745808616812
AsPC-1,285033,-0.5419823336362324
HuT 78,44462760,3.856546411209862
NCI-H2030,65064,5.8435941201320825
CML-T1,decitabine-carboplatin (1-1 mol-mol),-0.978509690631207
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
HuT 78,72376,-3.326794088490654
KMS-12-BM,44607531,1.4229825608705295
BT 328,1750826,2.2772741974811637
PE/CA-PJ41 (clone D2),2746,3.71543902732957
NCI-H1339,89928392,1.587053114541893
MIA PaCa-2,9840324,5.923337742177544
ESS-1,56946209,-5.121784419890302
SNU-213,44607531,1.4164757901683374
PF-382,5460769,-0.5383889446594711
KYSE-180,5746,1.1685724105246271
KMS-12-BM,16741245,2.1137703099951537
EHEB,613753,3.075305860436084
BFTC-909,2708,5.254338200716292
HEC-108,23725625,5.683398539557035
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
SF539,7251185,1.8205284874436192
BT 328,16725315,5.116957818378766
RKO,568763,0.6942409100068829
HuT 78,2746,0.9832751477780014
BFTC-909,11317348,4.568727931072339
CML-T1,decitabine-navitoclax (2-1 mol-mol),-1.9117963719087396
WM793,24964624,2.7889757819511996
BFTC-909,44202524,2.4582417316930916
NCI-H929,9927531,5.740923779315927
LMSU,2126,3.9441153876668
ACC-MESO-1,67291369,5.853456682413024
BT 320,60700,5.739551872199599
HCC2108,6505803,-0.7557590797286265
SW1783,5287620,-1.3610825750677231
H-STS,5281321,-2.5049759040326616
MIA PaCa-2,44632017,2.533907166670847
BT 248,3465537,1.7130202551321618
NCI-H929,25062766,1.424722824964366
PF-382,10026128,4.370506492826604
Mono-Mac-1,16741245,3.315980924789545
AsPC-1,9952709,5.897814669584309
HSC-3,3025944,4.431435908143169
NCI-H929,piperlongumine-MST-312 (1-1 mol-mol),3.099725979824717
SK-MEL-5,159324,3.0838844609903355
SW1783,25102847,3.1302980289461124
KYSE-450,16725315,5.267357391878718
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068
KLE,9915743,0.4681181116614699
Lu-65,9911830,1.689381922499865
BT 248,6184667,2.4270302543682307
Becker,89183176,4.612342413190254
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676
PF-382,6852167,1.6136489506938916
NCI-H2030,5746,1.2512356275194674
HCC2108,11612883,2.2731271711462573
PE/CA-PJ41 (clone D2),selumetinib-PLX-4032 (8-1 mol-mol),1.9711272671568492
ESS-1,2729026,3.152936804917953
ESS-1,2874250,4.555685369292356
LMSU,46926350,-4.277372765646079
OAW28,168313016,5.164256635335989
CML-T1,11609586,-0.1617986940719625
MIA PaCa-2,148198,-3.7289909178632383
MIA PaCa-2,25183872,-0.1921951242743396
SNU-423,25154868,5.138032001853866
AU565,5328940,1.3384832652905083
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
SNU-213,5746,2.024805354713622
BT 498,53392493,2.684342510752486
RKN,11178236,-3.061903912386503
MIA PaCa-2,11238147,1.7640354118108326
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613
HOP-62,65064,5.008164277666244
NCI-H929,5280436,3.412366721606299
SNU-886,31703,0.9003298590117994
Ri-1,71466445,1.3498732213426647
Namalwa,23582824,0.1050889456769123
SNU-119,5460769,2.8404840787101593
LXF 289,11234052,4.719623128458786
BFTC-909,123631,2.8792987518934403
SF539,ISOX-bortezomib (250-1 mol-mol),0.2487005267767388
ACC-MESO-1,6852167,4.128939666891623
SK-UT-1,44819697,-1.700169587058806
SF539,44137675,2.552438639753458
CML-T1,BRD-K03911514,3.1384749532861234
RKN,54619267,4.894700718514424
RKO,3038522,3.342495330103654
BT 498,5287969,-1.4350798060054029
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836
OAW28,216239,4.152270593115834
NCI-H929,119182,-0.7271204435080775
AU565,11656518,2.4577765871660353
Kasumi-2,107985,-4.524149027848321
OAW28,72376,-0.5739552302850919
ESS-1,10074640,3.3924948891566995
NCI-H1339,5281321,0.0024519736316222
ChaGo-K-1,6914657,-5.370737461229372
BT 248,53392493,1.7075191079379444
SNU-119,613753,3.5891543536371184
SNU-886,51039095,-2.8648807177568205
HOP-62,54618795,3.319315700053197
ChaGo-K-1,JQ-1-navitoclax (2-1 mol-mol),1.7850200550969848
NCI-H1339,5329102,3.0234364578964668
SK-UT-1,6505803,-1.8087484782267416
BT 286,637858,1.913556569209282
KMRC-20,2113511,6.253781367833113
HuT 78,11494412,0.3707002136667609
AU565,11612883,2.0019521527087982
HuT 78,60750,-3.915840643388668
PF-382,ISOX-bortezomib (250-1 mol-mol),-0.6876277836304979
OAW28,16720766,3.888951908869231
IST-Mes1,3062316,-4.79181247277669
NCI-H929,3825829,4.289333234926349
BT 286,969516,2.60301064067439
Panc 02.03,16038120,1.606654693103348
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834
SNU-119,6918289,2.523909001846346
ACC-MESO-1,3503,3.0585499361793915
SNU-886,UNC0638-navitoclax (1-1 mol-mol),-7.5974579555081725
OAW28,445455,5.326899909172617
HSC-3,46191454,1.6824478443738038
PF-382,638278,2.364690037141532
KLE,2858523,2.55520856351848
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367
SNU-213,3025986,-0.5037045377366649
BT 320,44566777,1.538730078733798
ChaGo-K-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2819364209592068
RERF-LC-MS,24797083,0.2985814331764478
CML-T1,44137675,3.6793288779986377
LMSU,11396600,3.695024866246392
BT 320,135411,3.5003751238841887
SW1783,5738263,4.365489196720114
HOP-62,44566777,-0.9345431833780878
CML-T1,3025944,4.207605674746215
Ri-1,16013152,3.7158961348364654
HCC2108,selumetinib-BRD-A02303741 (4-1 mol-mol),4.391486059277941
MJ,4578,3.855758936568702
SF539,107985,-2.833720447652478
OAW28,11396600,3.5740319462685535
KMS-12-BM,5328940,0.5023752913374658
SNU-423,46843906,3.685857483562859
Becker,doxorubicin-navitoclax (2-1 mol-mol),-0.0209389405027952
OAW28,11427553,3.602344276440211
Kasumi-2,11497983,-3.4342418883602406
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
Becker,11717001,6.335222819008729
KYSE-450,24964624,3.228483882418733
BT 328,57519531,5.35390801053985
SNU-213,51039095,3.053564627716872
KMS-12-BM,54618771,-0.8802136937205215
SW1783,36314,3.6045625119114506
BT 286,9444,5.020908896473072
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
CML-T1,1750826,-4.284831191139796
Becker,24964624,2.1875256687582256
AsPC-1,44607531,1.5574724897590664
SK-UT-1,10302451,4.065117068717504
WM793,selumetinib-tretinoin (2-1 mol-mol),2.5106551604776017
Mono-Mac-1,5566,3.0273684033793624
ESS-1,46199207,3.803521594847931
ChaGo-K-1,UNC0638-navitoclax (1-1 mol-mol),3.3725673517370662
Kasumi-2,7326481,4.035955767547482
H-STS,2746,2.861217997075228
Mono-Mac-1,36462,0.1065012305215149
SNU-886,374536,0.8487393236537821
RKO,4261,2.924548439505643
KMS-12-BM,55283,1.3656241179048696
PF-382,135423438,0.1628237790601052
CML-T1,12003241,-4.650247315633356
ACC-MESO-1,89928392,2.8278402664706803
H-STS,65064,3.392920845714817
Kasumi-2,568763,-0.985189730983464
Becker,11427553,3.222722363158399
BT 320,serdemetan-SCH-529074 (1-1 mol-mol),2.392228056514646
Namalwa,285033,-3.772881421892214
Karpas-422,25062766,1.6649379096464605
EHEB,67156097,-1.752576547113972
Ri-1,54619267,3.0614981170968507
HuT 78,11175137,-0.1403149097241058
BT 320,10184653,3.7290342309119686
LMSU,selumetinib-JQ-1 (4-1 mol-mol),3.5274573633732773
HuT 78,9887053,1.4751024014992844
AU565,5351362,0.5336942302969934
SNU-119,54649381,3.4431248050255636
KMS-12-BM,25102847,2.517658940945127
Ri-1,409805,4.02318209858409
Karpas-422,23582824,0.2486359902092493
KMS-12-BM,3854666,-0.1079800642722917
HuT 78,54649381,3.65840256094047
Karpas-422,46215462,1.4741959527668254
BT 320,25183872,-0.2453721787274933
SK-UT-1,5328940,1.756043494249043
OAW28,135421197,1.4901490212875883
RKO,387447,-4.452540898932811
RT-4,selumetinib-UNC0638 (4-1 mol-mol),3.4689576164003664
NCI-H2030,44259,1.1835601637938251
WM793,23582824,1.6229283221646535
KMS-12-BM,25154868,4.096426210892481
SF539,613000,2.586710034954353
OAW28,168313200,4.298133692275281
ESS-1,3081361,3.291100160208869
SF539,52912189,0.594338957036255
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
Namalwa,46191454,0.6470954103125317
NOMO-1,5351362,2.08054014163225
NCI-H1339,4096211,2.291996517068488
PE/CA-PJ41 (clone D2),24978538,3.2708324415161116
Ri-1,11964036,-3.160222236239868
AsPC-1,16659841,4.5181069426631
HSC-3,5287620,-2.9957645044589594
HEC-108,10302451,3.916028655528669
LXF 289,262093,3.4150141342974605
SK-UT-1,11364421,-4.077140333267383
NOMO-1,159324,1.6027654254866297
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
Panc 02.03,5328940,2.397017671249583
SNU-886,56946209,-2.6397102799841012
KYSE-180,9926054,1.7654325832877988
KMS-12-BM,67156097,-3.200598726498201
AsPC-1,6852167,3.622461858977091
ChaGo-K-1,2126,4.076708327869872
SNU-423,49793307,-2.496229045283288
NCI-H196,49850262,3.6752240843993937
Ri-1,71680916,3.540235110410058
H-STS,9911463,3.056276034663577
MJ,11656518,0.1125344640542434
BT 248,10410894,2.478264779428893
H-STS,selumetinib-MK-2206 (8-1 mol-mol),2.3802158766857935
HOP-62,7326481,2.9844448959210435
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636
SW1783,44489675,4.313226705523417
SW1783,9823820,5.69470825765173
PF-382,11507802,0.1200647165763234
SK-MEL-5,9840324,5.050338860461006
ACC-MESO-1,44507138,3.273543440527104
Karpas-422,136227924,2.027369566350396
Kasumi-2,322968,1.3079365029289678
Mono-Mac-1,11507802,1.0577941727742075
HEC-108,16722836,2.6260322097351447
BT 286,3689413,-0.1900658377643967
MIA PaCa-2,44491742,3.8709962970987464
KMS-12-BM,53232,3.5585540988187176
KMS-12-BM,5284373,1.9120963986235795
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
OAW28,9911463,4.007690751229585
Lu-65,navitoclax-pluripotin (1-1 mol-mol),0.4971122254843966
SK-MEL-5,5287620,-3.404659087231204
CML-T1,100016,5.302267949835527
SNU-213,49850262,3.7235778033832054
LXF 289,10385095,0.5776298837700374
RERF-LC-MS,6918837,-3.051376318733669
Lu-65,2945648,3.2114774914815554
BT 328,9935249,3.0923830009934843
SNU-213,vorinostat-navitoclax (4-1 mol-mol),1.9866746230538823
HuT 78,3465537,2.3062408835575923
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286
ChaGo-K-1,73707398,1.0973603524165894
HEC-108,44197249,3.927114018352238
KMRC-20,71304818,2.472376058947576
HuT 78,10296883,2.429678266579514
ChaGo-K-1,decitabine-navitoclax (2-1 mol-mol),3.968732833750204
KYSE-450,11175137,3.731022611434211
HCC2108,2828334,6.718139410602479
PF-382,52912189,-0.6597239458297713
CML-T1,6918328,-2.287128701752201
NCI-H929,71304818,2.3374127467417467
Kasumi-2,9866186,-1.4043484015282397
SK-UT-1,216468,3.1165109524206676
Karpas-422,1242560,3.007133880363242
Becker,4096211,1.303178754778439
LMSU,9907093,4.778478105374332
NCI-H1339,6852167,2.7157240163412206
BT 498,vorinostat-carboplatin (1-1 mol-mol),4.07022017256592
RT-4,5281672,5.093859609315912
LMSU,71751553,4.583903358050372
NCI-H196,9952709,3.608288450843416
SNU-423,10410894,4.683863656413666
KYSE-180,54619267,4.811647968153079
Mono-Mac-1,10296883,2.780550097818586
LMSU,16038120,1.0642114594696983
KLE,637858,1.7560393431403896
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
HuT 78,613753,2.0595917856735104
ChaGo-K-1,3038522,3.351925167852242
NCI-H196,15983966,-2.261561647250827
LXF 289,11977753,-2.1467130480879217
ChaGo-K-1,24180125,3.6677801491975006
ESS-1,navitoclax-piperlongumine (1-1 mol-mol),0.9788398984790389
SK-UT-1,446155,0.911002973182342
HuT 78,4521392,3.8389754666454254
SK-MEL-5,124202324,2.6727039143365148
RKN,9929138,7.419607622812729
KLE,navitoclax-birinapant (1-1 mol-mol),-3.2783800505738956
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196
OAW28,25154868,4.5321266568460805
LMSU,66577038,3.684475971972106
PF-382,54686904,2.766917504531429
BT 286,246676,1.6855048913308266
NCI-H1339,1641662,3.461186897446441
Lu-65,3038522,2.02089993104325
WM793,25062766,2.181773031529765
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
AU565,11719255,4.218610599596327
Karpas-422,44491742,3.8079113446891424
Kasumi-2,6450551,0.5816635943537883
Karpas-422,42642645,0.4716956796226118
NCI-H1339,carboplatin-UNC0638 (2-1 mol-mol),5.522805054348321
HCC2108,44489367,5.96526198558648
PF-382,216468,0.5105473489323931
BT 328,984333,0.810991187703125
SK-UT-1,2871966,0.4353806456595583
Lu-65,56946209,-5.150343216960287
RKO,20959075,-2.9107192765247536
HCC2108,66577038,3.559393194333952
MIA PaCa-2,11719255,3.34181844548168
RERF-LC-MS,5746,1.1068525081764873
RKO,9936388,0.8183869926163714
HSC-3,66577038,2.898702066993284
SK-UT-1,4261,3.439977939207012
KMRC-20,16115403,-5.152191129792824
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
Mono-Mac-1,3854666,0.6969728274023116
HSC-3,375860,-0.7997603409835673
PF-382,11178236,-3.5800251896914217
OAW28,44486219,3.976522680156617
SF539,168313200,1.6661816240555782
SF539,52947716,2.4386423311018284
RKO,15953870,3.3462063589818034
RT-4,56963564,2.308736271867476
CML-T1,51037431,4.458839280310569
OAW28,11214940,1.4072727029323666
AsPC-1,16722836,2.2980478994816425
RKN,135440466,3.1815161125023033
HOP-62,11404337,-1.0489074115392232
Mono-Mac-1,9444,2.9638254439415546
AsPC-1,15953870,5.362858272792295
ESS-1,676352,2.507808041358265
Mono-Mac-1,46943432,0.6845329233652461
AU565,25161177,3.67389505129512
RT-4,25150857,3.012978370734418
RT-4,89928392,1.3155194503405725
LXF 289,66577038,2.7615792990535937
CML-T1,4521392,4.044943461780163
Namalwa,11427553,1.1715511332950066
CML-T1,tretinoin-navitoclax (4-1 mol-mol),0.9331911225781374
KMRC-20,10127622,5.270569456722755
Mono-Mac-1,10113978,2.823328923190202
NOMO-1,984333,-1.7512214516120577
Karpas-422,49867930,6.07229360568805
EHEB,11234052,4.167418528594196
BT 248,11494412,3.557230805764516
EHEB,10074640,2.9654868346265024
LXF 289,3825829,3.6707575370566534
MIA PaCa-2,11656518,2.3369200972194566
Kasumi-2,89928392,-0.7212883806223124
Lu-65,2828334,6.02552770752455
AU565,56946209,-4.483098881483793
PE/CA-PJ41 (clone D2),23725625,6.914883641224904
HCC2108,selumetinib-vorinostat (8-1 mol-mol),2.476774013379894
BT 328,65064,5.830382460342701
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995
PF-382,2749,0.594868187564988
Kasumi-2,25183872,-1.7482434423211834
PE/CA-PJ41 (clone D2),409805,5.090011413594482
SNU-423,285033,-0.8949782324990676
ESS-1,123631,3.705774293108517
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868
Namalwa,56973724,1.9576150822856104
KYSE-450,16741245,5.34317896453295
MIA PaCa-2,67291369,2.035111955527258
Namalwa,44566777,-0.2625878239360741
BT 286,3038522,2.41353060244286
IST-Mes1,selumetinib-MK-2206 (8-1 mol-mol),3.5229121932796423
PF-382,135411,0.1083131735898056
KMRC-20,5311,1.9500827374985197
KYSE-450,7251185,3.3097037107461897
KYSE-180,638278,3.4681101119910243
PF-382,3136844,3.510785171533077
AU565,49793307,-1.974878634968376
Becker,6438330,3.285356333936618
Lu-65,24856436,-0.4374218733087953
BT 248,51037431,4.063284976838012
LMSU,2871966,3.076557585193087
LXF 289,5311281,0.8902308213691446
WM793,56649450,6.114929722972158
NCI-H1339,16725315,5.173954321185271
AsPC-1,9935249,3.639166614114404
CML-T1,15547703,2.6642294109203823
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
KMRC-20,124202324,3.9491419219303943
SNU-886,6918736,-1.3372974950718246
BT 248,46907787,3.027762940742573
SNU-886,3815108,2.9264370464975817
Karpas-422,54143018,1.1390909602039778
KMS-12-BM,448949,1.575561913547924
LXF 289,124202324,2.1762748500922657
KMS-12-BM,tretinoin-carboplatin (2-1 mol-mol),1.5291573634197104
RERF-LC-MS,4917,3.617944790726347
PE/CA-PJ41 (clone D2),126941,-0.78713258555783
Panc 02.03,107970,3.0394503344184214
Karpas-422,3543504,5.717794293894826
Panc 02.03,3854666,5.373190444337423
KYSE-180,carboplatin-etoposide (40-17 mol-mol),4.3219850025217434
SK-MEL-5,selumetinib-MK-2206 (8-1 mol-mol),1.6236684340065015
RT-4,44202524,1.5489412364823092
Namalwa,24180125,2.5255693450157697
AsPC-1,44462760,4.701078704400346
NCI-H196,72193861,2.0230633120282153
BT 328,10074640,3.6733046849863986
CML-T1,tretinoin-carboplatin (2-1 mol-mol),3.366911214203907
Ri-1,89183176,4.051914916929391
MJ,24797083,2.1256871707746976
NCI-H196,3634881,3.1207995201203285
SF539,navitoclax-sorafenib (1-1 mol-mol),1.515354296874044
SW1783,9927531,4.46381053918724
SK-MEL-5,9952709,2.563288864294084
WM793,168312962,3.5645743239810574
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
KMRC-20,54618164,4.251401203478906
ChaGo-K-1,753704,5.290331139863328
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
PF-382,9936388,-6.688930185968071
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402
BT 320,JQ-1-UNC0638 (2-1 mol-mol),3.976442415564575
NCI-H2030,54649381,4.795397326449117
IST-Mes1,10074640,3.5425729050518053
BT 286,446155,4.765644032421615
PF-382,136227924,2.0859082008018084
EHEB,702558,6.933646693723644
BT 286,11609586,2.876134676085447
MIA PaCa-2,5335621,4.5851883371080655
BT 328,selumetinib-PLX-4032 (8-1 mol-mol),4.625572383999939
RKN,656346,1.677354805367284
BT 328,3062316,3.412447048158849
KYSE-180,navitoclax-pluripotin (1-1 mol-mol),-0.399119188986255
PF-382,11396600,2.839145334831077
SNU-423,5278396,4.2566078482147205
NOMO-1,100016,4.546215242968586
HCC2108,crizotinib-PLX-4032 (2-1 mol-mol),1.5096161008299982
PF-382,2841722,3.918402091561414
Namalwa,11175137,2.736911908909365
ESS-1,2746,2.6118901158900423
OAW28,4261,1.5275003221448853
AU565,445455,4.9301368045011955
ESS-1,54618305,4.255754792589274
SF539,60700,-3.506506897271602
SNU-423,2729026,3.1858852581930197
SNU-119,89928392,1.8847686882331605
PE/CA-PJ41 (clone D2),445643,4.252936471702768
BT 498,10074640,3.4496274756730503
HEC-108,11640390,4.025636872827305
HOP-62,57519531,2.2403791786945377
SNU-423,219104,4.0496831719135775
OAW28,46398810,2.3633613380182386
HOP-62,24856436,2.288141937054854
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
OAW28,56946209,-4.450705744661636
ChaGo-K-1,2749,2.1238985145265215
AsPC-1,3062316,2.757974416117501
SF539,11717001,4.3610839531094525
Ri-1,16736978,-0.7212393996550502
Becker,439501,-2.817437349005285
SNU-886,46215462,1.5878302383488252
WM793,89928392,1.2506486576555742
LXF 289,89183176,5.264029999533809
NOMO-1,4477,1.0767445259598296
Ri-1,44607530,0.5403801994067887
RERF-LC-MS,11404337,1.609147033115388
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757
SNU-119,9887053,3.651062425326841
PE/CA-PJ41 (clone D2),119607,6.048359521662391
H-STS,54639701,4.360992090113951
Mono-Mac-1,637858,0.9949100169924338
KYSE-180,5351362,1.0664205921449423
SF539,44607531,1.4805513890450512
ACC-MESO-1,400769,-0.2870983394084955
HSC-3,613753,3.3276317630899337
HSC-3,72376,-2.5245503337218596
NCI-H2030,24772860,-1.256504466195007
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
BT 248,44819697,-0.5101915766327456
HuT 78,44137675,1.3553085189057965
KMS-12-BM,6184667,2.2804186491767857
EHEB,2749,0.1808975316830207
BT 248,67156097,4.587573075901519
BT 498,6918638,3.833356013639187
HOP-62,44489675,3.779587884252509
BT 286,12001922,0.9308288717182952
KMRC-20,46907787,3.5898907650473855
SF539,crizotinib-PLX-4032 (2-1 mol-mol),1.8440004340376177
Namalwa,2746,1.3872498592399898
NCI-H2030,135421197,3.075513669205883
PF-382,44543605,4.965650989009794
KMRC-20,44185566,2.4119459095392215
MJ,25102847,2.2666887172970367
OAW28,9956119,4.544482925716663
Kasumi-2,6918837,-5.725087899258232
Namalwa,46843906,1.285132441004268
KYSE-180,44202524,1.4429628152133265
AsPC-1,322968,4.827920048367381
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
OAW28,9911830,2.567685352724645
EHEB,24772860,-2.594982066939884
NCI-H1339,11626560,2.340137119918929
LXF 289,11178236,-2.9660816129263297
KMRC-20,vorinostat-navitoclax (4-1 mol-mol),1.5374427074415018
SF539,10385095,0.5044778211988786
RKN,44607531,3.612700906890815
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
WM793,44185566,2.5245605998161404
MJ,24772860,-2.9241484283006565
MIA PaCa-2,12003241,-0.7993036743010778
ESS-1,2858523,3.2684495269565703
PF-382,44259,0.4010800943421826
Becker,9866186,0.2753414496739798
HuT 78,448949,0.4485717539901531
HuT 78,52947716,2.981697525257689
ChaGo-K-1,135411,1.2465105696898682
BT 248,322968,2.9090533378149535
RT-4,6918328,0.8848146288984396
HOP-62,11427553,2.766588497834141
MJ,4917,2.3365129077988005
HEC-108,5351362,1.2308965787917867
Mono-Mac-1,4378219,0.2241292373980127
SK-UT-1,2749,1.8360529754995716
HSC-3,11427553,3.124864958342948
NCI-H196,6623618,3.122660560916228
H-STS,decitabine-carboplatin (1-1 mol-mol),5.177792515700317
SF539,2742550,3.134990737020823
IST-Mes1,46215462,2.5624084058363676
SNU-886,135398516,0.5445365742758462
ChaGo-K-1,45279963,2.8128871096969954
Kasumi-2,selumetinib-MK-2206 (8-1 mol-mol),1.1378728727000402
ESS-1,3634881,3.263518505021081
Kasumi-2,753704,4.42700120937948
Lu-65,16725315,5.265309122236909
AsPC-1,5287620,-2.2438477065180233
Karpas-422,168313200,3.637067495296451
AsPC-1,135421197,1.8824248695595285
BFTC-909,9956119,4.255413767268681
AU565,6184667,2.5363760520525247
EHEB,SNX-2112-bortezomib (250-1 mol-mol),-2.4396809580796908
NCI-H1339,71466445,4.88090882012996
PF-382,11625818,1.6689494002323595
KMS-12-BM,25150857,1.6071345823937382
ChaGo-K-1,11222830,1.3421917137510389
HSC-3,702558,5.870270989424734
ChaGo-K-1,11625818,4.687307934112527
HEC-108,17755052,3.4677210523800936
KLE,19582717,2.474003523492041
OAW28,5351362,2.5555782345102407
Lu-65,selumetinib-decitabine (4-1 mol-mol),1.2509124043421416
AsPC-1,136227924,3.2025742465891938
HuT 78,969516,2.200953925383129
SNU-119,11485656,2.5966291939022192
KYSE-180,46907787,3.816228061036196
SK-UT-1,11485656,2.414217391257394
BT 328,72193861,3.7422212299852946
AsPC-1,24772860,0.3605797719579043
IST-Mes1,54618771,0.8929247318821524
NCI-H196,24856436,-0.1495861740182834
IST-Mes1,3854666,2.0681561223579075
LMSU,9956119,4.695933157448729
AsPC-1,11396600,3.3240147605355506
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
Becker,42642645,-0.0222198712525443
HEC-108,54618771,2.78064765565191
HSC-3,24180125,3.0095192248544897
Ri-1,16720766,-3.633025161617667
SF539,7326481,2.919170434383445
RERF-LC-MS,11494412,1.0302757077826894
SNU-119,42642645,1.209873965485747
HOP-62,25183872,-0.4191267821474728
Namalwa,100016,3.934978584241161
BT 286,docetaxel-tanespimycin (2-1 mol-mol),-5.397859739208257
Becker,piperlongumine-MST-312 (1-1 mol-mol),1.772213641328724
SNU-423,136227924,3.242018782370702
KMS-12-BM,11396600,1.1666466615999174
SNU-423,5978,-2.486643599039795
WM793,44607531,2.1972673735163326
RERF-LC-MS,3634881,4.923247717838372
PE/CA-PJ41 (clone D2),5311,2.3549285264953284
BFTC-909,12001922,1.803559970478093
KMS-12-BM,1641662,2.032988332793844
SK-MEL-5,54143018,1.420602942100165
OAW28,1750826,-3.338956149870334
SK-UT-1,1242560,4.227021541575825
Karpas-422,24797083,1.0070769014114518
ChaGo-K-1,51037431,4.793639315792485
ChaGo-K-1,25161177,4.340700387322654
LXF 289,54649381,3.6309892426510406
Mono-Mac-1,6918736,-2.4376027103946662
ESS-1,9933475,2.1540018278931448
SNU-119,24771867,2.6075976586492624
SNU-886,10385095,1.1038149480439057
RKN,11238147,3.9265768628415487
SF539,119182,0.3961519921597609
PE/CA-PJ41 (clone D2),44486219,4.283609923317521
NCI-H2030,selumetinib-UNC0638 (4-1 mol-mol),7.069935114019918
PE/CA-PJ41 (clone D2),1566236,3.025698807379891
SF539,11707110,0.172094147016845
SNU-119,9935249,3.2348685245924726
NCI-H1339,54618771,2.498525802737919
BFTC-909,44589607,3.3115887945185496
Kasumi-2,25150857,1.3589874253765015
Namalwa,135875424,3.1964963879327355
NCI-H2030,5278396,3.8604955487006096
SF539,11507802,0.8173734074149668
HCC2108,11960529,3.759811240772432
BT 286,5282054,3.919367194238553
AsPC-1,54613361,2.957295670472447
HCC2108,10113978,2.890872158375319
ESS-1,51039095,3.5660815776575228
BT 248,71304818,1.6499217451033
CML-T1,135411,-2.1332231058037796
Namalwa,44607530,1.4976967359197746
SK-MEL-5,327653,4.002327934975705
BT 286,23635314,-1.7525741606507157
OAW28,25102847,1.9718431113444057
Kasumi-2,9956119,1.4541571674658873
SW1783,46398810,3.5693364639360747
BT 498,11494412,3.6640895055137017
LMSU,decitabine-navitoclax (2-1 mol-mol),4.230073302056037
AsPC-1,42611257,3.6284330949745094
SNU-423,54619267,4.1428626977074074
Namalwa,navitoclax-MST-312 (1-1 mol-mol),0.9145161531931786
SNU-213,11175137,2.461932867567342
BT 320,11396600,4.5560356349666
NCI-H209,56973724,3.023144714958246
MIA PaCa-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9197297717475186
KMS-12-BM,676352,1.9185611453511533
NCI-H1339,135411,0.7339446872015564
KYSE-180,68056272,3.810471876524393
KMRC-20,alisertib-navitoclax (2-1 mol-mol),1.9342461303816385
KLE,54618771,1.0287660425791825
KMS-12-BM,5113032,5.435585194289586
NOMO-1,24821094,3.1222382635594967
SNU-119,5470400,-2.350709459089954
ChaGo-K-1,446155,4.065867494589203
AU565,54765302,2.5229399839825604
SW1783,5335621,4.352005875752797
CML-T1,JQ-1-MK-0752 (1-1 mol-mol),0.6034690158877323
EHEB,73707398,0.3528380726382398
Namalwa,2949965,2.6372066790906903
RERF-LC-MS,5281321,-2.2570738048063257
HSC-3,ISOX-bortezomib (250-1 mol-mol),1.6231606918452472
LMSU,54618164,5.037763382519864
CML-T1,serdemetan-SCH-529074 (1-1 mol-mol),0.193373711840136
KMS-12-BM,11647372,-0.2688616751164015
HEC-108,46907787,5.113191551513952
HuT 78,53232,2.0901683388522385
RKN,327653,3.2518035953304434
Ri-1,285033,-2.9347943900721645
Karpas-422,262093,3.033308575813637
LMSU,4477,0.3546299550753337
NCI-H1339,72376,-1.8174283195884284
EHEB,119182,-1.3653952638717988
NCI-H196,navitoclax-pluripotin (1-1 mol-mol),-1.16175177819381
NOMO-1,24797083,1.0415171353084307
PF-382,6610216,3.7963864090602737
Lu-65,16741245,3.621639989162078
RKO,126941,-5.081226966265268
PF-382,327653,2.393380485895892
Lu-65,54619267,3.894734254993299
SNU-886,24901704,3.3518234737220265
HCC2108,docetaxel-tanespimycin (2-1 mol-mol),-0.9383807284852752
OAW28,6918878,3.220005605820797
HOP-62,9933475,1.560150054597467
SNU-119,24964624,2.885020861025008
AU565,11625818,3.8205404098717457
KMS-12-BM,10074640,2.4619415387123365
MIA PaCa-2,24180125,2.6361206455792066
LXF 289,5278396,2.6487510770020104
Lu-65,10296883,3.98979643435714
IST-Mes1,12001922,2.6228240364869113
Kasumi-2,104842,-5.6475576104946565
AU565,46199207,2.977397460043432
ACC-MESO-1,984333,1.021847289904778
BT 498,2871966,3.3818803701608804
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
PE/CA-PJ41 (clone D2),448949,2.558263610741337
SNU-423,6918837,-3.1518084379325075
RERF-LC-MS,637858,3.156110522031532
MIA PaCa-2,3385,4.980756808965862
OAW28,24180719,4.377592888188756
KMS-12-BM,24785538,-2.2279414711107943
OAW28,3854666,2.969576020962734
KYSE-180,4917,2.992329233033062
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955
AsPC-1,148198,-3.729188282050714
RT-4,1641662,3.4681958034174647
SNU-119,navitoclax-birinapant (1-1 mol-mol),1.664402595144999
LMSU,3689413,-0.2257013593388283
IST-Mes1,135999136,4.360333625305844
AsPC-1,216345,4.477392842458871
Lu-65,16720766,0.6350447621100811
Panc 02.03,216345,4.682043945218969
NCI-H1339,11612883,2.8336309454873674
H-STS,439501,-3.713409181758543
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
RERF-LC-MS,10231331,0.9954911948227504
Lu-65,126941,-4.746785925644256
Lu-65,11238147,3.117637715446455
NCI-H1339,6918328,1.022201685863086
Kasumi-2,5311037,4.15499666746129
Kasumi-2,56963564,-0.3250682085247875
RT-4,11427553,3.5858806335596483
CML-T1,44489367,4.494553632990814
LXF 289,24856436,0.8419130403195528
LMSU,42642645,1.4355208101232508
SNU-886,81146,5.0685074142197175
NCI-H1339,10074640,3.6833793292295582
ESS-1,100016,6.502595194480242
BT 286,JQ-1-UNC0638 (2-1 mol-mol),2.9164898287399432
BT 286,5494449,1.808530334685148
KMRC-20,4261,2.986732904038728
Namalwa,71304818,2.0125087813378824
HuT 78,navitoclax-PLX-4032 (1-1 mol-mol),0.749332467745858
HOP-62,5329102,1.983120425869131
RERF-LC-MS,71680916,4.2559060280924665
HEC-108,5281321,-0.2460018354270553
PE/CA-PJ41 (clone D2),tanespimycin-gemcitabine (1-1 mol-mol),0.0543714562940706
BT 286,44507138,4.569933407994329
LXF 289,56963564,0.2991276479966406
SF539,60750,-3.745453789943656
OAW28,46191454,1.726492969979986
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
KYSE-450,11485656,2.990129749938368
SK-MEL-5,72734382,4.773475794539037
ESS-1,9936388,3.356877818481439
ESS-1,11707110,4.9124560181161385
BT 248,168312962,0.3799536225395565
Mono-Mac-1,selumetinib-vorinostat (8-1 mol-mol),2.0513617036591323
KYSE-450,54618771,1.2705031609145587
BT 286,702558,3.161046018103092
BT 320,11152667,2.8584362453350427
RT-4,docetaxel-tanespimycin (2-1 mol-mol),-2.3839682334999823
Mono-Mac-1,25183872,-0.3782943347176429
BT 286,25150857,1.7551248829672594
KYSE-180,6610355,3.592606427588536
PE/CA-PJ41 (clone D2),navitoclax-sorafenib (1-1 mol-mol),3.206224908291627
HCC2108,3025986,-0.2941479125016869
HOP-62,441298,1.1234788887045837
RKO,452548,0.942587279069954
WM793,637858,1.8553013176450457
KYSE-180,53232,2.4967121988382983
BT 286,52947716,0.976045704659649
Lu-65,107970,1.8814184481987688
KYSE-180,124202324,3.3270800786084154
SW1783,tanespimycin-gemcitabine (1-1 mol-mol),1.8572225726753877
SK-UT-1,piperlongumine-MST-312 (1-1 mol-mol),2.2334203788003277
Lu-65,119607,4.501939294338365
SNU-423,4788,5.865866484331293
Lu-65,salermide-PLX-4032 (12-1 mol-mol),5.2610627077792635
HOP-62,5702613,3.604813520455167
H-STS,10113978,4.065703828677869
LXF 289,44607530,1.309750089611443
ACC-MESO-1,56946209,-1.916659581654868
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
OAW28,227681,3.168890693964491
RERF-LC-MS,11175137,3.6286013190581503
CML-T1,10410894,3.3337757256136245
ACC-MESO-1,3854666,3.6033422587717854
SNU-119,44489127,4.960346134562833
BT 498,53495165,2.4848345966210443
SK-UT-1,11612883,4.583054819879112
KMRC-20,5566,3.02131820134641
Panc 02.03,24785538,2.724480470289088
OAW28,71680916,5.167013104004298
BT 320,25102847,3.622666729654605
RERF-LC-MS,168313200,3.896073258981905
HCC2108,selumetinib-UNC0638 (4-1 mol-mol),4.394993613237598
NCI-H2030,136227924,3.923759704530775
SNU-119,25126798,4.429154191215383
AsPC-1,5746,2.3674241916356755
HCC2108,6918878,2.040858445754197
PF-382,6918837,-4.619504053552648
EHEB,241158,3.817598938948392
Becker,6914657,-3.22649296417791
HCC2108,216345,4.433678918617411
NCI-H1339,3385,5.726279931607606
PF-382,241158,3.333523301157689
SK-MEL-5,16013152,4.084760192264916
WM793,5329102,2.675345821939075
SK-UT-1,10127622,5.957744497618317
HSC-3,11626560,1.838283596867806
Namalwa,42611257,2.9717502787591883
KMRC-20,3503,3.139785484201302
BT 286,168312962,3.8822415532561863
KMS-12-BM,JQ-1-MK-0752 (1-1 mol-mol),-2.744831923995191
NCI-H1339,4259181,-0.3541173382827977
WM793,409805,4.444302991596743
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
Namalwa,5281321,-2.3909967724743755
WM793,135398516,2.614188359863261
OAW28,16722836,1.5279923407751788
MJ,25227462,-4.25671431982025
SNU-886,49846579,-0.4717946703025019
BT 320,107970,2.3152930812829497
SNU-886,4477,-0.049698052487978
Becker,17755052,1.6990126124044371
ESS-1,136227924,3.049003867547222
BT 286,11228183,2.2609540883188712
EHEB,44137675,1.9983784239702664
Becker,241158,3.23499622526182
ESS-1,selumetinib-vorinostat (8-1 mol-mol),3.369239403980627
Ri-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.018523415252616
HCC2108,51039095,3.0641076776382055
ACC-MESO-1,11455910,1.4227308564953651
CML-T1,4917,2.5218741140394476
SK-MEL-5,11427553,3.5667407987526607
Karpas-422,4261,0.072362955193048
HOP-62,BRD-A02303741-carboplatin (1-1 mol-mol),5.56274182787722
BT 248,262093,2.0571072545208926
SK-MEL-5,11178236,-2.684555956133374
PF-382,24180125,1.6002910588088834
LMSU,9903786,3.928631993031556
RT-4,24821094,3.143156783053102
SF539,1566236,1.697367188486211
BT 286,5738263,3.830646188768121
SF539,3854666,0.2673517991428248
BT 498,71729975,3.1089495974635835
WM793,11396600,4.503186389543736
HuT 78,3854666,0.8787104419208177
ACC-MESO-1,613753,4.536767429887022
RT-4,ISOX-bortezomib (250-1 mol-mol),1.1242037732608314
RKN,6918736,-2.1202784612128416
HOP-62,3634881,4.27388992864853
RKN,9956119,4.4432647969313
KLE,6184667,2.425235268333095
AsPC-1,5328940,1.7821313082315045
KYSE-180,navitoclax-MST-312 (1-1 mol-mol),1.0295834159957882
H-STS,vorinostat-carboplatin (1-1 mol-mol),1.9243801953461248
MIA PaCa-2,89183176,4.530070181887671
HOP-62,5978,3.979985245309929
BT 320,4378219,1.7610425663146678
KYSE-180,doxorubicin-navitoclax (2-1 mol-mol),0.1491747369052168
NCI-H1339,66577038,3.2327996972148347
CML-T1,9935249,2.5956918222650507
Mono-Mac-1,selumetinib-decitabine (4-1 mol-mol),3.5994209939270885
RT-4,387447,-3.0484703414890744
AsPC-1,446155,5.1652347554602995
NOMO-1,6450551,1.2307950565416117
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
CML-T1,107970,1.8137988275945616
Panc 02.03,7251185,3.0530850004567767
KYSE-180,3062316,1.1998242220985431
PF-382,20959075,-3.2590708818446306
SF539,444795,3.755252396278318
SNU-119,3062316,-1.081380158367377
BT 248,135875424,2.546043839111523
HuT 78,15983966,-6.777458587771195
H-STS,3081361,2.065492281733806
H-STS,tretinoin-navitoclax (4-1 mol-mol),4.079592330676085
Lu-65,46199207,2.9869217661237233
SF539,19582717,5.548936804809817
SW1783,doxorubicin-navitoclax (2-1 mol-mol),0.2822920316533508
RKO,73707398,0.9128481241529548
Namalwa,erlotinib-PLX-4032 (2-1 mol-mol),2.1227167490373
SNU-886,11167602,1.491891520160987
ESS-1,374536,5.146738438727042
IST-Mes1,3552672,2.081532957284865
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
KYSE-180,104842,-0.8703497694822725
NOMO-1,451668,-1.632426084818391
EHEB,JQ-1-UNC0638 (2-1 mol-mol),1.0981019184979366
AsPC-1,54618164,4.187549957668634
SNU-213,9840324,5.94367014011524
Mono-Mac-1,444795,3.2832788866841573
WM793,72193861,2.0745792283120084
Karpas-422,11719255,3.5310729907349305
EHEB,5566,2.7898733391986994
NCI-H1339,9884685,1.174532924558328
SNU-119,36462,1.6001107706429532
WM793,71680916,6.03913470036381
BT 498,644241,2.2010744744476742
ACC-MESO-1,676352,2.9772350584924148
KMRC-20,selumetinib-vorinostat (8-1 mol-mol),2.4254013680145663
KMS-12-BM,285033,-4.098643381088682
NCI-H1339,10385095,0.8150638105924319
Panc 02.03,42642645,1.4849485241267697
SK-UT-1,9926054,1.807396230777958
BFTC-909,1716436,3.115342072857748
PE/CA-PJ41 (clone D2),SNX-2112-bortezomib (250-1 mol-mol),-0.1200657947269847
Namalwa,11485656,1.3808834074055636
ChaGo-K-1,44566777,1.853342184320177
SK-UT-1,25227462,1.0186750982564137
Ri-1,44589607,0.9824671459990256
Namalwa,1242560,3.173059576229197
Ri-1,54613361,-0.945053953894062
BT 248,71576739,6.051378362255083
BT 328,25154868,6.16063190444204
Lu-65,135999136,6.05207061737822
PF-382,4096211,0.5237091038371171
NCI-H1339,8515,4.704049354821168
AsPC-1,66577038,3.0978373542257973
KMS-12-BM,16725315,3.09098323700468
Karpas-422,11427553,1.391441421390955
OAW28,10074640,2.8656652346665545
LXF 289,44241473,4.688676931788039
HCC2108,selumetinib-JQ-1 (4-1 mol-mol),3.0515246299931205
BFTC-909,5978,-2.385180460490498
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552
KMS-12-BM,24772860,-3.763334552284853
PF-382,11427553,0.9124764521092824
CML-T1,selumetinib-navitoclax (8-1 mol-mol),1.8946920670328231
ChaGo-K-1,11719255,2.388380161244114
MIA PaCa-2,salermide-PLX-4032 (12-1 mol-mol),5.361033693011522
NCI-H1339,216345,4.473442061179046
AsPC-1,448949,1.7535133746232512
SK-UT-1,6918328,1.9440877838795103
NCI-H196,6918289,3.1633997526775706
MIA PaCa-2,327653,3.0320730676471572
HEC-108,44489367,4.45975641268053
BT 286,3062316,3.138959885805486
Lu-65,71304818,1.8437698958476676
SNU-886,49766530,-1.8017914460493445
ESS-1,ISOX-bortezomib (250-1 mol-mol),0.2324495051743559
NCI-H929,11222830,0.7259966040230217
HuT 78,ISOX-bortezomib (250-1 mol-mol),-1.0650160762676202
KMRC-20,322968,4.283184334248703
BT 248,52947716,0.6891318567706715
NCI-H1339,23725625,5.053497821139807
Kasumi-2,10184653,1.2356790109659648
Lu-65,136227924,3.620246561182502
RERF-LC-MS,15983966,-4.090154567310139
AU565,24753719,4.632017214490639
IST-Mes1,9911463,4.127098730346426
SNU-119,decitabine-navitoclax (2-1 mol-mol),1.261288354016859
Lu-65,53495165,0.9943425194888544
KLE,tretinoin-navitoclax (4-1 mol-mol),0.0197424431924765
MIA PaCa-2,23635314,-3.2931554939430203
NCI-H929,50905018,3.952577942902894
BT 248,44491742,4.160095989296475
Ri-1,100016,4.838113149785687
Mono-Mac-1,11404337,-0.2219879905670924
KYSE-180,23635314,-1.91549509503103
KYSE-180,452548,0.8760289796861696
BT 286,327653,3.383263992676688
H-STS,4917,3.714262795675703
IST-Mes1,71751553,5.350652566949457
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831
ESS-1,54678924,1.5705216909139783
KMRC-20,51039095,3.0958869754937424
LMSU,23582824,1.2634743444733094
WM793,54613361,2.2041091886662736
KMS-12-BM,44486219,2.8899607356045443
RT-4,16720766,0.1240040302001555
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333
HEC-108,15953870,3.7106591750651736
BT 286,25062766,2.7885971140564365
PE/CA-PJ41 (clone D2),644241,2.3238637219547904
Namalwa,25183872,-2.048735574706111
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713
HEC-108,12001922,1.836445664605824
AsPC-1,176870,5.289710540069244
Kasumi-2,JQ-1-navitoclax (2-1 mol-mol),-2.2721346445712896
HuT 78,24964624,-2.2262621005839813
KLE,135411,0.8012767106548482
SNU-119,6438330,1.1490589890035967
OAW28,4259181,0.9119817479539226
LXF 289,100016,7.121965810949268
KLE,5311,0.8745221025044583
Mono-Mac-1,49867926,4.920962083206566
LMSU,25062766,1.5653135657494996
Ri-1,25126798,3.435804880824684
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
AsPC-1,44566777,0.4941234322675649
RERF-LC-MS,9908783,5.63449812951243
LMSU,16736978,1.7346374327663163
RERF-LC-MS,66577038,3.051572744120707
Ri-1,23582824,-4.965583795046114
SNU-423,5329102,1.8220903603969243
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
AU565,12003241,-0.6235660341918571
PF-382,tanespimycin-gemcitabine (1-1 mol-mol),-4.545409531146979
MIA PaCa-2,65064,5.109896885791301
BT 286,56649450,2.979701469874902
CML-T1,9840324,5.6593047828259495
NCI-H196,10385095,1.1966476706382554
SNU-886,24889392,3.4092549144778976
WM793,46843906,2.7108569638472666
SF539,36314,-4.467415246608935
LXF 289,9935249,3.315625346230847
ESS-1,753704,4.74318722205844
OAW28,11427553,3.602344276440211
SNU-213,5329102,2.6196578140344364
ESS-1,11214940,1.1922635318190942
ChaGo-K-1,24951314,1.3256791863947055
H-STS,44486219,3.861225962485261
SK-UT-1,3854666,2.1786369520498283
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
SF539,9936388,-8.641778658087059
SNU-886,51037431,2.211047490267374
SNU-119,168312962,2.91418669260086
OAW28,107985,-3.5497769626209217
BFTC-909,136227924,2.3418993883842134
KYSE-450,10302451,4.575458638647607
AsPC-1,9933475,2.7319135281095908
Becker,54618164,4.063586417108196
HuT 78,44185566,0.8459615226549172
LMSU,72193861,3.006947657487573
ChaGo-K-1,82146,3.945876441052169
H-STS,tretinoin-carboplatin (2-1 mol-mol),3.744726554678935
OAW28,613753,3.2856198284724742
OAW28,107985,-3.5497769626209217
Mono-Mac-1,409805,3.1107516004642406
HOP-62,421610,3.669034139736905
Lu-65,51039095,3.031508710595903
BT 286,9903786,1.725049982792706
Mono-Mac-1,11222830,0.4197694115665174
Karpas-422,52912189,-0.586182118148126
RKN,1750826,-6.055252220387113
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
LMSU,12001922,2.4559246423075707
AU565,9936388,-7.122590364363415
BT 320,24951314,2.328206990278251
SK-UT-1,216239,1.4894515561019788
MIA PaCa-2,56963564,0.5535442136787346
RKO,44819697,-0.2126149769206573
KMRC-20,15983966,1.928995908058428
BT 286,65628,3.2626686935167544
PE/CA-PJ41 (clone D2),252682,6.970257263547699
AU565,5291,4.2478378741719105
BT 328,6450551,3.790902491385394
KMRC-20,vorinostat-carboplatin (1-1 mol-mol),3.852034524239012
NCI-H196,119607,5.902084524849619
Mono-Mac-1,11234052,4.576402418208917
BT 498,6914657,-3.1017002535917717
AU565,81146,6.247262332137589
RKN,10074640,3.313081701902331
CML-T1,439501,-2.361432010025089
CML-T1,25183872,-2.27655686726873
CML-T1,68056272,2.531220488236934
AsPC-1,135440466,2.1679547773967314
PF-382,54649381,2.3884242532831768
SK-UT-1,5335621,5.433304981154406
HuT 78,selumetinib-piperlongumine (8-1 mol-mol),-3.245208706353043
SK-MEL-5,5282054,3.769587213204863
SNU-119,25105715,3.2927005530338933
NCI-H209,9884685,0.4313294242687383
Lu-65,selumetinib-UNC0638 (4-1 mol-mol),0.61966716985046
OAW28,46174525,4.143540766033049
BFTC-909,60700,0.4554202898414442
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
SNU-886,375860,-0.100716733121392
SNU-213,6918837,-1.773615773856713
SNU-119,12003241,-0.7435067493629696
MIA PaCa-2,9936388,-9.05612896602556
ESS-1,16720766,-0.0466822400972705
SNU-213,219104,4.630858879868153
MJ,decitabine-navitoclax (2-1 mol-mol),-0.3739812334084919
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
BT 248,82146,3.895792146901818
EHEB,9936388,-5.642934540589324
Ri-1,44491742,3.935960320926185
PF-382,71466445,1.9189761436188
Lu-65,15983966,-0.8514170816781186
RKN,107970,2.600341318615175
RKN,5278396,4.050807510430523
AsPC-1,17755052,1.5687054045124371
Mono-Mac-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2613516674403331
EHEB,6918837,-4.415870025794879
SF539,72193861,-0.071360284593044
SNU-423,9933475,1.8756797921904032
SK-UT-1,navitoclax-gemcitabine (1-1 mol-mol),-2.364824391850715
ESS-1,44589607,2.6194620218883116
AU565,2729026,2.5804084357046033
BT 286,5566,2.4505971297549927
RT-4,10302451,0.2321939311866163
KLE,3062316,2.3443438252501183
SNU-119,10427712,3.870149394322131
ESS-1,54596558,5.727088950348892
ChaGo-K-1,24785538,1.276067902472923
SF539,16725315,3.19850826981026
KLE,5566,3.110078979332344
PF-382,6918328,-1.623099323121265
HSC-3,148198,-2.120282407341815
PE/CA-PJ41 (clone D2),2729026,3.125352392959333
BT 320,3062316,3.917549487062472
BT 328,219104,4.206978092049304
PF-382,656346,-0.3937515411626462
Namalwa,107970,1.960491610604563
HCC2108,9967941,3.249509678327182
HCC2108,navitoclax-sorafenib (1-1 mol-mol),3.578397373026766
ChaGo-K-1,6917907,-5.942627725321459
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
EHEB,387447,-4.8695156526166175
MIA PaCa-2,227681,1.9846741973787292
CML-T1,5281321,-0.1268784610637486
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
ChaGo-K-1,2858523,2.9669113899986135
Kasumi-2,46398810,1.7112254413455064
SNU-423,11152667,0.7300251820386706
SNU-886,6505803,-0.0303295506780238
OAW28,25150857,2.5691026408672957
BT 320,11175137,3.303235141929386
SK-MEL-5,409805,5.871261975473595
RERF-LC-MS,56963564,0.3267097404636779
NCI-H209,11214940,0.3157566488603621
AsPC-1,9933475,2.7319135281095908
NCI-H929,448949,0.7498835801993375
RKO,135421197,1.472175761257966
KMS-12-BM,2733487,6.235161466652842
Ri-1,156414,0.7366105303424468
HEC-108,387447,-5.079207916782074
SNU-213,selumetinib-JQ-1 (4-1 mol-mol),1.0193842284675143
Karpas-422,46398810,1.673723968461422
Ri-1,19582717,3.0629165045655764
SF539,3465537,2.1777468091875125
Becker,49793307,0.1745324597336718
BT 498,2949965,3.1308462818813467
NCI-H1339,decitabine-navitoclax (2-1 mol-mol),5.5290643616840285
IST-Mes1,46398810,2.0674819997592406
HOP-62,23725625,5.46334509708726
SNU-119,24775005,4.181410107840803
RKN,5281321,-0.4803497212669658
BT 286,selumetinib-JQ-1 (4-1 mol-mol),-1.4917661989890287
Becker,54613361,-0.3252327078859965
ESS-1,322968,2.8286903155082137
HSC-3,12003241,-1.4285198417789524
EHEB,4259181,-0.3918316132670805
KYSE-450,44566777,1.0165509502605254
OAW28,5280436,5.165372214799318
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
Kasumi-2,148124,-6.270957848916609
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
NOMO-1,135440466,1.6123042261647436
PE/CA-PJ41 (clone D2),65628,4.385016080496858
HSC-3,piperlongumine-MST-312 (1-1 mol-mol),1.829264345451848
SW1783,selumetinib-piperlongumine (8-1 mol-mol),3.7422302368862104
SNU-119,446155,1.4772127449904695
NCI-H1339,60700,-1.071708126122017
Karpas-422,676352,1.784030767129966
BT 286,11640390,1.6291068565211342
HuT 78,7326481,3.898377103940941
KLE,11960529,3.6757240900091808
AsPC-1,984333,1.2969820633088274
KYSE-450,vorinostat-carboplatin (1-1 mol-mol),4.263576896954741
ChaGo-K-1,57519531,5.108001820042393
PF-382,89183176,-2.8788143153394476
BT 286,107985,-3.490112295441736
WM793,654092,0.4910491362613845
CML-T1,selumetinib-PLX-4032 (8-1 mol-mol),3.463736211464864
Karpas-422,5287969,-2.2383567156782385
Panc 02.03,25195348,3.9334722209588735
IST-Mes1,9915743,1.0557522455188102
CML-T1,46907787,-0.5465083296094366
CML-T1,24180125,2.207667320892802
SF539,3385,1.3053252400719229
WM793,387447,-3.0647343941704603
NOMO-1,24772860,-3.4546209155075687
AsPC-1,104842,0.0602967281328717
Lu-65,16013152,4.337400643693818
SNU-886,44589607,2.7373909096390743
KYSE-180,6184667,4.098294905261503
Mono-Mac-1,123631,1.906319126298777
IST-Mes1,selumetinib-decitabine (4-1 mol-mol),6.500937496154089
H-STS,285033,-3.6704179985350183
CML-T1,tanespimycin-gemcitabine (1-1 mol-mol),-3.893519256585349
ESS-1,46907787,0.8695499024183594
NCI-H196,10427712,5.32328303658605
LMSU,1750826,-1.6926974789891744
Mono-Mac-1,3552672,0.1467124788792889
BT 248,119607,5.038088774684491
OAW28,10302451,2.68651474445359
WM793,16065773,2.8314108092374
Becker,71751553,4.672382658610356
PE/CA-PJ41 (clone D2),11497983,4.526154771713417
HOP-62,11640390,4.182571164758542
NCI-H1339,11977753,-0.4583860757329758
SF539,11257553,0.3367320269985683
LXF 289,44137675,2.0502885463252665
Kasumi-2,navitoclax-PLX-4032 (1-1 mol-mol),-2.139769926295153
NCI-H196,navitoclax-MST-312 (1-1 mol-mol),1.3127280488868007
NCI-H2030,54618771,3.292263250244386
SNU-213,448949,4.454578697012804
Ri-1,15983966,-5.526352456110755
Ri-1,decitabine-carboplatin (1-1 mol-mol),0.1199514595226231
Panc 02.03,11609586,3.3931905350155915
Lu-65,5329102,2.383340911906642
ChaGo-K-1,11612883,3.1360501741625484
AsPC-1,1716436,2.9196038383716205
BT 328,216345,4.606684867794206
PF-382,156414,0.6060441396240198
LMSU,122327,5.769053061722797
NCI-H1339,15953870,3.9739600190387128
NCI-H929,9884685,-3.111418876103824
NCI-H929,11396600,-1.497885086375298
Karpas-422,vorinostat-navitoclax (4-1 mol-mol),0.5946112460810862
CML-T1,44819697,-2.8753334506591504
KLE,navitoclax-MST-312 (1-1 mol-mol),-1.4508493438218537
HCC2108,9936388,-4.897775231329417
SNU-886,1716436,2.5748440651933766
Namalwa,JQ-1-carboplatin (1-1 mol-mol),-0.7629380597950661
CML-T1,carboplatin-UNC0638 (2-1 mol-mol),2.1290435317203023
SK-MEL-5,46907787,3.947667418966643
Lu-65,1641662,3.4141993296588953
NCI-H196,5282054,3.9384077821930186
ESS-1,alisertib-navitoclax (2-1 mol-mol),-0.432728207962684
Namalwa,49766530,-1.8902019897608628
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
BT 320,16038120,1.884341751706396
ESS-1,6610216,4.607428871946369
NCI-H196,2733526,3.542986663855977
KLE,9907093,4.3310456736816185
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163
HSC-3,vorinostat-carboplatin (1-1 mol-mol),2.340341905839153
NCI-H1339,11427553,3.3170617363487342
OAW28,5281321,-1.4060991234994806
BT 498,6917907,3.9423727482890456
NCI-H929,5460769,1.81013287796662
ESS-1,10302451,3.294150768882909
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
Mono-Mac-1,doxorubicin-navitoclax (2-1 mol-mol),-2.387887810132074
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
IST-Mes1,5287620,-1.7840398419727848
SNU-213,5351362,2.981146821236434
HuT 78,439501,-3.2848313932186315
KLE,54686904,4.3325881562773185
NOMO-1,216468,1.212023833941809
Karpas-422,11178236,-5.8379981642330625
CML-T1,5746,-2.1549173035879803
LXF 289,135398744,6.087135496005038
ChaGo-K-1,navitoclax-birinapant (1-1 mol-mol),3.1686613266141013
KYSE-180,1242560,4.399331542534589
Ri-1,49850262,2.1062573336402357
HOP-62,11977753,-1.565204360127456
NCI-H1339,24964624,2.730311593553537
IST-Mes1,71304818,2.7451890534908427
KMRC-20,52912189,4.952328418850898
NCI-H196,969516,3.973912934217039
LXF 289,11964036,0.5627528071719251
KYSE-450,387447,-4.1038253742642725
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
WM793,2858523,3.206623504237894
IST-Mes1,6918878,2.524010054300984
BFTC-909,44185566,2.75887016136311
ESS-1,9866186,0.1543463253926908
Lu-65,387447,-3.75008165482626
MIA PaCa-2,6918328,-0.7045799700299202
CML-T1,2733526,2.616681149896765
SNU-886,5311,1.5331540985514145
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
PF-382,25126798,3.7444046465079888
SW1783,10074640,3.756288001729743
SNU-119,12001922,1.855369676663499
CML-T1,6918289,0.3823031541189219
EHEB,16736978,1.931050460573665
SNU-423,3634881,3.418662921647716
H-STS,25150857,2.2324697691811277
SK-UT-1,25154868,1.7438224060222909
AsPC-1,24901704,4.152315193440913
SNU-423,49766530,-2.309056121887604
EHEB,676352,2.3007932773454844
Mono-Mac-1,3038522,2.1652868385768933
MJ,10302451,4.214297869660198
BT 286,navitoclax-sorafenib (1-1 mol-mol),1.1049126484346263
Panc 02.03,3081361,3.1546648300373357
Karpas-422,UNC0638-navitoclax (1-1 mol-mol),0.995215523956661
SF539,15547703,3.038141832537276
HuT 78,12003241,-1.0527217193191982
Karpas-422,445643,4.1594524904300085
RT-4,439501,-1.136247834932354
Panc 02.03,BRD-K55473186,4.513191364064351
RKO,168313200,3.1169425006108455
Namalwa,15983966,-7.946057700179597
NOMO-1,4788,5.067002306940809
NCI-H1339,168313200,4.075069570376525
Namalwa,selumetinib-JQ-1 (4-1 mol-mol),0.0869925670736783
NCI-H2030,46398810,3.0729474851813023
Kasumi-2,11719255,0.7919357371697194
WM793,9825149,2.4189460978958266
AU565,262093,2.3992948308197093
SF539,135440466,1.1383079175014172
Karpas-422,17755052,-0.3521481937168509
MIA PaCa-2,10127622,3.0415633804655187
SW1783,675434,4.251921967331538
NCI-H196,3038522,4.30216886044297
Lu-65,9907093,4.5002962124125245
WM793,60750,-4.670115905093864
Namalwa,17755052,0.9119644675745306
Namalwa,4917,3.4280609586493376
Karpas-422,65628,4.69981691134154
ESS-1,24785538,2.1020731787092943
ACC-MESO-1,100016,6.4652465436588775
Karpas-422,1750826,0.2604258540554078
KMRC-20,12001922,1.7493187520827975
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
PE/CA-PJ41 (clone D2),2858523,3.268562133786411
OAW28,5460769,4.044755256654475
Lu-65,11964036,2.1963927399033376
SK-UT-1,44202524,2.9453109499095853
SNU-213,17759555,3.674310368381118
LXF 289,5113032,5.558232749512156
BT 248,216345,4.501699374414374
PF-382,135440466,1.8528493259308645
Karpas-422,6852167,0.067435343224215
NCI-H1339,11717001,4.589198179129786
AU565,5738263,3.0246848768630334
HuT 78,44607531,1.3859547211867245
Karpas-422,5282054,2.439551684268985
PF-382,168313047,1.8210212384762663
HSC-3,54613361,0.1816905747423905
Ri-1,44493528,4.227657049972306
BT 286,25227462,1.03002877262914
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
RKO,24779724,5.847036108864024
LMSU,6184667,3.2634858273175764
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999
SF539,5329102,1.5729222878136029
CML-T1,doxorubicin-navitoclax (2-1 mol-mol),-4.289526889070848
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
SK-MEL-5,1566236,2.4643263629353576
NCI-H929,carboplatin-UNC0638 (2-1 mol-mol),2.500876393607731
AsPC-1,135398516,2.7517064972229415
Mono-Mac-1,9887053,1.5534992217620511
MIA PaCa-2,241158,2.0398577340537587
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
RT-4,753704,6.379934835187104
Becker,44566777,-0.649720439158945
BT 498,25105715,3.8825206027116734
RKO,23635314,-2.140231911981244
BT 248,3384730,2.3830241448741987
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
LMSU,24951314,3.1918307701084276
PF-382,51039095,2.24186796125132
PF-382,9903786,1.7632578420268197
SK-UT-1,445643,4.614923035667888
AsPC-1,19582717,4.191920632274723
NCI-H196,navitoclax-birinapant (1-1 mol-mol),-1.0230250736340882
SK-MEL-5,6610216,3.979150432082891
HCC2108,11507802,2.2568660355978607
HEC-108,23635314,-2.542270451290658
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
AU565,135398516,2.596290086865212
ChaGo-K-1,selumetinib-JQ-1 (4-1 mol-mol),2.371471699435725
ChaGo-K-1,3025986,-1.4135171905436132
PE/CA-PJ41 (clone D2),15953870,4.204773718329985
OAW28,51037431,5.214608262969992
NCI-H209,alisertib-navitoclax (2-1 mol-mol),-1.2257273779937763
HEC-108,56963564,0.296809560260297
BFTC-909,4378219,4.497242068417329
RKO,19582717,4.345992572306107
SNU-423,tanespimycin-gemcitabine (1-1 mol-mol),-0.2099310969798299
NCI-H196,25105715,3.7516207923037586
HOP-62,docetaxel-tanespimycin (2-1 mol-mol),4.606611900152602
RT-4,9911830,1.893497559140728
Karpas-422,9933475,1.5593704380503386
WM793,3689413,0.565505634508756
Kasumi-2,15547703,3.1022786704275394
HCC2108,89183176,4.824317563947827
SNU-886,53392493,1.7509874369346907
Ri-1,151289,-0.1682876676947949
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
AsPC-1,24772860,0.3605797719579043
SNU-213,JQ-1-vorinostat (2-1 mol-mol),1.219028136943463
KMS-12-BM,54626689,3.649325161583167
NCI-H196,46398810,3.0723351173953386
SNU-423,23635314,-3.228765986553877
Panc 02.03,65064,5.367712415574159
PE/CA-PJ41 (clone D2),4917,3.8249790735030023
BT 328,53392493,3.725538863996033
NCI-H196,9926054,2.525003076989932
AU565,4578,4.456552707084199
NCI-H1339,24821094,3.97018187385564
LXF 289,9825149,1.6285560242869113
NCI-H929,selumetinib-tretinoin (2-1 mol-mol),3.262087806301954
ACC-MESO-1,5328940,1.919032168884594
OAW28,3025944,4.579278298637093
AsPC-1,2742550,5.133078791264603
ESS-1,25105715,3.705428666019564
ESS-1,135984461,4.427051677708814
RKO,54143018,-0.3751060369564643
KMRC-20,ISOX-bortezomib (250-1 mol-mol),1.611645137466779
SNU-213,637858,2.227184287849749
NCI-H929,5470400,-1.7946579824155076
NCI-H929,5278396,3.025125883131511
BFTC-909,73707398,1.325657316242966
MIA PaCa-2,10113978,3.4218122120666945
BT 286,5284373,3.081382449720317
RKO,11152667,-2.010180339323448
KMRC-20,5281321,0.8825507605959158
SK-UT-1,448949,1.7923015437003926
Panc 02.03,135440466,3.0724615257354153
BT 320,11640390,5.348028911341183
H-STS,11152667,-1.2361022970372575
CML-T1,262093,1.3151134240668207
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
BT 498,1714884,3.499299815864629
RKO,53232,4.485666667988006
LXF 289,3081361,2.235375481166719
ESS-1,selumetinib-MK-2206 (8-1 mol-mol),3.588494409489328
Panc 02.03,23725625,6.172373492037936
RERF-LC-MS,24180719,3.6010609924552455
KYSE-450,9915743,1.0249516523129705
Ri-1,119182,-3.3874396370579096
NOMO-1,10410894,2.884775843935945
SK-MEL-5,52947716,-6.537803077416063
Ri-1,6917907,-8.102917987031867
SK-UT-1,53232,1.9955922885483088
Ri-1,3503,1.1678473170955408
BT 248,135411,2.4646623802818577
CML-T1,26596,-2.14043660837674
Karpas-422,1716436,3.743993231733117
Kasumi-2,5470400,-0.4099593110944021
KMS-12-BM,60700,-3.455544016540571
IST-Mes1,11213558,3.9887472477266215
PE/CA-PJ41 (clone D2),54618164,4.303600867099711
BT 498,15983966,3.4496360554797256
HSC-3,135999136,4.352393936185964
BT 248,9952709,2.726522372177628
Karpas-422,11214940,1.589328143840321
LMSU,67156097,1.321844393975608
BT 328,9936388,2.1535847087745386
SNU-213,107985,-3.586157663071436
MIA PaCa-2,46398810,1.965688525236374
HOP-62,15983966,0.519021924007884
AsPC-1,46199207,3.695579616421397
RERF-LC-MS,9903786,2.6182355767545213
Ri-1,2746,1.8815592761229076
SNU-213,124202324,3.2763512137021173
Ri-1,11612883,1.214475027954666
NCI-H196,11222830,1.4902122717783377
SNU-213,9967941,3.2264836336541767
RKN,16720766,0.5941206863048918
KLE,446155,0.8514088628776029
WM793,148198,-1.495249919530428
Mono-Mac-1,46843906,0.8948290671337527
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
SNU-423,9907093,5.098934107063476
EHEB,24180125,1.8891722665908557
HOP-62,5282054,4.1860195429662435
Karpas-422,135875424,4.0020075582939
PE/CA-PJ41 (clone D2),46398810,3.7550130580304697
KMS-12-BM,44491742,3.489197811217823
ChaGo-K-1,6505803,0.7391022920837463
Mono-Mac-1,2746,1.2768381662660928
AsPC-1,76446078,5.483716778202627
HCC2108,100016,5.291323338255078
KMS-12-BM,44819697,-0.1317079524994108
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
LXF 289,44202524,1.498501439362416
BT 248,54618795,3.2071840181570477
HOP-62,3025944,4.708754552283396
BFTC-909,2130404,3.366307483642889
RERF-LC-MS,6918328,0.3946668064090056
Lu-65,72376,-1.8562106984479432
PE/CA-PJ41 (clone D2),navitoclax-pluripotin (1-1 mol-mol),-0.5987061323431718
ESS-1,219104,3.183003735039725
SW1783,46843906,3.6277750541017304
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
RERF-LC-MS,100016,6.56071523320666
Namalwa,25102847,2.0079159113458416
SK-UT-1,5566,3.086414513691759
SNU-213,148198,-1.214073512813324
KMRC-20,9911463,4.198821616328526
Lu-65,11485656,2.4652445580433713
IST-Mes1,vorinostat-carboplatin (1-1 mol-mol),3.785712345618982
HuT 78,9911830,2.253743254641726
Karpas-422,66577038,2.9957151824734503
CML-T1,24951314,-0.110872768404616
KYSE-450,54143018,5.589609383601229
KMS-12-BM,82146,2.660947076146562
ChaGo-K-1,54618771,2.4705381408155183
SK-UT-1,25062766,3.896240815707035
PF-382,46199207,2.6598109327538286
SNU-119,82146,3.4402803249569964
Namalwa,400769,-1.6280294138695752
RKO,107985,-4.24085601271806
NCI-H1339,327653,3.7168174136495735
AU565,9911463,3.1332064122278687
BFTC-909,25183872,0.7872065650622051
SNU-423,16659841,3.4666021367210043
HOP-62,135999136,4.132685432378933
HOP-62,56649450,4.64353502741552
HCC2108,1750826,-2.504101992023161
MIA PaCa-2,49793307,-3.74631189087296
SK-MEL-5,11222830,1.7200317816996988
NCI-H1339,15547703,4.319443685848728
NCI-H196,49766530,0.4460348160421952
SNU-119,16038120,0.2287829434664864
NCI-H929,44491742,4.424394304638718
Becker,4259181,1.0240306217869668
CML-T1,53232,4.305570613336498
Becker,66577038,3.69605042943235
HOP-62,25126798,4.500227959004911
Becker,5278396,3.3842823728851896
RKO,2113511,4.623772297498578
KYSE-180,2708,6.074726642360877
KMS-12-BM,107985,-5.423573263916533
NCI-H1339,23635314,-3.53807234526192
HOP-62,262093,4.19078744138027
Mono-Mac-1,241158,3.016187818443372
HCC2108,2945648,3.0780429998691723
Panc 02.03,25183872,-0.079390979301081
OAW28,11485656,3.2643123414600645
Mono-Mac-1,15547703,2.720539634744388
HEC-108,656346,1.215673304181218
RERF-LC-MS,46926350,-4.177207395055215
RKN,24785538,4.869460471506453
Mono-Mac-1,72967,4.124255908419064
KYSE-180,6852167,3.0076808179282213
BT 328,676352,2.591297575109724
SNU-423,409805,5.272007162134597
RKO,56649450,4.8662264096692684
KYSE-450,6450551,3.3363850258393124
AsPC-1,969516,2.9281765712067447
WM793,vorinostat-carboplatin (1-1 mol-mol),3.963017303085571
HCC2108,11364421,-0.8828017389399302
LXF 289,25150857,2.4132050810476
HSC-3,168312962,-2.4846947846374388
HEC-108,168312962,-2.000701767765318
SK-UT-1,46398810,3.3711222617391456
HCC2108,54454,1.8049440069965668
NCI-H929,1716436,3.574402272281363
PE/CA-PJ41 (clone D2),44185566,3.1395351078001443
H-STS,23635314,-4.332307696037408
KLE,119607,4.152483536976257
PE/CA-PJ41 (clone D2),71304818,3.216974363463292
RT-4,36462,2.6630323769700013
Lu-65,25105715,3.7592032368034207
ESS-1,3062316,-1.8450260242136765
NOMO-1,9936388,-6.523282887173488
SNU-423,10074640,3.5708164577593453
Panc 02.03,5351362,2.6810485074832
RKO,5278396,3.510721289362286
WM793,navitoclax-gemcitabine (1-1 mol-mol),-2.7261707189545783
SNU-886,selumetinib-MK-2206 (8-1 mol-mol),1.439939334739481
NCI-H929,36314,1.7139372343272217
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
KLE,241158,1.9293702793301108
Becker,12001922,2.507016459914465
ChaGo-K-1,969516,2.4869278268653163
KYSE-450,12001922,2.3081029542586027
EHEB,46398810,1.962348153679006
Kasumi-2,crizotinib-PLX-4032 (2-1 mol-mol),1.093787578488076
Ri-1,5287620,-1.9161748527305928
NCI-H196,46199207,3.4877738394964175
ACC-MESO-1,4259181,0.8154176587876882
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
OAW28,44819697,-1.5562690526140308
ESS-1,10322450,4.730793151305824
ACC-MESO-1,BRD-K27188169-navitoclax (2-1 mol-mol),3.904500927832786
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
HSC-3,327653,3.9955925666561263
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
HSC-3,676352,1.9440177898110005
BT 320,72193861,4.258668508473769
NCI-H1339,5278396,3.869150001588174
CML-T1,15983966,-4.817800919639036
PE/CA-PJ41 (clone D2),46191454,4.0230795719044705
PF-382,71466380,3.7425525322216746
NOMO-1,16741245,4.369418152152245
PE/CA-PJ41 (clone D2),5284373,4.689780873278642
SF539,9884685,-0.5281104713803977
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272
KYSE-180,9444,4.788423248663199
Mono-Mac-1,1641662,3.313449330193925
HOP-62,3081361,2.3557787666723087
Karpas-422,72376,-3.24630837699648
CML-T1,24753719,1.910679313408318
KMS-12-BM,56973724,1.1510862619514248
NCI-H929,9935249,2.217272904882535
LMSU,135398744,6.91211293627059
HuT 78,2733526,3.230584673721713
SNU-213,151289,2.6508507215309556
BT 286,5978,-2.527076531897684
SNU-213,16736978,1.6823342314211165
RT-4,9903786,1.1299984693284726
SW1783,216239,3.3394693883957616
RKN,1716436,3.648262431092988
RKO,44607530,2.6096687798301677
HuT 78,7251185,-0.7654974545197635
RKO,3825829,4.017808531984142
PF-382,44819697,-3.258888383810068
Namalwa,637858,0.9589719241333216
HSC-3,49766530,-2.4571890524447553
PF-382,54618305,4.182237982253296
AU565,5470400,-3.0594075513818995
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
KMS-12-BM,selumetinib-MK-2206 (8-1 mol-mol),1.5718969310043658
AU565,54626689,4.66017141288812
HSC-3,119182,-1.5654598491843
ChaGo-K-1,168313200,1.878692270372672
CML-T1,24180719,2.7823494948279373
SF539,16038120,0.889897204295874
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
NCI-H2030,16720766,0.9971193506864836
Namalwa,24775005,3.855969637926427
KLE,25062766,1.4887652323177143
PF-382,11656518,1.6205835275243787
BFTC-909,4259181,-0.0277162117211437
RKO,24772860,-3.046302255649564
ESS-1,10296883,4.371449070908232
KYSE-180,31703,-0.5178877164646636
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
BT 248,9935249,2.246614582121965
NCI-H196,1716436,5.019622183878195
LXF 289,44489675,4.904101073680104
HEC-108,11228183,1.0147252747004392
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
ESS-1,60700,-2.9575309810678414
Panc 02.03,89183176,4.957506748320777
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
WM793,51039095,3.547305313608344
Karpas-422,119182,-3.501110473344757
Namalwa,11234052,2.9664552534255155
Kasumi-2,1714884,3.668347649937234
Ri-1,72199292,-0.2882406263972568
AsPC-1,24785538,0.8298650260870277
SNU-119,208908,1.7146109385017043
Ri-1,10302451,1.5393417915178893
HCC2108,216468,5.043012995009322
PE/CA-PJ41 (clone D2),16659841,4.668346825790493
NCI-H1339,9956119,4.080996534733852
IST-Mes1,107970,2.9610434925705773
HOP-62,4917,2.990342105399023
AU565,151289,0.4389765151464501
H-STS,25195348,4.556158906706763
ChaGo-K-1,3081361,3.4773165896947384
SF539,3503,1.023946445304806
Kasumi-2,19582717,2.3340571924025326
Namalwa,10127622,5.61027703477677
Namalwa,246676,4.721429897591315
SNU-213,5281321,2.4238033705571143
Lu-65,1716436,3.8267089675065376
RERF-LC-MS,2858523,3.0171071482923826
SNU-213,107970,2.2765725167688045
SK-MEL-5,selumetinib-JQ-1 (4-1 mol-mol),2.584301952935506
AU565,9935249,2.085801217703038
HSC-3,2749,1.7452067990842526
BT 328,24821094,3.7290564258342904
RKN,16065773,2.958619348149216
Kasumi-2,11396600,2.2579616248243495
Lu-65,5738263,3.5766641086315465
BT 328,73707438,3.7767552618386087
LMSU,262093,3.167641110749879
BFTC-909,1641662,3.805506520632872
CML-T1,52912189,1.3905308136477008
LMSU,3854666,2.6863801842781863
PE/CA-PJ41 (clone D2),3136844,4.269989384929203
RT-4,46199207,3.146589071997412
Lu-65,24951314,2.358893147950346
OAW28,462382,0.1410996491293406
ESS-1,selumetinib-decitabine (4-1 mol-mol),5.708912466990789
RKO,637858,2.400395947377078
Karpas-422,24856436,0.2614680146489348
Kasumi-2,54618771,-0.6876381814105375
KLE,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7158414512435143
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
HCC2108,3025944,4.0723705952966975
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
NCI-H1339,7251185,3.0289389350094047
AsPC-1,11404337,0.3809720735493328
SNU-119,10127622,3.9443492007002146
KYSE-450,10296883,4.225795837642371
LXF 289,24951314,1.0119406639366386
Mono-Mac-1,2113511,3.959955844054084
AsPC-1,445091,6.474898015897582
Namalwa,54618771,0.6847017954935718
HOP-62,135398516,2.003594389042817
ChaGo-K-1,3062316,2.2658461036316213
MIA PaCa-2,2733526,4.136774974442715
MIA PaCa-2,9933475,1.5811525433625937
MIA PaCa-2,46926350,-5.336909626139248
BT 286,10427712,4.414930862618797
PF-382,637858,0.850873658302796
BFTC-909,72376,-1.4314875177558029
MIA PaCa-2,54618771,1.4864580952045414
AsPC-1,56946209,-4.100794030874608
Ri-1,216345,2.96853089827557
KYSE-450,1750826,-1.5410905710283038
HCC2108,3543504,4.151618491560986
SNU-423,11167602,4.222331627049854
KLE,159324,3.6720597167388
BT 320,322968,4.418694945814317
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
RERF-LC-MS,56946209,-3.4945734927118552
SW1783,5460769,4.078393209152703
AsPC-1,2871966,-0.1237405253519755
Panc 02.03,126941,-0.7071805078882285
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
RKN,73707386,3.296207724675486
SNU-886,6918289,1.884590673180862
RKN,10302451,3.971829298943927
LXF 289,16720766,0.4842655504206017
Ri-1,24964624,-1.9438756183580252
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
H-STS,11364421,-4.998126775681505
RKO,42642645,1.3055497818976145
Kasumi-2,44489675,3.5763019986617106
Ri-1,42642645,-0.2308158770997515
NCI-H929,9936388,-5.492803140929198
ESS-1,6252,2.853454302970564
Lu-65,carboplatin-UNC0638 (2-1 mol-mol),3.766616901554207
PF-382,168312962,-0.0454286282986012
SK-UT-1,16722836,2.949695748270546
